sampleID	_INTEGRATION	_PATIENT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_treatment_completion_success_outcome	adjuvant_rad_therapy_prior_admin	age_at_initial_pathologic_diagnosis	age_began_smoking_in_years	agent_total_dose_count	assessment_timepoint_category	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	birth_control_pill_history_usage_category	brachytherapy_administered_status	brachytherapy_first_reference_point_administered_total_dose	brachytherapy_method_other_specify_text	brachytherapy_method_type	cervical_carcinoma_corpus_uteri_involvement_indicator	cervical_carcinoma_pelvic_extension_text	cervical_neoplasm_pathologic_margin_involved_text	cervical_neoplasm_pathologic_margin_involved_type	chemotherapy_negation_radiation_therapy_concurrent_adminstrd_txt	chemotherapy_negation_radiation_therapy_concurrnt_nt_dmnstrd_rsn	chemotherapy_regimen_type	clinical_stage	concurrent_chemotherapy_dose	days_to_birth	days_to_brachytherapy_begin_occurrence	days_to_brachytherapy_end_occurrence	days_to_chemotherapy_end	days_to_chemotherapy_start	days_to_collection	days_to_death	days_to_diagnostic_computed_tomography_performed	days_to_diagnostic_mri_performed	days_to_fdg_or_ct_pet_performed	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	days_to_performance_status_assessment	days_to_radiation_therapy_end	days_to_radiation_therapy_start	death_cause_text	diagnostic_ct_result_outcome	diagnostic_mri_result_outcome	dose_frequency_text	eastern_cancer_oncology_group	ectopic_pregnancy_count	external_beam_radiation_therapy_administered_status	external_beam_radiation_therapy_administrd_prrtc_rgn_lymph_nd_ds	fdg_or_ct_pet_performed_outcome	female_breast_feeding_or_pregnancy_status_indicator	followup_case_report_form_submission_reason	form_completion_date	gender	height	histological_type	history_of_neoadjuvant_treatment	human_papillomavirus_laboratory_procedure_performed_name	human_papillomavirus_laboratory_procedure_performed_text	human_papillomavirus_other_type_text	human_papillomavirus_type	hysterectomy_performed_text	hysterectomy_performed_type	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	keratinizing_squamous_cell_carcinoma_present_indicator	lost_follow_up	lymph_node_examined_count	lymph_node_location_positive_pathology_name	lymph_node_location_positive_pathology_text	lymphovascular_invasion_indicator	menopause_status	neoplasm_histologic_grade	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_post_initial_therapy_diagnosis_method_text	new_neoplasm_event_post_initial_therapy_diagnosis_method_type	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	number_of_successful_pregnancies_which_resultd_n_t_lst_1_lv_brth	number_pack_years_smoked	oct_embedded	oligonucleotide_primer_pair_laboratory_procedure_performed_name	other_chemotherapy_agent_administration_specify	other_dx	pathologic_M	pathologic_N	pathologic_T	pathology_report_file_name	patient_death_reason	patient_history_immune_system_and_related_disorders_name	patient_history_immune_system_and_related_disorders_text	patient_id	patient_pregnancy_spontaneous_abortion_count	patient_pregnancy_therapeutic_abortion_count	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	pregnancy_stillbirth_count	primary_lymph_node_presentation_assessment	primary_therapy_outcome_success	radiation_therapy	radiation_therapy_not_administered_reason	radiation_therapy_not_administered_specify	radiation_type_notes	residual_disease_post_new_tumor_event_margin_status	rt_administered_type	rt_pelvis_administered_total_dose	sample_type	sample_type_id	standardized_uptake_value_cervix_uteri_assessment_measurement	stopped_smoking_year	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tobacco_smoking_history	total_number_of_pregnancies	tumor_response_cdus_type	tumor_tissue_site	vial_number	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_CESC_miRNA_HiSeq	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_data/public/TCGA/CESC/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_CESC_PDMRNAseq	_GENOMIC_ID_TCGA_CESC_RPPA	_GENOMIC_ID_TCGA_CESC_hMethyl450	_GENOMIC_ID_TCGA_CESC_mutation_bcgsc_gene	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_CESC_mutation	_GENOMIC_ID_TCGA_CESC_mutation_broad_gene	_GENOMIC_ID_TCGA_CESC_mutation_ucsc_maf_gene	_GENOMIC_ID_TCGA_CESC_mutation_curated_wustl_gene	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2	_GENOMIC_ID_TCGA_CESC_gistic2	_GENOMIC_ID_TCGA_CESC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_CESC_gistic2thd
TCGA-2W-A8YY-01	TCGA-2W-A8YY-01	TCGA-2W-A8YY	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		51		6		TCGA-2W-A8YY-F66376	TCGA-2W-A8YY	TCGA-2W-A8YY-01A	Former User		1500		HDR	PRESENT			Macroscopic parametrial involvement			Cisplatin	Stage IB2	56mg/56mL	-18886					93				145	0	533			357						Once weekly	0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-10-23	FEMALE	160	Adenosquamous	No						Radical Hysterectomy	C53.9	8560/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma	NO	18			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1		true			No	M0	N0	T2a2	TCGA-2W-A8YY.C24A4F00-23CD-44A4-B8B3-580A9CEAB16A.pdf				A8YY	0	0	Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					IMRT	4500	Primary Tumor	01		2000	2009	YES	YES	NO	2W	4	1		Cervical	A	LIVING	42	2013	3be9f1e8-94ae-476e-b146-38385d130f38	TCGA-2W-A8YY-01	3be9f1e8-94ae-476e-b146-38385d130f38	TCGA-2W-A8YY-01	TCGA-2W-A8YY-01	C29F674F-5572-4F11-9AA4-8D7F7464BE44	TCGA-2W-A8YY-01A-11D-A37Q-05		3be9f1e8-94ae-476e-b146-38385d130f38					3be9f1e8-94ae-476e-b146-38385d130f38	TCGA-2W-A8YY-01A-11D-A37M-01	TCGA-2W-A8YY-01	TCGA-2W-A8YY-01A-11D-A37M-01
TCGA-4J-AA1J-01	TCGA-4J-AA1J-01	TCGA-4J-AA1J	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		31				TCGA-4J-AA1J-F72061	TCGA-4J-AA1J	TCGA-4J-AA1J-01A	Never Used		40		HDR	ABSENT	no extension						Stage IB2		-11611					80					0	542			406							0	0						2015-4-7	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	590	NO	Non-keratinizing squamous cell carcinoma	NO	15			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		4		false			No	M0	N0	T1b2	TCGA-4J-AA1J.A052742F-3CD5-4881-B004-A7E13ECDC9C2.pdf				AA1J	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	4J	1	4		Cervical	A	LIVING	48	2013	9d09804a-304a-4f05-af84-af513c97f3ed	TCGA-4J-AA1J-01	9d09804a-304a-4f05-af84-af513c97f3ed	TCGA-4J-AA1J-01	TCGA-4J-AA1J-01	4EE077A4-25B8-4C6B-B0D3-06301827E402	TCGA-4J-AA1J-01A-21D-A388-05		9d09804a-304a-4f05-af84-af513c97f3ed					9d09804a-304a-4f05-af84-af513c97f3ed	TCGA-4J-AA1J-01A-21D-A386-01	TCGA-4J-AA1J-01	TCGA-4J-AA1J-01A-21D-A386-01
TCGA-BI-A0VR-01	TCGA-BI-A0VR-01	TCGA-BI-A0VR	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		53	22			TCGA-BI-A0VR-F34080	TCGA-BI-A0VR	TCGA-BI-A0VR-01A						PRESENT							Stage IIIB		-19473					1554		15			0	1505							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent				1				NO		2012-7-29	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	100	NO	Non-keratinizing squamous cell carcinoma	NO	43	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1		0	20	true			No	M0	N1	T2b	TCGA-BI-A0VR.BA4A1AA9-C1C7-4F84-A375-02B51FB95494.pdf				A0VR	2			TUMOR FREE	YES	3			YES							Primary Tumor	01		1995		YES	NO	YES	BI	4	6		Cervical	A	LIVING		2006	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	TCGA-BI-A0VR-01	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	TCGA-BI-A0VR-01	TCGA-BI-A0VR-01		TCGA-BI-A0VR-01A-11D-A10W-05	TCGA-BI-A0VR-01A-11D-A10S-08	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	TCGA-BI-A0VR-01A-11D-A10S-08	TCGA-BI-A0VR-01A-11D-A10S-08	TCGA-BI-A0VR-01A-11D-A10S-08	TCGA-BI-A0VR-01A-11D-A10S-08	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	TCGA-BI-A0VR-01A-11D-A10T-01	TCGA-BI-A0VR-01	TCGA-BI-A0VR-01A-11D-A10T-01
TCGA-BI-A0VS-01	TCGA-BI-A0VS-01	TCGA-BI-A0VS	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		48				TCGA-BI-A0VS-F34079	TCGA-BI-A0VS														Stage IB		-17839							12		12	0	1735							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO		2012-7-29	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)			Non-keratinizing squamous cell carcinoma	NO	8	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0						No	M0	N0	T1b1					A0VS	0	0		TUMOR FREE	NO	0		Complete Remission/Response	NO							Primary Tumor	01				NO	NO	YES	BI	2			Cervical		LIVING		2007	a57566b4-dd26-46bd-a00f-82136bc2a9be	TCGA-BI-A0VS-01	a57566b4-dd26-46bd-a00f-82136bc2a9be	TCGA-BI-A0VS-01	TCGA-BI-A0VS-01		TCGA-BI-A0VS-01A-11D-A10W-05	TCGA-BI-A0VS-01A-11D-A10S-08	a57566b4-dd26-46bd-a00f-82136bc2a9be	TCGA-BI-A0VS-01A-11D-A10S-08	TCGA-BI-A0VS-01A-11D-A10S-08	TCGA-BI-A0VS-01A-11D-A10S-08	TCGA-BI-A0VS-01A-11D-A10S-08	a57566b4-dd26-46bd-a00f-82136bc2a9be	TCGA-BI-A0VS-01A-11D-A10T-01	TCGA-BI-A0VS-01	TCGA-BI-A0VS-01A-11D-A10T-01
TCGA-BI-A20A-01	TCGA-BI-A20A-01	TCGA-BI-A20A	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		49				TCGA-BI-A20A-F55958	TCGA-BI-A20A	TCGA-BI-A20A-01A						PRESENT			Microscopic parametrial involvement				Stage IB1		-18215					218					0	720																	2014-1-22	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	60	NO	Non-keratinizing squamous cell carcinoma	NO	6			PRESENT		G3							NO	0		2		true			No	M0	N0	T1b1	TCGA-BI-A20A.FA32D74F-9855-489A-8217-F588682F96CE.pdf				A20A				TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			7th		NO	YES	BI		2		Cervical	A	LIVING	59	2010	5015be4c-acad-4536-bb65-59696b168717	TCGA-BI-A20A-01	5015be4c-acad-4536-bb65-59696b168717	TCGA-BI-A20A-01	TCGA-BI-A20A-01		TCGA-BI-A20A-01A-11D-A14Z-05	TCGA-BI-A20A-01A-11D-A14W-08	5015be4c-acad-4536-bb65-59696b168717	TCGA-BI-A20A-01A-11D-A14W-08	TCGA-BI-A20A-01A-11D-A14W-08	TCGA-BI-A20A-01A-11D-A14W-08	TCGA-BI-A20A-01A-11D-A14W-08	5015be4c-acad-4536-bb65-59696b168717	TCGA-BI-A20A-01A-11D-A14V-01	TCGA-BI-A20A-01	TCGA-BI-A20A-01A-11D-A14V-01
TCGA-C5-A0TN-01	TCGA-C5-A0TN-01	TCGA-C5-A0TN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	YES	Progressive Disease	YES	21				TCGA-C5-A0TN-F30748	TCGA-C5-A0TN	TCGA-C5-A0TN-01A						ABSENT			Microscopic parametrial involvement				Stage IB2		-7760					4740	348		-2		0			62		57	47			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent				Treatment not completed				Scheduled Follow-up Submission	2012-4-16	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	surgery	Other method, specify:	170	NO	Keratinizing squamous cell carcinoma		10	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Other, specify	CT	Other, specify	Distant Metastasis	Pelvis/Liver		YES	2		1		true			No	MX	N1	T1b	TCGA-C5-A0TN.33FE7DA3-EDB0-4301-BA6A-C51B75312FCA.pdf	Cervical Cancer			A0TN		3		WITH TUMOR			YES	Progressive Disease	YES					External beam radiation	1440	Primary Tumor	01			1995	NO	NO	YES	C5	1	4	Progression	Cervical	A	DECEASED	55	1997	edd006f4-1914-48b6-84d9-420a09dd82d1	TCGA-C5-A0TN-01	edd006f4-1914-48b6-84d9-420a09dd82d1	TCGA-C5-A0TN-01	TCGA-C5-A0TN-01	40F6A1D0-844F-412D-94CF-5F5BA0FD62E5	TCGA-C5-A0TN-01A-21D-A14Z-05	TCGA-C5-A0TN-01A-21D-A14W-08	edd006f4-1914-48b6-84d9-420a09dd82d1	TCGA-C5-A0TN-01A-21D-A14W-08	TCGA-C5-A0TN-01A-21D-A14W-08	TCGA-C5-A0TN-01A-21D-A14W-08	TCGA-C5-A0TN-01A-21D-A14W-08	edd006f4-1914-48b6-84d9-420a09dd82d1	TCGA-C5-A0TN-01A-21D-A14V-01	TCGA-C5-A0TN-01	TCGA-C5-A0TN-01A-21D-A14V-01
TCGA-C5-A1BE-01	TCGA-C5-A1BE-01	TCGA-C5-A1BE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease	YES	64				TCGA-C5-A1BE-F30504	TCGA-C5-A1BE	TCGA-C5-A1BE-01B		Completed as planned			HDR	PRESENT		Anterior lower uterine segment	Other Location, specify			Cisplatin	Stage IB2		-23727	65	90		84	3839	2094				0			1674		90	65						0	Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-11	FEMALE	149	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	40	NO	Non-keratinizing squamous cell carcinoma		38	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							YES	2		4		true			No	MX	N1	T1b	TCGA-C5-A1BE.0A21AE44-27DF-4F41-BAB5-209A25087C0A.pdf	Cervical Cancer			A1BE	1	1		WITH TUMOR		0	YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	C5	3	6		Cervical	B	DECEASED	76	2000	8b82c786-64be-410a-89bf-d28dc8d7c4e9	TCGA-C5-A1BE-01	8b82c786-64be-410a-89bf-d28dc8d7c4e9	TCGA-C5-A1BE-01	TCGA-C5-A1BE-01		TCGA-C5-A1BE-01B-11D-A13Z-05	TCGA-C5-A1BE-01B-11D-A13W-08	8b82c786-64be-410a-89bf-d28dc8d7c4e9	TCGA-C5-A1BE-01B-11D-A13W-08	TCGA-C5-A1BE-01B-11D-A13W-08	TCGA-C5-A1BE-01B-11D-A13W-08	TCGA-C5-A1BE-01B-11D-A13W-08	8b82c786-64be-410a-89bf-d28dc8d7c4e9	TCGA-C5-A1BE-01B-11D-A13V-01	TCGA-C5-A1BE-01	TCGA-C5-A1BE-01B-11D-A13V-01
TCGA-C5-A1BF-01	TCGA-C5-A1BF-01	TCGA-C5-A1BF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	YES	Progressive Disease	YES	46				TCGA-C5-A1BF-F30729	TCGA-C5-A1BF	TCGA-C5-A1BF-01B					HDR						Not done per treating physicians discretion		Stage IB		-16975					4992	570	13			0			93		69	26		Bladder Present|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent					Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-16	FEMALE		Cervical Squamous Cell Carcinoma	No				HPV 18			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO	Keratinizing squamous cell carcinoma		33					G1	Other, specify	CT/Core Biopsy	Other, specify	Distant Metastasis	Lung, Sternum		YES	0	0	4	30	true			No	MX	N0	TX	TCGA-C5-A1BF.45EC2A51-EDE1-44E9-8756-A094B998A68B.pdf	Cervical Cancer			A1BF	1			WITH TUMOR			YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			1995	NO	NO	YES	C5	2	5		Cervical	B	DECEASED	76	1997	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	TCGA-C5-A1BF-01	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	TCGA-C5-A1BF-01	TCGA-C5-A1BF-01		TCGA-C5-A1BF-01B-11D-A13Z-05	TCGA-C5-A1BF-01B-11D-A13W-08	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	TCGA-C5-A1BF-01B-11D-A13W-08	TCGA-C5-A1BF-01B-11D-A13W-08	TCGA-C5-A1BF-01B-11D-A13W-08	TCGA-C5-A1BF-01B-11D-A13W-08	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	TCGA-C5-A1BF-01B-11D-A13V-01	TCGA-C5-A1BF-01	TCGA-C5-A1BF-01B-11D-A13V-01
TCGA-C5-A1BI-01	TCGA-C5-A1BI-01	TCGA-C5-A1BI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	31	16	6		TCGA-C5-A1BI-F57886	TCGA-C5-A1BI		Former User	Completed as planned			HDR							Cisplatin	Stage IIIB		-11564	62	74	74	27			1		16	0	1112				74	27		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly		0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES	ECC	Other method, specify:				YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			2	15				No								A1BI	0	1		TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation	4320	Primary Tumor	01			1995	YES	NO	YES	C5	2	3		Cervical		LIVING	59	2001	cde3fda7-c23f-480b-bc20-ac27bcfe4536	TCGA-C5-A1BI-01	cde3fda7-c23f-480b-bc20-ac27bcfe4536	TCGA-C5-A1BI-01	TCGA-C5-A1BI-01		TCGA-C5-A1BI-01B-11D-A13Z-05	TCGA-C5-A1BI-01B-11D-A13W-08	cde3fda7-c23f-480b-bc20-ac27bcfe4536	TCGA-C5-A1BI-01B-11D-A13W-08	TCGA-C5-A1BI-01B-11D-A13W-08	TCGA-C5-A1BI-01B-11D-A13W-08	TCGA-C5-A1BI-01B-11D-A13W-08	cde3fda7-c23f-480b-bc20-ac27bcfe4536	TCGA-C5-A1BI-01B-11D-A13V-01	TCGA-C5-A1BI-01	TCGA-C5-A1BI-01B-11D-A13V-01
TCGA-C5-A1BJ-01	TCGA-C5-A1BJ-01	TCGA-C5-A1BJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	34	24			TCGA-C5-A1BJ-F57082	TCGA-C5-A1BJ	TCGA-C5-A1BJ-01A		Completed as planned			HDR						Not done per treating physicians discretion		Stage IIB		-12611	21	35			4972					0	4385				57	2						0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	169	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO		YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			0	10	true			No				TCGA-C5-A1BJ.9F012D5B-DF59-43C3-96FC-4E6EE55BDAD6.pdf				A1BJ	0	0		TUMOR FREE		0		Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1997	1995	NO	NO	YES	C5	4	0		Cervical	A	LIVING	49	1997	a1d00776-9535-4361-af77-8896e51465fe	TCGA-C5-A1BJ-01	a1d00776-9535-4361-af77-8896e51465fe	TCGA-C5-A1BJ-01	TCGA-C5-A1BJ-01	AD09DC41-D11F-40EC-BEDA-17B761E52DC8	TCGA-C5-A1BJ-01A-11D-A13Z-05	TCGA-C5-A1BJ-01A-11D-A13W-08	a1d00776-9535-4361-af77-8896e51465fe	TCGA-C5-A1BJ-01A-11D-A13W-08	TCGA-C5-A1BJ-01A-11D-A13W-08	TCGA-C5-A1BJ-01A-11D-A13W-08	TCGA-C5-A1BJ-01A-11D-A13W-08	a1d00776-9535-4361-af77-8896e51465fe	TCGA-C5-A1BJ-01A-11D-A13V-01	TCGA-C5-A1BJ-01	TCGA-C5-A1BJ-01A-11D-A13V-01
TCGA-C5-A1BK-01	TCGA-C5-A1BK-01	TCGA-C5-A1BK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	36				TCGA-C5-A1BK-F62484	TCGA-C5-A1BK							ABSENT		margins free of tumor	Other Location, specify		Participant refusal		Stage IB		-13297										0	5385											0				NO	Scheduled Follow-up Submission	2014-7-17	FEMALE	151	Cervical Squamous Cell Carcinoma	No			52	HPV 16|Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES	ECC	Other method, specify:			Keratinizing squamous cell carcinoma	YES	20			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	4					No	MX	N0	T1b					A1BK	0	0		TUMOR FREE		0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01			1988	NO	NO	YES	C5	1	4		Cervical		LIVING	82	1994	feb35af1-052d-41a6-9e76-f47b610ab956	TCGA-C5-A1BK-01	feb35af1-052d-41a6-9e76-f47b610ab956	TCGA-C5-A1BK-01	TCGA-C5-A1BK-01		TCGA-C5-A1BK-01B-11D-A13Z-05	TCGA-C5-A1BK-01B-11D-A13W-08	feb35af1-052d-41a6-9e76-f47b610ab956	TCGA-C5-A1BK-01B-11D-A13W-08	TCGA-C5-A1BK-01B-11D-A13W-08	TCGA-C5-A1BK-01B-11D-A13W-08	TCGA-C5-A1BK-01B-11D-A13W-08	feb35af1-052d-41a6-9e76-f47b610ab956	TCGA-C5-A1BK-01B-11D-A13V-01	TCGA-C5-A1BK-01	TCGA-C5-A1BK-01B-11D-A13V-01
TCGA-C5-A1BL-01	TCGA-C5-A1BL-01	TCGA-C5-A1BL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	32	16			TCGA-C5-A1BL-F57887	TCGA-C5-A1BL	TCGA-C5-A1BL-01A	Never Used	Completed as planned	8867		HDR	ABSENT				On randomized study and received arm without chemotherapy	Other		Stage IB		-11723	33	54			5950		1			0	5271			1479	64	19		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	168	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Non-keratinizing squamous cell carcinoma	YES	25	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1	0	1	12	true	GP5+/GP6+		No				TCGA-C5-A1BL.C3312E18-832F-4126-8E9E-F829128F7530.pdf				A1BL	0	0	Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1988	1988	NO	NO	YES	C5	4	1	Complete response	Cervical	A	LIVING	78	1994	5a7840e4-48ef-4d10-8709-c963b6b4c25a	TCGA-C5-A1BL-01	5a7840e4-48ef-4d10-8709-c963b6b4c25a	TCGA-C5-A1BL-01	TCGA-C5-A1BL-01	BB6DD49D-01BA-4049-828A-8CA7BE399418	TCGA-C5-A1BL-01A-11D-A13Z-05	TCGA-C5-A1BL-01A-11D-A13W-08	5a7840e4-48ef-4d10-8709-c963b6b4c25a	TCGA-C5-A1BL-01A-11D-A13W-08	TCGA-C5-A1BL-01A-11D-A13W-08	TCGA-C5-A1BL-01A-11D-A13W-08	TCGA-C5-A1BL-01A-11D-A13W-08	5a7840e4-48ef-4d10-8709-c963b6b4c25a	TCGA-C5-A1BL-01A-11D-A13V-01	TCGA-C5-A1BL-01	TCGA-C5-A1BL-01A-11D-A13V-01
TCGA-C5-A1BM-01	TCGA-C5-A1BM-01	TCGA-C5-A1BM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	78				TCGA-C5-A1BM-F30745	TCGA-C5-A1BM	TCGA-C5-A1BM-01A		Completed as planned			HDR	PRESENT			Positive vaginal margin				Stage IB		-28815	171	186			4853	2520	22		102	0						154						0	Completed as Planned		Extra-Pelvic Metastatic Disease Present	NO	Scheduled Follow-up Submission	2012-4-16	FEMALE	171	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Non-keratinizing squamous cell carcinoma		23	Pelvic (external iliac, internal iliac, obturator)|Other Location, specify	perigastric	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	8	0	2		true			No	MX	N1	T2	TCGA-C5-A1BM.D23DE232-F930-40C8-A560-4B75C41C6115.pdf	Other, specify			A1BM	1	0		TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	4	3		Cervical	A	DECEASED	56	1997	0bb1946f-bc01-47d8-887f-e63f3a16e32d	TCGA-C5-A1BM-01	0bb1946f-bc01-47d8-887f-e63f3a16e32d	TCGA-C5-A1BM-01	TCGA-C5-A1BM-01		TCGA-C5-A1BM-01A-11D-A13Z-05	TCGA-C5-A1BM-01A-11D-A13W-08	0bb1946f-bc01-47d8-887f-e63f3a16e32d	TCGA-C5-A1BM-01A-11D-A13W-08	TCGA-C5-A1BM-01A-11D-A13W-08	TCGA-C5-A1BM-01A-11D-A13W-08	TCGA-C5-A1BM-01A-11D-A13W-08	0bb1946f-bc01-47d8-887f-e63f3a16e32d	TCGA-C5-A1BM-01A-11D-A13V-01	TCGA-C5-A1BM-01	TCGA-C5-A1BM-01A-11D-A13V-01
TCGA-C5-A1BN-01	TCGA-C5-A1BN-01	TCGA-C5-A1BN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease	YES	26	15			TCGA-C5-A1BN-F30414	TCGA-C5-A1BN	TCGA-C5-A1BN-01B	Never Used	Completed as planned			HDR							Cisplatin	Stage IB2		-9783	36	85	67	32	1253	166			1	0					85	36						0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2012-4-9	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO						PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			2	11	true			No				TCGA-C5-A1BN.541610BD-6ACC-4EE7-8942-8524C8BE0515.pdf	Cervical Cancer			A1BN	0	0		WITH TUMOR		0		Progressive Disease	YES					External beam radiation		Primary Tumor	01	17.36		1995	YES	NO	YES	C5	2	2		Cervical	B	DECEASED	68	2007	3f679347-cd3b-4711-aa6c-e5d87fa93052	TCGA-C5-A1BN-01	3f679347-cd3b-4711-aa6c-e5d87fa93052	TCGA-C5-A1BN-01	TCGA-C5-A1BN-01		TCGA-C5-A1BN-01B-11D-A14Z-05	TCGA-C5-A1BN-01B-11D-A14W-08	3f679347-cd3b-4711-aa6c-e5d87fa93052	TCGA-C5-A1BN-01B-11D-A14W-08	TCGA-C5-A1BN-01B-11D-A14W-08	TCGA-C5-A1BN-01B-11D-A14W-08	TCGA-C5-A1BN-01B-11D-A14W-08	3f679347-cd3b-4711-aa6c-e5d87fa93052	TCGA-C5-A1BN-01B-11D-A14V-01	TCGA-C5-A1BN-01	TCGA-C5-A1BN-01B-11D-A14V-01
TCGA-C5-A1BQ-01	TCGA-C5-A1BQ-01	TCGA-C5-A1BQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		65	12	6		TCGA-C5-A1BQ-F34245	TCGA-C5-A1BQ						HDR							Cisplatin	Stage IIIB		-24018						604				0										Once weekly		0						2012-8-7	FEMALE	147	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			6	25				No					Cervical Cancer			A1BQ	3	0		TUMOR FREE	YES	1		Partial Remission/Response	YES					External beam radiation		Primary Tumor	01		1999	1995	YES	NO	YES	C5	4	10		Cervical		DECEASED	69	2002	ab31f363-93f1-4ef9-a47a-731657fdf534	TCGA-C5-A1BQ-01	ab31f363-93f1-4ef9-a47a-731657fdf534	TCGA-C5-A1BQ-01	TCGA-C5-A1BQ-01		TCGA-C5-A1BQ-01C-11D-A212-05	TCGA-C5-A1BQ-01C-11D-A20U-09	ab31f363-93f1-4ef9-a47a-731657fdf534			TCGA-C5-A1BQ-01C-11D-A20U-09	TCGA-C5-A1BQ-01C-11D-A20U-09	ab31f363-93f1-4ef9-a47a-731657fdf534	TCGA-C5-A1BQ-01C-11D-A20T-01	TCGA-C5-A1BQ-01	TCGA-C5-A1BQ-01C-11D-A20T-01
TCGA-C5-A1M5-01	TCGA-C5-A1M5-01	TCGA-C5-A1M5	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	NO			53				TCGA-C5-A1M5-F29081	TCGA-C5-A1M5	TCGA-C5-A1M5-01A						ABSENT		margins free of tumor	Other Location, specify				Stage IB		-19672					5395	2052				0			1804									0				NO	Additional New Tumor Event	2012-3-7	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	190	NO	Keratinizing squamous cell carcinoma		59			PRESENT	Indeterminate (neither Pre or Postmenopausal)	G2	Other, specify		Tumor Resection	Distant Metastasis	vagina		YES	0	0	4		true			No	M0	N0	T1b	TCGA-C5-A1M5.B7A07894-8654-49F3-9583-7AD930443F08.pdf				A1M5	0	0		WITH TUMOR		0	YES									Primary Tumor	01			1995		NO	YES	C5	1	4		Cervical	A	DECEASED	70	1996	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	TCGA-C5-A1M5-01	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	TCGA-C5-A1M5-01	TCGA-C5-A1M5-01	36EF8DA6-EB98-460D-B983-553061F6C566	TCGA-C5-A1M5-01A-11D-A13Z-05	TCGA-C5-A1M5-01A-11D-A13W-08	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	TCGA-C5-A1M5-01A-11D-A13W-08	TCGA-C5-A1M5-01A-11D-A13W-08	TCGA-C5-A1M5-01A-11D-A13W-08	TCGA-C5-A1M5-01A-11D-A13W-08	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	TCGA-C5-A1M5-01A-11D-A13V-01	TCGA-C5-A1M5-01	TCGA-C5-A1M5-01A-11D-A13V-01
TCGA-C5-A1M6-01	TCGA-C5-A1M6-01	TCGA-C5-A1M6	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease	YES	55				TCGA-C5-A1M6-F29215	TCGA-C5-A1M6	TCGA-C5-A1M6-01A	Former User	Completed as planned									Not done per treating physicians discretion		Stage IIB		-20090	20	75			4668	955	316			0			316	204	75	20		Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2012-3-12	FEMALE	165	Cervical Squamous Cell Carcinoma	No				HPV 18			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	CT	Other, specify	Distant Metastasis			YES			1		true			No				TCGA-C5-A1M6.849F2BBF-C820-4C31-B213-648545060C3E.pdf	Cervical Cancer			A1M6	0	0	Post-Adjuvant Therapy	WITH TUMOR		0		Complete Remission/Response	YES					External beam radiation	5840	Primary Tumor	01			1995	NO	NO	YES	C5	1	1		Cervical	A	DECEASED	77	1998	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	TCGA-C5-A1M6-01	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	TCGA-C5-A1M6-01	TCGA-C5-A1M6-01	1F43A50D-9930-4F21-8EF8-1A09A5DABDF4	TCGA-C5-A1M6-01A-11D-A13Z-05	TCGA-C5-A1M6-01A-11D-A13W-08	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	TCGA-C5-A1M6-01A-11D-A13W-08	TCGA-C5-A1M6-01A-11D-A13W-08	TCGA-C5-A1M6-01A-11D-A13W-08	TCGA-C5-A1M6-01A-11D-A13W-08	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	TCGA-C5-A1M6-01A-11D-A13V-01	TCGA-C5-A1M6-01	TCGA-C5-A1M6-01A-11D-A13V-01
TCGA-C5-A1M7-01	TCGA-C5-A1M7-01	TCGA-C5-A1M7	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	37	16			TCGA-C5-A1M7-F57890	TCGA-C5-A1M7	TCGA-C5-A1M7-01A	Never Used					ABSENT		margins free of tumor	Other Location, specify				Stage IB		-13808					4265					0	1409			228							1	0				NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR			HPV 18		Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Radical Hysterectomy	Other method, specify:	90	NO	Non-keratinizing squamous cell carcinoma	YES	30			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	4	26	true	GP5+/GP6+		No	MX	N0	T1b	TCGA-C5-A1M7.ABC2B2A7-E5EE-4198-80E0-E64A6305B47A.pdf				A1M7	0	0	Post-Adjuvant Therapy	TUMOR FREE		1	YES	Complete Remission/Response	NO	Other						Primary Tumor	01			1995		NO	YES	C5	2	5	Complete response	Cervical	A	LIVING	69	1999	a8717ede-a85b-4133-bafc-48abd7892f71	TCGA-C5-A1M7-01	a8717ede-a85b-4133-bafc-48abd7892f71	TCGA-C5-A1M7-01	TCGA-C5-A1M7-01	FC4D06F1-DFC3-4660-A049-EDED1CF39AE4	TCGA-C5-A1M7-01A-11D-A13Z-05	TCGA-C5-A1M7-01A-11D-A13W-08	a8717ede-a85b-4133-bafc-48abd7892f71	TCGA-C5-A1M7-01A-11D-A13W-08	TCGA-C5-A1M7-01A-11D-A13W-08	TCGA-C5-A1M7-01A-11D-A13W-08	TCGA-C5-A1M7-01A-11D-A13W-08	a8717ede-a85b-4133-bafc-48abd7892f71	TCGA-C5-A1M7-01A-11D-A13V-01	TCGA-C5-A1M7-01	TCGA-C5-A1M7-01A-11D-A13V-01
TCGA-C5-A1M8-01	TCGA-C5-A1M8-01	TCGA-C5-A1M8	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	43				TCGA-C5-A1M8-F57891	TCGA-C5-A1M8	TCGA-C5-A1M8-01A	Never Used					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB1		-15848					3397			4		0	919			-273	130	64			Pelvic Nodes Present		0	0	Completed as Planned			NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	100	NO		YES	13			ABSENT	Indeterminate (neither Pre or Postmenopausal)	G2							NO	0	0	0		true			No	MX	N0	T1b	TCGA-C5-A1M8.7EC6DEFF-B0FC-45FF-9B45-92714D5EDBEB.pdf				A1M8	0	1	Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	1	1		Cervical	A	LIVING	75	2001	a4de3863-03d5-44b0-b711-87aadcb29008	TCGA-C5-A1M8-01	a4de3863-03d5-44b0-b711-87aadcb29008	TCGA-C5-A1M8-01	TCGA-C5-A1M8-01	11C08BC4-2E3E-47BB-80F7-4758587F2EF6	TCGA-C5-A1M8-01A-21D-A13Z-05	TCGA-C5-A1M8-01A-21D-A13W-08	a4de3863-03d5-44b0-b711-87aadcb29008	TCGA-C5-A1M8-01A-21D-A13W-08	TCGA-C5-A1M8-01A-21D-A13W-08	TCGA-C5-A1M8-01A-21D-A13W-08	TCGA-C5-A1M8-01A-21D-A13W-08	a4de3863-03d5-44b0-b711-87aadcb29008	TCGA-C5-A1M8-01A-21D-A13V-01	TCGA-C5-A1M8-01	TCGA-C5-A1M8-01A-21D-A13V-01
TCGA-C5-A1M9-01	TCGA-C5-A1M9-01	TCGA-C5-A1M9	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease	YES	46		6		TCGA-C5-A1M9-F29254	TCGA-C5-A1M9	TCGA-C5-A1M9-01A	Former User					ABSENT		margins free of tumor	Other Location, specify			Cisplatin	Stage IB1		-17020			116	81	3120	1065	5		5	0			555	215	116	76		Extra-Pelvic Metastatic Disease Present|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	1	0	Completed as Planned	540	Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	155	Endocervical Type of Adenocarcinoma	No				HPV 16		Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO			19	Pelvic (external iliac, internal iliac, obturator)|Para-aortic|Supraclavicular		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	CT	Other, specify	Distant Metastasis			YES	14		0		true			No	M0	N1	T3b	TCGA-C5-A1M9.6D91450A-9499-4B66-90DF-E68B4880E64C.pdf	Cervical Cancer			A1M9	0	1	Post-Adjuvant Therapy	WITH TUMOR		0	YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	C5	1	1		Cervical	A	DECEASED	49	2002	721c59a5-22b6-4388-a47d-d0108ea2c1aa	TCGA-C5-A1M9-01	721c59a5-22b6-4388-a47d-d0108ea2c1aa	TCGA-C5-A1M9-01	TCGA-C5-A1M9-01	9169E928-8406-4FF7-824A-AA5FA7B3BF5A	TCGA-C5-A1M9-01A-11D-A13Z-05	TCGA-C5-A1M9-01A-11D-A13W-08	721c59a5-22b6-4388-a47d-d0108ea2c1aa	TCGA-C5-A1M9-01A-11D-A13W-08		TCGA-C5-A1M9-01A-11D-A13W-08	TCGA-C5-A1M9-01A-11D-A13W-08	721c59a5-22b6-4388-a47d-d0108ea2c1aa	TCGA-C5-A1M9-01A-11D-A13V-01	TCGA-C5-A1M9-01	TCGA-C5-A1M9-01A-11D-A13V-01
TCGA-C5-A1ME-01	TCGA-C5-A1ME-01	TCGA-C5-A1ME	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	40	18			TCGA-C5-A1ME-F29281	TCGA-C5-A1ME	TCGA-C5-A1ME-01A	Former User					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB1		-14970					2632		13			0	1756			69							0	0				NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	165	Endocervical Type of Adenocarcinoma	No				HPV 16		Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO			27			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0	0	1	22	true			No	M0	N0	T1b1	TCGA-C5-A1ME.00322045-7A7F-44D1-8381-94F027200227.pdf				A1ME	0	0	Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01		2003	1995	NO	NO	YES	C5	4	1		Cervical	A	LIVING	69	2003	318e2cdd-08c5-4611-913f-7f4a6f49677d	TCGA-C5-A1ME-01	318e2cdd-08c5-4611-913f-7f4a6f49677d	TCGA-C5-A1ME-01	TCGA-C5-A1ME-01	B27BC67D-DE4A-4713-A07F-65322FB64A5B	TCGA-C5-A1ME-01A-11D-A13Z-05	TCGA-C5-A1ME-01A-11D-A13W-08	318e2cdd-08c5-4611-913f-7f4a6f49677d	TCGA-C5-A1ME-01A-11D-A13W-08	TCGA-C5-A1ME-01A-11D-A13W-08	TCGA-C5-A1ME-01A-11D-A13W-08	TCGA-C5-A1ME-01A-11D-A13W-08	318e2cdd-08c5-4611-913f-7f4a6f49677d	TCGA-C5-A1ME-01A-11D-A13V-01	TCGA-C5-A1ME-01	TCGA-C5-A1ME-01A-11D-A13V-01
TCGA-C5-A1MF-01	TCGA-C5-A1MF-01	TCGA-C5-A1MF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	49	20			TCGA-C5-A1MF-F55178	TCGA-C5-A1MF	TCGA-C5-A1MF-01A	Former User	Completed as planned			HDR	ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB2		-17911	72	119			2591		31			0	1617			168	119	72		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0	Completed as Planned	0		NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	163	Cervical Squamous Cell Carcinoma	No	PCR		45	Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Keratinizing squamous cell carcinoma	YES	40			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2	10	true	GP5+/GP6+		No	MX	N0	T1b2	TCGA-C5-A1MF.1FEEF445-9E69-4AAB-A336-C688BA807CDA.pdf				A1MF	0	0	Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1995	1995	NO	NO	YES	C5	4	2	Complete response	Cervical	A	LIVING	70	2004	70b5a53a-d822-4634-b181-79fef68346c0	TCGA-C5-A1MF-01	70b5a53a-d822-4634-b181-79fef68346c0	TCGA-C5-A1MF-01	TCGA-C5-A1MF-01	AE69D647-895F-4476-873B-18BA147D1489	TCGA-C5-A1MF-01A-11D-A13Z-05	TCGA-C5-A1MF-01A-11D-A13W-08	70b5a53a-d822-4634-b181-79fef68346c0	TCGA-C5-A1MF-01A-11D-A13W-08	TCGA-C5-A1MF-01A-11D-A13W-08	TCGA-C5-A1MF-01A-11D-A13W-08	TCGA-C5-A1MF-01A-11D-A13W-08	70b5a53a-d822-4634-b181-79fef68346c0	TCGA-C5-A1MF-01A-11D-A13V-01	TCGA-C5-A1MF-01	TCGA-C5-A1MF-01A-11D-A13V-01
TCGA-C5-A1MH-01	TCGA-C5-A1MH-01	TCGA-C5-A1MH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease	YES	71				TCGA-C5-A1MH-F29283	TCGA-C5-A1MH	TCGA-C5-A1MH-01A		Completed as planned			HDR							Cisplatin	Stage IIIB		-26234	38	71	65	8	2417	1186	-2		1	0			178	155	71	38		Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0	Completed as Planned		Extra-Pelvic Metastatic Disease Absent	NO	Scheduled Follow-up Submission	2012-3-13	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Keratinizing squamous cell carcinoma						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	PET, needle biopsy	Other, specify	Distant Metastasis			YES			2	15	true			No				TCGA-C5-A1MH.4FDCED4B-0729-4B37-8EA7-F66293680952.pdf	Cervical Cancer			A1MH	0	0	Post-Adjuvant Therapy	WITH TUMOR		0		Complete Remission/Response	YES					External beam radiation		Primary Tumor	01	9.95	2003	1995	YES	NO	YES	C5	3	2	Progression	Cervical	A	DECEASED		2004	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	TCGA-C5-A1MH-01	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	TCGA-C5-A1MH-01	TCGA-C5-A1MH-01	4790E476-B3DE-4E7A-AFB1-03842F146150	TCGA-C5-A1MH-01A-11D-A14Z-05	TCGA-C5-A1MH-01A-11D-A14W-08	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	TCGA-C5-A1MH-01A-11D-A14W-08	TCGA-C5-A1MH-01A-11D-A14W-08	TCGA-C5-A1MH-01A-11D-A14W-08	TCGA-C5-A1MH-01A-11D-A14W-08	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	TCGA-C5-A1MH-01A-11D-A14V-01	TCGA-C5-A1MH-01	TCGA-C5-A1MH-01A-11D-A14V-01
TCGA-C5-A1MI-01	TCGA-C5-A1MI-01	TCGA-C5-A1MI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease	YES	50	15	6		TCGA-C5-A1MI-F29733	TCGA-C5-A1MI	TCGA-C5-A1MI-01A		Completed as planned	1200		HDR	ABSENT						Cisplatin	Stage IB1	40mg/m2/wk	-18336	83	118	118	76	2346	1083	16		23	0			805	41	125	76		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	1	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2012-3-28	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO			17	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Peri (6-12 months since last menstrual period)	G2	Other, specify			Distant Metastasis	distant recurrence multiple sites		YES	1		2	35	true			No	M0	N1	T1b1	TCGA-C5-A1MI.FD31F805-C852-467E-9708-7D00339944B5.pdf	Cervical Cancer	Other, specify	Herpes	A1MI	2	2	Pre-Adjuvant Therapy	WITH TUMOR		0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	C5	2	7		Cervical	A	DECEASED	77	2004	e5452386-f28c-450f-b13b-4b1ef4713fa1	TCGA-C5-A1MI-01	e5452386-f28c-450f-b13b-4b1ef4713fa1	TCGA-C5-A1MI-01	TCGA-C5-A1MI-01	6424B36F-37F0-4816-8964-D1DB61A06F63	TCGA-C5-A1MI-01A-11D-A14Z-05	TCGA-C5-A1MI-01A-11D-A14W-08	e5452386-f28c-450f-b13b-4b1ef4713fa1	TCGA-C5-A1MI-01A-11D-A14W-08	TCGA-C5-A1MI-01A-11D-A14W-08	TCGA-C5-A1MI-01A-11D-A14W-08	TCGA-C5-A1MI-01A-11D-A14W-08	e5452386-f28c-450f-b13b-4b1ef4713fa1	TCGA-C5-A1MI-01A-11D-A14V-01	TCGA-C5-A1MI-01	TCGA-C5-A1MI-01A-11D-A14V-01
TCGA-C5-A1MJ-01	TCGA-C5-A1MJ-01	TCGA-C5-A1MJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					61				TCGA-C5-A1MJ-F29745	TCGA-C5-A1MJ	TCGA-C5-A1MJ-01A						ABSENT		margins free of tumor	Other Location, specify				Stage IB1		-22308					2234	14				0				-69							1	1				NO	Scheduled Follow-up Submission	2012-3-28	FEMALE	165	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO			18			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								0	0	3		true			No	MX	N0	T1b1	TCGA-C5-A1MJ.A0D7B6A3-BE64-4736-894D-AF69320180AC.pdf	Other, specify			A1MJ	0	2	Preoperative	TUMOR FREE		0	YES									Primary Tumor	01			1995		NO	YES	C5	1	6		Cervical	A	DECEASED	75	2005	45ce60c9-d18f-43a2-b240-8dc7d854cd27	TCGA-C5-A1MJ-01	45ce60c9-d18f-43a2-b240-8dc7d854cd27	TCGA-C5-A1MJ-01	TCGA-C5-A1MJ-01	A0036B29-51AD-4A3B-A405-7929D1A483E1	TCGA-C5-A1MJ-01A-11D-A14Z-05	TCGA-C5-A1MJ-01A-11D-A14W-08	45ce60c9-d18f-43a2-b240-8dc7d854cd27	TCGA-C5-A1MJ-01A-11D-A14W-08	TCGA-C5-A1MJ-01A-11D-A14W-08	TCGA-C5-A1MJ-01A-11D-A14W-08	TCGA-C5-A1MJ-01A-11D-A14W-08	45ce60c9-d18f-43a2-b240-8dc7d854cd27	TCGA-C5-A1MJ-01A-11D-A14V-01	TCGA-C5-A1MJ-01	TCGA-C5-A1MJ-01A-11D-A14V-01
TCGA-C5-A1MK-01	TCGA-C5-A1MK-01	TCGA-C5-A1MK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease	YES	79		5		TCGA-C5-A1MK-F30183	TCGA-C5-A1MK	TCGA-C5-A1MK-01A		Treatment not completed			HDR							Carboplatin	Stage IIIB		-28939	41	74	74	41	2052	74				0					74	41				Once weekly		0	Treatment not completed	2200	Paraaortic Nodes Present|Pelvic Nodes Present	NO	Scheduled Follow-up Submission	2012-4-4	FEMALE	155	Cervical Squamous Cell Carcinoma	No			58	Other HPV type(s)			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO	Keratinizing squamous cell carcinoma						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2		true			No				TCGA-C5-A1MK.75B6D26C-3C3C-4D2E-BFDD-C9CB81AE3793.pdf	Cervical Cancer			A1MK	0	2		WITH TUMOR		1		Progressive Disease	YES					External beam radiation	1980	Primary Tumor	01			1995	YES	NO	YES	C5	1	5		Cervical	A	DECEASED	63	2005	174159b7-d7a4-43d5-8c04-7f62f8d0db14	TCGA-C5-A1MK-01	174159b7-d7a4-43d5-8c04-7f62f8d0db14	TCGA-C5-A1MK-01	TCGA-C5-A1MK-01		TCGA-C5-A1MK-01A-11D-A14Z-05	TCGA-C5-A1MK-01A-11D-A14W-08	174159b7-d7a4-43d5-8c04-7f62f8d0db14	TCGA-C5-A1MK-01A-11D-A14W-08	TCGA-C5-A1MK-01A-11D-A14W-08	TCGA-C5-A1MK-01A-11D-A14W-08	TCGA-C5-A1MK-01A-11D-A14W-08	174159b7-d7a4-43d5-8c04-7f62f8d0db14	TCGA-C5-A1MK-01A-11D-A14V-01	TCGA-C5-A1MK-01	TCGA-C5-A1MK-01A-11D-A14V-01
TCGA-C5-A1ML-01	TCGA-C5-A1ML-01	TCGA-C5-A1ML	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease	YES	49				TCGA-C5-A1ML-F30188	TCGA-C5-A1ML	TCGA-C5-A1ML-01A		Completed as planned			HDR						Other		Stage IB2		-18067	68	111			2037	636	37		37	0					111	68		Extra-Pelvic Metastatic Disease Present	Extra-Pelvic Metastatic Disease Present			0	Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-4	FEMALE		Cervical Squamous Cell Carcinoma	No				HPV 16			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2	37	true			No				TCGA-C5-A1ML.D27AF07C-E69A-46DE-B1E6-4F494E3602B5.pdf	Cervical Cancer			A1ML	0	0		WITH TUMOR		0		Progressive Disease	YES					External beam radiation	5040	Primary Tumor	01	14.46		1995	NO	NO	YES	C5	2	2		Cervical	A	DECEASED	120	2005	1f870a12-9d70-4fe4-a176-4cbee06c44e6	TCGA-C5-A1ML-01	1f870a12-9d70-4fe4-a176-4cbee06c44e6	TCGA-C5-A1ML-01	TCGA-C5-A1ML-01		TCGA-C5-A1ML-01A-11D-A14Z-05	TCGA-C5-A1ML-01A-11D-A14W-08	1f870a12-9d70-4fe4-a176-4cbee06c44e6	TCGA-C5-A1ML-01A-11D-A14W-08	TCGA-C5-A1ML-01A-11D-A14W-08	TCGA-C5-A1ML-01A-11D-A14W-08	TCGA-C5-A1ML-01A-11D-A14W-08	1f870a12-9d70-4fe4-a176-4cbee06c44e6	TCGA-C5-A1ML-01A-11D-A14V-01	TCGA-C5-A1ML-01	TCGA-C5-A1ML-01A-11D-A14V-01
TCGA-C5-A1MN-01	TCGA-C5-A1MN-01	TCGA-C5-A1MN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix				YES	42				TCGA-C5-A1MN-F30192	TCGA-C5-A1MN	TCGA-C5-A1MN-01A	Former User	Completed as planned			HDR							Cisplatin	Stage IIIB		-15499	25			25	1441	1245			1	0				875		25					1	0	Completed as Planned		Parametrium Present|Pelvic Nodes Present	NO	Scheduled Follow-up Submission	2012-4-4	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			0	25	true			No				TCGA-C5-A1MN.8C677406-F68A-429E-BC9A-9AE26928D226.pdf	Other, specify			A1MN	0	0	Post-Adjuvant Therapy	TUMOR FREE		0		Complete Remission/Response	YES					IMRT		Primary Tumor	01	16.92		1995	YES	NO	YES	C5	2	0	Complete response	Cervical	A	DECEASED	64	2007	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	TCGA-C5-A1MN-01	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	TCGA-C5-A1MN-01	TCGA-C5-A1MN-01	FCCC4EAA-62B7-4005-887C-716C7FB52D63	TCGA-C5-A1MN-01A-11D-A14Z-05	TCGA-C5-A1MN-01A-11D-A14W-08	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	TCGA-C5-A1MN-01A-11D-A14W-08	TCGA-C5-A1MN-01A-11D-A14W-08	TCGA-C5-A1MN-01A-11D-A14W-08	TCGA-C5-A1MN-01A-11D-A14W-08	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	TCGA-C5-A1MN-01A-11D-A14V-01	TCGA-C5-A1MN-01	TCGA-C5-A1MN-01A-11D-A14V-01
TCGA-C5-A1MP-01	TCGA-C5-A1MP-01	TCGA-C5-A1MP	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	34				TCGA-C5-A1MP-F57086	TCGA-C5-A1MP	TCGA-C5-A1MP-01A								margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB2		-12692					747		7		7	0	109											0				NO	Scheduled Follow-up Submission	2014-3-3	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		YES	54	Pelvic (external iliac, internal iliac, obturator)|Common iliac|Para-aortic		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	6		3		true			No	MX	N1	T1b2	TCGA-C5-A1MP.AA5A1858-A926-4CCE-BC1C-1F1E964EAA96.pdf				A1MP	0	0		TUMOR FREE		0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01	8.7		1995	NO	NO	YES	C5	1	3		Cervical	A	LIVING		2009	a1ff456d-7a22-4200-a429-c2a41e5c3e04	TCGA-C5-A1MP-01	a1ff456d-7a22-4200-a429-c2a41e5c3e04	TCGA-C5-A1MP-01	TCGA-C5-A1MP-01	42E384BE-242F-4BBB-87B1-FAF9D49D8C3D	TCGA-C5-A1MP-01A-11D-A14Z-05	TCGA-C5-A1MP-01A-11D-A14W-08	a1ff456d-7a22-4200-a429-c2a41e5c3e04	TCGA-C5-A1MP-01A-11D-A14W-08	TCGA-C5-A1MP-01A-11D-A14W-08	TCGA-C5-A1MP-01A-11D-A14W-08	TCGA-C5-A1MP-01A-11D-A14W-08	a1ff456d-7a22-4200-a429-c2a41e5c3e04	TCGA-C5-A1MP-01A-11D-A14V-01	TCGA-C5-A1MP-01	TCGA-C5-A1MP-01A-11D-A14V-01
TCGA-C5-A1MQ-01	TCGA-C5-A1MQ-01	TCGA-C5-A1MQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	35		6		TCGA-C5-A1MQ-F31340	TCGA-C5-A1MQ	TCGA-C5-A1MQ-01A		Completed as planned	2400		HDR	ABSENT			Microscopic parametrial involvement			Cisplatin	Stage IIA	70mg	-12836	99	151	151	99	667				23	0	1031			1031	151	99				Once weekly	0	0	Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-30	FEMALE	175	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO			33			PRESENT		G2							NO	0	0	2		true			No	M0	N0	T2b	TCGA-C5-A1MQ.C77E58E6-6536-4DBE-9703-8EA34A3C908B.pdf				A1MQ	2	0	Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation	5120	Primary Tumor	01			1995	YES	NO	YES	C5	1	4		Cervical	A	LIVING	116	2009	1e7b2ed2-be35-4cce-a613-9c8203c49ebb	TCGA-C5-A1MQ-01	1e7b2ed2-be35-4cce-a613-9c8203c49ebb	TCGA-C5-A1MQ-01	TCGA-C5-A1MQ-01	135CDBF1-DF8E-4F67-A2BF-821C1E48EF15	TCGA-C5-A1MQ-01A-11D-A14Z-05	TCGA-C5-A1MQ-01A-11D-A14W-08	1e7b2ed2-be35-4cce-a613-9c8203c49ebb	TCGA-C5-A1MQ-01A-11D-A14W-08	TCGA-C5-A1MQ-01A-11D-A14W-08	TCGA-C5-A1MQ-01A-11D-A14W-08	TCGA-C5-A1MQ-01A-11D-A14W-08	1e7b2ed2-be35-4cce-a613-9c8203c49ebb			
TCGA-C5-A2LS-01	TCGA-C5-A2LS-01	TCGA-C5-A2LS	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					37	17			TCGA-C5-A2LS-F55254	TCGA-C5-A2LS	TCGA-C5-A2LS-01A								margins free of tumor	Other Location, specify				Stage IB2		-13857					2199					0	1345											0						2014-1-3	FEMALE	173	Endocervical Adenocarcinoma of the Usual Type	No						Radical Hysterectomy	C53.9	8380/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO		YES	41					G1							NO	0		2	11	false			No	M0	N0	T1b2	TCGA-C5-A2LS.0D3F75AE-DFF5-47DB-A875-78D35DE393E0.pdf				A2LS	1	0		TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			1995	NO	NO	YES	C5	2	3		Cervical	A	LIVING	92	2005	06121f93-9719-4d96-94e1-5b8afcc347a7	TCGA-C5-A2LS-01	06121f93-9719-4d96-94e1-5b8afcc347a7	TCGA-C5-A2LS-01	TCGA-C5-A2LS-01		TCGA-C5-A2LS-01A-22D-A230-05	TCGA-C5-A2LS-01A-22D-A22X-09	06121f93-9719-4d96-94e1-5b8afcc347a7			TCGA-C5-A2LS-01A-22D-A22X-09	TCGA-C5-A2LS-01A-22D-A22X-09	06121f93-9719-4d96-94e1-5b8afcc347a7	TCGA-C5-A2LS-01A-22D-A22W-01	TCGA-C5-A2LS-01	TCGA-C5-A2LS-01A-22D-A22W-01
TCGA-C5-A2LT-01	TCGA-C5-A2LT-01	TCGA-C5-A2LT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	38	20	6		TCGA-C5-A2LT-F20928	TCGA-C5-A2LT	TCGA-C5-A2LT-01A	Current User					ABSENT		margins free of tumor	Other Location, specify			Cisplatin	Stage IB	50mg/m2	-13966			152	115	3715					0	2226			110	152	115				Once weekly	1	0	Completed as Planned	0		NO	Scheduled Follow-up Submission	2012-1-25	FEMALE	163	Cervical Squamous Cell Carcinoma	No	PCR		70	Other HPV type(s)		Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Keratinizing squamous cell carcinoma		31			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	2	19	false	GP5+/GP6+		No	M0	N0	T1b	TCGA-C5-A2LT.C9125C3D-81F0-4E3A-93BB-E2DD191B0B78.pdf				A2LT	0	0	Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	C5	2	2	Complete response	Cervical	A	LIVING	59	2001	26616de7-08df-4359-9c00-c649409b1480	TCGA-C5-A2LT-01	26616de7-08df-4359-9c00-c649409b1480	TCGA-C5-A2LT-01	TCGA-C5-A2LT-01	A1308ED2-5DA8-4E39-A1D4-6290246973ED	TCGA-C5-A2LT-01A-11D-A18K-05	TCGA-C5-A2LT-01A-11D-A18J-09	26616de7-08df-4359-9c00-c649409b1480			TCGA-C5-A2LT-01A-11D-A18J-09	TCGA-C5-A2LT-01A-11D-A18J-09	26616de7-08df-4359-9c00-c649409b1480	TCGA-C5-A2LT-01A-11D-A18H-01	TCGA-C5-A2LT-01	TCGA-C5-A2LT-01A-11D-A18H-01
TCGA-C5-A2LV-01	TCGA-C5-A2LV-01	TCGA-C5-A2LV	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	36	20		post-operative	TCGA-C5-A2LV-F57088	TCGA-C5-A2LV	TCGA-C5-A2LV-01A	Never Used					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-13447					3016		8			0	2234			69				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0				NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	YES	49	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	1	0	3	16	false	GP5+/GP6+		No	MX	N1	T1b	TCGA-C5-A2LV.7D80B4D1-8480-4C06-9067-CF78DA3EBA69.pdf				A2LV	1	2	Other	TUMOR FREE		0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	C5	2	6	Complete response	Cervical	A	LIVING	84	2003	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	TCGA-C5-A2LV-01	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	TCGA-C5-A2LV-01	TCGA-C5-A2LV-01	7BB3C290-D76B-4013-B020-527ADA351E3F	TCGA-C5-A2LV-01A-11D-A18K-05	TCGA-C5-A2LV-01A-11D-A18J-09	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a			TCGA-C5-A2LV-01A-11D-A18J-09	TCGA-C5-A2LV-01A-11D-A18J-09	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	TCGA-C5-A2LV-01A-11D-A18H-01	TCGA-C5-A2LV-01	TCGA-C5-A2LV-01A-11D-A18H-01
TCGA-C5-A2LX-01	TCGA-C5-A2LX-01	TCGA-C5-A2LX	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	54	18	6		TCGA-C5-A2LX-F57087	TCGA-C5-A2LX	TCGA-C5-A2LX-01A	Former User	Completed as planned			HDR	ABSENT	severe squamous dysplasia (CIN3) extending to the vaginal margin of excision		Positive vaginal margin			Cisplatin	Stage IB1		-20070	77	134	134	77	1583				31	0	2526			73	134	93				Once weekly	1	0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Keratinizing squamous cell carcinoma	NO	39	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	3	0	4	35	false	GP5+/GP6+		No	MX	N1	T2	TCGA-C5-A2LX.CF12FC3E-41CA-48EE-AF88-15ACA2C0067D.pdf				A2LX	0	0	Pre-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					IMRT	5120	Primary Tumor	01			1995	YES	NO	YES	C5	2	4	Complete response	Cervical	A	LIVING	65	2007	c188647f-7c72-4228-acd8-de6e5892f7fe	TCGA-C5-A2LX-01	c188647f-7c72-4228-acd8-de6e5892f7fe	TCGA-C5-A2LX-01	TCGA-C5-A2LX-01	48EC2082-9A47-44FB-9E0E-19120B7365A7	TCGA-C5-A2LX-01A-11D-A18K-05	TCGA-C5-A2LX-01A-11D-A18J-09	c188647f-7c72-4228-acd8-de6e5892f7fe			TCGA-C5-A2LX-01A-11D-A18J-09	TCGA-C5-A2LX-01A-11D-A18J-09	c188647f-7c72-4228-acd8-de6e5892f7fe	TCGA-C5-A2LX-01A-11D-A18H-01	TCGA-C5-A2LX-01	TCGA-C5-A2LX-01A-11D-A18H-01
TCGA-C5-A2LY-01	TCGA-C5-A2LY-01	TCGA-C5-A2LY	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	30		6		TCGA-C5-A2LY-F55200	TCGA-C5-A2LY	TCGA-C5-A2LY-01A	Former User	Completed as planned			HDR	ABSENT						Cisplatin	Stage IB1	40mg/m2	-11018	78	106	106	45	3169		12		12	0	2383			110	106	45		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	0	0	Completed as Planned	0	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	160	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO	Non-keratinizing squamous cell carcinoma	YES	8			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	1		false	GP5+/GP6+		No	M0	N0	T1b1	TCGA-C5-A2LY.BA97051E-10A1-46D8-B5EF-D8163C5430D9.pdf				A2LY	0	0	Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	C5	1	1	Complete response	Cervical	A	LIVING	88	2002	0046fef7-052b-4d4e-b264-b3bf2e2699b1	TCGA-C5-A2LY-01	0046fef7-052b-4d4e-b264-b3bf2e2699b1	TCGA-C5-A2LY-01	TCGA-C5-A2LY-01	C159F07D-C0B9-450E-BC7D-777552F38ADD	TCGA-C5-A2LY-01A-31D-A18K-05	TCGA-C5-A2LY-01A-31D-A18J-09	0046fef7-052b-4d4e-b264-b3bf2e2699b1			TCGA-C5-A2LY-01A-31D-A18J-09	TCGA-C5-A2LY-01A-31D-A18J-09	0046fef7-052b-4d4e-b264-b3bf2e2699b1	TCGA-C5-A2LY-01A-31D-A18H-01	TCGA-C5-A2LY-01	TCGA-C5-A2LY-01A-31D-A18H-01
TCGA-C5-A2LZ-01	TCGA-C5-A2LZ-01	TCGA-C5-A2LZ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		65	15			TCGA-C5-A2LZ-F33609	TCGA-C5-A2LZ	TCGA-C5-A2LZ-01A					LDR						Not done per treating physicians discretion		Stage IIIB		-24059					4886	3046				0			2893									0						2012-7-10	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2				Distant Metastasis			YES			4	50	false			No				TCGA-C5-A2LZ.EF2D354D-F959-45B3-AA5C-170E00AF3F45.pdf	Cervical Cancer			A2LZ	1	0		WITH TUMOR	NO	0		Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			1995	NO	NO	YES	C5	2	5		Cervical	A	DECEASED	85	1998	93810b75-cbbb-4dbb-bbe1-efb66d19516d	TCGA-C5-A2LZ-01	93810b75-cbbb-4dbb-bbe1-efb66d19516d	TCGA-C5-A2LZ-01	TCGA-C5-A2LZ-01	11B6B548-475A-4F7F-A3F1-DBFC8B2BDE6F	TCGA-C5-A2LZ-01A-11D-A212-05	TCGA-C5-A2LZ-01A-11D-A20U-09	93810b75-cbbb-4dbb-bbe1-efb66d19516d			TCGA-C5-A2LZ-01A-11D-A20U-09	TCGA-C5-A2LZ-01A-11D-A20U-09	93810b75-cbbb-4dbb-bbe1-efb66d19516d	TCGA-C5-A2LZ-01A-11D-A20T-01	TCGA-C5-A2LZ-01	TCGA-C5-A2LZ-01A-11D-A20T-01
TCGA-C5-A2M1-01	TCGA-C5-A2M1-01	TCGA-C5-A2M1	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	37				TCGA-C5-A2M1-F63928	TCGA-C5-A2M1	TCGA-C5-A2M1-01A	Former User					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB1		-13835					2275					0	1169			86							1	0				NO	Scheduled Follow-up Submission	2014-8-21	FEMALE	168	Endocervical Type of Adenocarcinoma	No	PCR			HPV 16		Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO		YES	31			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2		false	GP5+/GP6+		No	MX	N0	T1b1	TCGA-C5-A2M1.13B5E17B-0613-4A86-8DB5-1DD3B5AF7A23.pdf				A2M1	0	0	Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	C5	1	2	Complete response	Cervical	A	LIVING	76	2005	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	TCGA-C5-A2M1-01	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	TCGA-C5-A2M1-01	TCGA-C5-A2M1-01		TCGA-C5-A2M1-01A-11D-A18K-05	TCGA-C5-A2M1-01A-11D-A18J-09	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8			TCGA-C5-A2M1-01A-11D-A18J-09	TCGA-C5-A2M1-01A-11D-A18J-09	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	TCGA-C5-A2M1-01A-11D-A18H-01	TCGA-C5-A2M1-01	TCGA-C5-A2M1-01A-11D-A18H-01
TCGA-C5-A2M2-01	TCGA-C5-A2M2-01	TCGA-C5-A2M2	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					56	24			TCGA-C5-A2M2-F55539	TCGA-C5-A2M2	TCGA-C5-A2M2-01A	Former User												Stage IB2		-20480					774	1011			18	0	25											0			Bladder Absent|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-3	FEMALE		Endocervical Type of Adenocarcinoma	No							C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			1	8	false			No				TCGA-C5-A2M2.716583F1-32F6-4CAC-853F-7A0773BB31F9.pdf				A2M2	0	0				0										Primary Tumor	01		2003	2009		NO	YES	C5	4	1		Cervical	A	DECEASED		2009	00471faf-5a40-430a-8555-564fa885f618	TCGA-C5-A2M2-01	00471faf-5a40-430a-8555-564fa885f618	TCGA-C5-A2M2-01	TCGA-C5-A2M2-01	E8A1C40D-96A1-4505-9E4B-42CC804182E2	TCGA-C5-A2M2-01A-21D-A18K-05	TCGA-C5-A2M2-01A-21D-A18J-09	00471faf-5a40-430a-8555-564fa885f618			TCGA-C5-A2M2-01A-21D-A18J-09	TCGA-C5-A2M2-01A-21D-A18J-09	00471faf-5a40-430a-8555-564fa885f618	TCGA-C5-A2M2-01A-21D-A18H-01	TCGA-C5-A2M2-01	TCGA-C5-A2M2-01A-21D-A18H-01
TCGA-C5-A3HD-01	TCGA-C5-A3HD-01	TCGA-C5-A3HD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	51	16			TCGA-C5-A3HD-F55537	TCGA-C5-A3HD		Former User	Completed as planned			HDR							Cisplatin	Stage IIB		-18690	13			17					3	0	1582			0		13					1	0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	170	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				YES						G2							NO			2	27				No								A3HD	0	0	Preoperative	TUMOR FREE		0		Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1995	1995	YES	NO	YES	C5	4	2	Complete response	Cervical		LIVING	83	2004	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	TCGA-C5-A3HD-01	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	TCGA-C5-A3HD-01	TCGA-C5-A3HD-01		TCGA-C5-A3HD-01B-11D-A212-05	TCGA-C5-A3HD-01B-11D-A20U-09	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d			TCGA-C5-A3HD-01B-11D-A20U-09	TCGA-C5-A3HD-01B-11D-A20U-09	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	TCGA-C5-A3HD-01B-11D-A20T-01	TCGA-C5-A3HD-01	TCGA-C5-A3HD-01B-11D-A20T-01
TCGA-C5-A3HE-01	TCGA-C5-A3HE-01	TCGA-C5-A3HE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					44				TCGA-C5-A3HE-F55255	TCGA-C5-A3HE	TCGA-C5-A3HE-01A								margins free of tumor	Other Location, specify				Stage IB2		-16139					1801					0	548											0						2014-1-3	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO	Non-keratinizing squamous cell carcinoma	YES						G3							YES			0		true			No	M0	N0	T1b2	TCGA-C5-A3HE.8D7665DB-F820-4545-81C8-233A3AE3F9C9.pdf				A3HE	0	1			NO	0	NO		YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	1	1		Cervical	A	LIVING		2006	e26f5a99-6a8d-429e-8849-8a9b5680d466	TCGA-C5-A3HE-01	e26f5a99-6a8d-429e-8849-8a9b5680d466	TCGA-C5-A3HE-01	TCGA-C5-A3HE-01	8AD07B41-00BD-4A85-84CA-F529626BF6C3	TCGA-C5-A3HE-01A-21D-A230-05	TCGA-C5-A3HE-01A-21D-A22X-09	e26f5a99-6a8d-429e-8849-8a9b5680d466			TCGA-C5-A3HE-01A-21D-A22X-09	TCGA-C5-A3HE-01A-21D-A22X-09	e26f5a99-6a8d-429e-8849-8a9b5680d466	TCGA-C5-A3HE-01A-21D-A22W-01	TCGA-C5-A3HE-01	TCGA-C5-A3HE-01A-21D-A22W-01
TCGA-C5-A3HF-01	TCGA-C5-A3HF-01	TCGA-C5-A3HF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	NO	Progressive Disease	YES	24	16			TCGA-C5-A3HF-F30756	TCGA-C5-A3HF	TCGA-C5-A3HF-01A		Completed as planned			HDR						Not done per treating physicians discretion		Stage IB2		-9115	71	88			5464	543				0			450		101	57						0	Completed as Planned	5040		NO	Scheduled Follow-up Submission	2012-4-16	FEMALE		Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO			32	Pelvic (external iliac, internal iliac, obturator)|Para-aortic			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify	CT	Other, specify	Distant Metastasis	Pelvis		YES	11		1	9	true			No				TCGA-C5-A3HF.BDC1F089-937D-4812-9EF6-259A00FEAB80.pdf	Cervical Cancer			A3HF	0	0		WITH TUMOR		0	YES		YES					External beam radiation	5040	Primary Tumor	01			1995	NO	NO	YES	C5	2	1		Cervical	A	DECEASED		1996	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	TCGA-C5-A3HF-01	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	TCGA-C5-A3HF-01	TCGA-C5-A3HF-01	98528687-3F27-43C9-9472-C399EA10D856	TCGA-C5-A3HF-01A-11D-A212-05	TCGA-C5-A3HF-01A-11D-A20U-09	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa			TCGA-C5-A3HF-01A-11D-A20U-09	TCGA-C5-A3HF-01A-11D-A20U-09	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	TCGA-C5-A3HF-01A-11D-A20T-01	TCGA-C5-A3HF-01	TCGA-C5-A3HF-01A-11D-A20T-01
TCGA-C5-A3HL-01	TCGA-C5-A3HL-01	TCGA-C5-A3HL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	76				TCGA-C5-A3HL-F47688	TCGA-C5-A3HL	TCGA-C5-A3HL-01A	Never Used					ABSENT		margins free of tumor	Other Location, specify				Stage IB2		-27963					1519					0	621				174	130						0	Completed as Planned			NO	Scheduled Follow-up Submission	2014-6-16	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Keratinizing squamous cell carcinoma	YES	21			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	4		true			No	MX	N0	T1b2	TCGA-C5-A3HL.0A258AD5-AE6C-4866-AE39-78C29DB89CAF.pdf				A3HL	0	1		TUMOR FREE		0	YES	Complete Remission/Response	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	1	5	Complete response	Cervical	A	LIVING		2007	3337929b-5381-41ae-88f2-b6dbeb17f088	TCGA-C5-A3HL-01	3337929b-5381-41ae-88f2-b6dbeb17f088	TCGA-C5-A3HL-01	TCGA-C5-A3HL-01	7DA4AAC5-2CE9-49F6-A3AA-DBD843C5CF20	TCGA-C5-A3HL-01A-11D-A212-05	TCGA-C5-A3HL-01A-11D-A20U-09	3337929b-5381-41ae-88f2-b6dbeb17f088			TCGA-C5-A3HL-01A-11D-A20U-09	TCGA-C5-A3HL-01A-11D-A20U-09	3337929b-5381-41ae-88f2-b6dbeb17f088	TCGA-C5-A3HL-01A-11D-A20T-01	TCGA-C5-A3HL-01	TCGA-C5-A3HL-01A-11D-A20T-01
TCGA-C5-A7CG-01	TCGA-C5-A7CG-01	TCGA-C5-A7CG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		55				TCGA-C5-A7CG-F63991	TCGA-C5-A7CG	TCGA-C5-A7CG-01A	Never Used							margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-20242					6043		20			0	6408											0						2014-8-22	FEMALE	169	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Keratinizing squamous cell carcinoma	NO	47					G2							NO	0		5		true			No	MX	N0	T1b	TCGA-C5-A7CG.E511E773-AAEF-4685-AC83-3EF5F31C489F.pdf				A7CG	0	0		TUMOR FREE	NO	1	YES		NO							Primary Tumor	01			1995	NO	NO	YES	C5	1	6		Cervical	A	LIVING	94	1997	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	TCGA-C5-A7CG-01	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	TCGA-C5-A7CG-01	TCGA-C5-A7CG-01	9864C71F-FFC6-4BAD-99FA-EA39BEBD99DC	TCGA-C5-A7CG-01A-11D-A32T-05	TCGA-C5-A7CG-01A-11D-A32I-09	5abdff9b-a6a9-4564-9ac3-98a563f65fe6			TCGA-C5-A7CG-01A-11D-A32I-09	TCGA-C5-A7CG-01A-11D-A32I-09	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	TCGA-C5-A7CG-01A-11D-A32H-01	TCGA-C5-A7CG-01	TCGA-C5-A7CG-01A-11D-A32H-01
TCGA-C5-A7CH-01	TCGA-C5-A7CH-01	TCGA-C5-A7CH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		43				TCGA-C5-A7CH-F63994	TCGA-C5-A7CH	TCGA-C5-A7CH-01A													Stage IIB		-15777					4329					0	4694											0						2014-8-22	FEMALE	161	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Keratinizing squamous cell carcinoma	NO						G2							NO			8		true			No				TCGA-C5-A7CH.68C37151-5277-4370-BEA9-5DBD6429E06F.pdf				A7CH	0	1		TUMOR FREE	YES	0			YES							Primary Tumor	01			1995	YES	NO	YES	C5	1	9		Cervical	A	LIVING	104	2001	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	TCGA-C5-A7CH-01	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	TCGA-C5-A7CH-01	TCGA-C5-A7CH-01		TCGA-C5-A7CH-01A-11D-A340-05	TCGA-C5-A7CH-01A-11D-A33O-09	09f55b71-b6ee-42a5-96eb-6a2929e35bbf			TCGA-C5-A7CH-01A-11D-A33O-09	TCGA-C5-A7CH-01A-11D-A33O-09	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	TCGA-C5-A7CH-01A-11D-A33N-01	TCGA-C5-A7CH-01	TCGA-C5-A7CH-01A-11D-A33N-01
TCGA-C5-A7CJ-01	TCGA-C5-A7CJ-01	TCGA-C5-A7CJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					42	22				TCGA-C5-A7CJ	TCGA-C5-A7CJ-01A								margins free of tumor	Other Location, specify			Cisplatin	Stage IIA		-15652					3977	3097				0												0						2014-1-3	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Keratinizing squamous cell carcinoma		30	Pelvic (external iliac, internal iliac, obturator)				G2							NO	2		2	30	true			No	MX	N1	T2a	TCGA-C5-A7CJ.3EA65A3A-81EC-4121-AFA9-620B37BB23A8.pdf				A7CJ	0	0		TUMOR FREE	YES	0	YES		YES					External beam radiation		Primary Tumor	01			1995	YES	NO	YES	C5	2	2		Cervical	A	DECEASED	60	2002	723cafa2-ce72-4c19-954b-9be09a1b08e9	TCGA-C5-A7CJ-01	723cafa2-ce72-4c19-954b-9be09a1b08e9	TCGA-C5-A7CJ-01	TCGA-C5-A7CJ-01		TCGA-C5-A7CJ-01A-11D-A32T-05	TCGA-C5-A7CJ-01A-11D-A32I-09	723cafa2-ce72-4c19-954b-9be09a1b08e9			TCGA-C5-A7CJ-01A-11D-A32I-09	TCGA-C5-A7CJ-01A-11D-A32I-09	723cafa2-ce72-4c19-954b-9be09a1b08e9	TCGA-C5-A7CJ-01A-11D-A32H-01	TCGA-C5-A7CJ-01	TCGA-C5-A7CJ-01A-11D-A32H-01
TCGA-C5-A7CK-01	TCGA-C5-A7CK-01	TCGA-C5-A7CK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					58					TCGA-C5-A7CK	TCGA-C5-A7CK-01A												Cisplatin	Stage IVA		-21520					4483	4086				0												0						2014-1-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Keratinizing squamous cell carcinoma							G2							NO			3	40	true			No				TCGA-C5-A7CK.6E6806E3-7BAD-48EB-AAE9-9C15DAC56B2E.pdf				A7CK	0	0		TUMOR FREE	YES	0			YES							Primary Tumor	01			1995	YES	NO	YES	C5	5	3		Cervical	A	DECEASED	55	2001	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	TCGA-C5-A7CK-01	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	TCGA-C5-A7CK-01	TCGA-C5-A7CK-01	6BA5E751-37D0-493C-B9C6-69062263C497	TCGA-C5-A7CK-01A-11D-A32T-05	TCGA-C5-A7CK-01A-11D-A32I-09	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb			TCGA-C5-A7CK-01A-11D-A32I-09	TCGA-C5-A7CK-01A-11D-A32I-09	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	TCGA-C5-A7CK-01A-11D-A32H-01	TCGA-C5-A7CK-01	TCGA-C5-A7CK-01A-11D-A32H-01
TCGA-C5-A7CL-01	TCGA-C5-A7CL-01	TCGA-C5-A7CL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					48	29				TCGA-C5-A7CL	TCGA-C5-A7CL-01A												Cisplatin	Stage IIIB		-17869					4090	471				0												0						2014-1-3	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO	Keratinizing squamous cell carcinoma							G2							NO			3	20	true			No				TCGA-C5-A7CL.8AC84EA1-1A57-4263-9AA1-832DFAABBA08.pdf	Cervical Cancer			A7CL	0	0		WITH TUMOR	YES	0			YES							Primary Tumor	01			1995	YES	NO	YES	C5	2	3		Cervical	A	DECEASED	103	2002	131525c8-7f24-48c3-bef9-cc9414e793b8	TCGA-C5-A7CL-01	131525c8-7f24-48c3-bef9-cc9414e793b8	TCGA-C5-A7CL-01	TCGA-C5-A7CL-01		TCGA-C5-A7CL-01A-11D-A32T-05	TCGA-C5-A7CL-01A-11D-A32I-09	131525c8-7f24-48c3-bef9-cc9414e793b8			TCGA-C5-A7CL-01A-11D-A32I-09	TCGA-C5-A7CL-01A-11D-A32I-09	131525c8-7f24-48c3-bef9-cc9414e793b8	TCGA-C5-A7CL-01A-11D-A32H-01	TCGA-C5-A7CL-01	TCGA-C5-A7CL-01A-11D-A32H-01
TCGA-C5-A7CM-01	TCGA-C5-A7CM-01	TCGA-C5-A7CM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		35				TCGA-C5-A7CM-F63996	TCGA-C5-A7CM						HDR							Cisplatin	Stage IB2		-12853										0	619			294							0							2014-8-22	FEMALE	168	Endocervical Adenocarcinoma of the Usual Type	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO						G2							NO								No								A7CM			Post-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1997	2009	YES	NO	YES	C5	4			Cervical		LIVING	75	2012	f227e397-0bc7-4e98-a7ea-befd78191cc3	TCGA-C5-A7CM-01	f227e397-0bc7-4e98-a7ea-befd78191cc3	TCGA-C5-A7CM-01	TCGA-C5-A7CM-01		TCGA-C5-A7CM-01A-11D-A340-05	TCGA-C5-A7CM-01A-11D-A33O-09	f227e397-0bc7-4e98-a7ea-befd78191cc3			TCGA-C5-A7CM-01A-11D-A33O-09	TCGA-C5-A7CM-01A-11D-A33O-09	f227e397-0bc7-4e98-a7ea-befd78191cc3	TCGA-C5-A7CM-01A-11D-A33N-01	TCGA-C5-A7CM-01	TCGA-C5-A7CM-01A-11D-A33N-01
TCGA-C5-A7CO-01	TCGA-C5-A7CO-01	TCGA-C5-A7CO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		68	20			TCGA-C5-A7CO-F63995	TCGA-C5-A7CO	TCGA-C5-A7CO-01A												Cisplatin	Stage IB2		-25045					4117					0	4482											0						2014-8-22	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.0	8070/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			5	38	true			No				TCGA-C5-A7CO.D677E858-2615-413D-859E-5889286B4398.pdf				A7CO	0	0		TUMOR FREE	YES	0		Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1972	1995	YES	NO	YES	C5	3	5		Cervical	A	LIVING	98	2002	3292c30c-9fa5-4c11-a6ff-57282c7961fa	TCGA-C5-A7CO-01	3292c30c-9fa5-4c11-a6ff-57282c7961fa	TCGA-C5-A7CO-01	TCGA-C5-A7CO-01		TCGA-C5-A7CO-01A-11D-A357-05	TCGA-C5-A7CO-01A-11D-A351-09	3292c30c-9fa5-4c11-a6ff-57282c7961fa			TCGA-C5-A7CO-01A-11D-A351-09	TCGA-C5-A7CO-01A-11D-A351-09	3292c30c-9fa5-4c11-a6ff-57282c7961fa	TCGA-C5-A7CO-01A-11D-A350-01	TCGA-C5-A7CO-01	TCGA-C5-A7CO-01A-11D-A350-01
TCGA-C5-A7UC-01	TCGA-C5-A7UC-01	TCGA-C5-A7UC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					48					TCGA-C5-A7UC	TCGA-C5-A7UC-01A								margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-17765					3993	523				0																		2014-1-3	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES			20	NO	Non-keratinizing squamous cell carcinoma		27					G3								0				true			No	M0	N0	T1b	TCGA-C5-A7UC.C9E3A2CF-96E4-4DB5-A47B-9CADB3555A61.pdf				A7UC				TUMOR FREE	NO		YES		NO							Primary Tumor	01			1995	NO	NO	YES	C5				Cervical	A	DECEASED		2002	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	TCGA-C5-A7UC-01	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	TCGA-C5-A7UC-01	TCGA-C5-A7UC-01		TCGA-C5-A7UC-01A-11D-A357-05	TCGA-C5-A7UC-01A-11D-A351-09	4dfd8634-77b6-40c5-9b01-e9e4e354be1e			TCGA-C5-A7UC-01A-11D-A351-09	TCGA-C5-A7UC-01A-11D-A351-09	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	TCGA-C5-A7UC-01A-11D-A350-01	TCGA-C5-A7UC-01	TCGA-C5-A7UC-01A-11D-A350-01
TCGA-C5-A7UE-01	TCGA-C5-A7UE-01	TCGA-C5-A7UE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		45	17	6		TCGA-C5-A7UE-F66716	TCGA-C5-A7UE	TCGA-C5-A7UE-01A					HDR							Cisplatin	Stage IB1	1000 ml	-16473					4375					0	4738											0						2014-10-22	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO		NO	23	Pelvic (external iliac, internal iliac, obturator)				G2	Lung			New Primary Tumor			YES	1		3	35	true			No				TCGA-C5-A7UE.445F27B0-FFBC-474E-A750-04052A852FB2.pdf				A7UE	0	1		TUMOR FREE	YES	0	YES	Complete Remission/Response	YES						3060	Primary Tumor	01			1995	YES	NO	YES	C5	2	4		Cervical	A	LIVING	63	2001	41a6b734-2741-4d93-8813-ed27b21c81c0	TCGA-C5-A7UE-01	41a6b734-2741-4d93-8813-ed27b21c81c0	TCGA-C5-A7UE-01	TCGA-C5-A7UE-01		TCGA-C5-A7UE-01A-11D-A340-05	TCGA-C5-A7UE-01A-11D-A33O-09	41a6b734-2741-4d93-8813-ed27b21c81c0			TCGA-C5-A7UE-01A-11D-A33O-09	TCGA-C5-A7UE-01A-11D-A33O-09	41a6b734-2741-4d93-8813-ed27b21c81c0	TCGA-C5-A7UE-01A-11D-A33N-01	TCGA-C5-A7UE-01	TCGA-C5-A7UE-01A-11D-A33N-01
TCGA-C5-A7UH-01	TCGA-C5-A7UH-01	TCGA-C5-A7UH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		55				TCGA-C5-A7UH-F66737	TCGA-C5-A7UH	TCGA-C5-A7UH-01A	Former User				HDR							Cisplatin	Stage IIIB		-20189					3604					0	3988											0						2014-10-22	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	10	NO		NO						G3							NO			2		true			No				TCGA-C5-A7UH.5D5876DB-6A68-4862-8982-8E15F26C9BF9.pdf				A7UH	0	0		TUMOR FREE	YES	0			YES					External beam radiation		Primary Tumor	01			1995	YES	NO	YES	C5	1	2		Cervical	A	LIVING	56	2003	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	TCGA-C5-A7UH-01	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	TCGA-C5-A7UH-01	TCGA-C5-A7UH-01		TCGA-C5-A7UH-01A-11D-A357-05	TCGA-C5-A7UH-01A-11D-A351-09	1bf205a9-a7fb-4a53-8b3d-9943b91481c2			TCGA-C5-A7UH-01A-11D-A351-09	TCGA-C5-A7UH-01A-11D-A351-09	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	TCGA-C5-A7UH-01A-11D-A350-01	TCGA-C5-A7UH-01	TCGA-C5-A7UH-01A-11D-A350-01
TCGA-C5-A7UI-01	TCGA-C5-A7UI-01	TCGA-C5-A7UI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					42					TCGA-C5-A7UI	TCGA-C5-A7UI-01A								margins free of tumor	Other Location, specify				Stage IB1		-15349					3221	2888				0																		2014-4-1	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma		24					G3							NO	0		3	12	true			No	MX	N0	T1b1	TCGA-C5-A7UI.A07E7AF1-55EA-4EA1-A5DA-A54E17771CA9.pdf				A7UI	1			TUMOR FREE	NO		YES		NO							Primary Tumor	01			1995		NO	YES	C5	2	4		Cervical	A	DECEASED	86	2004	01d666b4-9605-422a-bfba-231b0d6ef20f	TCGA-C5-A7UI-01	01d666b4-9605-422a-bfba-231b0d6ef20f	TCGA-C5-A7UI-01	TCGA-C5-A7UI-01		TCGA-C5-A7UI-01A-11D-A36K-05		01d666b4-9605-422a-bfba-231b0d6ef20f					01d666b4-9605-422a-bfba-231b0d6ef20f	TCGA-C5-A7UI-01A-11D-A36I-01	TCGA-C5-A7UI-01	TCGA-C5-A7UI-01A-11D-A36I-01
TCGA-C5-A7X3-01	TCGA-C5-A7X3-01	TCGA-C5-A7X3	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					70					TCGA-C5-A7X3	TCGA-C5-A7X3-01A	Never Used				HDR							Cisplatin|Other	Stage IIIB		-25665					5915	284				0												0						2014-1-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma							G2							NO			7		true		|5 fu RTOG protocol	No				TCGA-C5-A7X3.34E0772A-D90C-48BE-86CF-E7968CADDFD7.pdf				A7X3	0	0		TUMOR FREE	YES	0			YES					External beam radiation	3060	Primary Tumor	01			1995	YES	NO	YES	C5	1	7		Cervical	A	DECEASED	79	1997	fb4a5161-67f4-4679-8d85-bb1843f3b897	TCGA-C5-A7X3-01	fb4a5161-67f4-4679-8d85-bb1843f3b897	TCGA-C5-A7X3-01	TCGA-C5-A7X3-01	BB6C8BE2-DCC9-43E3-A15F-19252A08BBA9	TCGA-C5-A7X3-01A-11D-A357-05	TCGA-C5-A7X3-01A-11D-A351-09	fb4a5161-67f4-4679-8d85-bb1843f3b897			TCGA-C5-A7X3-01A-11D-A351-09	TCGA-C5-A7X3-01A-11D-A351-09	fb4a5161-67f4-4679-8d85-bb1843f3b897	TCGA-C5-A7X3-01A-11D-A350-01	TCGA-C5-A7X3-01	TCGA-C5-A7X3-01A-11D-A350-01
TCGA-C5-A7X5-01	TCGA-C5-A7X5-01	TCGA-C5-A7X5	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					72					TCGA-C5-A7X5	TCGA-C5-A7X5-01A					HDR							Carboplatin|Other	Stage IVB		-26542					3836	414				0																		2014-1-3	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Keratinizing squamous cell carcinoma							G3							NO					true		|Taxol	No				TCGA-C5-A7X5.0807894B-043D-4074-85C4-6C7BFB2C8C54.pdf	Cervical Cancer			A7X5				WITH TUMOR	YES				YES							Primary Tumor	01			1995	YES	NO	YES	C5				Cervical	A	DECEASED	59	2003	39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	TCGA-C5-A7X5-01	39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	TCGA-C5-A7X5-01	TCGA-C5-A7X5-01		TCGA-C5-A7X5-01A-11D-A36K-05		39d645d6-f7ca-4a01-a3b0-5ae3754c8a68					39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	TCGA-C5-A7X5-01A-11D-A36I-01	TCGA-C5-A7X5-01	TCGA-C5-A7X5-01A-11D-A36I-01
TCGA-C5-A7X8-01	TCGA-C5-A7X8-01	TCGA-C5-A7X8	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					35	25				TCGA-C5-A7X8	TCGA-C5-A7X8-01A					HDR			margins free of tumor	Other Location, specify			Cisplatin	Stage IB1		-12977					3868					0	83											0						2014-1-3	FEMALE	170	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO			27	Pelvic (external iliac, internal iliac, obturator)		PRESENT		G2							NO	1		2	5	true			No	M0	N1	T2a	TCGA-C5-A7X8.06979EDA-C06B-46E7-A4B0-C20D1E340F4B.pdf				A7X8	1	0		TUMOR FREE	YES	0	YES		YES					External beam radiation	720	Primary Tumor	01			1995	YES	NO	YES	C5	2	3		Cervical	A	LIVING	74	2003	7a835fc9-6dfb-464a-bbe0-d42782abab4c	TCGA-C5-A7X8-01	7a835fc9-6dfb-464a-bbe0-d42782abab4c	TCGA-C5-A7X8-01	TCGA-C5-A7X8-01		TCGA-C5-A7X8-01A-11D-A36K-05		7a835fc9-6dfb-464a-bbe0-d42782abab4c					7a835fc9-6dfb-464a-bbe0-d42782abab4c	TCGA-C5-A7X8-01A-11D-A36I-01	TCGA-C5-A7X8-01	TCGA-C5-A7X8-01A-11D-A36I-01
TCGA-C5-A7XC-01	TCGA-C5-A7XC-01	TCGA-C5-A7XC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					26				TCGA-C5-A7XC-F66722	TCGA-C5-A7XC	TCGA-C5-A7XC-01A								margins free of tumor	Other Location, specify				Stage IB1		-9776					3358					0	1551																	2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO		YES	42					G2							NO	0		1	5	true			No	M0	N0	T1b	TCGA-C5-A7XC.5BE71CCD-AA13-4B9E-BD99-2122F9A00B3A.pdf				A7XC				TUMOR FREE	NO		YES		NO							Primary Tumor	01			1995		NO	YES	C5	2	1		Cervical	A	LIVING	53	2004	8130cfd8-49c8-429d-b559-7ff8f1d359fa	TCGA-C5-A7XC-01	8130cfd8-49c8-429d-b559-7ff8f1d359fa	TCGA-C5-A7XC-01	TCGA-C5-A7XC-01		TCGA-C5-A7XC-01A-11D-A388-05		8130cfd8-49c8-429d-b559-7ff8f1d359fa					8130cfd8-49c8-429d-b559-7ff8f1d359fa	TCGA-C5-A7XC-01A-11D-A386-01	TCGA-C5-A7XC-01	TCGA-C5-A7XC-01A-11D-A386-01
TCGA-C5-A8XH-01	TCGA-C5-A8XH-01	TCGA-C5-A8XH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					39					TCGA-C5-A8XH									margins free of tumor	Other Location, specify				Stage IB1		-14444						1394				0																		2014-4-17	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Keratinizing squamous cell carcinoma		33												NO	0		2	20				No	MX	N0	T1b1					A8XH				TUMOR FREE	NO		YES		NO							Primary Tumor	01		2007	2009		NO	YES	C5	4	2		Cervical		DECEASED	60	2007	ea9fda3a-9efa-4847-aea0-d85f22ab14ca	TCGA-C5-A8XH-01	ea9fda3a-9efa-4847-aea0-d85f22ab14ca	TCGA-C5-A8XH-01	TCGA-C5-A8XH-01		TCGA-C5-A8XH-01A-11D-A37Q-05		ea9fda3a-9efa-4847-aea0-d85f22ab14ca					ea9fda3a-9efa-4847-aea0-d85f22ab14ca	TCGA-C5-A8XH-01A-11D-A37M-01	TCGA-C5-A8XH-01	TCGA-C5-A8XH-01A-11D-A37M-01
TCGA-C5-A8XI-01	TCGA-C5-A8XI-01	TCGA-C5-A8XI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					69	29			TCGA-C5-A8XI-F66724	TCGA-C5-A8XI	TCGA-C5-A8XI-01A								margins free of tumor	Other Location, specify				Stage IB2		-25220					2069					0	254																	2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	YES	10				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		4	57	true			No	MX	N0	T1b2	TCGA-C5-A8XI.57D0E001-5535-4687-B04D-5CBEF5D6EF6F.pdf				A8XI	1			TUMOR FREE	YES		YES		YES							Primary Tumor	01			1995		NO	YES	C5	2	5		Cervical	A	LIVING		2008	d1d352f8-4919-4288-8e6a-bbf550a7236b	TCGA-C5-A8XI-01	d1d352f8-4919-4288-8e6a-bbf550a7236b	TCGA-C5-A8XI-01	TCGA-C5-A8XI-01	49680150-87AC-4D5E-A4CE-CE96E2997D53	TCGA-C5-A8XI-01A-11D-A37Q-05		d1d352f8-4919-4288-8e6a-bbf550a7236b					d1d352f8-4919-4288-8e6a-bbf550a7236b	TCGA-C5-A8XI-01A-11D-A37M-01	TCGA-C5-A8XI-01	TCGA-C5-A8XI-01A-11D-A37M-01
TCGA-C5-A8XJ-01	TCGA-C5-A8XJ-01	TCGA-C5-A8XJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		74				TCGA-C5-A8XJ-F66731	TCGA-C5-A8XJ	TCGA-C5-A8XJ-01A													Stage IB		-27087					4175					0	4467																	2014-10-22	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		NO													NO			4		true			Yes				TCGA-C5-A8XJ.0758C57C-F182-48E1-BEA7-27C5B9206FB9.pdf				A8XJ				TUMOR FREE	YES		NO		YES							Primary Tumor	01			1995		NO	YES	C5	1	4		Cervical	A	LIVING	114	2002	971dec7f-6cb5-4575-85f7-be59097ae606	TCGA-C5-A8XJ-01	971dec7f-6cb5-4575-85f7-be59097ae606	TCGA-C5-A8XJ-01	TCGA-C5-A8XJ-01	E396C1F2-2B80-413F-822F-056FA27A5C88	TCGA-C5-A8XJ-01A-11D-A37Q-05		971dec7f-6cb5-4575-85f7-be59097ae606					971dec7f-6cb5-4575-85f7-be59097ae606	TCGA-C5-A8XJ-01A-11D-A37M-01	TCGA-C5-A8XJ-01	TCGA-C5-A8XJ-01A-11D-A37M-01
TCGA-C5-A8XK-01	TCGA-C5-A8XK-01	TCGA-C5-A8XK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					30				TCGA-C5-A8XK-F66732	TCGA-C5-A8XK	TCGA-C5-A8XK-01A															-11268					4840					0	3039																	2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO		YES						G3							NO					true			No				TCGA-C5-A8XK.1F6ED6D4-2EF5-4F87-8F4E-08CD7834A2E5.pdf				A8XK				TUMOR FREE	YES		NO		YES							Primary Tumor	01				YES	NO	YES	C5				Cervical	A	LIVING		2000	94f22e5d-e471-4add-9291-27bc5c96a519	TCGA-C5-A8XK-01	94f22e5d-e471-4add-9291-27bc5c96a519	TCGA-C5-A8XK-01	TCGA-C5-A8XK-01		TCGA-C5-A8XK-01A-11D-A37Q-05		94f22e5d-e471-4add-9291-27bc5c96a519					94f22e5d-e471-4add-9291-27bc5c96a519	TCGA-C5-A8XK-01A-11D-A37M-01	TCGA-C5-A8XK-01	TCGA-C5-A8XK-01A-11D-A37M-01
TCGA-C5-A8YQ-01	TCGA-C5-A8YQ-01	TCGA-C5-A8YQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					79	23				TCGA-C5-A8YQ														Stage IB1		-28873						715				0																		2014-4-17	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)					23				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	3		1	56				No					Cervical Cancer			A8YQ				WITH TUMOR	YES		YES		YES							Primary Tumor	01			1995		NO	YES	C5	2	2		Cervical		DECEASED	70	2006	f11b075c-7ada-4945-b3a2-2eee097c077d	TCGA-C5-A8YQ-01	f11b075c-7ada-4945-b3a2-2eee097c077d	TCGA-C5-A8YQ-01	TCGA-C5-A8YQ-01		TCGA-C5-A8YQ-01A-11D-A37Q-05		f11b075c-7ada-4945-b3a2-2eee097c077d					f11b075c-7ada-4945-b3a2-2eee097c077d	TCGA-C5-A8YQ-01A-11D-A37M-01	TCGA-C5-A8YQ-01	TCGA-C5-A8YQ-01A-11D-A37M-01
TCGA-C5-A8YR-01	TCGA-C5-A8YR-01	TCGA-C5-A8YR	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					56					TCGA-C5-A8YR	TCGA-C5-A8YR-01A													Stage IB		-20672					7049	837				0																		2014-4-1	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO	Non-keratinizing squamous cell carcinoma		29					G3							YES	0		4		true			No	M0	N0	T1b	TCGA-C5-A8YR.C808B5E4-A426-4E68-9BFE-A98533562FD4.pdf				A8YR	2				NO		YES		NO							Primary Tumor	01			1988		NO	YES	C5	1	6		Cervical	A	DECEASED	80	1994	073d66b5-917e-45e3-8104-b8d4dfa28e6b	TCGA-C5-A8YR-01	073d66b5-917e-45e3-8104-b8d4dfa28e6b	TCGA-C5-A8YR-01	TCGA-C5-A8YR-01		TCGA-C5-A8YR-01A-12D-A37Q-05		073d66b5-917e-45e3-8104-b8d4dfa28e6b					073d66b5-917e-45e3-8104-b8d4dfa28e6b	TCGA-C5-A8YR-01A-12D-A37M-01	TCGA-C5-A8YR-01	TCGA-C5-A8YR-01A-12D-A37M-01
TCGA-C5-A8YT-01	TCGA-C5-A8YT-01	TCGA-C5-A8YT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					36	16			TCGA-C5-A8YT-F66723	TCGA-C5-A8YT	TCGA-C5-A8YT-01A	Never Used												Stage IB1		-13253					1939	633				0	186																	2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO						G3							NO			3	20	true			No				TCGA-C5-A8YT.78E3AF70-E5A9-4A7F-ABD1-4E08238EAB9D.pdf				A8YT				WITH TUMOR	YES		NO		YES							Primary Tumor	01			1995		NO	YES	C5	2	3		Cervical	A	DECEASED		2008	6cec0faf-100b-48b0-9221-fb1be7ff8597	TCGA-C5-A8YT-01	6cec0faf-100b-48b0-9221-fb1be7ff8597	TCGA-C5-A8YT-01	TCGA-C5-A8YT-01		TCGA-C5-A8YT-01A-11D-A37Q-05		6cec0faf-100b-48b0-9221-fb1be7ff8597					6cec0faf-100b-48b0-9221-fb1be7ff8597	TCGA-C5-A8YT-01A-11D-A37M-01	TCGA-C5-A8YT-01	TCGA-C5-A8YT-01A-11D-A37M-01
TCGA-C5-A8ZZ-01	TCGA-C5-A8ZZ-01	TCGA-C5-A8ZZ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					41	21			TCGA-C5-A8ZZ-F66736	TCGA-C5-A8ZZ	TCGA-C5-A8ZZ-01A													Stage IIB		-15262					3023					0	636											0						2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Cone Biopsy / LEEP	70	NO	Keratinizing squamous cell carcinoma	YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			4	20	false			No				TCGA-C5-A8ZZ.38E42051-6D04-4C54-BA9A-8206CC0AFBCB.pdf				A8ZZ	0	0		TUMOR FREE	YES	0			YES							Primary Tumor	01			1995		NO	YES	C5	2	4		Cervical	A	LIVING		2005	5f23cd19-f7f0-43e3-961d-0236da5f49ae	TCGA-C5-A8ZZ-01	5f23cd19-f7f0-43e3-961d-0236da5f49ae	TCGA-C5-A8ZZ-01	TCGA-C5-A8ZZ-01		TCGA-C5-A8ZZ-01A-11D-A37Q-05		5f23cd19-f7f0-43e3-961d-0236da5f49ae					5f23cd19-f7f0-43e3-961d-0236da5f49ae	TCGA-C5-A8ZZ-01A-11D-A37M-01	TCGA-C5-A8ZZ-01	TCGA-C5-A8ZZ-01A-11D-A37M-01
TCGA-C5-A901-01	TCGA-C5-A901-01	TCGA-C5-A901	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					44				TCGA-C5-A901-F66739	TCGA-C5-A901	TCGA-C5-A901-01A									Positive vaginal margin						-16186					4811					0	518																	2014-10-22	FEMALE	166	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	20	NO	Keratinizing squamous cell carcinoma	YES	19	Pelvic (external iliac, internal iliac, obturator)				G2							NO	2			2	false			No	MX	N1	TX	TCGA-C5-A901.5190FB9E-E28B-4CAB-9FB1-9DF839F2D977.pdf				A901				TUMOR FREE	NO		YES		NO							Primary Tumor	01			5th		NO	YES	C5	5	0		Cervical	A	LIVING	54	2000	8f532265-5436-4bd8-9766-4b768c84514a	TCGA-C5-A901-01	8f532265-5436-4bd8-9766-4b768c84514a	TCGA-C5-A901-01	TCGA-C5-A901-01		TCGA-C5-A901-01A-11D-A37Q-05		8f532265-5436-4bd8-9766-4b768c84514a					8f532265-5436-4bd8-9766-4b768c84514a			
TCGA-C5-A902-01	TCGA-C5-A902-01	TCGA-C5-A902	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					35	14			TCGA-C5-A902-F66734	TCGA-C5-A902	TCGA-C5-A902-01A													Stage IB2		-12959					1829					0	149																	2014-10-22	FEMALE	177	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		YES						G3							NO			1	21	false			No				TCGA-C5-A902.72D0C467-BF42-45A3-B472-00652B7B1705.pdf				A902				TUMOR FREE	YES		NO		YES							Primary Tumor	01			2009		NO	YES	C5	2	1		Cervical	A	LIVING	83	2008	7a1a71ad-c117-4091-bc20-88617bcb99d9	TCGA-C5-A902-01	7a1a71ad-c117-4091-bc20-88617bcb99d9	TCGA-C5-A902-01	TCGA-C5-A902-01		TCGA-C5-A902-01A-11D-A37Q-05		7a1a71ad-c117-4091-bc20-88617bcb99d9					7a1a71ad-c117-4091-bc20-88617bcb99d9			
TCGA-C5-A905-01	TCGA-C5-A905-01	TCGA-C5-A905	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					37				TCGA-C5-A905-F66740	TCGA-C5-A905	TCGA-C5-A905-01A													Stage IB		-13584					7129					0	4879																	2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma	YES	33					G2							NO	0		9		false			No	MX	N0	T1b	TCGA-C5-A905.A2899C0E-696C-4613-8443-35FDC795CD01.pdf				A905				TUMOR FREE	NO		YES		NO							Primary Tumor	01			1988		NO	YES	C5		9		Cervical	A	LIVING	73	1994	729d243c-73f2-42d2-8737-55275a062a8f	TCGA-C5-A905-01	729d243c-73f2-42d2-8737-55275a062a8f	TCGA-C5-A905-01	TCGA-C5-A905-01		TCGA-C5-A905-01A-11D-A37Q-05		729d243c-73f2-42d2-8737-55275a062a8f					729d243c-73f2-42d2-8737-55275a062a8f			
TCGA-C5-A907-01	TCGA-C5-A907-01	TCGA-C5-A907	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		47	17	6		TCGA-C5-A907-F69361	TCGA-C5-A907	TCGA-C5-A907-01A												Cisplatin	Stage IB2		-17304					48					0	448									Once weekly								2015-1-7	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		NO						G2							NO			3		false			No				TCGA-C5-A907.6AC8C0C6-A43A-427E-90D3-6584FC2F723E.pdf				A907	1			TUMOR FREE	YES		NO		YES						4860	Primary Tumor	01		2006	2009	YES	NO	YES	C5	4	4		Cervical	A	LIVING	95	2013	13b52657-459f-45f6-a4ce-a2da459104ac	TCGA-C5-A907-01	13b52657-459f-45f6-a4ce-a2da459104ac	TCGA-C5-A907-01	TCGA-C5-A907-01	2396FB56-1204-4736-8BD4-7C40A569A39E	TCGA-C5-A907-01A-11D-A37Q-05		13b52657-459f-45f6-a4ce-a2da459104ac					13b52657-459f-45f6-a4ce-a2da459104ac	TCGA-C5-A907-01A-11D-A37M-01	TCGA-C5-A907-01	TCGA-C5-A907-01A-11D-A37M-01
TCGA-DG-A2KH-01	TCGA-DG-A2KH-01	TCGA-DG-A2KH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					25				TCGA-DG-A2KH-F49830	TCGA-DG-A2KH	TCGA-DG-A2KH-01A						ABSENT	The pelvic nodules show circumscribed area of adipose tissue with local fat necrosis. No evidence of malignancy within this pelvic nodule.						Stage IB1		-9209										0	34										0							2013-10-11	FEMALE		Adenosquamous	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO		YES	12			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX								0	0	1		false			No	M0	N0	T1b1	TCGA-DG-A2KH.E92814BB-F3A7-45E6-9F18-B775CD53693F.pdf				A2KH			Pre-Adjuvant Therapy				YES									Primary Tumor	01			1995		NO	YES	DG	4			Cervical	A	LIVING			a5793d2b-3dec-477f-b29b-163d235431ac	TCGA-DG-A2KH-01	a5793d2b-3dec-477f-b29b-163d235431ac	TCGA-DG-A2KH-01	TCGA-DG-A2KH-01	857EBB46-CE0C-4F46-80F5-DFDD54ECC704	TCGA-DG-A2KH-01A-21D-A230-05	TCGA-DG-A2KH-01A-21D-A22X-09	a5793d2b-3dec-477f-b29b-163d235431ac			TCGA-DG-A2KH-01A-21D-A22X-09	TCGA-DG-A2KH-01A-21D-A22X-09	a5793d2b-3dec-477f-b29b-163d235431ac	TCGA-DG-A2KH-01A-21D-A22W-01	TCGA-DG-A2KH-01	TCGA-DG-A2KH-01A-21D-A22W-01
TCGA-DG-A2KJ-01	TCGA-DG-A2KJ-01	TCGA-DG-A2KJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		50			Follow-up visit	TCGA-DG-A2KJ-F65461	TCGA-DG-A2KJ							ABSENT							Stage IIIB		-18453										0	2893							Bladder AbsentParametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		0							2014-9-23	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	endometrial biopsy	Other method, specify:			Non-keratinizing squamous cell carcinoma	NO	23	Pelvic (external iliac, internal iliac, obturator)				G3							NO	1							No	M0	N1	T1b					A2KJ			Other	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			1995	YES	NO	YES	DG				Cervical		LIVING		2006	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	TCGA-DG-A2KJ-01	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	TCGA-DG-A2KJ-01	TCGA-DG-A2KJ-01		TCGA-DG-A2KJ-01A-11D-A18K-05	TCGA-DG-A2KJ-01A-11D-A18J-09	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc			TCGA-DG-A2KJ-01A-11D-A18J-09	TCGA-DG-A2KJ-01A-11D-A18J-09	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	TCGA-DG-A2KJ-01A-11D-A18H-01	TCGA-DG-A2KJ-01	TCGA-DG-A2KJ-01A-11D-A18H-01
TCGA-DG-A2KK-01	TCGA-DG-A2KK-01	TCGA-DG-A2KK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		51	27		Endocrinology and Metabolism Clinical Note	TCGA-DG-A2KK-F65463	TCGA-DG-A2KK	TCGA-DG-A2KK-01A						ABSENT		Not involved	Other Location, specify				Stage IIIB		-18834										0	2496							Bladder AbsentParametrium AbsentPelvic Nodes Present	Bladder AbsentParametrium AbsentPelvic Nodes Present|		0							2014-9-23	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	280	NO		NO	28	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	2	0		25	false			No	M0	N1	T1b1	TCGA-DG-A2KK.D01A3CDE-6669-434E-800D-3344E2A5FA48.pdf				A2KK			Other	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01		2007	1995	YES	NO	YES	DG	4	0		Cervical	A	LIVING	64	2007	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	TCGA-DG-A2KK-01	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	TCGA-DG-A2KK-01	TCGA-DG-A2KK-01	E86D642C-A5D4-4D95-9BD0-16FEB48F2960	TCGA-DG-A2KK-01A-11D-A17Z-05	TCGA-DG-A2KK-01A-11D-A17W-09	b58a46e6-797d-4f88-88ef-932d0d2a6f6e			TCGA-DG-A2KK-01A-11D-A17W-09	TCGA-DG-A2KK-01A-11D-A17W-09	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	TCGA-DG-A2KK-01A-11D-A17U-01	TCGA-DG-A2KK-01	TCGA-DG-A2KK-01A-11D-A17U-01
TCGA-DG-A2KL-01	TCGA-DG-A2KL-01	TCGA-DG-A2KL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		53				TCGA-DG-A2KL-F61032	TCGA-DG-A2KL	TCGA-DG-A2KL-01A						ABSENT			Positive vaginal margin				Stage IIA		-19539										0	1367							Bladder AbsentParametrium AbsentPelvic Nodes Absent|			0	0						2014-6-20	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Dilation and curettage	Other method, specify:	380	NO	Keratinizing squamous cell carcinoma	YES	8			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	0	5	25	false			No	M0	N0	T2a	TCGA-DG-A2KL.A0EED671-A0A6-4F3E-86B2-AB8277B134ED.pdf				A2KL	0	0	Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01			1995	YES	NO	YES	DG	2	5		Cervical	A	LIVING	75		b107d3e2-8d45-425c-9aa7-0293463b6d66	TCGA-DG-A2KL-01	b107d3e2-8d45-425c-9aa7-0293463b6d66	TCGA-DG-A2KL-01	TCGA-DG-A2KL-01	5BF84867-52E7-4E3A-9B13-944FA8E8EAC4	TCGA-DG-A2KL-01A-11D-A17Z-05	TCGA-DG-A2KL-01A-11D-A17W-09	b107d3e2-8d45-425c-9aa7-0293463b6d66			TCGA-DG-A2KL-01A-11D-A17W-09	TCGA-DG-A2KL-01A-11D-A17W-09	b107d3e2-8d45-425c-9aa7-0293463b6d66	TCGA-DG-A2KL-01A-11D-A17U-01	TCGA-DG-A2KL-01	TCGA-DG-A2KL-01A-11D-A17U-01
TCGA-DG-A2KM-01	TCGA-DG-A2KM-01	TCGA-DG-A2KM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		46				TCGA-DG-A2KM-F68502	TCGA-DG-A2KM	TCGA-DG-A2KM-01A	Former User					ABSENT							Stage IB1		-16808										0	1946							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0							2014-11-20	FEMALE	169	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO		NO	9	Pelvic (external iliac, internal iliac, obturator)		ABSENT		G2							NO	4	0	2		false			No	M0	N1	T1b1	TCGA-DG-A2KM.CDF128FF-AEED-450F-B882-09A020F3DB36.pdf				A2KM			Other	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			1995	YES	NO	YES	DG	1	2		Cervical	A	LIVING		2008	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	TCGA-DG-A2KM-01	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	TCGA-DG-A2KM-01	TCGA-DG-A2KM-01	655D5978-8AF4-42DB-9ADB-801D8ACEDFB8	TCGA-DG-A2KM-01A-11D-A17Z-05	TCGA-DG-A2KM-01A-11D-A17W-09	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123			TCGA-DG-A2KM-01A-11D-A17W-09	TCGA-DG-A2KM-01A-11D-A17W-09	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	TCGA-DG-A2KM-01A-11D-A17U-01	TCGA-DG-A2KM-01	TCGA-DG-A2KM-01A-11D-A17U-01
TCGA-DR-A0ZL-01	TCGA-DR-A0ZL-01	TCGA-DR-A0ZL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	53				TCGA-DR-A0ZL-F17115	TCGA-DR-A0ZL	TCGA-DR-A0ZL-01A	Never Used					ABSENT							Stage IB		-19384					2384		9			0	2669			4				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0				NO	Scheduled Follow-up Submission	2011-3-28	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma		24			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	1		false			No	M0	N0	T1b1	TCGA-DR-A0ZL.6CE9D5FB-FE9B-4727-974E-43691EF974F6.pdf				A0ZL	0	0	Preoperative	TUMOR FREE		0	YES	Complete Remission/Response	NO	Other						Primary Tumor	01			2009		NO	YES	DR	1	1	Complete response	Cervical	A	LIVING	57	2004	6252138d-526e-4ed4-8369-7d6e4bde3fbe	TCGA-DR-A0ZL-01	6252138d-526e-4ed4-8369-7d6e4bde3fbe	TCGA-DR-A0ZL-01	TCGA-DR-A0ZL-01		TCGA-DR-A0ZL-01A-11D-A10W-05	TCGA-DR-A0ZL-01A-11D-A10S-08	6252138d-526e-4ed4-8369-7d6e4bde3fbe	TCGA-DR-A0ZL-01A-11D-A10S-08	TCGA-DR-A0ZL-01A-11D-A10S-08	TCGA-DR-A0ZL-01A-11D-A10S-08	TCGA-DR-A0ZL-01A-11D-A10S-08	6252138d-526e-4ed4-8369-7d6e4bde3fbe	TCGA-DR-A0ZL-01A-11D-A10T-01	TCGA-DR-A0ZL-01	TCGA-DR-A0ZL-01A-11D-A10T-01
TCGA-DR-A0ZM-01	TCGA-DR-A0ZM-01	TCGA-DR-A0ZM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	61	30	6		TCGA-DR-A0ZM-F17116	TCGA-DR-A0ZM		Former User					PRESENT		Patient had clear margins	Other Location, specify			Cisplatin	Stage IIIB		-22464							8	519	521	0	1791			1289	92	55		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		0		Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2011-3-28	FEMALE	158	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP			Non-keratinizing squamous cell carcinoma		58	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	3	15				No	M0	N0	T2b					A0ZM	1		Post-Adjuvant Therapy	TUMOR FREE			YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	DR	2	4	Complete response	Cervical		LIVING	64	2006	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	TCGA-DR-A0ZM-01	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	TCGA-DR-A0ZM-01	TCGA-DR-A0ZM-01		TCGA-DR-A0ZM-01A-12D-A10W-05	TCGA-DR-A0ZM-01A-12D-A10S-08	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	TCGA-DR-A0ZM-01A-12D-A10S-08	TCGA-DR-A0ZM-01A-12D-A10S-08	TCGA-DR-A0ZM-01A-12D-A10S-08	TCGA-DR-A0ZM-01A-12D-A10S-08	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	TCGA-DR-A0ZM-01A-12D-A10T-01	TCGA-DR-A0ZM-01	TCGA-DR-A0ZM-01A-12D-A10T-01
TCGA-DS-A0VK-01	TCGA-DS-A0VK-01	TCGA-DS-A0VK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	YES	Progressive Disease		45				TCGA-DS-A0VK-F71138	TCGA-DS-A0VK	TCGA-DS-A0VK-01A	Never Used					ABSENT			Positive vaginal margin				Stage IB		-16792					5025	1118	-1			0		209	209	-71			Renal failure	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO		2015-3-18	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Surgery	Other method, specify:	210	NO	Keratinizing squamous cell carcinoma		16	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Other, specify			Distant Metastasis	Vagina		YES	1	0	1		true			No	M0	N1	T1b1	TCGA-DS-A0VK.0E3B9035-0498-4DDB-B2CD-12C823C5521B.pdf	Other, specify			A0VK	0	3	Preoperative	WITH TUMOR		0		Progressive Disease	NO				RX			Primary Tumor	01				NO	NO	YES	DS	4	4	Progression	Cervical	A	DECEASED	52	1996	7e67a342-4e90-47f9-9c95-03d32009e858	TCGA-DS-A0VK-01	7e67a342-4e90-47f9-9c95-03d32009e858	TCGA-DS-A0VK-01	TCGA-DS-A0VK-01	4FB37041-5A5A-492B-B730-CE4D9D0839F7	TCGA-DS-A0VK-01A-21D-A10W-05	TCGA-DS-A0VK-01A-21D-A10S-08	7e67a342-4e90-47f9-9c95-03d32009e858	TCGA-DS-A0VK-01A-21D-A10S-08	TCGA-DS-A0VK-01A-21D-A10S-08	TCGA-DS-A0VK-01A-21D-A10S-08	TCGA-DS-A0VK-01A-21D-A10S-08	7e67a342-4e90-47f9-9c95-03d32009e858	TCGA-DS-A0VK-01A-21D-A10T-01	TCGA-DS-A0VK-01	TCGA-DS-A0VK-01A-21D-A10T-01
TCGA-DS-A0VL-01	TCGA-DS-A0VL-01	TCGA-DS-A0VL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		25				TCGA-DS-A0VL-F71085	TCGA-DS-A0VL	TCGA-DS-A0VL-01A	Never Used					ABSENT		Posterior radical soft tissue	Other Location, specify				Stage IB		-9186					3243					0	81			81							0	0				NO		2015-3-17	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma		8			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								0	0	4		true			No	M0	N0	T1b1	TCGA-DS-A0VL.89391955-6647-4F46-969D-9AC4205B2D9C.pdf				A0VL	1	0	Pre-Adjuvant Therapy	TUMOR FREE		0		Complete Remission/Response	NO							Primary Tumor	01				NO	NO	YES	DS	1	5	Complete response	Cervical	A	LIVING	86	2001	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	TCGA-DS-A0VL-01	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	TCGA-DS-A0VL-01	TCGA-DS-A0VL-01	8B8C4526-49B9-4DF0-9298-772F08C6CC21	TCGA-DS-A0VL-01A-21D-A10W-05	TCGA-DS-A0VL-01A-21D-A10S-08	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	TCGA-DS-A0VL-01A-21D-A10S-08	TCGA-DS-A0VL-01A-21D-A10S-08	TCGA-DS-A0VL-01A-21D-A10S-08	TCGA-DS-A0VL-01A-21D-A10S-08	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	TCGA-DS-A0VL-01A-21D-A10T-01	TCGA-DS-A0VL-01	TCGA-DS-A0VL-01A-21D-A10T-01
TCGA-DS-A0VM-01	TCGA-DS-A0VM-01	TCGA-DS-A0VM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	NO	Complete Response		51				TCGA-DS-A0VM-F71160	TCGA-DS-A0VM	TCGA-DS-A0VM-01A	Former User					ABSENT		No involved margins. Margins clear as per pathology report.	Other Location, specify				Stage IB		-18839					2813		1			0	2128	907	868	0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO		2015-3-19	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Non-keratinizing squamous cell carcinoma		21	Other Location, specify	Parametrial	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung			Distant Metastasis		YES	YES	1	0	2		true			No	M0	N1	T1b1	TCGA-DS-A0VM.7C9830C1-15CB-4D38-8995-3A061E80741F.pdf				A0VM	0	0	Preoperative	TUMOR FREE		0		Complete Remission/Response	NO				R0			Primary Tumor	01				YES	NO	YES	DS	1	2	Complete response	Cervical	A	LIVING	69	2003	16ced370-3e97-40a5-9743-6bdd7bbc37d3	TCGA-DS-A0VM-01	16ced370-3e97-40a5-9743-6bdd7bbc37d3	TCGA-DS-A0VM-01	TCGA-DS-A0VM-01	B2E5BD97-D176-4560-8FC7-B082EF9A66E9	TCGA-DS-A0VM-01A-11D-A10W-05	TCGA-DS-A0VM-01A-11D-A10S-08	16ced370-3e97-40a5-9743-6bdd7bbc37d3	TCGA-DS-A0VM-01A-11D-A10S-08	TCGA-DS-A0VM-01A-11D-A10S-08	TCGA-DS-A0VM-01A-11D-A10S-08	TCGA-DS-A0VM-01A-11D-A10S-08	16ced370-3e97-40a5-9743-6bdd7bbc37d3	TCGA-DS-A0VM-01A-11D-A10T-01	TCGA-DS-A0VM-01	TCGA-DS-A0VM-01A-11D-A10T-01
TCGA-DS-A0VN-01	TCGA-DS-A0VN-01	TCGA-DS-A0VN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		47				TCGA-DS-A0VN-F71086	TCGA-DS-A0VN	TCGA-DS-A0VN-01A	Former User					ABSENT		deep cervical	Other Location, specify				Stage IB		-17433					2831		8			0	2910			18				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO		2015-3-17	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	190	NO	Keratinizing squamous cell carcinoma		19			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								0	0	2		true			No	M0	N0	T1b2	TCGA-DS-A0VN.F98AC018-6C95-44F5-BEF4-4A5C422970C4.pdf				A0VN	0	2	Preoperative	TUMOR FREE		0		Complete Remission/Response	YES							Primary Tumor	01				YES	NO	YES	DS	1	4	Complete response	Cervical	A	LIVING	81	2002	1fc14ee0-e307-4349-a2ac-9e28c31163f2	TCGA-DS-A0VN-01	1fc14ee0-e307-4349-a2ac-9e28c31163f2	TCGA-DS-A0VN-01	TCGA-DS-A0VN-01	A833FC95-34C0-4E8B-82C6-BE2E99E23411	TCGA-DS-A0VN-01A-21D-A10W-05	TCGA-DS-A0VN-01A-21D-A10S-08	1fc14ee0-e307-4349-a2ac-9e28c31163f2	TCGA-DS-A0VN-01A-21D-A10S-08	TCGA-DS-A0VN-01A-21D-A10S-08	TCGA-DS-A0VN-01A-21D-A10S-08	TCGA-DS-A0VN-01A-21D-A10S-08	1fc14ee0-e307-4349-a2ac-9e28c31163f2	TCGA-DS-A0VN-01A-21D-A10T-01	TCGA-DS-A0VN-01	TCGA-DS-A0VN-01A-21D-A10T-01
TCGA-DS-A1O9-01	TCGA-DS-A1O9-01	TCGA-DS-A1O9	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix				NO	75				TCGA-DS-A1O9-F15174	TCGA-DS-A1O9	TCGA-DS-A1O9-01A	Never Used					PRESENT			Positive vaginal margin		Not done per treating physicians discretion		Stage IVA		-27433					4152	266	-18			0	266			10				Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO	Scheduled Follow-up Submission	2011-8-12	FEMALE	132	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	210	NO	Keratinizing squamous cell carcinoma		19			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	2		true			No	M0	N0	T4	TCGA-DS-A1O9.DDC9EA73-6412-4D20-A422-0F57A8925536.pdf	Cervical Cancer			A1O9	0	0	Preoperative	WITH TUMOR		0	YES		NO	Participant refusal						Primary Tumor	01			2009		NO	YES	DS	2	2	Complete response	Cervical	A	DECEASED	32	1999	4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0	TCGA-DS-A1O9-01	4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0	TCGA-DS-A1O9-01	TCGA-DS-A1O9-01	3B37639D-EC0D-426D-ABC5-9243B346F13D	TCGA-DS-A1O9-01A-11D-A14Z-05		4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0					4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0			
TCGA-DS-A1OA-01	TCGA-DS-A1OA-01	TCGA-DS-A1OA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO		YES	77		5		TCGA-DS-A1OA-F15176	TCGA-DS-A1OA	TCGA-DS-A1OA-01A	Never Used	Completed as planned	1000		LDR	ABSENT		None	Other Location, specify			Carboplatin	Stage IB	150 mg	-28160	113	120	91	63	3621	879	24			0	879		379	29				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	0	0				NO	Scheduled Follow-up Submission	2003-8-12	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Non-keratinizing squamous cell carcinoma		8	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3				Locoregional Recurrence			YES	8	0	7		true			No	M0	N1	T1b1	TCGA-DS-A1OA.A2FAE559-D2B2-4132-9B16-37E677C1B09A.pdf	Cervical Cancer			A1OA	0	0	Preoperative	WITH TUMOR		0	YES		YES							Primary Tumor	01			1995	YES	NO	YES	DS	1	7	Partial response	Cervical	A	DECEASED	51	2001	656bb2ee-b7f9-4cee-a694-1217fecf25a7	TCGA-DS-A1OA-01	656bb2ee-b7f9-4cee-a694-1217fecf25a7	TCGA-DS-A1OA-01	TCGA-DS-A1OA-01	C1F108EE-1D61-4EC1-9F0E-A85272154696	TCGA-DS-A1OA-01A-11D-A14Z-05	TCGA-DS-A1OA-01A-11D-A16Y-08	656bb2ee-b7f9-4cee-a694-1217fecf25a7		TCGA-DS-A1OA-01A-11D-A16Y-08	TCGA-DS-A1OA-01A-11D-A16Y-08	TCGA-DS-A1OA-01A-11D-A16Y-08	656bb2ee-b7f9-4cee-a694-1217fecf25a7			
TCGA-DS-A1OB-01	TCGA-DS-A1OB-01	TCGA-DS-A1OB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Complete Response	YES	45		3		TCGA-DS-A1OB-F19926	TCGA-DS-A1OB	TCGA-DS-A1OB-01A	Never Used					ABSENT		None	Other Location, specify			Carboplatin|Other	Stage IB		-16685					1199	861				0			652	29	121	70					1		Completed as Planned			NO	Scheduled Follow-up Submission	2012-1-4	FEMALE	152	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Keratinizing squamous cell carcinoma		31	Pelvic (external iliac, internal iliac, obturator)|Common iliac|Para-aortic		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Head & Neck		Other, specify	Distant Metastasis			YES	16	0	1		true		Taxol	No	M0	N1	T1b2	TCGA-DS-A1OB.65C2A525-AEE4-48E9-83F3-CFBADAF161C1.pdf	Cervical Cancer			A1OB			Preoperative	WITH TUMOR			YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	DS		4	Progression	Cervical	A	DECEASED	72	2007	aabf5831-8886-4570-9266-00cd858ba17b	TCGA-DS-A1OB-01	aabf5831-8886-4570-9266-00cd858ba17b	TCGA-DS-A1OB-01	TCGA-DS-A1OB-01	6F74B999-D13D-458C-90F2-30D59F8D9B54	TCGA-DS-A1OB-01A-11D-A14Z-05	TCGA-DS-A1OB-01A-11D-A16Y-08	aabf5831-8886-4570-9266-00cd858ba17b		TCGA-DS-A1OB-01A-11D-A16Y-08	TCGA-DS-A1OB-01A-11D-A16Y-08		aabf5831-8886-4570-9266-00cd858ba17b			
TCGA-DS-A1OC-01	TCGA-DS-A1OC-01	TCGA-DS-A1OC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	47		4		TCGA-DS-A1OC-F64299	TCGA-DS-A1OC	TCGA-DS-A1OC-01A						ABSENT		None	Other Location, specify			Cisplatin|Other	Stage IB	Cisplatin: 90 mg; Gemzar: 1770 mg	-17357			332	252	378		34			0	376			0	155	117		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0	Completed as Planned			NO	Scheduled Follow-up Submission	2014-8-28	FEMALE	140	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	190	NO	Keratinizing squamous cell carcinoma	YES	19	Other Location, specify	Left External Iliac/Obturator		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	2	0	3		true		Gemzar	Yes	M0	N1	T1b1	TCGA-DS-A1OC.8E48E714-87FA-4B0A-86DB-75E58784AA2C.pdf				A1OC	0	0	Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	NO	YES	DS	4	3	Complete response	Cervical	A	LIVING	78	2010	694a3bf4-f789-4aef-9dc8-13f4f8ae0283	TCGA-DS-A1OC-01	694a3bf4-f789-4aef-9dc8-13f4f8ae0283	TCGA-DS-A1OC-01	TCGA-DS-A1OC-01	53BE8C06-2C3C-42EF-A4B8-202A39B34E36	TCGA-DS-A1OC-01A-11D-A14Z-05	TCGA-DS-A1OC-01A-11D-A14W-08	694a3bf4-f789-4aef-9dc8-13f4f8ae0283	TCGA-DS-A1OC-01A-11D-A14W-08	TCGA-DS-A1OC-01A-11D-A14W-08	TCGA-DS-A1OC-01A-11D-A14W-08		694a3bf4-f789-4aef-9dc8-13f4f8ae0283			
TCGA-DS-A1OD-01	TCGA-DS-A1OD-01	TCGA-DS-A1OD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	49		4		TCGA-DS-A1OD-F51565	TCGA-DS-A1OD	TCGA-DS-A1OD-01A	Never Used					ABSENT		None	Other Location, specify			Cisplatin	Stage IB1	70 mg	-17954			96	75	2968		2			0	3874			5	96	71		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2013-11-26	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Keratinizing squamous cell carcinoma	NO	16			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	1		true			No	M0	N0	T1b1	TCGA-DS-A1OD.81536C16-0708-483D-AAE9-DD3477D85177.pdf				A1OD	0	0	Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	DS	4	1	Complete response	Cervical	A	LIVING	89	2003	3ed6846b-8a17-4eed-bc64-c28fb9aed192	TCGA-DS-A1OD-01	3ed6846b-8a17-4eed-bc64-c28fb9aed192	TCGA-DS-A1OD-01	TCGA-DS-A1OD-01	04640F98-D09E-4760-9F47-5E68498D3176	TCGA-DS-A1OD-01A-11D-A14Z-05	TCGA-DS-A1OD-01A-11D-A14W-08	3ed6846b-8a17-4eed-bc64-c28fb9aed192	TCGA-DS-A1OD-01A-11D-A14W-08	TCGA-DS-A1OD-01A-11D-A14W-08	TCGA-DS-A1OD-01A-11D-A14W-08		3ed6846b-8a17-4eed-bc64-c28fb9aed192			
TCGA-DS-A3LQ-01	TCGA-DS-A3LQ-01	TCGA-DS-A3LQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	46		6		TCGA-DS-A3LQ-F51567	TCGA-DS-A3LQ	TCGA-DS-A3LQ-01A	Former User							None	Other Location, specify			Cisplatin	Stage IIIB	40 mg/m2	-16861			89	54	175					0	699			2	90	55				Once weekly	1		Completed as Planned			NO	Scheduled Follow-up Submission	2013-11-26	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	180	NO	Non-keratinizing squamous cell carcinoma	NO	8	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	1	0	2		true			No	M0	N1	T3b	TCGA-DS-A3LQ.179CB483-18CC-4770-9C5E-22B5CC1E80C4.pdf				A3LQ			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES						4500	Primary Tumor	01		1978	2009	YES	YES	NO	DS	3	7	Complete response	Cervical	A	LIVING	72	2011	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	TCGA-DS-A3LQ-01	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	TCGA-DS-A3LQ-01	TCGA-DS-A3LQ-01	8048B959-1198-4626-B674-E34FB36F51CD	TCGA-DS-A3LQ-01A-21D-A21R-05	TCGA-DS-A3LQ-01A-21D-A21Q-09	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2			TCGA-DS-A3LQ-01A-21D-A21Q-09	TCGA-DS-A3LQ-01A-21D-A21Q-09	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	TCGA-DS-A3LQ-01A-21D-A21P-01	TCGA-DS-A3LQ-01	TCGA-DS-A3LQ-01A-21D-A21P-01
TCGA-DS-A5RQ-01	TCGA-DS-A5RQ-01	TCGA-DS-A5RQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		80	27	6		TCGA-DS-A5RQ-F53355	TCGA-DS-A5RQ	TCGA-DS-A5RQ-01A						ABSENT						Cisplatin	Stage IB1	60 mg	-29526					203		32			0	512			0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0						2013-12-11	FEMALE	148	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO	Keratinizing squamous cell carcinoma	NO	42			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	3	35	true			No	MX	N0	T1b1	TCGA-DS-A5RQ.DE25B703-53D6-488B-AFAF-BFA8DA52FF62.pdf				A5RQ	0	0	Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	DS	2	3		Cervical	A	LIVING	61	2012	80241bee-c4e9-4ce7-a920-022f8b00e21d	TCGA-DS-A5RQ-01	80241bee-c4e9-4ce7-a920-022f8b00e21d	TCGA-DS-A5RQ-01	TCGA-DS-A5RQ-01	D4ECE36C-3B7F-467F-AB01-BFA1F7DE7684	TCGA-DS-A5RQ-01A-11D-A28C-05	TCGA-DS-A5RQ-01A-11D-A28B-09	80241bee-c4e9-4ce7-a920-022f8b00e21d			TCGA-DS-A5RQ-01A-11D-A28B-09	TCGA-DS-A5RQ-01A-11D-A28B-09	80241bee-c4e9-4ce7-a920-022f8b00e21d	TCGA-DS-A5RQ-01A-11D-A28A-01	TCGA-DS-A5RQ-01	TCGA-DS-A5RQ-01A-11D-A28A-01
TCGA-DS-A7WF-01	TCGA-DS-A7WF-01	TCGA-DS-A7WF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	YES	Partial Response		41				TCGA-DS-A7WF-F54754	TCGA-DS-A7WF	TCGA-DS-A7WF-01A	Never Used				Other							Cisplatin	Stage IB2		-15319					2483	492				0			321								1	0						2013-12-23	FEMALE	160	Adenosquamous	No						Radical Hysterectomy	C53.9	8560/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	230	NO	Non-keratinizing squamous cell carcinoma	NO	23			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	CT scan		Distant Metastasis		NO	YES	0	0	1	7	true			No	MX	N0	T1b2	TCGA-DS-A7WF.0C2D7B64-5F80-4F95-BCFC-D550A9674A2E.pdf	Cervical Cancer			A7WF	1	1	Preoperative	WITH TUMOR	YES	0	YES	Partial Remission/Response	YES							Primary Tumor	01			1995	YES	NO	YES	DS	2	3		Cervical	A	DECEASED	63	2006	5f6b58e1-df96-4c94-aa88-e4f23339794c	TCGA-DS-A7WF-01	5f6b58e1-df96-4c94-aa88-e4f23339794c	TCGA-DS-A7WF-01	TCGA-DS-A7WF-01		TCGA-DS-A7WF-01A-11D-A357-05	TCGA-DS-A7WF-01A-11D-A351-09	5f6b58e1-df96-4c94-aa88-e4f23339794c			TCGA-DS-A7WF-01A-11D-A351-09	TCGA-DS-A7WF-01A-11D-A351-09	5f6b58e1-df96-4c94-aa88-e4f23339794c	TCGA-DS-A7WF-01A-11D-A350-01	TCGA-DS-A7WF-01	TCGA-DS-A7WF-01A-11D-A350-01
TCGA-DS-A7WH-01	TCGA-DS-A7WH-01	TCGA-DS-A7WH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		34		7		TCGA-DS-A7WH-F63889	TCGA-DS-A7WH	TCGA-DS-A7WH-01A	Former User											Cisplatin	Stage IB1	40 mg/m2	-12644					230				5	0	533			502						Once weekly	0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-8-20	FEMALE	168	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.9	8480/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO	Non-keratinizing squamous cell carcinoma	NO	22				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	0		true			No	MX	N0	T1b1	TCGA-DS-A7WH.069FDE0B-57A4-4398-856D-F3FE511F89B4.pdf				A7WH	1	1	Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	YES	NO	DS	1	2		Cervical	A	LIVING	50	2013	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	TCGA-DS-A7WH-01	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	TCGA-DS-A7WH-01	TCGA-DS-A7WH-01	BB0D8B6B-4065-4562-A677-A92977A81BC9	TCGA-DS-A7WH-01A-22D-A357-05	TCGA-DS-A7WH-01A-22D-A351-09	3380e6d8-52a0-4b19-acb1-2fb686cbd5df			TCGA-DS-A7WH-01A-22D-A351-09	TCGA-DS-A7WH-01A-22D-A351-09	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	TCGA-DS-A7WH-01A-22D-A350-01	TCGA-DS-A7WH-01	TCGA-DS-A7WH-01A-22D-A350-01
TCGA-DS-A7WI-01	TCGA-DS-A7WI-01	TCGA-DS-A7WI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	NO	Complete Response		43		5		TCGA-DS-A7WI-F54771	TCGA-DS-A7WI	TCGA-DS-A7WI-01A	Never Used											Cisplatin	Stage IIA2	40 mg/m2	-15970					222	252	4			0			206					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	1	0						2013-12-23	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	NO	15	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Locoregional Recurrence	Retroperitoneum	NO	YES	1	0	7		true			No	MX	N1	T2a2	TCGA-DS-A7WI.4538B5EA-E6C8-4EEA-8387-A1E3C5A754F9.pdf	Cervical Cancer			A7WI	1	0	Preoperative	WITH TUMOR	YES	0	YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	YES	NO	DS	1	8		Cervical	A	DECEASED	57	2013	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	TCGA-DS-A7WI-01	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	TCGA-DS-A7WI-01	TCGA-DS-A7WI-01	817F7D56-55EA-4F67-999F-5E94870D3AAB	TCGA-DS-A7WI-01A-12D-A357-05	TCGA-DS-A7WI-01A-12D-A351-09	fcbdaa46-c576-42e9-ac1f-0ba553247f4f			TCGA-DS-A7WI-01A-12D-A351-09	TCGA-DS-A7WI-01A-12D-A351-09	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	TCGA-DS-A7WI-01A-12D-A350-01	TCGA-DS-A7WI-01	TCGA-DS-A7WI-01A-12D-A350-01
TCGA-EA-A1QS-01	TCGA-EA-A1QS-01	TCGA-EA-A1QS	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		46			At last contact	TCGA-EA-A1QS-F66103	TCGA-EA-A1QS	TCGA-EA-A1QS-01A	Never Used					ABSENT							Stage IB1		-16923					80					0	1203			1203							0	0						2014-10-2	FEMALE	164	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1240	NO	Non-keratinizing squamous cell carcinoma	NO	18			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			No	M0	N0	T1b1	TCGA-EA-A1QS.827FEDD4-5D89-4706-A81D-DAFA017EC7FF.pdf				A1QS	0	4	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	6		Cervical	A	LIVING	60	2010	88ee3a4f-7688-4247-b03c-73f6e3af7493	TCGA-EA-A1QS-01	88ee3a4f-7688-4247-b03c-73f6e3af7493	TCGA-EA-A1QS-01	TCGA-EA-A1QS-01	A770A8A6-09BA-46E2-B221-3B81ECA16660	TCGA-EA-A1QS-01A-61D-A230-05	TCGA-EA-A1QS-01A-61D-A22X-09	88ee3a4f-7688-4247-b03c-73f6e3af7493			TCGA-EA-A1QS-01A-61D-A22X-09	TCGA-EA-A1QS-01A-61D-A22X-09	88ee3a4f-7688-4247-b03c-73f6e3af7493	TCGA-EA-A1QS-01A-61D-A22W-01	TCGA-EA-A1QS-01	TCGA-EA-A1QS-01A-61D-A22W-01
TCGA-EA-A1QT-01	TCGA-EA-A1QT-01	TCGA-EA-A1QT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	47				TCGA-EA-A1QT-F65806	TCGA-EA-A1QT	TCGA-EA-A1QT-01A	Never Used					ABSENT							Stage IB		-17475					64					0	1243			376							0	0				NO	Scheduled Follow-up Submission	2014-9-30	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	680	NO	Non-keratinizing squamous cell carcinoma	NO	18			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			No	M0	N0	T1b	TCGA-EA-A1QT.87B05129-51AC-401B-AAEC-CAF13E97061E.pdf				A1QT	0	3	Preoperative	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01			2009		YES	NO	EA	1	5		Cervical	A	LIVING	68	2011	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	TCGA-EA-A1QT-01	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	TCGA-EA-A1QT-01	TCGA-EA-A1QT-01	C7D3A64F-5697-4AE3-A459-947CDE9BBFAF	TCGA-EA-A1QT-01A-11D-A14Z-05	TCGA-EA-A1QT-01A-11D-A14W-08	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	TCGA-EA-A1QT-01A-11D-A14W-08	TCGA-EA-A1QT-01A-11D-A14W-08	TCGA-EA-A1QT-01A-11D-A14W-08	TCGA-EA-A1QT-01A-11D-A14W-08	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	TCGA-EA-A1QT-01A-11D-A14V-01	TCGA-EA-A1QT-01	TCGA-EA-A1QT-01A-11D-A14V-01
TCGA-EA-A3HQ-01	TCGA-EA-A3HQ-01	TCGA-EA-A3HQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		60			At last contact	TCGA-EA-A3HQ-F66107	TCGA-EA-A3HQ	TCGA-EA-A3HQ-01A	Never Used					ABSENT							Stage II		-21966					244					0	1136			1136							0	0				NO		2014-10-2	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1360	NO	Non-keratinizing squamous cell carcinoma	NO	13			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			No	M0	N0	T2a	TCGA-EA-A3HQ.868FEAAA-6A22-47A9-A309-49119D36E75E.pdf				A3HQ	0	2	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	4	Complete response	Cervical	A	LIVING	88	2011	886e8f4f-107d-4ebd-a312-7cdbacabd35e	TCGA-EA-A3HQ-01	886e8f4f-107d-4ebd-a312-7cdbacabd35e	TCGA-EA-A3HQ-01	TCGA-EA-A3HQ-01	C8052E35-8571-457C-8A92-A7806AB50F69	TCGA-EA-A3HQ-01A-11D-A212-05	TCGA-EA-A3HQ-01A-11D-A20U-09	886e8f4f-107d-4ebd-a312-7cdbacabd35e			TCGA-EA-A3HQ-01A-11D-A20U-09	TCGA-EA-A3HQ-01A-11D-A20U-09	886e8f4f-107d-4ebd-a312-7cdbacabd35e	TCGA-EA-A3HQ-01A-11D-A20T-01	TCGA-EA-A3HQ-01	TCGA-EA-A3HQ-01A-11D-A20T-01
TCGA-EA-A3HR-01	TCGA-EA-A3HR-01	TCGA-EA-A3HR	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		57			At last contact	TCGA-EA-A3HR-F66108	TCGA-EA-A3HR	TCGA-EA-A3HR-01A	Never Used					ABSENT							Stage II		-20980					219					0	940			940							0					NO		2014-10-2	FEMALE	146	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1820	NO	Non-keratinizing squamous cell carcinoma	NO	11			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			No	M0	N0	T2a	TCGA-EA-A3HR.BE99BE0C-3FB8-4AE6-B66D-977B858D880E.pdf				A3HR	0	13	Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	15	Complete response	Cervical	A	LIVING	86	2011	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	TCGA-EA-A3HR-01	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	TCGA-EA-A3HR-01	TCGA-EA-A3HR-01	1AC7B9FF-7D24-4540-98B2-CAC49BFC4E5C	TCGA-EA-A3HR-01A-11D-A212-05	TCGA-EA-A3HR-01A-11D-A20U-09	7feffd22-85c5-4bf9-9a41-28a1f4e0586d			TCGA-EA-A3HR-01A-11D-A20U-09	TCGA-EA-A3HR-01A-11D-A20U-09	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	TCGA-EA-A3HR-01A-11D-A20T-01	TCGA-EA-A3HR-01	TCGA-EA-A3HR-01A-11D-A20T-01
TCGA-EA-A3HS-01	TCGA-EA-A3HS-01	TCGA-EA-A3HS	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		35			At last contact	TCGA-EA-A3HS-F66110	TCGA-EA-A3HS	TCGA-EA-A3HS-01A	Never Used					ABSENT							Stage IB		-13117					219					0	959			959							0	0				NO		2014-10-2	FEMALE	169	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1586	NO	Keratinizing squamous cell carcinoma	NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0	0	1		true			No	M0	N0	T1b	TCGA-EA-A3HS.103C790B-65FE-4E6A-9CD8-C8B35BB09ABB.pdf				A3HS	0	1	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	2	Complete response	Cervical	A	LIVING	54	2011	833baf21-bec9-4fde-aa6b-fb1b1256ae26	TCGA-EA-A3HS-01	833baf21-bec9-4fde-aa6b-fb1b1256ae26	TCGA-EA-A3HS-01	TCGA-EA-A3HS-01	B8DA1194-2F9C-4792-8B40-B582F8D8B501	TCGA-EA-A3HS-01A-11D-A212-05	TCGA-EA-A3HS-01A-11D-A20U-09	833baf21-bec9-4fde-aa6b-fb1b1256ae26			TCGA-EA-A3HS-01A-11D-A20U-09		833baf21-bec9-4fde-aa6b-fb1b1256ae26	TCGA-EA-A3HS-01A-11D-A20T-01	TCGA-EA-A3HS-01	TCGA-EA-A3HS-01A-11D-A20T-01
TCGA-EA-A3HT-01	TCGA-EA-A3HT-01	TCGA-EA-A3HT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		68			At last contact	TCGA-EA-A3HT-F66111	TCGA-EA-A3HT	TCGA-EA-A3HT-01A	Never Used					ABSENT							Stage IB		-25138					198					0	954			954							0	0				NO		2014-10-2	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1	NO	Keratinizing squamous cell carcinoma	NO	9			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	0	1		true			No	M0	N0	T1b	TCGA-EA-A3HT.ADE9CA35-C9F2-417E-8B27-59ACC7E1AE32.pdf				A3HT	0	2	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	3	Complete response	Cervical	A	LIVING	83	2011	6cf5747f-22b4-498f-b8ce-13e4a2741883	TCGA-EA-A3HT-01	6cf5747f-22b4-498f-b8ce-13e4a2741883	TCGA-EA-A3HT-01	TCGA-EA-A3HT-01	F2BA7AA4-9BFA-463E-A2A8-EC141BC66ACA	TCGA-EA-A3HT-01A-61D-A21R-05	TCGA-EA-A3HT-01A-61D-A21Q-09	6cf5747f-22b4-498f-b8ce-13e4a2741883			TCGA-EA-A3HT-01A-61D-A21Q-09	TCGA-EA-A3HT-01A-61D-A21Q-09	6cf5747f-22b4-498f-b8ce-13e4a2741883	TCGA-EA-A3HT-01A-61D-A21P-01	TCGA-EA-A3HT-01	TCGA-EA-A3HT-01A-61D-A21P-01
TCGA-EA-A3HU-01	TCGA-EA-A3HU-01	TCGA-EA-A3HU	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		43			At last contact	TCGA-EA-A3HU-F66112	TCGA-EA-A3HU	TCGA-EA-A3HU-01A	Never Used					ABSENT							Stage II		-15909					182					0	1013			1013							0	0				NO		2014-10-2	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1440	NO	Non-keratinizing squamous cell carcinoma	NO	14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2		true			No	M0	N0	T2a2	TCGA-EA-A3HU.3A6FE044-430D-4D43-9365-9FA788758BE5.pdf				A3HU	0	10	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	12	Complete response	Cervical	A	LIVING	68	2011	b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91	TCGA-EA-A3HU-01	b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91	TCGA-EA-A3HU-01	TCGA-EA-A3HU-01	852A3427-BBBC-436E-884F-B58AF5A7ACF3	TCGA-EA-A3HU-01A-11D-A212-05	TCGA-EA-A3HU-01A-11D-A20U-09	b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91			TCGA-EA-A3HU-01A-11D-A20U-09	TCGA-EA-A3HU-01A-11D-A20U-09	b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91			
TCGA-EA-A3QD-01	TCGA-EA-A3QD-01	TCGA-EA-A3QD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		59				TCGA-EA-A3QD-F58163	TCGA-EA-A3QD	TCGA-EA-A3QD-01A	Former User												Stage IIIB		-21655					146					0	397			395							0	0				NO		2014-4-1	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	250	NO	Non-keratinizing squamous cell carcinoma	YES	6			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1	0	5		true			No	M0	N1	T1b1	TCGA-EA-A3QD.C5F8BF41-F7A7-4870-890E-861D2DE51DBE.pdf				A3QD	1	0	Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	EA	1	6	Complete response	Cervical	A	LIVING	105	2011	e35790f7-26df-4d0a-9474-88f13372d606	TCGA-EA-A3QD-01	e35790f7-26df-4d0a-9474-88f13372d606	TCGA-EA-A3QD-01	TCGA-EA-A3QD-01	C86A293C-53BA-4937-AC97-FF272952998A	TCGA-EA-A3QD-01A-32D-A230-05	TCGA-EA-A3QD-01A-32D-A22X-09	e35790f7-26df-4d0a-9474-88f13372d606			TCGA-EA-A3QD-01A-32D-A22X-09	TCGA-EA-A3QD-01A-32D-A22X-09	e35790f7-26df-4d0a-9474-88f13372d606	TCGA-EA-A3QD-01A-32D-A22W-01	TCGA-EA-A3QD-01	TCGA-EA-A3QD-01A-32D-A22W-01
TCGA-EA-A3QE-01	TCGA-EA-A3QE-01	TCGA-EA-A3QE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		45			At last contact	TCGA-EA-A3QE-F66113	TCGA-EA-A3QE	TCGA-EA-A3QE-01A	Never Used					ABSENT							Stage IB		-16460					126					0	761			761							0	0				NO		2014-10-2	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	380	NO	Non-keratinizing squamous cell carcinoma	NO	14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			1		true			No	M0	N0	T1b	TCGA-EA-A3QE.E3358197-B104-4672-863F-8BE50488B2D0.pdf				A3QE	0	4	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	5	Complete response	Cervical	A	LIVING	73	2011	6edc7d3a-9f83-449f-a371-c040d8b5164d	TCGA-EA-A3QE-01	6edc7d3a-9f83-449f-a371-c040d8b5164d	TCGA-EA-A3QE-01	TCGA-EA-A3QE-01	0C3AE6A1-F10D-4EE1-A357-D2F3E0F217D1	TCGA-EA-A3QE-01A-21D-A21R-05	TCGA-EA-A3QE-01A-21D-A21Q-09	6edc7d3a-9f83-449f-a371-c040d8b5164d			TCGA-EA-A3QE-01A-21D-A21Q-09	TCGA-EA-A3QE-01A-21D-A21Q-09	6edc7d3a-9f83-449f-a371-c040d8b5164d	TCGA-EA-A3QE-01A-21D-A21P-01	TCGA-EA-A3QE-01	TCGA-EA-A3QE-01A-21D-A21P-01
TCGA-EA-A3Y4-01	TCGA-EA-A3Y4-01	TCGA-EA-A3Y4	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		40				TCGA-EA-A3Y4-F71527	TCGA-EA-A3Y4	TCGA-EA-A3Y4-01A						ABSENT							Stage IB		-14706					146					0	1122			35							1	0						2015-3-26	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Simple Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1310	NO	Non-keratinizing squamous cell carcinoma	NO	12			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1		true			No	M0	N0	T1b	TCGA-EA-A3Y4.D0A5BC9D-D39C-4A0D-9832-E062AA024D17.pdf				A3Y4	0	2	Pre-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	EA	1	3		Cervical	A	LIVING	99	2012	6171e1c5-1243-4fde-8964-7d1a4d387a86	TCGA-EA-A3Y4-01	6171e1c5-1243-4fde-8964-7d1a4d387a86	TCGA-EA-A3Y4-01	TCGA-EA-A3Y4-01	5D8CB763-CC51-417E-B960-560E5C59938A	TCGA-EA-A3Y4-01A-51D-A244-05	TCGA-EA-A3Y4-01A-51D-A243-09	6171e1c5-1243-4fde-8964-7d1a4d387a86			TCGA-EA-A3Y4-01A-51D-A243-09	TCGA-EA-A3Y4-01A-51D-A243-09	6171e1c5-1243-4fde-8964-7d1a4d387a86	TCGA-EA-A3Y4-01A-51D-A242-01	TCGA-EA-A3Y4-01	TCGA-EA-A3Y4-01A-51D-A242-01
TCGA-EA-A410-01	TCGA-EA-A410-01	TCGA-EA-A410	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		51			At last contact	TCGA-EA-A410-F66115	TCGA-EA-A410	TCGA-EA-A410-01A	Never Used					ABSENT							Stage IIA2		-18720					172					0	803			803							0	0						2014-10-2	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	700	NO	Non-keratinizing squamous cell carcinoma	NO	14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true			No	M0	N0	T2a2	TCGA-EA-A410.EA3DC9B0-2680-4F3C-B14A-05CB047305BD.pdf				A410	0	4	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	6		Cervical	A	LIVING	80	2012	e9e998be-4353-441e-83ec-d8c010b0dc79	TCGA-EA-A410-01	e9e998be-4353-441e-83ec-d8c010b0dc79	TCGA-EA-A410-01	TCGA-EA-A410-01	5852B79F-E34E-4B67-ADDA-CD19B9FDF975	TCGA-EA-A410-01A-11D-A244-05	TCGA-EA-A410-01A-11D-A243-09	e9e998be-4353-441e-83ec-d8c010b0dc79			TCGA-EA-A410-01A-11D-A243-09	TCGA-EA-A410-01A-11D-A243-09	e9e998be-4353-441e-83ec-d8c010b0dc79	TCGA-EA-A410-01A-11D-A242-01	TCGA-EA-A410-01	TCGA-EA-A410-01A-11D-A242-01
TCGA-EA-A411-01	TCGA-EA-A411-01	TCGA-EA-A411	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		50			At last contact	TCGA-EA-A411-F66116	TCGA-EA-A411	TCGA-EA-A411-01A	Former User					ABSENT							Stage IB1		-18561					100					0	747			747							0	0						2014-10-2	FEMALE	176	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	740	NO	Non-keratinizing squamous cell carcinoma	NO	13			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0		2		true			No	M0	N0	T1b1	TCGA-EA-A411.A7CCC7A3-CF3C-4722-B1F5-890B3A4D9A6D.pdf				A411	0	3	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	1	5		Cervical	A	LIVING	74	2012	27e35f6c-7d6c-46e8-844d-e08a5920af3e	TCGA-EA-A411-01	27e35f6c-7d6c-46e8-844d-e08a5920af3e	TCGA-EA-A411-01	TCGA-EA-A411-01	A92FDF5F-D4BE-4084-B677-6AAB64AD1342	TCGA-EA-A411-01A-11D-A244-05	TCGA-EA-A411-01A-11D-A243-09	27e35f6c-7d6c-46e8-844d-e08a5920af3e			TCGA-EA-A411-01A-11D-A243-09	TCGA-EA-A411-01A-11D-A243-09	27e35f6c-7d6c-46e8-844d-e08a5920af3e	TCGA-EA-A411-01A-11D-A242-01	TCGA-EA-A411-01	TCGA-EA-A411-01A-11D-A242-01
TCGA-EA-A439-01	TCGA-EA-A439-01	TCGA-EA-A439	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	NO	Complete Response		50				TCGA-EA-A439-F45847	TCGA-EA-A439	TCGA-EA-A439-01A						PRESENT	No pelvic spread						Stage IIA1		-18529					98		12			0	965	321	316	965				Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent			0							2014-12-24	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	500	NO	Non-keratinizing squamous cell carcinoma	NO				PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Cervix			Locoregional Recurrence		YES	NO			2		true			No	M0	N0	T2a1	TCGA-EA-A439.15BB85F2-5EF6-4569-B354-D543A0466983.pdf				A439			Post-Adjuvant Therapy	TUMOR FREE	NO		NO	Complete Remission/Response	YES				R0			Primary Tumor	01			2009	NO	YES	NO	EA	1	2		Cervical	A	LIVING	47	2012	f930146b-0cec-4630-8f79-0e233c238b15	TCGA-EA-A439-01	f930146b-0cec-4630-8f79-0e233c238b15	TCGA-EA-A439-01	TCGA-EA-A439-01	6614076A-C936-48EA-97E2-3A12301EDC8A	TCGA-EA-A439-01A-11D-A244-05	TCGA-EA-A439-01A-11D-A243-09	f930146b-0cec-4630-8f79-0e233c238b15			TCGA-EA-A439-01A-11D-A243-09	TCGA-EA-A439-01A-11D-A243-09	f930146b-0cec-4630-8f79-0e233c238b15	TCGA-EA-A439-01A-11D-A242-01	TCGA-EA-A439-01	TCGA-EA-A439-01A-11D-A242-01
TCGA-EA-A43B-01	TCGA-EA-A43B-01	TCGA-EA-A43B	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		43				TCGA-EA-A43B-F58719	TCGA-EA-A43B	TCGA-EA-A43B-01A	Never Used												Stage IB1		-15871					196		36			0	791			53				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0							2014-4-22	FEMALE	164	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	540	NO	Keratinizing squamous cell carcinoma	NO	24				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true			No	M0	N0	T1b1	TCGA-EA-A43B.D2D8553E-1C68-4ADC-9D3E-024D04E948C1.pdf				A43B			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	EA	1	2		Cervical	A	LIVING	72	2012	05dbcfac-b558-4621-bc29-30d46658a121	TCGA-EA-A43B-01	05dbcfac-b558-4621-bc29-30d46658a121	TCGA-EA-A43B-01	TCGA-EA-A43B-01	485976D3-82C9-44C3-99E9-DC8A454E7225	TCGA-EA-A43B-01A-81D-A244-05	TCGA-EA-A43B-01A-81D-A243-09	05dbcfac-b558-4621-bc29-30d46658a121			TCGA-EA-A43B-01A-81D-A243-09	TCGA-EA-A43B-01A-81D-A243-09	05dbcfac-b558-4621-bc29-30d46658a121	TCGA-EA-A43B-01A-81D-A242-01	TCGA-EA-A43B-01	TCGA-EA-A43B-01A-81D-A242-01
TCGA-EA-A44S-01	TCGA-EA-A44S-01	TCGA-EA-A44S	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Stable Disease		31				TCGA-EA-A44S-F49899	TCGA-EA-A44S	TCGA-EA-A44S-01A	Never Used					ABSENT							Stage IIIB		-11621					120					0	369			9							1	0						2013-10-14	FEMALE	182	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1200	NO	Non-keratinizing squamous cell carcinoma	NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	4		1		true			No	M0	N1	T2a2	TCGA-EA-A44S.25D56763-173A-4F45-AA4E-118382CD2296.pdf				A44S	0	0	Preoperative	TUMOR FREE	YES	0	YES	Stable Disease	YES							Primary Tumor	01			2009	YES	YES	NO	EA	1	1		Cervical	A	LIVING	83	2012	41c1975d-219d-4131-a77e-e70224ed6c41	TCGA-EA-A44S-01	41c1975d-219d-4131-a77e-e70224ed6c41	TCGA-EA-A44S-01	TCGA-EA-A44S-01	DA2D285B-32D4-475C-8195-DCEF5563578C	TCGA-EA-A44S-01A-12D-A26S-05	TCGA-EA-A44S-01A-12D-A26G-09	41c1975d-219d-4131-a77e-e70224ed6c41			TCGA-EA-A44S-01A-12D-A26G-09	TCGA-EA-A44S-01A-12D-A26G-09	41c1975d-219d-4131-a77e-e70224ed6c41	TCGA-EA-A44S-01A-12D-A26F-01	TCGA-EA-A44S-01	TCGA-EA-A44S-01A-12D-A26F-01
TCGA-EA-A4BA-01	TCGA-EA-A4BA-01	TCGA-EA-A4BA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		49				TCGA-EA-A4BA-F63128	TCGA-EA-A4BA	TCGA-EA-A4BA-01A	Never Used					ABSENT							Stage IB2		-17995					122					0	755			7							1							2014-7-31	FEMALE	162	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	400	NO		NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true			No	M0	N0	T1b2	TCGA-EA-A4BA.E9335EB7-5DF6-4C05-AC5C-FEEC629ED84E.pdf				A4BA		2	Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	EA	1	4		Cervical	A	LIVING	96	2012	c3db032d-a822-4eca-8891-2c4d13a5866a	TCGA-EA-A4BA-01	c3db032d-a822-4eca-8891-2c4d13a5866a	TCGA-EA-A4BA-01	TCGA-EA-A4BA-01	7F604A99-19D9-42F8-BA04-4E42C885D118	TCGA-EA-A4BA-01A-21D-A26S-05	TCGA-EA-A4BA-01A-21D-A26G-09	c3db032d-a822-4eca-8891-2c4d13a5866a			TCGA-EA-A4BA-01A-21D-A26G-09	TCGA-EA-A4BA-01A-21D-A26G-09	c3db032d-a822-4eca-8891-2c4d13a5866a	TCGA-EA-A4BA-01A-21D-A26F-01	TCGA-EA-A4BA-01	TCGA-EA-A4BA-01A-21D-A26F-01
TCGA-EA-A50E-01	TCGA-EA-A50E-01	TCGA-EA-A50E	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		45				TCGA-EA-A50E-F45973	TCGA-EA-A50E	TCGA-EA-A50E-01A	Former User					PRESENT	Pelvic spread		Positive bladder margin				Stage IVA		-16609					142	227	-1			0	8		208															2013-7-26	FEMALE	152	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1520	NO	Non-keratinizing squamous cell carcinoma	NO	6	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Vulva			Locoregional Recurrence		NO	YES	6		2		true			No	M0	N1	T4	TCGA-EA-A50E.9AF109CD-57A9-4560-8B36-9977F208AEE1.pdf	Cervical Cancer			A50E				WITH TUMOR	NO		YES	Progressive Disease	NO							Primary Tumor	01			2009	NO	YES	NO	EA	1	2		Cervical	A	DECEASED	45	2012	6b9951d1-1bae-4c66-acad-c6c618d5387d	TCGA-EA-A50E-01	6b9951d1-1bae-4c66-acad-c6c618d5387d	TCGA-EA-A50E-01	TCGA-EA-A50E-01	F6177AB7-60E5-414C-87A0-80D3AA346E5D	TCGA-EA-A50E-01A-21D-A26S-05	TCGA-EA-A50E-01A-21D-A26G-09	6b9951d1-1bae-4c66-acad-c6c618d5387d			TCGA-EA-A50E-01A-21D-A26G-09	TCGA-EA-A50E-01A-21D-A26G-09	6b9951d1-1bae-4c66-acad-c6c618d5387d	TCGA-EA-A50E-01A-21D-A26F-01	TCGA-EA-A50E-01	TCGA-EA-A50E-01A-21D-A26F-01
TCGA-EA-A556-01	TCGA-EA-A556-01	TCGA-EA-A556	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		38	18		At time of last contact	TCGA-EA-A556-F53440	TCGA-EA-A556	TCGA-EA-A556-01A	Never Used					ABSENT							Stage IB1		-13988					119					0	453			453							0	0						2013-12-11	FEMALE	160	Endometrioid Adenocarcinoma of Endocervix	No						Radical Hysterectomy	C53.9	8380/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	360	NO		NO	7				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1	20	true			No	M0	N0	T1b1	TCGA-EA-A556.EDEF2B45-54BF-4329-B7ED-FBF59E13B438.pdf				A556	0	0	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	EA	2	1		Cervical	A	LIVING	62	2012	0dadcb32-0c50-4d9b-8112-d4e533e789d6	TCGA-EA-A556-01	0dadcb32-0c50-4d9b-8112-d4e533e789d6	TCGA-EA-A556-01	TCGA-EA-A556-01	DE361C5C-452A-4E8B-AC77-E037AC111087	TCGA-EA-A556-01A-11D-A26S-05	TCGA-EA-A556-01A-11D-A26G-09	0dadcb32-0c50-4d9b-8112-d4e533e789d6			TCGA-EA-A556-01A-11D-A26G-09	TCGA-EA-A556-01A-11D-A26G-09	0dadcb32-0c50-4d9b-8112-d4e533e789d6	TCGA-EA-A556-01A-11D-A26F-01	TCGA-EA-A556-01	TCGA-EA-A556-01A-11D-A26F-01
TCGA-EA-A5FO-01	TCGA-EA-A5FO-01	TCGA-EA-A5FO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		59				TCGA-EA-A5FO-F67795	TCGA-EA-A5FO	TCGA-EA-A5FO-01A						ABSENT							Stage IB1		-21561					132					0	815			45							1							2014-11-11	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	570	NO	Non-keratinizing squamous cell carcinoma	NO	21			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0		2		true			No	M0	N0	T1b1	TCGA-EA-A5FO.4022C7F9-CECA-4C6B-92D5-729518405F30.pdf				A5FO			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009		YES	NO	EA	1			Cervical	A	LIVING	58	2012	1ff2db10-00fe-4ddc-98d1-e15ffea42333	TCGA-EA-A5FO-01	1ff2db10-00fe-4ddc-98d1-e15ffea42333	TCGA-EA-A5FO-01	TCGA-EA-A5FO-01	D91C5622-88A7-4D01-ACA5-14A0123D0ADF	TCGA-EA-A5FO-01A-21D-A28C-05	TCGA-EA-A5FO-01A-21D-A28B-09	1ff2db10-00fe-4ddc-98d1-e15ffea42333			TCGA-EA-A5FO-01A-21D-A28B-09	TCGA-EA-A5FO-01A-21D-A28B-09	1ff2db10-00fe-4ddc-98d1-e15ffea42333	TCGA-EA-A5FO-01A-21D-A28A-01	TCGA-EA-A5FO-01	TCGA-EA-A5FO-01A-21D-A28A-01
TCGA-EA-A5O9-01	TCGA-EA-A5O9-01	TCGA-EA-A5O9	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		39				TCGA-EA-A5O9-F68730	TCGA-EA-A5O9	TCGA-EA-A5O9-01A	Never Used					ABSENT							Stage IB2		-14472					112					0	788			26							1	0						2014-12-12	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.1	8070/3	C53.1	YES		Biopsy (cervical / CT-guided / Other)	330	NO	Non-keratinizing squamous cell carcinoma	NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		4		true			No	M0	N0	T1b2	TCGA-EA-A5O9.289C553F-685F-4308-B429-C741585BD25F.pdf				A5O9	0	7	Preoperative	TUMOR FREE	NO	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	EA	1	11		Cervical	A	LIVING	99	2012	9ecc833d-b92d-474a-a981-d6e0c12292e0	TCGA-EA-A5O9-01	9ecc833d-b92d-474a-a981-d6e0c12292e0	TCGA-EA-A5O9-01	TCGA-EA-A5O9-01	F287E787-B947-4C1D-9B34-66D426732136	TCGA-EA-A5O9-01A-11D-A28C-05	TCGA-EA-A5O9-01A-11D-A28B-09	9ecc833d-b92d-474a-a981-d6e0c12292e0			TCGA-EA-A5O9-01A-11D-A28B-09	TCGA-EA-A5O9-01A-11D-A28B-09	9ecc833d-b92d-474a-a981-d6e0c12292e0	TCGA-EA-A5O9-01A-11D-A28A-01	TCGA-EA-A5O9-01	TCGA-EA-A5O9-01A-11D-A28A-01
TCGA-EA-A5ZD-01	TCGA-EA-A5ZD-01	TCGA-EA-A5ZD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		40				TCGA-EA-A5ZD-F70877	TCGA-EA-A5ZD	TCGA-EA-A5ZD-01A						ABSENT							Stage IB1		-14629					102					0	830																	2015-3-10	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	2290	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			2		true			No	M0	N0	T1b1	TCGA-EA-A5ZD.4BB00D13-61EA-409C-AB1D-07DE3B949C85.pdf				A5ZD	1			TUMOR FREE	NO		NO	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	YES	NO	EA	1	3		Cervical	A	LIVING	47	2012	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	TCGA-EA-A5ZD-01	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	TCGA-EA-A5ZD-01	TCGA-EA-A5ZD-01	C681D567-D4DB-460D-BABE-AD14C6FB9D92	TCGA-EA-A5ZD-01A-11D-A28C-05	TCGA-EA-A5ZD-01A-11D-A28B-09	8bb52467-45b2-40d5-abd2-69ff0ad83bc5			TCGA-EA-A5ZD-01A-11D-A28B-09	TCGA-EA-A5ZD-01A-11D-A28B-09	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	TCGA-EA-A5ZD-01A-11D-A28A-01	TCGA-EA-A5ZD-01	TCGA-EA-A5ZD-01A-11D-A28A-01
TCGA-EA-A5ZE-01	TCGA-EA-A5ZE-01	TCGA-EA-A5ZE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix		NO	Complete Response		54				TCGA-EA-A5ZE-F57092	TCGA-EA-A5ZE	TCGA-EA-A5ZE-01A	Former User					ABSENT							Stage IB1		-19868					101					0	829	425	425															2015-3-10	FEMALE	153	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	2320	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Peri (6-12 months since last menstrual period)	G3	Other, specify			Distant Metastasis	Lymph node, inguinal	YES	NO			3		true			No	M0	N0	T1b1	TCGA-EA-A5ZE.316CE4CE-B951-4DFA-B2CC-B0512AA86871.pdf				A5ZE				TUMOR FREE	NO		NO	Complete Remission/Response	NO				R0			Primary Tumor	01			2009	NO	YES	NO	EA	1	3		Cervical	A	LIVING	55	2012	0ec8f213-1b87-4c8e-86b8-90362601df4a	TCGA-EA-A5ZE-01	0ec8f213-1b87-4c8e-86b8-90362601df4a	TCGA-EA-A5ZE-01	TCGA-EA-A5ZE-01	07182B36-7B4A-4EE6-9A92-E922AC718242	TCGA-EA-A5ZE-01A-11D-A28C-05	TCGA-EA-A5ZE-01A-11D-A28B-09	0ec8f213-1b87-4c8e-86b8-90362601df4a			TCGA-EA-A5ZE-01A-11D-A28B-09	TCGA-EA-A5ZE-01A-11D-A28B-09	0ec8f213-1b87-4c8e-86b8-90362601df4a	TCGA-EA-A5ZE-01A-11D-A28A-01	TCGA-EA-A5ZE-01	TCGA-EA-A5ZE-01A-11D-A28A-01
TCGA-EA-A5ZF-01	TCGA-EA-A5ZF-01	TCGA-EA-A5ZF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		56				TCGA-EA-A5ZF-F57094	TCGA-EA-A5ZF	TCGA-EA-A5ZF-01A	Former User					ABSENT							Stage IB1		-20506					100					0	828	440	440															2015-3-10	FEMALE	151	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1060	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Peri (6-12 months since last menstrual period)	G2	Cervix			Locoregional Recurrence		YES	NO			3		true			No	M0	NX	T1b1	TCGA-EA-A5ZF.B4189C9E-2244-4C36-AABB-00B57F9540FF.pdf				A5ZF				WITH TUMOR	NO		NO	Complete Remission/Response	NO				R0			Primary Tumor	01			2009		YES	NO	EA	1	3		Cervical	A	LIVING	51	2012	687d43fb-fb87-464d-a661-697889b99aed	TCGA-EA-A5ZF-01	687d43fb-fb87-464d-a661-697889b99aed	TCGA-EA-A5ZF-01	TCGA-EA-A5ZF-01	A2E4E986-D906-4AF4-B9E8-A14D9B8F9F07	TCGA-EA-A5ZF-01A-11D-A28C-05	TCGA-EA-A5ZF-01A-11D-A28B-09	687d43fb-fb87-464d-a661-697889b99aed			TCGA-EA-A5ZF-01A-11D-A28B-09	TCGA-EA-A5ZF-01A-11D-A28B-09	687d43fb-fb87-464d-a661-697889b99aed	TCGA-EA-A5ZF-01A-11D-A28A-01	TCGA-EA-A5ZF-01	TCGA-EA-A5ZF-01A-11D-A28A-01
TCGA-EA-A6QX-01	TCGA-EA-A6QX-01	TCGA-EA-A6QX	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		49				TCGA-EA-A6QX-F71637	TCGA-EA-A6QX	TCGA-EA-A6QX-01A						ABSENT							Stage IIIB		-18035					99					0	730																	2015-3-27	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1260	NO	Non-keratinizing squamous cell carcinoma	NO	3	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Peri (6-12 months since last menstrual period)	G3							NO	2		2		true			No	M0	N1	T1b1	TCGA-EA-A6QX.84774C0F-D4E4-4BE3-9159-4E932890F7EC.pdf				A6QX		2		TUMOR FREE	NO		YES	Complete Remission/Response								Primary Tumor	01			2009		YES	NO	EA	1	4		Cervical	A	LIVING	49	2013	9ce21675-b3ac-45b0-85c6-f3b2e4188944	TCGA-EA-A6QX-01	9ce21675-b3ac-45b0-85c6-f3b2e4188944	TCGA-EA-A6QX-01	TCGA-EA-A6QX-01	A8AC0A62-1CC2-43E6-AFC2-6B455B8F5759	TCGA-EA-A6QX-01A-12D-A340-05	TCGA-EA-A6QX-01A-12D-A33O-09	9ce21675-b3ac-45b0-85c6-f3b2e4188944			TCGA-EA-A6QX-01A-12D-A33O-09	TCGA-EA-A6QX-01A-12D-A33O-09	9ce21675-b3ac-45b0-85c6-f3b2e4188944	TCGA-EA-A6QX-01A-12D-A33N-01	TCGA-EA-A6QX-01	TCGA-EA-A6QX-01A-12D-A33N-01
TCGA-EA-A78R-01	TCGA-EA-A78R-01	TCGA-EA-A78R	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		54				TCGA-EA-A78R-F59968	TCGA-EA-A78R	TCGA-EA-A78R-01A						ABSENT							Stage IB1		-19942					126					0	410																	2014-5-27	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	890	NO	Non-keratinizing squamous cell carcinoma	NO				PRESENT	Peri (6-12 months since last menstrual period)	G2							NO			3		true			No	M0	NX	T1b1	TCGA-EA-A78R.36A90083-5078-435F-B9C2-337B75807716.pdf				A78R				TUMOR FREE			NO	Complete Remission/Response								Primary Tumor	01			2009		YES	NO	EA	1	3		Cervical	A	LIVING	63	2013	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	TCGA-EA-A78R-01	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	TCGA-EA-A78R-01	TCGA-EA-A78R-01	6E230015-A5EA-43CD-9BCE-4FB37061E492	TCGA-EA-A78R-01A-11D-A32T-05	TCGA-EA-A78R-01A-11D-A32I-09	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4			TCGA-EA-A78R-01A-11D-A32I-09	TCGA-EA-A78R-01A-11D-A32I-09	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	TCGA-EA-A78R-01A-11D-A32H-01	TCGA-EA-A78R-01	TCGA-EA-A78R-01A-11D-A32H-01
TCGA-EA-A97N-01	TCGA-EA-A97N-01	TCGA-EA-A97N	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					38				TCGA-EA-A97N-F68492	TCGA-EA-A97N	TCGA-EA-A97N-01A	Never Used					ABSENT							Stage IB2		-13984					83					0	11			11							1							2014-11-24	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	630	NO	Non-keratinizing squamous cell carcinoma	YES	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true			No	M0	N0	T1b2	TCGA-EA-A97N.23982BB4-8B3A-4F8B-98EE-11E63B92FA17.pdf				A97N		3	Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	YES	NO	EA	1	5		Cervical	A	LIVING	60	2013	05293acf-1896-4a84-af90-0fe7483bdb66	TCGA-EA-A97N-01	05293acf-1896-4a84-af90-0fe7483bdb66	TCGA-EA-A97N-01	TCGA-EA-A97N-01	DA5131EF-4E20-4519-BE27-4C016B087F14	TCGA-EA-A97N-01A-11D-A388-05		05293acf-1896-4a84-af90-0fe7483bdb66					05293acf-1896-4a84-af90-0fe7483bdb66	TCGA-EA-A97N-01A-11D-A386-01	TCGA-EA-A97N-01	TCGA-EA-A97N-01A-11D-A386-01
TCGA-EK-A2GZ-01	TCGA-EK-A2GZ-01	TCGA-EK-A2GZ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix				NO	64				TCGA-EK-A2GZ-F31876	TCGA-EK-A2GZ	TCGA-EK-A2GZ-01A											Other		Stage IIIB		-23599					1099				-3	0	383			26							0						Scheduled Follow-up Submission	2012-5-10	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma		14				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO		0	5		false			Yes				TCGA-EK-A2GZ.793DCC7F-E9F9-4A23-A5C3-2738AD4E0091.pdf				A2GZ			Preoperative	WITH TUMOR			YES		NO							Primary Tumor	01			1995		NO	YES	EK		5		Cervical	A	LIVING	64	2008	76e090d4-d2c2-4918-97d8-4dd1dbea5452	TCGA-EK-A2GZ-01	76e090d4-d2c2-4918-97d8-4dd1dbea5452	TCGA-EK-A2GZ-01	TCGA-EK-A2GZ-01		TCGA-EK-A2GZ-01A-11D-A17Z-05	TCGA-EK-A2GZ-01A-11D-A17W-09	76e090d4-d2c2-4918-97d8-4dd1dbea5452			TCGA-EK-A2GZ-01A-11D-A17W-09	TCGA-EK-A2GZ-01A-11D-A17W-09	76e090d4-d2c2-4918-97d8-4dd1dbea5452	TCGA-EK-A2GZ-01A-11D-A17U-01	TCGA-EK-A2GZ-01	TCGA-EK-A2GZ-01A-11D-A17U-01
TCGA-EK-A2H0-01	TCGA-EK-A2H0-01	TCGA-EK-A2H0	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	24		6		TCGA-EK-A2H0-F65241	TCGA-EK-A2H0	TCGA-EK-A2H0-01A		Completed as planned	60		HDR							Cisplatin	Stage IIB	385 mg/m2	-8918	79	100	90	54	1268				21	0	1847			28	112	54				Once weekly	0		Treatment not completed	0			Scheduled Follow-up Submission	2014-9-19	FEMALE	156	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			0		false			No				TCGA-EK-A2H0.AEDD5CA3-2E0A-414F-AA38-CCF5229EC7F2.pdf				A2H0			Preoperative	TUMOR FREE	YES			Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	EK		0		Cervical	A	LIVING	88	2007	c59486e3-0de6-4fd2-adef-b3b369d41e7c	TCGA-EK-A2H0-01	c59486e3-0de6-4fd2-adef-b3b369d41e7c	TCGA-EK-A2H0-01	TCGA-EK-A2H0-01	A420B883-B083-453C-BF60-128E2737BBE3	TCGA-EK-A2H0-01A-11D-A17Z-05	TCGA-EK-A2H0-01A-11D-A17W-09	c59486e3-0de6-4fd2-adef-b3b369d41e7c			TCGA-EK-A2H0-01A-11D-A17W-09	TCGA-EK-A2H0-01A-11D-A17W-09	c59486e3-0de6-4fd2-adef-b3b369d41e7c	TCGA-EK-A2H0-01A-11D-A17U-01	TCGA-EK-A2H0-01	TCGA-EK-A2H0-01A-11D-A17U-01
TCGA-EK-A2H1-01	TCGA-EK-A2H1-01	TCGA-EK-A2H1	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix				YES	20				TCGA-EK-A2H1-F21350	TCGA-EK-A2H1	TCGA-EK-A2H1-01A												Other	Stage IB2		-7649				70	1319					0	799			44		70					0						Scheduled Follow-up Submission	2012-2-10	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES	Endocervical curettage, cervical cone biopsy	Other method, specify:	140	NO	Non-keratinizing squamous cell carcinoma					ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO					false		Cetuximab	No				TCGA-EK-A2H1.90313D4A-1DB7-42E5-8778-2CB92794B05D.pdf				A2H1			Pre-Adjuvant Therapy	TUMOR FREE					YES							Primary Tumor	01			1995	YES	NO	YES	EK				Cervical	A	LIVING	62	2007	4b80a4f6-c58b-4955-b390-53c9d722ebfa	TCGA-EK-A2H1-01	4b80a4f6-c58b-4955-b390-53c9d722ebfa	TCGA-EK-A2H1-01	TCGA-EK-A2H1-01	FDBD4A06-DE72-4AB2-9949-A4929D93B712	TCGA-EK-A2H1-01A-11D-A17Z-05	TCGA-EK-A2H1-01A-11D-A17W-09	4b80a4f6-c58b-4955-b390-53c9d722ebfa			TCGA-EK-A2H1-01A-11D-A17W-09	TCGA-EK-A2H1-01A-11D-A17W-09	4b80a4f6-c58b-4955-b390-53c9d722ebfa	TCGA-EK-A2H1-01A-11D-A17U-01	TCGA-EK-A2H1-01	TCGA-EK-A2H1-01A-11D-A17U-01
TCGA-EK-A2IP-01	TCGA-EK-A2IP-01	TCGA-EK-A2IP	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix				NO	28				TCGA-EK-A2IP-F21349	TCGA-EK-A2IP	TCGA-EK-A2IP-01A													Stage IB1		-10347					1675		-2			0	202			8							0						Scheduled Follow-up Submission	2012-2-10	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma		18					G3							NO			1		false			No	MX	N0	T1b1	TCGA-EK-A2IP.973889C0-DC63-43F2-9DF4-CA67AFADFA87.pdf				A2IP	1		Preoperative				YES		NO							Primary Tumor	01			1995		NO	YES	EK		2		Cervical	A	LIVING	69	2006	099a51db-4d31-4d90-b9cb-fd482309479a	TCGA-EK-A2IP-01	099a51db-4d31-4d90-b9cb-fd482309479a	TCGA-EK-A2IP-01	TCGA-EK-A2IP-01	939F11BA-747F-4A0A-A885-FCF46C2500F7	TCGA-EK-A2IP-01A-11D-A17Z-05	TCGA-EK-A2IP-01A-11D-A17W-09	099a51db-4d31-4d90-b9cb-fd482309479a			TCGA-EK-A2IP-01A-11D-A17W-09	TCGA-EK-A2IP-01A-11D-A17W-09	099a51db-4d31-4d90-b9cb-fd482309479a	TCGA-EK-A2IP-01A-11D-A17U-01	TCGA-EK-A2IP-01	TCGA-EK-A2IP-01A-11D-A17U-01
TCGA-EK-A2IR-01	TCGA-EK-A2IR-01	TCGA-EK-A2IR	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	NO	48				TCGA-EK-A2IR-F21345	TCGA-EK-A2IR	TCGA-EK-A2IR-01A						ABSENT							Stage IB2		-17581					4950				4	0	3442			-7							0						Scheduled Follow-up Submission	2012-2-10	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Retroperitoneal pelvic and para-aortic lymph node dissection, radical hysterectomy and BSO.	Other method, specify:	130	NO	Keratinizing squamous cell carcinoma		24			PRESENT		G3							NO			1	18	false			No	MX	N0	T1b	TCGA-EK-A2IR.2A0B2B7B-4EBC-49BC-929C-2E5AED2CCBC5.pdf				A2IR			Preoperative	TUMOR FREE			YES	Complete Remission/Response	NO							Primary Tumor	01			1995		NO	YES	EK		1		Cervical	A	LIVING	61	1997	3c109286-fa30-4f6b-98d1-70cd89f87f31	TCGA-EK-A2IR-01	3c109286-fa30-4f6b-98d1-70cd89f87f31	TCGA-EK-A2IR-01	TCGA-EK-A2IR-01	4E99977A-5CA0-49FC-A1AC-69B4138A18BF	TCGA-EK-A2IR-01A-11D-A17Z-05		3c109286-fa30-4f6b-98d1-70cd89f87f31					3c109286-fa30-4f6b-98d1-70cd89f87f31			
TCGA-EK-A2PG-01	TCGA-EK-A2PG-01	TCGA-EK-A2PG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					88				TCGA-EK-A2PG-F58223	TCGA-EK-A2PG	TCGA-EK-A2PG-01A															-32500					2165					0	46			0							4							2014-4-2	FEMALE	155	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO		YES					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3												false			No				TCGA-EK-A2PG.373213AD-4641-426B-AD9F-6C868CAE2868.pdf				A2PG			Preoperative													Primary Tumor	01			1988		NO	YES	EK				Cervical	A	LIVING	55	2005	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	TCGA-EK-A2PG-01	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	TCGA-EK-A2PG-01	TCGA-EK-A2PG-01		TCGA-EK-A2PG-01A-11D-A18K-05	TCGA-EK-A2PG-01A-11D-A18J-09	9f86c904-9c2f-4413-a5ad-95a6fd65cb71			TCGA-EK-A2PG-01A-11D-A18J-09	TCGA-EK-A2PG-01A-11D-A18J-09	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	TCGA-EK-A2PG-01A-11D-A18H-01	TCGA-EK-A2PG-01	TCGA-EK-A2PG-01A-11D-A18H-01
TCGA-EK-A2PI-01	TCGA-EK-A2PI-01	TCGA-EK-A2PI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		44				TCGA-EK-A2PI-F63394	TCGA-EK-A2PI	TCGA-EK-A2PI-01A													Stage IIIB		-16324					881					0	586			0							0							2014-8-7	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO						G2							NO					false			No				TCGA-EK-A2PI.1DA80321-4DC2-4BEF-B932-1B38B6BEDB24.pdf				A2PI			Preoperative	WITH TUMOR	NO				NO							Primary Tumor	01			1988		NO	YES	EK				Cervical	A	LIVING	53	2009	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	TCGA-EK-A2PI-01	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	TCGA-EK-A2PI-01	TCGA-EK-A2PI-01		TCGA-EK-A2PI-01A-11D-A18K-05	TCGA-EK-A2PI-01A-11D-A18J-09	689fb0d6-789a-45c2-8f2f-12cc3a2ea553			TCGA-EK-A2PI-01A-11D-A18J-09	TCGA-EK-A2PI-01A-11D-A18J-09	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	TCGA-EK-A2PI-01A-11D-A18H-01	TCGA-EK-A2PI-01	TCGA-EK-A2PI-01A-11D-A18H-01
TCGA-EK-A2PK-01	TCGA-EK-A2PK-01	TCGA-EK-A2PK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					43				TCGA-EK-A2PK-F58250	TCGA-EK-A2PK	TCGA-EK-A2PK-01A													Stage IB1		-15939					2043					0	12			0							1							2014-4-3	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical Hysterectomy	Other method, specify:	110	NO	Non-keratinizing squamous cell carcinoma	YES	35				Indeterminate (neither Pre or Postmenopausal)	G3												false			No				TCGA-EK-A2PK.F447FFBB-73CD-404F-A078-A894079F30C2.pdf				A2PK			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK			Stable	Cervical	A	LIVING	94	2006	1e176d9d-dba9-4d41-946e-05b7f35eba64	TCGA-EK-A2PK-01	1e176d9d-dba9-4d41-946e-05b7f35eba64	TCGA-EK-A2PK-01	TCGA-EK-A2PK-01	580103D7-9873-4F83-857F-4D46A9DD24A2	TCGA-EK-A2PK-01A-11D-A18K-05	TCGA-EK-A2PK-01A-11D-A18J-09	1e176d9d-dba9-4d41-946e-05b7f35eba64			TCGA-EK-A2PK-01A-11D-A18J-09	TCGA-EK-A2PK-01A-11D-A18J-09	1e176d9d-dba9-4d41-946e-05b7f35eba64	TCGA-EK-A2PK-01A-11D-A18H-01	TCGA-EK-A2PK-01	TCGA-EK-A2PK-01A-11D-A18H-01
TCGA-EK-A2PL-01	TCGA-EK-A2PL-01	TCGA-EK-A2PL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					36				TCGA-EK-A2PL-F58252	TCGA-EK-A2PL	TCGA-EK-A2PL-01A													Stage IIIB		-13384					1181					0	13			13							0							2014-4-3	FEMALE	167	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	YES																3		false			No				TCGA-EK-A2PL.B51554EF-AA39-4A99-BC15-A80EC759316E.pdf				A2PL			Preoperative	WITH TUMOR												Primary Tumor	01			1988		NO	YES	EK		6		Cervical	A	LIVING	113	2008	550b677c-c33a-499c-95dc-68250384b6a8	TCGA-EK-A2PL-01	550b677c-c33a-499c-95dc-68250384b6a8	TCGA-EK-A2PL-01	TCGA-EK-A2PL-01	338F2045-F35A-402B-A07C-83AFC37DB6E4	TCGA-EK-A2PL-01A-11D-A18K-05	TCGA-EK-A2PL-01A-11D-A18J-09	550b677c-c33a-499c-95dc-68250384b6a8			TCGA-EK-A2PL-01A-11D-A18J-09	TCGA-EK-A2PL-01A-11D-A18J-09	550b677c-c33a-499c-95dc-68250384b6a8	TCGA-EK-A2PL-01A-11D-A18H-01	TCGA-EK-A2PL-01	TCGA-EK-A2PL-01A-11D-A18H-01
TCGA-EK-A2PM-01	TCGA-EK-A2PM-01	TCGA-EK-A2PM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					81				TCGA-EK-A2PM-F58253	TCGA-EK-A2PM	TCGA-EK-A2PM-01A													Stage IIB		-29747					1199					0	18			18							0							2014-4-3	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO	Keratinizing squamous cell carcinoma	YES					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3										3		false			No				TCGA-EK-A2PM.B1AB121F-E75E-4AE1-9C9A-16076A3B7879.pdf				A2PM			Preoperative	WITH TUMOR												Primary Tumor	01			1988		NO	YES	EK		3		Cervical	A	LIVING	51	2008	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	TCGA-EK-A2PM-01	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	TCGA-EK-A2PM-01	TCGA-EK-A2PM-01	62C8376A-9A66-4499-A4E3-E7C0102B5EB4	TCGA-EK-A2PM-01A-11D-A18K-05	TCGA-EK-A2PM-01A-11D-A18J-09	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476			TCGA-EK-A2PM-01A-11D-A18J-09	TCGA-EK-A2PM-01A-11D-A18J-09	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	TCGA-EK-A2PM-01A-11D-A18H-01	TCGA-EK-A2PM-01	TCGA-EK-A2PM-01A-11D-A18H-01
TCGA-EK-A2R7-01	TCGA-EK-A2R7-01	TCGA-EK-A2R7	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					45				TCGA-EK-A2R7-F58254	TCGA-EK-A2R7	TCGA-EK-A2R7-01A	Current User												Stage IB		-16487					546					0	27			16							0							2014-4-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		YES	21			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3										2		false			No	M0	N1	T1b1	TCGA-EK-A2R7.5EE5A64B-9025-4C3E-8CD8-8293515BC1F8.pdf				A2R7			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK		2	Complete response	Cervical	A	LIVING	75	2010	ebe70126-032b-4f1e-9d89-1e0bd2f05907	TCGA-EK-A2R7-01	ebe70126-032b-4f1e-9d89-1e0bd2f05907	TCGA-EK-A2R7-01	TCGA-EK-A2R7-01	5084B39A-9371-4D27-9812-371724EED76C	TCGA-EK-A2R7-01A-11D-A18K-05	TCGA-EK-A2R7-01A-11D-A18J-09	ebe70126-032b-4f1e-9d89-1e0bd2f05907			TCGA-EK-A2R7-01A-11D-A18J-09	TCGA-EK-A2R7-01A-11D-A18J-09	ebe70126-032b-4f1e-9d89-1e0bd2f05907	TCGA-EK-A2R7-01A-11D-A18H-01	TCGA-EK-A2R7-01	TCGA-EK-A2R7-01A-11D-A18H-01
TCGA-EK-A2R8-01	TCGA-EK-A2R8-01	TCGA-EK-A2R8	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					48				TCGA-EK-A2R8-F58216	TCGA-EK-A2R8	TCGA-EK-A2R8-01A						ABSENT							Stage IB2		-17692					554					0	44			44							0							2014-4-2	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO	Keratinizing squamous cell carcinoma	YES	17			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3										5		false			No	MX	N1	T1b2	TCGA-EK-A2R8.7E69142C-4F3A-4F81-9DC8-72C86F689083.pdf				A2R8			Preoperative	WITH TUMOR			YES									Primary Tumor	01			1988		NO	YES	EK		5		Cervical	A	LIVING	75	2010	5ff64ded-bdb0-4125-b1b9-8a3945e82810	TCGA-EK-A2R8-01	5ff64ded-bdb0-4125-b1b9-8a3945e82810	TCGA-EK-A2R8-01	TCGA-EK-A2R8-01	AC94BFF4-8049-498D-987E-297D102E8F1D	TCGA-EK-A2R8-01A-21D-A18K-05	TCGA-EK-A2R8-01A-21D-A18J-09	5ff64ded-bdb0-4125-b1b9-8a3945e82810			TCGA-EK-A2R8-01A-21D-A18J-09	TCGA-EK-A2R8-01A-21D-A18J-09	5ff64ded-bdb0-4125-b1b9-8a3945e82810	TCGA-EK-A2R8-01A-21D-A18H-01	TCGA-EK-A2R8-01	TCGA-EK-A2R8-01A-21D-A18H-01
TCGA-EK-A2R9-01	TCGA-EK-A2R9-01	TCGA-EK-A2R9	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					58				TCGA-EK-A2R9-F58255	TCGA-EK-A2R9	TCGA-EK-A2R9-01A						ABSENT							Stage IB1		-21242					230					0	4			4							0							2014-4-3	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical Total Abdominal Hysterectomy and BSO	Other method, specify:	100	NO		YES	14			PRESENT		G3												false			No		N0	T1b1	TCGA-EK-A2R9.05E84255-196B-424A-B317-9A4D2072BD5D.pdf				A2R9			Preoperative	WITH TUMOR			YES									Primary Tumor	01			1988		NO	YES	EK				Cervical	A	LIVING	185	2011	359ed529-c947-47f9-8119-78f2fd038ee5	TCGA-EK-A2R9-01	359ed529-c947-47f9-8119-78f2fd038ee5	TCGA-EK-A2R9-01	TCGA-EK-A2R9-01	58CD44F1-118D-4675-A3F8-0F28F8F98EF9	TCGA-EK-A2R9-01A-11D-A18K-05	TCGA-EK-A2R9-01A-11D-A18J-09	359ed529-c947-47f9-8119-78f2fd038ee5			TCGA-EK-A2R9-01A-11D-A18J-09	TCGA-EK-A2R9-01A-11D-A18J-09	359ed529-c947-47f9-8119-78f2fd038ee5	TCGA-EK-A2R9-01A-11D-A18H-01	TCGA-EK-A2R9-01	TCGA-EK-A2R9-01A-11D-A18H-01
TCGA-EK-A2RA-01	TCGA-EK-A2RA-01	TCGA-EK-A2RA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		74	41			TCGA-EK-A2RA-F62993	TCGA-EK-A2RA	TCGA-EK-A2RA-01A						PRESENT							Stage IIA2		-27209					232		30			0	1246			0							0							2014-7-29	FEMALE	160	Cervical Squamous Cell Carcinoma	No					Total Abdominal Hysterectomy	Other	C53.9	8072/3	C53.9	YES	aortic and pelvic lymphadenectomy, total abdominal hysterectomy and BSO.	Other method, specify:	130	NO	Non-keratinizing squamous cell carcinoma	NO	32			ABSENT		G3							NO	0	0			false			No	MX	N0	T2a2	TCGA-EK-A2RA.4BF58062-E21B-4C5E-91D3-8AB242D8D62E.pdf				A2RA			Preoperative	WITH TUMOR	NO		YES		NO							Primary Tumor	01		2010	2009		NO	YES	EK	4			Cervical	A	LIVING	72	2011	95a815e7-101e-416c-90b0-5c6c568ab897	TCGA-EK-A2RA-01	95a815e7-101e-416c-90b0-5c6c568ab897	TCGA-EK-A2RA-01	TCGA-EK-A2RA-01	A6DF7C14-361B-4DFF-B886-9EE48F169CD4	TCGA-EK-A2RA-01A-11D-A18K-05	TCGA-EK-A2RA-01A-11D-A18J-09	95a815e7-101e-416c-90b0-5c6c568ab897			TCGA-EK-A2RA-01A-11D-A18J-09	TCGA-EK-A2RA-01A-11D-A18J-09	95a815e7-101e-416c-90b0-5c6c568ab897	TCGA-EK-A2RA-01A-11D-A18H-01	TCGA-EK-A2RA-01	TCGA-EK-A2RA-01A-11D-A18H-01
TCGA-EK-A2RB-01	TCGA-EK-A2RB-01	TCGA-EK-A2RB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					48			post-op	TCGA-EK-A2RB-F58259	TCGA-EK-A2RB	TCGA-EK-A2RB-01A													Stage IVB		-17752					169					0	9			2							0							2014-4-3	FEMALE	175	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES	Cervical biopsies and cystoscopy	Other method, specify:	70	NO		YES						G3												false			No				TCGA-EK-A2RB.F973731C-16D2-4391-ACCF-381C362B8438.pdf				A2RB			Other	TUMOR FREE			NO									Primary Tumor	01			1988		NO	YES	EK	2			Cervical	A	LIVING	105	2011	59d21a33-8d29-4c23-95a8-7986d2a3db36	TCGA-EK-A2RB-01	59d21a33-8d29-4c23-95a8-7986d2a3db36	TCGA-EK-A2RB-01	TCGA-EK-A2RB-01		TCGA-EK-A2RB-01A-11D-A18K-05	TCGA-EK-A2RB-01A-11D-A18J-09	59d21a33-8d29-4c23-95a8-7986d2a3db36			TCGA-EK-A2RB-01A-11D-A18J-09	TCGA-EK-A2RB-01A-11D-A18J-09	59d21a33-8d29-4c23-95a8-7986d2a3db36	TCGA-EK-A2RB-01A-11D-A18H-01	TCGA-EK-A2RB-01	TCGA-EK-A2RB-01A-11D-A18H-01
TCGA-EK-A2RC-01	TCGA-EK-A2RC-01	TCGA-EK-A2RC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					33			after surgery	TCGA-EK-A2RC-F58260	TCGA-EK-A2RC	TCGA-EK-A2RC-01A									Positive vaginal margin				Stage IB1		-12353					786					0	129			125							0					NO		2014-4-3	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Biopsy and endocervical curettage	Other method, specify:	100	NO		YES	16			PRESENT		G3										3		false			No				TCGA-EK-A2RC.1FBD6F5F-52DB-4DA3-AB1D-BB81200A032B.pdf				A2RC			Other	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK		4	Complete response	Cervical	A	LIVING	72	2009	fa8d81bb-a026-426c-8e24-2c8ca93007c4	TCGA-EK-A2RC-01	fa8d81bb-a026-426c-8e24-2c8ca93007c4	TCGA-EK-A2RC-01	TCGA-EK-A2RC-01	272D7304-B95D-43A9-B70C-20E37C81082C	TCGA-EK-A2RC-01A-11D-A18K-05	TCGA-EK-A2RC-01A-11D-A18J-09	fa8d81bb-a026-426c-8e24-2c8ca93007c4			TCGA-EK-A2RC-01A-11D-A18J-09	TCGA-EK-A2RC-01A-11D-A18J-09	fa8d81bb-a026-426c-8e24-2c8ca93007c4	TCGA-EK-A2RC-01A-11D-A18H-01	TCGA-EK-A2RC-01	TCGA-EK-A2RC-01A-11D-A18H-01
TCGA-EK-A2RD-01	TCGA-EK-A2RD-01	TCGA-EK-A2RD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					47				TCGA-EK-A2RD-F58262	TCGA-EK-A2RD	TCGA-EK-A2RD-01A													Stage IB1		-17191					658					0	2			0							0							2014-4-3	FEMALE	161	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Biopsy, Robotic Hysterectomy, BSO, Pelvic and periaortic LN dissection.	Other method, specify:	120	NO	Non-keratinizing squamous cell carcinoma	YES	10			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										2		false			No	MX	N0	T1b1	TCGA-EK-A2RD.CD011A7E-A4C0-4BCE-8D21-C2CC6B97E85E.pdf				A2RD			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK		2		Cervical	A	LIVING	114	2009		TCGA-EK-A2RD-01		TCGA-EK-A2RD-01		84C57E10-A656-4563-8F7A-71CD0ECD84B0	TCGA-EK-A2RD-01A-12D-A212-05	TCGA-EK-A2RD-01A-12D-A20U-09				TCGA-EK-A2RD-01A-12D-A20U-09	TCGA-EK-A2RD-01A-12D-A20U-09		TCGA-EK-A2RD-01A-12D-A20T-01		TCGA-EK-A2RD-01A-12D-A20T-01
TCGA-EK-A2RE-01	TCGA-EK-A2RE-01	TCGA-EK-A2RE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					26				TCGA-EK-A2RE-F58263	TCGA-EK-A2RE	TCGA-EK-A2RE-01A						ABSENT							Stage IIA		-9743					364					0	57			0							0							2014-4-3	FEMALE	161	Cervical Squamous Cell Carcinoma	No			atypia positive hpv	Other HPV type(s)			C53.9	8071/3	C53.9	YES	laparoscopic-assisted radical vaginal trachelectomy with pelvic periaortic lymph node dissection and cerclage	Other method, specify:	120	NO	Keratinizing squamous cell carcinoma	YES	21			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2												false			No	MX	N0	T2a2	TCGA-EK-A2RE.86AFFE75-2DB8-40E3-9BCA-A2F695173DCC.pdf				A2RE			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK				Cervical	A	LIVING	54	2010	51257d94-f973-4dfd-93d7-72ec4013def7	TCGA-EK-A2RE-01	51257d94-f973-4dfd-93d7-72ec4013def7	TCGA-EK-A2RE-01	TCGA-EK-A2RE-01	CC285FB3-7E31-4A64-BEFF-36F0909E6C8D	TCGA-EK-A2RE-01A-11D-A18K-05	TCGA-EK-A2RE-01A-11D-A18J-09	51257d94-f973-4dfd-93d7-72ec4013def7			TCGA-EK-A2RE-01A-11D-A18J-09	TCGA-EK-A2RE-01A-11D-A18J-09	51257d94-f973-4dfd-93d7-72ec4013def7	TCGA-EK-A2RE-01A-11D-A18H-01	TCGA-EK-A2RE-01	TCGA-EK-A2RE-01A-11D-A18H-01
TCGA-EK-A2RJ-01	TCGA-EK-A2RJ-01	TCGA-EK-A2RJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					51				TCGA-EK-A2RJ-F58265	TCGA-EK-A2RJ	TCGA-EK-A2RJ-01A													Stage IB2		-18664					714					0	53			33							0							2014-4-3	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	YES	22			PRESENT		G3										1		false			No	MX	N0	T1b2	TCGA-EK-A2RJ.6761746F-0149-4AE4-840F-D99B8FCEF6F5.pdf				A2RJ			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK		1		Cervical	A	LIVING	85	2009	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	TCGA-EK-A2RJ-01	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	TCGA-EK-A2RJ-01	TCGA-EK-A2RJ-01	23F28333-7FA9-41C6-8039-57739EC99A30	TCGA-EK-A2RJ-01A-11D-A18K-05	TCGA-EK-A2RJ-01A-11D-A18J-09	48ee0be7-9c0f-4e6d-81cf-638c52beef8b			TCGA-EK-A2RJ-01A-11D-A18J-09	TCGA-EK-A2RJ-01A-11D-A18J-09	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	TCGA-EK-A2RJ-01A-11D-A18H-01	TCGA-EK-A2RJ-01	TCGA-EK-A2RJ-01A-11D-A18H-01
TCGA-EK-A2RK-01	TCGA-EK-A2RK-01	TCGA-EK-A2RK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					67				TCGA-EK-A2RK-F58268	TCGA-EK-A2RK	TCGA-EK-A2RK-01A									Positive vaginal margin				Stage IA2		-24541					709					0	13			0							0							2014-4-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical hysterectomy, BSO, bilateral pelvic lymphadenectomy	Other method, specify:	120	NO	Non-keratinizing squamous cell carcinoma	YES	27			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3										1		false			No	MX	N0	T1b1	TCGA-EK-A2RK.53039912-13F8-4EB8-B8DD-39B39F2AE486.pdf				A2RK	1		Preoperative				YES									Primary Tumor	01			1988		NO	YES	EK		2		Cervical	A	LIVING	101	2009	2713b35a-f04a-4078-85c6-34140350398f	TCGA-EK-A2RK-01	2713b35a-f04a-4078-85c6-34140350398f	TCGA-EK-A2RK-01	TCGA-EK-A2RK-01	8946907D-9AB9-4A3F-80CD-5689DAAB4556	TCGA-EK-A2RK-01A-11D-A18K-05	TCGA-EK-A2RK-01A-11D-A18J-09	2713b35a-f04a-4078-85c6-34140350398f			TCGA-EK-A2RK-01A-11D-A18J-09	TCGA-EK-A2RK-01A-11D-A18J-09	2713b35a-f04a-4078-85c6-34140350398f	TCGA-EK-A2RK-01A-11D-A18H-01	TCGA-EK-A2RK-01	TCGA-EK-A2RK-01A-11D-A18H-01
TCGA-EK-A2RL-01	TCGA-EK-A2RL-01	TCGA-EK-A2RL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		32				TCGA-EK-A2RL-F58210	TCGA-EK-A2RL	TCGA-EK-A2RL-01A						PRESENT							Stage IB		-12047					723	1453	20			0	721		1143	29							0							2014-4-2	FEMALE	154	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES	biopsy and endocervical curettage	Other method, specify:	140	NO		NO	33	Pelvic (external iliac, internal iliac, obturator)		ABSENT		G2	Cervix	Radiographic		Locoregional Recurrence			YES					false			No	MX	N1	T1b1	TCGA-EK-A2RL.7AE4CF2E-602B-4860-8919-095EA5378504.pdf	Cervical Cancer			A2RL			Preoperative	WITH TUMOR	YES		YES	Progressive Disease	NO							Primary Tumor	01			1988	NO	NO	YES	EK				Cervical	A	DECEASED	89	2009	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	TCGA-EK-A2RL-01	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	TCGA-EK-A2RL-01	TCGA-EK-A2RL-01	7E06C3E0-3B9D-4AEF-B73B-2793790747FA	TCGA-EK-A2RL-01A-11D-A18K-05	TCGA-EK-A2RL-01A-11D-A18J-09	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125			TCGA-EK-A2RL-01A-11D-A18J-09	TCGA-EK-A2RL-01A-11D-A18J-09	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	TCGA-EK-A2RL-01A-11D-A18H-01	TCGA-EK-A2RL-01	TCGA-EK-A2RL-01A-11D-A18H-01
TCGA-EK-A2RM-01	TCGA-EK-A2RM-01	TCGA-EK-A2RM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					40				TCGA-EK-A2RM-F58215	TCGA-EK-A2RM	TCGA-EK-A2RM-01A													Stage IB		-14842					778					0	50			0							1							2014-4-2	FEMALE	167	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Radical Hysterectomy, BSO	Other method, specify:	100	NO		YES	36			PRESENT		G3										4		false			No				TCGA-EK-A2RM.3810E8FD-27A9-4E65-9BD2-BFA5594813B8.pdf				A2RM			Preoperative	WITH TUMOR			YES									Primary Tumor	01			1988		NO	YES	EK		4		Cervical	A	LIVING	105	2009	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	TCGA-EK-A2RM-01	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	TCGA-EK-A2RM-01	TCGA-EK-A2RM-01	8E91B507-4AF4-432F-9A6A-1B07118A6AE2	TCGA-EK-A2RM-01A-21D-A18K-05	TCGA-EK-A2RM-01A-21D-A18J-09	1a6ee24e-975c-4ba8-8cc3-666555fb89d6			TCGA-EK-A2RM-01A-21D-A18J-09	TCGA-EK-A2RM-01A-21D-A18J-09	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	TCGA-EK-A2RM-01A-21D-A18H-01	TCGA-EK-A2RM-01	TCGA-EK-A2RM-01A-21D-A18H-01
TCGA-EK-A2RN-01	TCGA-EK-A2RN-01	TCGA-EK-A2RN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					45				TCGA-EK-A2RN-F58269	TCGA-EK-A2RN									parametrial involvement on the right side only	Other Location, specify				Stage IB1		-16487										0	71			0							0							2014-4-3	FEMALE	176	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Cone Biopsy / LEEP			Keratinizing squamous cell carcinoma	YES	15	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										0					No	MX	N1	T2b					A2RN		1	Preoperative	WITH TUMOR			YES									Primary Tumor	01			1988		NO	YES	EK		1		Cervical		LIVING	68	2009	f1f0a4e6-8757-43f2-96c5-5b6bae173590	TCGA-EK-A2RN-01	f1f0a4e6-8757-43f2-96c5-5b6bae173590	TCGA-EK-A2RN-01	TCGA-EK-A2RN-01		TCGA-EK-A2RN-01A-12D-A212-05	TCGA-EK-A2RN-01A-12D-A20U-09	f1f0a4e6-8757-43f2-96c5-5b6bae173590			TCGA-EK-A2RN-01A-12D-A20U-09	TCGA-EK-A2RN-01A-12D-A20U-09	f1f0a4e6-8757-43f2-96c5-5b6bae173590	TCGA-EK-A2RN-01A-12D-A20T-01	TCGA-EK-A2RN-01	TCGA-EK-A2RN-01A-12D-A20T-01
TCGA-EK-A2RO-01	TCGA-EK-A2RO-01	TCGA-EK-A2RO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					59				TCGA-EK-A2RO-F58270	TCGA-EK-A2RO	TCGA-EK-A2RO-01A													Stage IIB		-21844					409				-11	0	2			1							0							2014-4-3	FEMALE	168	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8072/3	C53.9	YES		Lymph node sampling or dissection	90	NO	Keratinizing squamous cell carcinoma	YES	32				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1								0	0			false			No				TCGA-EK-A2RO.49E0E89E-7DB0-4FFD-8246-1EF8E4308829.pdf				A2RO			Preoperative	WITH TUMOR			YES									Primary Tumor	01	12		1988		NO	YES	EK				Cervical	A	LIVING	77	2010	6c6c44ac-3626-482e-8d33-adbd122f8352	TCGA-EK-A2RO-01	6c6c44ac-3626-482e-8d33-adbd122f8352	TCGA-EK-A2RO-01	TCGA-EK-A2RO-01	33DF4CED-0F6D-4E70-BD3F-D21D94310B95	TCGA-EK-A2RO-01A-11D-A18K-05	TCGA-EK-A2RO-01A-11D-A18J-09	6c6c44ac-3626-482e-8d33-adbd122f8352			TCGA-EK-A2RO-01A-11D-A18J-09	TCGA-EK-A2RO-01A-11D-A18J-09	6c6c44ac-3626-482e-8d33-adbd122f8352	TCGA-EK-A2RO-01A-11D-A18H-01	TCGA-EK-A2RO-01	TCGA-EK-A2RO-01A-11D-A18H-01
TCGA-EK-A3GJ-01	TCGA-EK-A3GJ-01	TCGA-EK-A3GJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					51				TCGA-EK-A3GJ-F58271	TCGA-EK-A3GJ	TCGA-EK-A3GJ-01A						ABSENT							Stage IB1		-18630					407					0	3			-1							1							2014-4-3	FEMALE	171	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Radical hysterectomy with bso and pnd	Other method, specify:	90	NO	Keratinizing squamous cell carcinoma	YES	24			ABSENT		G3										6		false			No		N0	T1b1	TCGA-EK-A3GJ.45318527-2DCC-472C-8712-8639CCF4931D.pdf				A3GJ			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK		10		Cervical	A	LIVING	96	2010	1dbe0951-14cc-4489-aaf2-f3592be05f07	TCGA-EK-A3GJ-01	1dbe0951-14cc-4489-aaf2-f3592be05f07	TCGA-EK-A3GJ-01	TCGA-EK-A3GJ-01		TCGA-EK-A3GJ-01A-21D-A212-05	TCGA-EK-A3GJ-01A-21D-A20U-09	1dbe0951-14cc-4489-aaf2-f3592be05f07			TCGA-EK-A3GJ-01A-21D-A20U-09	TCGA-EK-A3GJ-01A-21D-A20U-09	1dbe0951-14cc-4489-aaf2-f3592be05f07	TCGA-EK-A3GJ-01A-21D-A20T-01	TCGA-EK-A3GJ-01	TCGA-EK-A3GJ-01A-21D-A20T-01
TCGA-EK-A3GK-01	TCGA-EK-A3GK-01	TCGA-EK-A3GK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					33				TCGA-EK-A3GK-F58272	TCGA-EK-A3GK	TCGA-EK-A3GK-01A	Current User					ABSENT							Stage IB1		-12207					744					0	15			0							0							2014-4-3	FEMALE	165	Endocervical Type of Adenocarcinoma	No				HPV 16		Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Radical hysterectomy, BSO, Bilateral pelvic LND, upper vaginectomy, omental and cecal biopsy.	Other method, specify:	90	NO		YES	22			PRESENT		G3								0	0	0		false			No	MX	N0	T1b1	TCGA-EK-A3GK.FA43F625-0F3A-4CAD-B55D-A00113DEA927.pdf				A3GK			Preoperative	TUMOR FREE			YES									Primary Tumor	01			1988		NO	YES	EK		0		Cervical	A	LIVING	73	2009	6878010a-30d5-44ef-bd70-99f532a584d5	TCGA-EK-A3GK-01	6878010a-30d5-44ef-bd70-99f532a584d5	TCGA-EK-A3GK-01	TCGA-EK-A3GK-01	84DFB78B-2D19-4F71-BCB0-F7A141BC6690	TCGA-EK-A3GK-01A-11D-A212-05	TCGA-EK-A3GK-01A-11D-A20U-09	6878010a-30d5-44ef-bd70-99f532a584d5			TCGA-EK-A3GK-01A-11D-A20U-09	TCGA-EK-A3GK-01A-11D-A20U-09	6878010a-30d5-44ef-bd70-99f532a584d5	TCGA-EK-A3GK-01A-11D-A20T-01	TCGA-EK-A3GK-01	TCGA-EK-A3GK-01A-11D-A20T-01
TCGA-EK-A3GM-01	TCGA-EK-A3GM-01	TCGA-EK-A3GM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					65				TCGA-EK-A3GM-F58222	TCGA-EK-A3GM	TCGA-EK-A3GM-01A						ABSENT							Stage IIA		-23879					2122					0	0			0							0							2014-4-2	FEMALE	150	Endocervical Type of Adenocarcinoma	No				Not applicable			C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO		YES				ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										10		false			No				TCGA-EK-A3GM.15E809A3-4A09-426E-B816-C31246ECCCA4.pdf				A3GM			Preoperative													Primary Tumor	01			1988		NO	YES	EK	1	10		Cervical	A	LIVING	83	2006	8bae571a-8285-48dd-aea3-9eb002c0610b	TCGA-EK-A3GM-01	8bae571a-8285-48dd-aea3-9eb002c0610b	TCGA-EK-A3GM-01	TCGA-EK-A3GM-01	E932E7D1-9C9C-446B-B772-CAA451D3A27E	TCGA-EK-A3GM-01A-11D-A212-05	TCGA-EK-A3GM-01A-11D-A20U-09	8bae571a-8285-48dd-aea3-9eb002c0610b			TCGA-EK-A3GM-01A-11D-A20U-09	TCGA-EK-A3GM-01A-11D-A20U-09	8bae571a-8285-48dd-aea3-9eb002c0610b	TCGA-EK-A3GM-01A-11D-A20T-01	TCGA-EK-A3GM-01	TCGA-EK-A3GM-01A-11D-A20T-01
TCGA-EK-A3GN-01	TCGA-EK-A3GN-01	TCGA-EK-A3GN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					47				TCGA-EK-A3GN-F21156	TCGA-EK-A3GN	TCGA-EK-A3GN-01A						ABSENT							Stage IIIB		-17425					2374					0	27			0							1						Scheduled Follow-up Submission	2014-4-2	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO						ABSENT		G3												false			No		NX	TX	TCGA-EK-A3GN.357A8CB5-F1BF-4BFC-97DF-07CEF0D55026.pdf				A3GN			Preoperative	WITH TUMOR					NO							Primary Tumor	01			1988		NO	YES	EK				Cervical	A	LIVING	83	2005	b74c4373-3809-4536-85ef-4c9e651a913e	TCGA-EK-A3GN-01	b74c4373-3809-4536-85ef-4c9e651a913e	TCGA-EK-A3GN-01	TCGA-EK-A3GN-01	C68D40B8-F4FA-49CF-A16D-CBA515D9EEC9	TCGA-EK-A3GN-01A-11D-A212-05	TCGA-EK-A3GN-01A-11D-A20U-09	b74c4373-3809-4536-85ef-4c9e651a913e			TCGA-EK-A3GN-01A-11D-A20U-09	TCGA-EK-A3GN-01A-11D-A20U-09	b74c4373-3809-4536-85ef-4c9e651a913e	TCGA-EK-A3GN-01A-11D-A20T-01	TCGA-EK-A3GN-01	TCGA-EK-A3GN-01A-11D-A20T-01
TCGA-EX-A1H5-01	TCGA-EX-A1H5-01	TCGA-EX-A1H5	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response	YES	58	33			TCGA-EX-A1H5-F50657	TCGA-EX-A1H5	TCGA-EX-A1H5-01A	Never Used					ABSENT			Microscopic parametrial involvement	not part of recommended treatment plan	Other		Stage IIB		-21338					163					0	619												Completed as Planned				Scheduled Follow-up Submission	2013-10-28	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	220	NO	Non-keratinizing squamous cell carcinoma	NO	21	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	4		4	12	false			No	MX	N1	T2b	TCGA-EX-A1H5.C596A314-A98F-4E6C-92FA-017BDF820E88.pdf				A1H5				TUMOR FREE	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	EX	2	4	Complete response	Cervical	A	LIVING	67	2010	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	TCGA-EX-A1H5-01	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	TCGA-EX-A1H5-01	TCGA-EX-A1H5-01	05E67180-E51A-488E-BD2D-BD24DA4F2D38	TCGA-EX-A1H5-01A-31D-A13Z-05	TCGA-EX-A1H5-01A-31D-A13W-08	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	TCGA-EX-A1H5-01A-31D-A13W-08	TCGA-EX-A1H5-01A-31D-A13W-08	TCGA-EX-A1H5-01A-31D-A13W-08	TCGA-EX-A1H5-01A-31D-A13W-08	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	TCGA-EX-A1H5-01A-31D-A13V-01	TCGA-EX-A1H5-01	TCGA-EX-A1H5-01A-31D-A13V-01
TCGA-EX-A1H6-01	TCGA-EX-A1H6-01	TCGA-EX-A1H6	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					38				TCGA-EX-A1H6-F38911	TCGA-EX-A1H6	TCGA-EX-A1H6-01B	Current User					ABSENT							Stage IB1		-14214					576		24			0	241							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent										2013-1-8	FEMALE	158	Endocervical Type of Adenocarcinoma	No							C53.9	8140/3	C53.9	YES		Cone Biopsy / LEEP	50	NO		YES	20			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0		2		false			No	MX	N0	T1b1	TCGA-EX-A1H6.C0A44D8D-EE10-45EF-8B23-23A2E793E5D5.pdf				A1H6		1		TUMOR FREE	NO		YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01			2009		NO	YES	EX	1	3		Cervical	B	LIVING	74	2009	7fb5882c-6f15-462f-83e6-8bff997bf16d	TCGA-EX-A1H6-01	7fb5882c-6f15-462f-83e6-8bff997bf16d	TCGA-EX-A1H6-01	TCGA-EX-A1H6-01		TCGA-EX-A1H6-01B-11D-A230-05	TCGA-EX-A1H6-01B-11D-A22X-09	7fb5882c-6f15-462f-83e6-8bff997bf16d			TCGA-EX-A1H6-01B-11D-A22X-09	TCGA-EX-A1H6-01B-11D-A22X-09	7fb5882c-6f15-462f-83e6-8bff997bf16d	TCGA-EX-A1H6-01B-11D-A22W-01	TCGA-EX-A1H6-01	TCGA-EX-A1H6-01B-11D-A22W-01
TCGA-EX-A3L1-01	TCGA-EX-A3L1-01	TCGA-EX-A3L1	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		32				TCGA-EX-A3L1-F38130	TCGA-EX-A3L1	TCGA-EX-A3L1-01A	Current User					ABSENT							Stage IIA1		-11943					161					0	463															NO		2012-12-11	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma	NO	22			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		3		false			No	M0	N0	T2a1	TCGA-EX-A3L1.39B5AD4F-9206-4AE5-96EF-AC8E5B2B10E5.pdf				A3L1				TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	EX	1	3	Complete response	Cervical	A	LIVING	57	2011	576cc9e7-f32b-4478-a8a6-e77c16a07e35	TCGA-EX-A3L1-01	576cc9e7-f32b-4478-a8a6-e77c16a07e35	TCGA-EX-A3L1-01	TCGA-EX-A3L1-01		TCGA-EX-A3L1-01A-11D-A21R-05	TCGA-EX-A3L1-01A-11D-A21Q-09	576cc9e7-f32b-4478-a8a6-e77c16a07e35			TCGA-EX-A3L1-01A-11D-A21Q-09	TCGA-EX-A3L1-01A-11D-A21Q-09	576cc9e7-f32b-4478-a8a6-e77c16a07e35	TCGA-EX-A3L1-01A-11D-A21P-01	TCGA-EX-A3L1-01	TCGA-EX-A3L1-01A-11D-A21P-01
TCGA-EX-A449-01	TCGA-EX-A449-01	TCGA-EX-A449	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		42				TCGA-EX-A449-F47567	TCGA-EX-A449	TCGA-EX-A449-01A						ABSENT			Macroscopic parametrial involvement				Stage IVB		-15559					79		-12			0	447							Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent										2013-8-27	FEMALE	168	Endocervical Type of Adenocarcinoma	No					Total Abdominal	Other	C53.9	8384/3	C53.9	YES	Total Abdominal Hysterectomy	Other method, specify:	360	NO		NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO			1		false			Yes	M1	NX	T1b1	TCGA-EX-A449.C758E08B-3903-4C72-8F2D-5B064F24BCC1.pdf				A449		1		TUMOR FREE	YES	1	NO	Complete Remission/Response	YES							Primary Tumor	01			7th	YES	YES	NO	EX		3		Cervical	A	LIVING	107	2012	028824a6-0890-43c9-a46f-48a23483d205		028824a6-0890-43c9-a46f-48a23483d205		TCGA-EX-A449-01	4F8CD975-7A4D-43CD-A503-7ADE21803B47	TCGA-EX-A449-01A-11D-A244-05	TCGA-EX-A449-01A-11D-A243-09	028824a6-0890-43c9-a46f-48a23483d205			TCGA-EX-A449-01A-11D-A243-09	TCGA-EX-A449-01A-11D-A243-09	028824a6-0890-43c9-a46f-48a23483d205	TCGA-EX-A449-01A-11D-A242-01	TCGA-EX-A449-01	TCGA-EX-A449-01A-11D-A242-01
TCGA-EX-A69L-01	TCGA-EX-A69L-01	TCGA-EX-A69L	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		41				TCGA-EX-A69L-F63787	TCGA-EX-A69L	TCGA-EX-A69L-01A	Never Used										Not done per treating physicians discretion		Stage IB1		-15121					148		11			0	602							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|										2014-8-18	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	530	NO	Non-keratinizing squamous cell carcinoma	NO	26				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1		false			No	M0	N0	T1b1	TCGA-EX-A69L.6B157876-04F4-49D6-BACB-87F8E2B921CE.pdf				A69L	1			TUMOR FREE	NO		YES	Complete Remission/Response	NO	Participant refusal						Primary Tumor	01			2009	NO	YES	NO	EX	1	2		Cervical	A	LIVING	73	2012	c51e3133-d702-41cd-af51-094a31f449d4	TCGA-EX-A69L-01	c51e3133-d702-41cd-af51-094a31f449d4	TCGA-EX-A69L-01	TCGA-EX-A69L-01	A34C4C91-F909-4102-95A8-2DCE367AEDA8	TCGA-EX-A69L-01A-11D-A32T-05	TCGA-EX-A69L-01A-11D-A32I-09	c51e3133-d702-41cd-af51-094a31f449d4			TCGA-EX-A69L-01A-11D-A32I-09	TCGA-EX-A69L-01A-11D-A32I-09	c51e3133-d702-41cd-af51-094a31f449d4	TCGA-EX-A69L-01A-11D-A32H-01	TCGA-EX-A69L-01	TCGA-EX-A69L-01A-11D-A32H-01
TCGA-EX-A69M-01	TCGA-EX-A69M-01	TCGA-EX-A69M	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		62				TCGA-EX-A69M-F59393	TCGA-EX-A69M	TCGA-EX-A69M-01A	Never Used										Not done per treating physicians discretion		Stage IB2		-22917					148	253			18	0	186						Lung Cancer				1	1			Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-5-12	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Other, specify	Immunostain	HPV 63	HPV 16|Other HPV type(s)			C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	690	NO	Non-keratinizing squamous cell carcinoma	NO	11				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							YES	0		3		false			Yes	M0	N0	T1b2	TCGA-EX-A69M.808A38A8-4E74-42A4-8258-C883A7F6CA0C.pdf	Other, specify			A69M			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01		2012	2009	NO	YES	NO	EX	4	4		Cervical	A	DECEASED	58	2012	81417e28-9132-4081-a85f-ed63396427c3	TCGA-EX-A69M-01	81417e28-9132-4081-a85f-ed63396427c3	TCGA-EX-A69M-01	TCGA-EX-A69M-01	E473C4E8-6073-41A2-9ABD-7E02564303CB	TCGA-EX-A69M-01A-11D-A32T-05	TCGA-EX-A69M-01A-11D-A32I-09	81417e28-9132-4081-a85f-ed63396427c3			TCGA-EX-A69M-01A-11D-A32I-09	TCGA-EX-A69M-01A-11D-A32I-09	81417e28-9132-4081-a85f-ed63396427c3	TCGA-EX-A69M-01A-11D-A32H-01	TCGA-EX-A69M-01	TCGA-EX-A69M-01A-11D-A32H-01
TCGA-EX-A8YF-01	TCGA-EX-A8YF-01	TCGA-EX-A8YF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES		Progressive Disease		44				TCGA-EX-A8YF-F68767	TCGA-EX-A8YF	TCGA-EX-A8YF-01A													Stage IB1		-16258					111		21			0	473		396					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent										2014-12-15	FEMALE	168	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	950	NO	Non-keratinizing squamous cell carcinoma	NO	37			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Other, specify	Dx biopsy		Locoregional Recurrence	Vagina	NO	YES	0		2		false			No	M0	N0	T2a1	TCGA-EX-A8YF.AD08339B-E984-4E09-A8BF-C9FFE92E83F2.pdf				A8YF				WITH TUMOR	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009		YES	NO	EX	1	3		Cervical	A	LIVING	57	2013	1c3b1633-b318-486c-9d82-101c4a0364cd	TCGA-EX-A8YF-01	1c3b1633-b318-486c-9d82-101c4a0364cd	TCGA-EX-A8YF-01	TCGA-EX-A8YF-01	25907BD2-AF9F-4497-8B88-8E0E47BC3C33	TCGA-EX-A8YF-01A-11D-A37Q-05		1c3b1633-b318-486c-9d82-101c4a0364cd					1c3b1633-b318-486c-9d82-101c4a0364cd	TCGA-EX-A8YF-01A-11D-A37M-01	TCGA-EX-A8YF-01	TCGA-EX-A8YF-01A-11D-A37M-01
TCGA-FU-A23K-01	TCGA-FU-A23K-01	TCGA-FU-A23K	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		28				TCGA-FU-A23K-F65840	TCGA-FU-A23K	TCGA-FU-A23K-01A													Stage IIIB		-10551					192		6			0	372							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent								NO		2014-9-30	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8083/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO	Non-keratinizing squamous cell carcinoma	YES	24	Common iliac		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	1		2		false			No	MX	N1	T1b1	TCGA-FU-A23K.D5E65FAE-5BC9-43A9-89D0-AA7D266F3C06.pdf				A23K				TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		NO	YES	FU	1	2		Cervical	A	LIVING	91	2010	0375a538-64dc-4f7b-807e-d765c8d88c23	TCGA-FU-A23K-01	0375a538-64dc-4f7b-807e-d765c8d88c23	TCGA-FU-A23K-01	TCGA-FU-A23K-01	1533008F-A3B8-4B50-A280-0A1C1FFACEFD	TCGA-FU-A23K-01A-11D-A16P-05	TCGA-FU-A23K-01A-11D-A16O-08	0375a538-64dc-4f7b-807e-d765c8d88c23	TCGA-FU-A23K-01A-11D-A16O-08	TCGA-FU-A23K-01A-11D-A16O-08	TCGA-FU-A23K-01A-11D-A16O-08	TCGA-FU-A23K-01A-11D-A16O-08	0375a538-64dc-4f7b-807e-d765c8d88c23	TCGA-FU-A23K-01A-11D-A16M-01	TCGA-FU-A23K-01	TCGA-FU-A23K-01A-11D-A16M-01
TCGA-FU-A23L-01	TCGA-FU-A23L-01	TCGA-FU-A23L	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		60				TCGA-FU-A23L-F56151	TCGA-FU-A23L	TCGA-FU-A23L-01A						PRESENT							Stage IIA1		-21962					165					0	725			725							0					NO		2014-1-29	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO		NO	11			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		4		false			No	MX	N0	T2a1	TCGA-FU-A23L.717358E4-EB69-4232-B0AE-36C7058531A9.pdf				A23L			Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	NO	YES	FU	1			Cervical	A	LIVING	56	2010	58ccb54d-2d23-4bce-b05d-02e543d83306	TCGA-FU-A23L-01	58ccb54d-2d23-4bce-b05d-02e543d83306	TCGA-FU-A23L-01	TCGA-FU-A23L-01	179BC59D-8509-4989-8D44-D7C6EB2CCF8B	TCGA-FU-A23L-01A-11D-A16P-05	TCGA-FU-A23L-01A-11D-A16O-08	58ccb54d-2d23-4bce-b05d-02e543d83306	TCGA-FU-A23L-01A-11D-A16O-08	TCGA-FU-A23L-01A-11D-A16O-08	TCGA-FU-A23L-01A-11D-A16O-08	TCGA-FU-A23L-01A-11D-A16O-08	58ccb54d-2d23-4bce-b05d-02e543d83306	TCGA-FU-A23L-01A-11D-A16M-01	TCGA-FU-A23L-01	TCGA-FU-A23L-01A-11D-A16M-01
TCGA-FU-A2QG-01	TCGA-FU-A2QG-01	TCGA-FU-A2QG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		29	14			TCGA-FU-A2QG-F43199	TCGA-FU-A2QG	TCGA-FU-A2QG-01A	Former User												Stage IB1		-10865					77					0	579			579							1	0				NO		2013-5-15	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Keratinizing squamous cell carcinoma	NO	32			ABSENT	Peri (6-12 months since last menstrual period)	G2							NO	0	0	1	15	false			No		N0	T1b1	TCGA-FU-A2QG.9616EC35-D8F6-4EE1-AF0A-BF955C6A4C14.pdf				A2QG	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01		2011	2009		YES	NO	FU	4	1		Cervical	A	LIVING	138	2011	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	TCGA-FU-A2QG-01	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	TCGA-FU-A2QG-01	TCGA-FU-A2QG-01	BF0B2734-8B91-46D0-BC54-D21D1EB1C035	TCGA-FU-A2QG-01A-11D-A18K-05	TCGA-FU-A2QG-01A-11D-A18J-09	7e7e0d0f-aa97-4c0d-bffc-7d8977288836			TCGA-FU-A2QG-01A-11D-A18J-09	TCGA-FU-A2QG-01A-11D-A18J-09	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	TCGA-FU-A2QG-01A-11D-A18H-01	TCGA-FU-A2QG-01	TCGA-FU-A2QG-01A-11D-A18H-01
TCGA-FU-A3EO-01	TCGA-FU-A3EO-01	TCGA-FU-A3EO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		55	15			TCGA-FU-A3EO-F44091	TCGA-FU-A3EO		Former User					ABSENT			Positive vaginal margin				Stage IIB		-20207										0	490			394							1	0				NO		2013-6-11	FEMALE	165	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	23			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2	40				No	MX	N0	T2b					A3EO	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	FU	2	2	Complete response	Cervical		LIVING	64	2011	d7954ccb-a03f-45cb-a059-88fc217cb753	TCGA-FU-A3EO-01	d7954ccb-a03f-45cb-a059-88fc217cb753	TCGA-FU-A3EO-01	TCGA-FU-A3EO-01		TCGA-FU-A3EO-01A-11D-A212-05	TCGA-FU-A3EO-01A-11D-A20U-09	d7954ccb-a03f-45cb-a059-88fc217cb753			TCGA-FU-A3EO-01A-11D-A20U-09	TCGA-FU-A3EO-01A-11D-A20U-09	d7954ccb-a03f-45cb-a059-88fc217cb753	TCGA-FU-A3EO-01A-11D-A20T-01	TCGA-FU-A3EO-01	TCGA-FU-A3EO-01A-11D-A20T-01
TCGA-FU-A3EO-11	TCGA-FU-A3EO-11	TCGA-FU-A3EO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		55	15			TCGA-FU-A3EO-F44091	TCGA-FU-A3EO	TCGA-FU-A3EO-11A	Former User					ABSENT			Positive vaginal margin				Stage IIB		-20207					137					0	490			394							1	0				NO		2013-6-11	FEMALE	165	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO	23			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2	40	false			No	MX	N0	T2b					A3EO	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	YES							Solid Tissue Normal	11			2009	NO	YES	NO	FU	2	2	Complete response	Cervical	A	LIVING	64	2011	3349e197-7ef8-4cfd-b365-1dbf5c7db58d	TCGA-FU-A3EO-11	3349e197-7ef8-4cfd-b365-1dbf5c7db58d	TCGA-FU-A3EO-11			TCGA-FU-A3EO-11A-13D-A212-05		3349e197-7ef8-4cfd-b365-1dbf5c7db58d					3349e197-7ef8-4cfd-b365-1dbf5c7db58d			
TCGA-FU-A3HY-01	TCGA-FU-A3HY-01	TCGA-FU-A3HY	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		47	16			TCGA-FU-A3HY-F64205	TCGA-FU-A3HY	TCGA-FU-A3HY-01A	Former User												Stage IB2		-17228					77					0	954											0				NO		2014-8-27	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	15	NO	Non-keratinizing squamous cell carcinoma	NO	39	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1		6	5	false			No	MX	N1	T1b2	TCGA-FU-A3HY.4048896F-495E-434F-8849-1DA13FD6C2A2.pdf				A3HY	0	0		TUMOR FREE	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	FU	2	6	Complete response	Cervical	A	LIVING	74	2011	8724d94d-c194-491b-8c0e-38675b59c2e8	TCGA-FU-A3HY-01	8724d94d-c194-491b-8c0e-38675b59c2e8	TCGA-FU-A3HY-01	TCGA-FU-A3HY-01		TCGA-FU-A3HY-01A-11D-A21R-05	TCGA-FU-A3HY-01A-11D-A21Q-09	8724d94d-c194-491b-8c0e-38675b59c2e8			TCGA-FU-A3HY-01A-11D-A21Q-09	TCGA-FU-A3HY-01A-11D-A21Q-09	8724d94d-c194-491b-8c0e-38675b59c2e8	TCGA-FU-A3HY-01A-11D-A21P-01	TCGA-FU-A3HY-01	TCGA-FU-A3HY-01A-11D-A21P-01
TCGA-FU-A3HZ-01	TCGA-FU-A3HZ-01	TCGA-FU-A3HZ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		64			Follow-up Office Visit	TCGA-FU-A3HZ-F64224	TCGA-FU-A3HZ							PRESENT							Stage IIA2		-23565							-7			0	1103			758				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Pelvic Nodes Absent			0	0				NO		2014-8-27	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	curettage	Other method, specify:			Non-keratinizing squamous cell carcinoma	NO	9			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	0					No	M0	N0	T2a2					A3HZ	0	0	Other	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	NO	YES	FU	1	0	Complete response	Cervical		LIVING	66	2010	a886bebc-9578-424a-910c-43ebff0d5696	TCGA-FU-A3HZ-01	a886bebc-9578-424a-910c-43ebff0d5696	TCGA-FU-A3HZ-01	TCGA-FU-A3HZ-01		TCGA-FU-A3HZ-01A-11D-A212-05	TCGA-FU-A3HZ-01A-11D-A20U-09	a886bebc-9578-424a-910c-43ebff0d5696			TCGA-FU-A3HZ-01A-11D-A20U-09	TCGA-FU-A3HZ-01A-11D-A20U-09	a886bebc-9578-424a-910c-43ebff0d5696	TCGA-FU-A3HZ-01A-11D-A20T-01	TCGA-FU-A3HZ-01	TCGA-FU-A3HZ-01A-11D-A20T-01
TCGA-FU-A3NI-01	TCGA-FU-A3NI-01	TCGA-FU-A3NI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					45				TCGA-FU-A3NI-F65839	TCGA-FU-A3NI	TCGA-FU-A3NI-01A													Stage IB1		-16533					466	638	14			0	44							Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent								NO		2014-9-30	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Keratinizing squamous cell carcinoma	NO	29	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								2		2		false			No	MX	N1	T1b1	TCGA-FU-A3NI.3FD96F22-8669-4908-8DEC-9B9A82A8D5D5.pdf				A3NI				TUMOR FREE	YES		YES		YES							Primary Tumor	01			2009		NO	YES	FU	2		Complete response	Cervical	A	DECEASED	57	2010	38948bd8-bc9a-4e38-9f7a-f72d3531050e	TCGA-FU-A3NI-01	38948bd8-bc9a-4e38-9f7a-f72d3531050e	TCGA-FU-A3NI-01	TCGA-FU-A3NI-01		TCGA-FU-A3NI-01A-11D-A21R-05	TCGA-FU-A3NI-01A-11D-A21Q-09	38948bd8-bc9a-4e38-9f7a-f72d3531050e			TCGA-FU-A3NI-01A-11D-A21Q-09	TCGA-FU-A3NI-01A-11D-A21Q-09	38948bd8-bc9a-4e38-9f7a-f72d3531050e	TCGA-FU-A3NI-01A-11D-A21P-01	TCGA-FU-A3NI-01	TCGA-FU-A3NI-01A-11D-A21P-01
TCGA-FU-A3TQ-01	TCGA-FU-A3TQ-01	TCGA-FU-A3TQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		55	30			TCGA-FU-A3TQ-F65841	TCGA-FU-A3TQ	TCGA-FU-A3TQ-01A						PRESENT							Stage IIIB		-20302					561					0	795											0						2014-9-30	FEMALE	152	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	200	NO	Non-keratinizing squamous cell carcinoma	YES	12	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	2		3	50	false			No	MX	N1	T2b	TCGA-FU-A3TQ.76E32FF4-F62D-4ECD-87DF-5C9D9506B3EC.pdf				A3TQ	0	0		TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009		NO	YES	FU	2	3		Cervical	A	LIVING	59	2010	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	TCGA-FU-A3TQ-01	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	TCGA-FU-A3TQ-01	TCGA-FU-A3TQ-01	ED4A2082-B683-4D56-A7D3-1136F0F1764F	TCGA-FU-A3TQ-01A-11D-A230-05	TCGA-FU-A3TQ-01A-11D-A22X-09	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337			TCGA-FU-A3TQ-01A-11D-A22X-09	TCGA-FU-A3TQ-01A-11D-A22X-09	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	TCGA-FU-A3TQ-01A-11D-A22W-01	TCGA-FU-A3TQ-01	TCGA-FU-A3TQ-01A-11D-A22W-01
TCGA-FU-A3TX-01	TCGA-FU-A3TX-01	TCGA-FU-A3TX	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					78	20				TCGA-FU-A3TX	TCGA-FU-A3TX-01A													Stage IB2		-28825					78		8		8	0	45																	2012-8-6	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	140	NO	Keratinizing squamous cell carcinoma		30			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		3		false			Yes	M0	N0	T1b2	TCGA-FU-A3TX.8206742A-1778-4B5F-AD56-32D9501EDA3C.pdf				A3TX							YES									Primary Tumor	01		1993	2009		YES	NO	FU	4	3		Cervical	A	LIVING	67	2012	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	TCGA-FU-A3TX-01	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	TCGA-FU-A3TX-01	TCGA-FU-A3TX-01	ADB7A8CB-073E-42FE-8219-650EDE7B72DF	TCGA-FU-A3TX-01A-11D-A230-05	TCGA-FU-A3TX-01A-11D-A22X-09	d1f596d6-1f2c-4728-be8c-0ef9cc402f88			TCGA-FU-A3TX-01A-11D-A22X-09	TCGA-FU-A3TX-01A-11D-A22X-09	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	TCGA-FU-A3TX-01A-11D-A22W-01	TCGA-FU-A3TX-01	TCGA-FU-A3TX-01A-11D-A22W-01
TCGA-FU-A3WB-01	TCGA-FU-A3WB-01	TCGA-FU-A3WB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		43	16			TCGA-FU-A3WB-F64233	TCGA-FU-A3WB		Former User					ABSENT							Stage IIA2		-15833										0	491			0							2							2014-8-27	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	D&C	Other method, specify:			Non-keratinizing squamous cell carcinoma	NO	43			ABSENT		G2							NO	0		1	25				No	MX	N0	T2a2					A3WB			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01		2012	2009	YES	YES	NO	FU	4	3		Cervical		LIVING	89	2012	a1dbd227-73b7-466f-b766-063a3006a206	TCGA-FU-A3WB-01	a1dbd227-73b7-466f-b766-063a3006a206	TCGA-FU-A3WB-01	TCGA-FU-A3WB-01		TCGA-FU-A3WB-01A-11D-A230-05	TCGA-FU-A3WB-01A-11D-A22X-09	a1dbd227-73b7-466f-b766-063a3006a206			TCGA-FU-A3WB-01A-11D-A22X-09	TCGA-FU-A3WB-01A-11D-A22X-09	a1dbd227-73b7-466f-b766-063a3006a206	TCGA-FU-A3WB-01A-11D-A22W-01	TCGA-FU-A3WB-01	TCGA-FU-A3WB-01A-11D-A22W-01
TCGA-FU-A3YQ-01	TCGA-FU-A3YQ-01	TCGA-FU-A3YQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		35	23			TCGA-FU-A3YQ-F64203	TCGA-FU-A3YQ	TCGA-FU-A3YQ-01A	Former User												Stage IB1		-12816					139					0	861																	2014-8-27	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma	NO	24				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0		3	10	false			No	MX	N0	T1b1	TCGA-FU-A3YQ.6BF77930-F8F4-41C5-86EF-EF43157BA6B5.pdf				A3YQ	1			TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	FU	2	4		Cervical	A	LIVING	101	2012	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	TCGA-FU-A3YQ-01	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	TCGA-FU-A3YQ-01	TCGA-FU-A3YQ-01		TCGA-FU-A3YQ-01A-11D-A230-05	TCGA-FU-A3YQ-01A-11D-A22X-09	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11			TCGA-FU-A3YQ-01A-11D-A22X-09	TCGA-FU-A3YQ-01A-11D-A22X-09	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	TCGA-FU-A3YQ-01A-11D-A22W-01	TCGA-FU-A3YQ-01	TCGA-FU-A3YQ-01A-11D-A22W-01
TCGA-FU-A40J-01	TCGA-FU-A40J-01	TCGA-FU-A40J	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		38				TCGA-FU-A40J-F64213	TCGA-FU-A40J	TCGA-FU-A40J-01A						ABSENT							Stage IIIB		-14182					76			10		0	426								Extra-Pelvic Metastatic Disease Absent|Parametrium Absent									2014-8-27	FEMALE	160	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO		NO	28	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	4		3		false			No	MX	N1	T2a1	TCGA-FU-A40J.7C1993F0-1B9B-4C33-B644-ED3FC16F3A7F.pdf				A40J				TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	FU	1	3		Cervical	A	LIVING	78	2012	26cdb816-44f0-4ff6-a674-93ec31d64fed	TCGA-FU-A40J-01	26cdb816-44f0-4ff6-a674-93ec31d64fed	TCGA-FU-A40J-01	TCGA-FU-A40J-01	70D677F9-4C07-4C10-BC21-D75784B8AFA4	TCGA-FU-A40J-01A-11D-A244-05	TCGA-FU-A40J-01A-11D-A243-09	26cdb816-44f0-4ff6-a674-93ec31d64fed			TCGA-FU-A40J-01A-11D-A243-09	TCGA-FU-A40J-01A-11D-A243-09	26cdb816-44f0-4ff6-a674-93ec31d64fed	TCGA-FU-A40J-01A-11D-A242-01	TCGA-FU-A40J-01	TCGA-FU-A40J-01A-11D-A242-01
TCGA-FU-A57G-01	TCGA-FU-A57G-01	TCGA-FU-A57G	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		49				TCGA-FU-A57G-F65838	TCGA-FU-A57G	TCGA-FU-A57G-01A	Former User					ABSENT							Stage IB2		-17905					684					0	1078			40							1							2014-9-30	FEMALE	160	Endocervical Type of Adenocarcinoma	No				Not applicable		Radical Hysterectomy	C53.0	8384/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO	26			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		false			No	MX	N0	T1b2	TCGA-FU-A57G.39B03354-F9B3-4FBA-8D7E-126E3AE752DA.pdf				A57G	1		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	FU	1	3		Cervical	A	LIVING	57	2011	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	TCGA-FU-A57G-01	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	TCGA-FU-A57G-01	TCGA-FU-A57G-01	03EE5C70-AD05-49F8-83F9-AB7C4A1F323A	TCGA-FU-A57G-01A-11D-A26S-05	TCGA-FU-A57G-01A-11D-A26G-09	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342			TCGA-FU-A57G-01A-11D-A26G-09	TCGA-FU-A57G-01A-11D-A26G-09	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	TCGA-FU-A57G-01A-11D-A26F-01	TCGA-FU-A57G-01	TCGA-FU-A57G-01A-11D-A26F-01
TCGA-FU-A5XV-01	TCGA-FU-A5XV-01	TCGA-FU-A5XV	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		32	14			TCGA-FU-A5XV-F66004	TCGA-FU-A5XV	TCGA-FU-A5XV-01A													Stage IIIB		-11692					105					0	321			55							1	1						2014-10-1	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	70	NO	Non-keratinizing squamous cell carcinoma	NO	63	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	2		2	18	false			No	MX	N1	T1b2	TCGA-FU-A5XV.650F9C07-D8FB-46BD-8565-D03E83F049D6.pdf				A5XV			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	FU	2			Cervical	A	LIVING	69	2012	97a13a19-7b9b-4e53-9dfe-6a5836a44510	TCGA-FU-A5XV-01	97a13a19-7b9b-4e53-9dfe-6a5836a44510	TCGA-FU-A5XV-01	TCGA-FU-A5XV-01		TCGA-FU-A5XV-01A-11D-A28C-05	TCGA-FU-A5XV-01A-11D-A28B-09	97a13a19-7b9b-4e53-9dfe-6a5836a44510			TCGA-FU-A5XV-01A-11D-A28B-09	TCGA-FU-A5XV-01A-11D-A28B-09	97a13a19-7b9b-4e53-9dfe-6a5836a44510	TCGA-FU-A5XV-01A-11D-A28A-01	TCGA-FU-A5XV-01	TCGA-FU-A5XV-01A-11D-A28A-01
TCGA-FU-A770-01	TCGA-FU-A770-01	TCGA-FU-A770	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					33	16				TCGA-FU-A770	TCGA-FU-A770-01A	Former User					ABSENT	Tumor extends 1.0cm into 1.3 cm thick cervical/lower uterine segment wall						Stage IIIB		-12248					139				0	0	34			30							1	0						2014-2-26	FEMALE	175	Endocervical Adenocarcinoma of the Usual Type	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES	D&C	Other method, specify:	40	NO			10	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1		1	7	true			No	MX	N1	T2a2	TCGA-FU-A770.23DD976D-0D35-4BFF-89FF-94D9160F2228.pdf				A770	1	0	Preoperative	TUMOR FREE		0	YES									Primary Tumor	01			2009		YES	NO	FU	2	2		Cervical	A	LIVING	67	2013	75aa1caf-bfa3-4365-a066-31a968ad3d9b	TCGA-FU-A770-01	75aa1caf-bfa3-4365-a066-31a968ad3d9b	TCGA-FU-A770-01	TCGA-FU-A770-01		TCGA-FU-A770-01A-11D-A340-05	TCGA-FU-A770-01A-11D-A33O-09	75aa1caf-bfa3-4365-a066-31a968ad3d9b			TCGA-FU-A770-01A-11D-A33O-09	TCGA-FU-A770-01A-11D-A33O-09	75aa1caf-bfa3-4365-a066-31a968ad3d9b	TCGA-FU-A770-01A-11D-A33N-01	TCGA-FU-A770-01	TCGA-FU-A770-01A-11D-A33N-01
TCGA-GH-A9DA-01	TCGA-GH-A9DA-01	TCGA-GH-A9DA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		27	14		routine follow-up visit	TCGA-GH-A9DA-F71246	TCGA-GH-A9DA	TCGA-GH-A9DA-01A						ABSENT					Not done per treating physicians discretion		Stage IB1		-10160					174				42	0	540			540							0				Pelvic Nodes Present			2015-3-23	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	230	NO	Non-keratinizing squamous cell carcinoma	NO	15			ABSENT		G3							NO	0	0	3	6.5	false			No	MX	N0	T1b	TCGA-GH-A9DA.AAB3DEEA-D415-4495-A42E-E9A6B7AD0D33.pdf				A9DA	2		Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01	11.6		2009	NO	YES	NO	GH	2	5		Cervical	A	LIVING		2013	6977f6c7-f4cf-4669-81fd-7740fd5e64f1	TCGA-GH-A9DA-01	6977f6c7-f4cf-4669-81fd-7740fd5e64f1	TCGA-GH-A9DA-01	TCGA-GH-A9DA-01	9D9F055F-E99A-472E-8A9A-660B8BA451D5	TCGA-GH-A9DA-01A-21D-A37Q-05		6977f6c7-f4cf-4669-81fd-7740fd5e64f1					6977f6c7-f4cf-4669-81fd-7740fd5e64f1	TCGA-GH-A9DA-01A-21D-A37M-01	TCGA-GH-A9DA-01	TCGA-GH-A9DA-01A-21D-A37M-01
TCGA-HG-A2PA-01	TCGA-HG-A2PA-01	TCGA-HG-A2PA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Partial Response		38				TCGA-HG-A2PA-F33511	TCGA-HG-A2PA	TCGA-HG-A2PA-01A						PRESENT							Stage IB2		-14025					729	773	2			0	773			21				Bladder Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			0	0				NO		2012-7-5	FEMALE	164	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Non-keratinizing squamous cell carcinoma	NO	30			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Locoregional Recurrence			YES	0		4		true			No	M0	N0	T1b2	TCGA-HG-A2PA.63D65B11-EE47-4B19-A811-56D61DB0D7EC.pdf				A2PA	1	0	Preoperative	WITH TUMOR	YES	0	YES	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	NO	YES	HG	2	5	Partial response	Cervical	A	DECEASED	95	2009	cf0a3802-710c-4ec7-9778-2d8150656ab7	TCGA-HG-A2PA-01	cf0a3802-710c-4ec7-9778-2d8150656ab7	TCGA-HG-A2PA-01	TCGA-HG-A2PA-01	265071B8-67FE-4D9C-BA29-34AF6E92F53D	TCGA-HG-A2PA-01A-11D-A212-05	TCGA-HG-A2PA-01A-11D-A20U-09	cf0a3802-710c-4ec7-9778-2d8150656ab7			TCGA-HG-A2PA-01A-11D-A20U-09	TCGA-HG-A2PA-01A-11D-A20U-09	cf0a3802-710c-4ec7-9778-2d8150656ab7	TCGA-HG-A2PA-01A-11D-A20T-01	TCGA-HG-A2PA-01	TCGA-HG-A2PA-01A-11D-A20T-01
TCGA-HG-A9SC-01	TCGA-HG-A9SC-01	TCGA-HG-A9SC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		49		5		TCGA-HG-A9SC-F70995	TCGA-HG-A9SC	TCGA-HG-A9SC-01A	Former User											Cisplatin	Stage IIB	40mg/m2	-17963					98		3			0	504			504						Once weekly	0							2015-3-18	FEMALE	173	Adenosquamous	No						Radical Hysterectomy	C53.9	8560/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO		NO	21			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO					true			No	MX	N0	T2b	TCGA-HG-A9SC.288F7530-84F0-40F6-93F6-517DE1A481E0.pdf				A9SC			Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	NO	YES	HG	1	0		Cervical	A	LIVING	68	2013		TCGA-HG-A9SC-01		TCGA-HG-A9SC-01		6F7ABE28-0E7B-48F7-9713-F18E9D295340	TCGA-HG-A9SC-01A-21D-A42P-05								TCGA-HG-A9SC-01A-21D-A42N-01		TCGA-HG-A9SC-01A-21D-A42N-01
TCGA-HM-A3JJ-01	TCGA-HM-A3JJ-01	TCGA-HM-A3JJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	YES	Progressive Disease	YES	40		5		TCGA-HM-A3JJ-F29259	TCGA-HM-A3JJ	TCGA-HM-A3JJ-01A	Former User											Cisplatin	Stage IB1	70 mg	-14736			138	110	629	659	13			0			385	26	150	110		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0		Completed as Planned			NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	173	Cervical Squamous Cell Carcinoma	No			18,31,33,35,39,45,51,52,56,58,59,68	Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	680	NO	Non-keratinizing squamous cell carcinoma		41			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3		FINE NEEDLE ASPIRATION BIOPSY	Other, specify	Distant Metastasis			YES	4		5		false			No	MX	N1	T1b1	TCGA-HM-A3JJ.5F8358A7-34EB-4DAA-81F0-18B27BDCDF65.pdf	Cervical Cancer			A3JJ		1	Preoperative	WITH TUMOR			YES	Complete Remission/Response	YES						5040	Primary Tumor	01			2009	YES	YES	NO	HM		6	Complete response	Cervical	A	DECEASED	72	2010	4811ba43-5130-4cd4-8317-6d4495144c9e	TCGA-HM-A3JJ-01	4811ba43-5130-4cd4-8317-6d4495144c9e	TCGA-HM-A3JJ-01	TCGA-HM-A3JJ-01	8AE5BF11-9C43-4107-81B3-B4033B96D0F5	TCGA-HM-A3JJ-01A-21D-A21R-05	TCGA-HM-A3JJ-01A-21D-A21Q-09	4811ba43-5130-4cd4-8317-6d4495144c9e			TCGA-HM-A3JJ-01A-21D-A21Q-09	TCGA-HM-A3JJ-01A-21D-A21Q-09	4811ba43-5130-4cd4-8317-6d4495144c9e	TCGA-HM-A3JJ-01A-21D-A21P-01	TCGA-HM-A3JJ-01	TCGA-HM-A3JJ-01A-21D-A21P-01
TCGA-HM-A3JJ-11	TCGA-HM-A3JJ-11	TCGA-HM-A3JJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	YES	Progressive Disease	YES	40		5		TCGA-HM-A3JJ-F29259	TCGA-HM-A3JJ	TCGA-HM-A3JJ-11A	Former User											Cisplatin	Stage IB1	70 mg	-14736			138	110	629	659	13			0			385	26	150	110		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0		Completed as Planned			NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	173	Cervical Squamous Cell Carcinoma	No			18,31,33,35,39,45,51,52,56,58,59,68	Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	950	NO	Non-keratinizing squamous cell carcinoma		41			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3		FINE NEEDLE ASPIRATION BIOPSY	Other, specify	Distant Metastasis			YES	4		5		false			No	MX	N1	T1b1		Cervical Cancer			A3JJ		1	Preoperative	WITH TUMOR			YES	Complete Remission/Response	YES						5040	Solid Tissue Normal	11			2009	YES	YES	NO	HM		6	Complete response	Cervical	A	DECEASED	72	2010	0a78e78c-f31a-488a-bf37-c47b108954fd	TCGA-HM-A3JJ-11	0a78e78c-f31a-488a-bf37-c47b108954fd	TCGA-HM-A3JJ-11			TCGA-HM-A3JJ-11A-12D-A21R-05		0a78e78c-f31a-488a-bf37-c47b108954fd					0a78e78c-f31a-488a-bf37-c47b108954fd			
TCGA-HM-A3JK-01	TCGA-HM-A3JK-01	TCGA-HM-A3JK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		64				TCGA-HM-A3JK-F41748	TCGA-HM-A3JK		Never Used						carcinoma involves all sections of the cervix with direct extension into the myometrial wall, parametrial tissues and upper vagina.						Stage IIA2		-23618							17		17	0	632			21				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO		2013-3-27	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	51	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1		0					No	MX	N1	T2b					A3JK	0	0	Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01	13.8	2008	2009		YES	NO	HM	4	0		Cervical		LIVING	94	2011	beb89362-12a9-41bd-a1a2-b597138c16fb	TCGA-HM-A3JK-01	beb89362-12a9-41bd-a1a2-b597138c16fb	TCGA-HM-A3JK-01	TCGA-HM-A3JK-01		TCGA-HM-A3JK-01A-11D-A21R-05	TCGA-HM-A3JK-01A-11D-A21Q-09	beb89362-12a9-41bd-a1a2-b597138c16fb			TCGA-HM-A3JK-01A-11D-A21Q-09	TCGA-HM-A3JK-01A-11D-A21Q-09	beb89362-12a9-41bd-a1a2-b597138c16fb	TCGA-HM-A3JK-01A-11D-A21P-01	TCGA-HM-A3JK-01	TCGA-HM-A3JK-01A-11D-A21P-01
TCGA-HM-A4S6-01	TCGA-HM-A4S6-01	TCGA-HM-A4S6	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		51	14			TCGA-HM-A4S6-F49848	TCGA-HM-A4S6	TCGA-HM-A4S6-01A	Former User					ABSENT		Squamous cell carcinoma in situ focallly extends to the cervical cuff margin(6-9 oclock	Other Location, specify	Concurent chemo RT Ongoing-treatment delayed due to postoperative complications.	Other		Stage IIIB		-18903					117		11		24	0	454			38				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|			0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2013-10-11	FEMALE	152	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Tissue in the cervix during pelvic exam was passed ans sent for pathology	Other method, specify:	390	NO		NO	13	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	2		5	10	false			No	MX	N1	T1b2	TCGA-HM-A4S6.B4118FB2-3A61-44B4-BC2F-020EB53542A1.pdf				A4S6	1		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES	Other	Radiation currently ongoing- treatment delayed due to postoperative complication					Primary Tumor	01		1995	2009	YES	YES	NO	HM	3	6		Cervical	A	LIVING	101	2012	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	TCGA-HM-A4S6-01	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	TCGA-HM-A4S6-01	TCGA-HM-A4S6-01	0BB4A1E7-3861-4E40-895F-0C25B47E8E57	TCGA-HM-A4S6-01A-11D-A26S-05	TCGA-HM-A4S6-01A-11D-A26G-09	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf			TCGA-HM-A4S6-01A-11D-A26G-09	TCGA-HM-A4S6-01A-11D-A26G-09	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	TCGA-HM-A4S6-01A-11D-A26F-01	TCGA-HM-A4S6-01	TCGA-HM-A4S6-01A-11D-A26F-01
TCGA-HM-A6W2-01	TCGA-HM-A6W2-01	TCGA-HM-A6W2	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		34	27	6		TCGA-HM-A6W2-F57139	TCGA-HM-A6W2	TCGA-HM-A6W2-01A	Former User						Metastases to Right Ovary					Cisplatin	Stage IVB	70mg	-12775					51		9		62	0	287			28				|Paraaortic Nodes Absent|Pelvic Nodes Absent		Once weekly	0				Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-3-27	FEMALE	160	Adenosquamous	No						Radical Hysterectomy	C56.9	8070/3	C56.9	YES		Biopsy (cervical / CT-guided / Other)	1280	NO		NO	7			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			2	8	false			No	M1	N0	T2a	TCGA-HM-A6W2.611A1962-1D19-48DF-B086-4FBA139822FF.pdf				A6W2			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES					IMRT	4500	Primary Tumor	01			2009	YES	YES	NO	HM	2	2		Cervical	A	LIVING	89	2013	459f5e07-fffc-4f47-904b-3c51367c83f1	TCGA-HM-A6W2-01	459f5e07-fffc-4f47-904b-3c51367c83f1	TCGA-HM-A6W2-01	TCGA-HM-A6W2-01		TCGA-HM-A6W2-01A-21D-A340-05	TCGA-HM-A6W2-01A-21D-A33O-09	459f5e07-fffc-4f47-904b-3c51367c83f1			TCGA-HM-A6W2-01A-21D-A33O-09	TCGA-HM-A6W2-01A-21D-A33O-09	459f5e07-fffc-4f47-904b-3c51367c83f1	TCGA-HM-A6W2-01A-21D-A33N-01	TCGA-HM-A6W2-01	TCGA-HM-A6W2-01A-21D-A33N-01
TCGA-HM-A6W2-06	TCGA-HM-A6W2-06	TCGA-HM-A6W2	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		34	27	6		TCGA-HM-A6W2-F57139	TCGA-HM-A6W2	TCGA-HM-A6W2-06A	Former User						Metastases to Right Ovary					Cisplatin	Stage IVB	70mg	-12775					51		9		62	0	287			28				|Paraaortic Nodes Absent|Pelvic Nodes Absent		Once weekly	0				Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-3-27	FEMALE	160	Adenosquamous	No						Radical Hysterectomy	C56.9	8070/3	C56.9	YES		Biopsy (cervical / CT-guided / Other)	1340	NO		NO	7			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			2	8	false			No	M1	N0	T2a	TCGA-HM-A6W2.FD13C302-78F0-4FEE-B90A-95A10C236CE9.pdf				A6W2			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES					IMRT	4500	Metastatic	06			2009	YES	YES	NO	HM	2	2		Cervical	A	LIVING	89	2013	386214f6-caab-4e0f-b3ed-e6103110c3bb	TCGA-HM-A6W2-06	386214f6-caab-4e0f-b3ed-e6103110c3bb	TCGA-HM-A6W2-06			TCGA-HM-A6W2-06A-22D-A340-05	TCGA-HM-A6W2-06A-22D-A33O-09	386214f6-caab-4e0f-b3ed-e6103110c3bb			TCGA-HM-A6W2-06A-22D-A33O-09		386214f6-caab-4e0f-b3ed-e6103110c3bb			
TCGA-IR-A3L7-01	TCGA-IR-A3L7-01	TCGA-IR-A3L7	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		37	17			TCGA-IR-A3L7-F38287	TCGA-IR-A3L7	TCGA-IR-A3L7-01A	Former User					ABSENT							Stage IB1		-13559					4286					0	4483											0				NO		2012-12-14	FEMALE	177	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	110	NO		NO	20			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	3	10	true			No	M0	N0	T1b1	TCGA-IR-A3L7.411A8FF2-4778-43AD-99F7-FD5BD23559DD.pdf				A3L7	0	0		TUMOR FREE	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01		1990	2009	YES	NO	YES	IR	4	3	Complete response	Cervical	A	LIVING	89	2000	953f918b-a82a-408f-b080-d0cb4441e1ef	TCGA-IR-A3L7-01	953f918b-a82a-408f-b080-d0cb4441e1ef	TCGA-IR-A3L7-01	TCGA-IR-A3L7-01	05FAF119-1842-40FE-9B3D-A97D8E6B9662	TCGA-IR-A3L7-01A-21D-A212-05	TCGA-IR-A3L7-01A-21D-A20U-09	953f918b-a82a-408f-b080-d0cb4441e1ef			TCGA-IR-A3L7-01A-21D-A20U-09	TCGA-IR-A3L7-01A-21D-A20U-09	953f918b-a82a-408f-b080-d0cb4441e1ef	TCGA-IR-A3L7-01A-21D-A20T-01	TCGA-IR-A3L7-01	TCGA-IR-A3L7-01A-21D-A20T-01
TCGA-IR-A3LA-01	TCGA-IR-A3LA-01	TCGA-IR-A3LA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		60		4|4		TCGA-IR-A3LA-F56115	TCGA-IR-A3LA	TCGA-IR-A3LA-01A	Never Used					ABSENT						Cisplatin|Other	Stage IB1	70 mg/m2|750 mg/m2	-21949					3401					0	4172													0				2014-1-28	FEMALE	157	Endometrioid Adenocarcinoma of Endocervix	No						Simple Hysterectomy	C53.9	8384/3	C53.9	YES	Dilation & curettage	Other method, specify:	170	NO		NO	18			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	0		true		|Fluorouracil (5-FU)	No	M0	N0	T1b1	TCGA-IR-A3LA.65E053F4-BCDB-40E2-A76B-1CA62FD61E1B.pdf				A3LA				TUMOR FREE	YES		YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	NO	YES	IR	1	2		Cervical	A	LIVING	101	2002	249a179f-25d7-4508-b64c-be08aaafc82a	TCGA-IR-A3LA-01	249a179f-25d7-4508-b64c-be08aaafc82a	TCGA-IR-A3LA-01	TCGA-IR-A3LA-01	23FD746E-B0D7-4779-BF26-BB319461F879	TCGA-IR-A3LA-01A-11D-A230-05	TCGA-IR-A3LA-01A-11D-A22X-09	249a179f-25d7-4508-b64c-be08aaafc82a			TCGA-IR-A3LA-01A-11D-A22X-09	TCGA-IR-A3LA-01A-11D-A22X-09	249a179f-25d7-4508-b64c-be08aaafc82a	TCGA-IR-A3LA-01A-11D-A22W-01	TCGA-IR-A3LA-01	TCGA-IR-A3LA-01A-11D-A22W-01
TCGA-IR-A3LB-01	TCGA-IR-A3LB-01	TCGA-IR-A3LB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					53	17	4|4			TCGA-IR-A3LB	TCGA-IR-A3LB-01A	Never Used					ABSENT						Cisplatin|Other	Stage IB1	70mg/m2|1000mg/m2	-19374					3385	2032				0														0				2013-1-24	FEMALE	168	Endocervical Type of Adenocarcinoma	No					Radical trachelectomy	Other	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO			29			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							YES	0	0	2	2.5	true		|Fluorouracil (5-FU)	No	M0	N0	T1b1	TCGA-IR-A3LB.8E99E100-EB4F-472A-BB28-36592B1AA26E.pdf				A3LB				WITH TUMOR	YES		YES	Complete Remission/Response	YES					External beam radiation	5040	Primary Tumor	01		1972	2009	YES	NO	YES	IR	3	4		Cervical	A	DECEASED	94	2002	135d2983-9bfc-476a-8313-661f8bde6d06	TCGA-IR-A3LB-01	135d2983-9bfc-476a-8313-661f8bde6d06	TCGA-IR-A3LB-01	TCGA-IR-A3LB-01	512D1B08-402F-433F-974C-B134628CBA33	TCGA-IR-A3LB-01A-11D-A244-05	TCGA-IR-A3LB-01A-11D-A243-09	135d2983-9bfc-476a-8313-661f8bde6d06			TCGA-IR-A3LB-01A-11D-A243-09	TCGA-IR-A3LB-01A-11D-A243-09	135d2983-9bfc-476a-8313-661f8bde6d06	TCGA-IR-A3LB-01A-11D-A242-01	TCGA-IR-A3LB-01	TCGA-IR-A3LB-01A-11D-A242-01
TCGA-IR-A3LC-01	TCGA-IR-A3LC-01	TCGA-IR-A3LC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		40				TCGA-IR-A3LC-F68417	TCGA-IR-A3LC	TCGA-IR-A3LC-01A	Current User					ABSENT							Stage IB1		-14697					3214					0	3935											0				NO		2014-11-17	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO	48			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	3		true			No	M0	N0	T1b1	TCGA-IR-A3LC.97FF892D-6CAD-4376-BB48-082EC5BC4C39.pdf				A3LC	0	0		TUMOR FREE	YES	0	YES		YES							Primary Tumor	01			2009		NO	YES	IR	1	3	Complete response	Cervical	A	LIVING	64	2003	50b34335-7e00-417a-8e0d-c50a4384b4c9	TCGA-IR-A3LC-01	50b34335-7e00-417a-8e0d-c50a4384b4c9	TCGA-IR-A3LC-01	TCGA-IR-A3LC-01	ED5836F8-2919-4EC1-85ED-0859F071B5A9	TCGA-IR-A3LC-01A-11D-A212-05	TCGA-IR-A3LC-01A-11D-A20U-09	50b34335-7e00-417a-8e0d-c50a4384b4c9			TCGA-IR-A3LC-01A-11D-A20U-09	TCGA-IR-A3LC-01A-11D-A20U-09	50b34335-7e00-417a-8e0d-c50a4384b4c9	TCGA-IR-A3LC-01A-11D-A20T-01	TCGA-IR-A3LC-01	TCGA-IR-A3LC-01A-11D-A20T-01
TCGA-IR-A3LF-01	TCGA-IR-A3LF-01	TCGA-IR-A3LF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		64				TCGA-IR-A3LF-F60818	TCGA-IR-A3LF	TCGA-IR-A3LF-01A	Never Used		2500		HDR	ABSENT					Not done per treating physicians discretion		Stage IB1		-23721					2814					0	2949											0		0				2014-6-17	FEMALE	155	Endocervical Adenocarcinoma of the Usual Type	No						Simple Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	240	NO		YES	16			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			No	M0	N0	T1b1	TCGA-IR-A3LF.8F0D0E63-D4E5-49A9-AC56-7D538284E917.pdf				A3LF	1	0		TUMOR FREE	NO	0	YES	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			2009	NO	NO	YES	IR	1	3		Cervical	A	LIVING	86	2004	851064c8-582a-414a-bfcc-e1042bb9ff7b	TCGA-IR-A3LF-01	851064c8-582a-414a-bfcc-e1042bb9ff7b	TCGA-IR-A3LF-01	TCGA-IR-A3LF-01	B65F36C5-75E0-45AA-B254-16ABC4C5DF64	TCGA-IR-A3LF-01A-21D-A230-05	TCGA-IR-A3LF-01A-21D-A22X-09	851064c8-582a-414a-bfcc-e1042bb9ff7b			TCGA-IR-A3LF-01A-21D-A22X-09	TCGA-IR-A3LF-01A-21D-A22X-09	851064c8-582a-414a-bfcc-e1042bb9ff7b	TCGA-IR-A3LF-01A-21D-A22W-01	TCGA-IR-A3LF-01	TCGA-IR-A3LF-01A-21D-A22W-01
TCGA-IR-A3LH-01	TCGA-IR-A3LH-01	TCGA-IR-A3LH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		49	24			TCGA-IR-A3LH-F68422	TCGA-IR-A3LH	TCGA-IR-A3LH-01A	Former User					ABSENT			Positive vaginal margin				Stage IIA1		-18118					2501					0	2394											1				NO		2014-11-17	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	340	NO		YES	40			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G4							NO	0	0	1	20	true			No	M0	N0	T2a1	TCGA-IR-A3LH.7204DF29-2167-48A0-AA56-51E9AFFBB0D5.pdf				A3LH	0	0		TUMOR FREE	YES	0	YES		YES							Primary Tumor	01		2000	2009		NO	YES	IR	4	2	Complete response	Cervical	A	LIVING	74	2005	2cdcd676-9056-4b42-8029-5b8dc44d3b57	TCGA-IR-A3LH-01	2cdcd676-9056-4b42-8029-5b8dc44d3b57	TCGA-IR-A3LH-01	TCGA-IR-A3LH-01	321A85A8-BC4A-4D64-B8E6-89FC29A338CB	TCGA-IR-A3LH-01A-21D-A212-05	TCGA-IR-A3LH-01A-21D-A20U-09	2cdcd676-9056-4b42-8029-5b8dc44d3b57			TCGA-IR-A3LH-01A-21D-A20U-09	TCGA-IR-A3LH-01A-21D-A20U-09	2cdcd676-9056-4b42-8029-5b8dc44d3b57	TCGA-IR-A3LH-01A-21D-A20T-01	TCGA-IR-A3LH-01	TCGA-IR-A3LH-01A-21D-A20T-01
TCGA-IR-A3LI-01	TCGA-IR-A3LI-01	TCGA-IR-A3LI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		48				TCGA-IR-A3LI-F68426	TCGA-IR-A3LI	TCGA-IR-A3LI-01A	Never Used					ABSENT			Microscopic parametrial involvement				Stage IVB		-17741					2326					0	2493											0				NO		2014-11-17	FEMALE	169	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Surgical resection	Other method, specify:	180	NO		YES	25	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Peri (6-12 months since last menstrual period)	G2							NO	1	0	2		true			No	M1	N1	T2b	TCGA-IR-A3LI.203CED2B-3E76-4539-9B52-D6F8FBF7E642.pdf				A3LI	0	2		TUMOR FREE	YES	0	YES		YES							Primary Tumor	01			2009		NO	YES	IR	1	4	Complete response	Cervical	A	LIVING	71	2005	e77c56f5-7575-46f0-9751-723085dbd6fc	TCGA-IR-A3LI-01	e77c56f5-7575-46f0-9751-723085dbd6fc	TCGA-IR-A3LI-01	TCGA-IR-A3LI-01	CAC8649C-9172-4F4F-8083-62EFF39FB4D6	TCGA-IR-A3LI-01A-11D-A212-05	TCGA-IR-A3LI-01A-11D-A20U-09	e77c56f5-7575-46f0-9751-723085dbd6fc			TCGA-IR-A3LI-01A-11D-A20U-09	TCGA-IR-A3LI-01A-11D-A20U-09	e77c56f5-7575-46f0-9751-723085dbd6fc	TCGA-IR-A3LI-01A-11D-A20T-01	TCGA-IR-A3LI-01	TCGA-IR-A3LI-01A-11D-A20T-01
TCGA-IR-A3LK-01	TCGA-IR-A3LK-01	TCGA-IR-A3LK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease		69				TCGA-IR-A3LK-F38333	TCGA-IR-A3LK	TCGA-IR-A3LK-01A	Never Used					ABSENT			Microscopic parametrial involvement				Stage IB2		-25440					779	908				0	808		574									0				NO		2012-12-14	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO		NO	17				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Needle biopsy		Distant Metastasis	thoracic lymph nodes, liver, abdominal wall	NO	YES	0	0	1		true			No	M0	N0	T1b2	TCGA-IR-A3LK.3AE8F93E-83B7-4501-B916-EC4EA9959F99.pdf	Cervical Cancer			A3LK	0	0		WITH TUMOR	YES	0	YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	NO	YES	IR	1	1	Complete response	Cervical	A	DECEASED	96	2009	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	TCGA-IR-A3LK-01	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	TCGA-IR-A3LK-01	TCGA-IR-A3LK-01	9F4623A9-D7C2-4EB5-8CA9-6F0C67828AEB	TCGA-IR-A3LK-01A-12D-A212-05	TCGA-IR-A3LK-01A-12D-A20U-09	9fd5309d-03cc-4123-8bc8-d7dfba4955d2			TCGA-IR-A3LK-01A-12D-A20U-09	TCGA-IR-A3LK-01A-12D-A20U-09	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	TCGA-IR-A3LK-01A-12D-A20T-01	TCGA-IR-A3LK-01	TCGA-IR-A3LK-01A-12D-A20T-01
TCGA-IR-A3LL-01	TCGA-IR-A3LL-01	TCGA-IR-A3LL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		60				TCGA-IR-A3LL-F45361	TCGA-IR-A3LL	TCGA-IR-A3LL-01A						ABSENT							Stage IB1		-22123					614					0	1106											0				NO		2013-7-11	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	370	NO		NO	15			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			No	M0	N0	T1b1	TCGA-IR-A3LL.CF29FB41-6E3C-4798-A958-37A1B1F9E7AD.pdf				A3LL	0	0		TUMOR FREE	YES	0	YES		YES							Primary Tumor	01			2009		NO	YES	IR	1	2	Complete response	Cervical	A	LIVING	92	2010	386fbf20-f41e-41e1-96de-578066c35560	TCGA-IR-A3LL-01	386fbf20-f41e-41e1-96de-578066c35560	TCGA-IR-A3LL-01	TCGA-IR-A3LL-01	4157E44A-BFC9-479E-B2DE-D7B6A8C373B9	TCGA-IR-A3LL-01A-11D-A212-05	TCGA-IR-A3LL-01A-11D-A20U-09	386fbf20-f41e-41e1-96de-578066c35560			TCGA-IR-A3LL-01A-11D-A20U-09	TCGA-IR-A3LL-01A-11D-A20U-09	386fbf20-f41e-41e1-96de-578066c35560	TCGA-IR-A3LL-01A-11D-A20T-01	TCGA-IR-A3LL-01	TCGA-IR-A3LL-01A-11D-A20T-01
TCGA-JW-A5VG-01	TCGA-JW-A5VG-01	TCGA-JW-A5VG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		35		5		TCGA-JW-A5VG-F58243	TCGA-JW-A5VG	TCGA-JW-A5VG-01A	Never Used		4500		LDR							Cisplatin	Stage IIA	40 mg/m2	-13109					342		-8			0	834			834				Pelvic Nodes Present		Once weekly	0	0		0				2014-4-3	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			5		false			No	MX	NX	T2a	TCGA-JW-A5VG.679E2EDC-A950-49A4-AC1A-9472CCB3447D.pdf				A5VG	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0		Complete Remission/Response	NO					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	JW	1	5		Cervical	A	LIVING	110	2012	40eb69ac-5c96-42c7-adfc-877580c58cc5	TCGA-JW-A5VG-01	40eb69ac-5c96-42c7-adfc-877580c58cc5	TCGA-JW-A5VG-01	TCGA-JW-A5VG-01		TCGA-JW-A5VG-01A-11D-A28C-05	TCGA-JW-A5VG-01A-11D-A28B-09	40eb69ac-5c96-42c7-adfc-877580c58cc5			TCGA-JW-A5VG-01A-11D-A28B-09	TCGA-JW-A5VG-01A-11D-A28B-09	40eb69ac-5c96-42c7-adfc-877580c58cc5	TCGA-JW-A5VG-01A-11D-A28A-01	TCGA-JW-A5VG-01	TCGA-JW-A5VG-01A-11D-A28A-01
TCGA-JW-A5VH-01	TCGA-JW-A5VH-01	TCGA-JW-A5VH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		53		2	N/A	TCGA-JW-A5VH-F69375	TCGA-JW-A5VH	TCGA-JW-A5VH-01A											Not done per treating physicians discretion	Carboplatin	Stage IVB		-19423					405	100	7			0			94	5				Extra-Pelvic Metastatic Disease Present|Pelvic Nodes Present		Once weekly	2	0		0				2015-1-20	FEMALE	163	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO	Non-keratinizing squamous cell carcinoma	YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Distant Metastasis	Brain		YES			2		false			No	M1	NX	T4	TCGA-JW-A5VH.D5B62718-1D34-45F7-8DDB-B106AC85B102.pdf	Cervical Cancer			A5VH	0	0	Other	WITH TUMOR	YES	0	NO	Progressive Disease	YES	Other	Brain and Pulmonary Metastases leading to death			External beam radiation	1900	Primary Tumor	01			2009	NO	NO	YES	JW	1	2		Cervical	A	DECEASED	80	2012	87bab535-6f15-4b0f-a274-571a4a81d1be	TCGA-JW-A5VH-01	87bab535-6f15-4b0f-a274-571a4a81d1be	TCGA-JW-A5VH-01	TCGA-JW-A5VH-01		TCGA-JW-A5VH-01A-11D-A28C-05	TCGA-JW-A5VH-01A-11D-A28B-09	87bab535-6f15-4b0f-a274-571a4a81d1be			TCGA-JW-A5VH-01A-11D-A28B-09	TCGA-JW-A5VH-01A-11D-A28B-09	87bab535-6f15-4b0f-a274-571a4a81d1be	TCGA-JW-A5VH-01A-11D-A28A-01	TCGA-JW-A5VH-01	TCGA-JW-A5VH-01A-11D-A28A-01
TCGA-JW-A5VI-01	TCGA-JW-A5VI-01	TCGA-JW-A5VI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Partial Response		45	26	5		TCGA-JW-A5VI-F58233	TCGA-JW-A5VI		Former User		4644		LDR							Cisplatin	Stage IIB	40 mg/m2	-16444							6			0	747		558	747				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Pelvic Nodes Present		Once weekly	1	0		0				2014-4-3	FEMALE	158	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	Lung Biopsy		Distant Metastasis		NO	YES			2	10				No	MX	NX	T2b					A5VI	0	0	Post-Adjuvant Therapy	WITH TUMOR	NO	0	NO	[Discrepancy]	NO					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	JW	2	2		Cervical		LIVING	59	2012	e5bafefb-df41-4686-9bbe-b176f954d131	TCGA-JW-A5VI-01	e5bafefb-df41-4686-9bbe-b176f954d131	TCGA-JW-A5VI-01	TCGA-JW-A5VI-01		TCGA-JW-A5VI-01A-11D-A28C-05	TCGA-JW-A5VI-01A-11D-A28B-09	e5bafefb-df41-4686-9bbe-b176f954d131			TCGA-JW-A5VI-01A-11D-A28B-09	TCGA-JW-A5VI-01A-11D-A28B-09	e5bafefb-df41-4686-9bbe-b176f954d131	TCGA-JW-A5VI-01A-11D-A28A-01	TCGA-JW-A5VI-01	TCGA-JW-A5VI-01A-11D-A28A-01
TCGA-JW-A5VJ-01	TCGA-JW-A5VJ-01	TCGA-JW-A5VJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	YES	Progressive Disease		56		5	at hospiace	TCGA-JW-A5VJ-F58231	TCGA-JW-A5VJ		Never Used		4200		LDR							Cisplatin	Stage IIB	40mg/m2	-20714							0			0	652		267	652				Paraaortic Nodes Present|Pelvic Nodes Present		Once weekly	3	1						2014-6-27	FEMALE	155	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Head & Neck	F of supraclavicular LN positive for malignancy		Distant Metastasis		NO	NO			2					No	MX	NX	T2b					A5VJ	0	0	Other	WITH TUMOR	NO	0	NO	Progressive Disease	NO					External beam radiation	5040	Primary Tumor	01			2009	YES	YES	NO	JW	1	3		Cervical		LIVING	57	2012	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	TCGA-JW-A5VJ-01	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	TCGA-JW-A5VJ-01	TCGA-JW-A5VJ-01		TCGA-JW-A5VJ-01A-11D-A28C-05	TCGA-JW-A5VJ-01A-11D-A28B-09	fef94ae2-4cd8-4e24-9220-3fa17ef1230a			TCGA-JW-A5VJ-01A-11D-A28B-09	TCGA-JW-A5VJ-01A-11D-A28B-09	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	TCGA-JW-A5VJ-01A-11D-A28A-01	TCGA-JW-A5VJ-01	TCGA-JW-A5VJ-01A-11D-A28A-01
TCGA-JW-A5VK-01	TCGA-JW-A5VK-01	TCGA-JW-A5VK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					43	33	5		TCGA-JW-A5VK-F58232	TCGA-JW-A5VK		Never Used		4725		LDR							Cisplatin	Stage IB2	40 mg/m2	-15965							16			0	623			623				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	0	0		4500				2014-4-3	FEMALE	158	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8052/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			1	1				No	MX	NX	T1b2					A5VK	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0		Complete Remission/Response	NO					External beam radiation	5500	Primary Tumor	01			2009	YES	YES	NO	JW	3	1		Cervical		LIVING	68	2012	d8e69719-3717-4c5d-8928-6b921d6ac187	TCGA-JW-A5VK-01	d8e69719-3717-4c5d-8928-6b921d6ac187	TCGA-JW-A5VK-01	TCGA-JW-A5VK-01		TCGA-JW-A5VK-01A-11D-A28C-05	TCGA-JW-A5VK-01A-11D-A28B-09	d8e69719-3717-4c5d-8928-6b921d6ac187			TCGA-JW-A5VK-01A-11D-A28B-09	TCGA-JW-A5VK-01A-11D-A28B-09	d8e69719-3717-4c5d-8928-6b921d6ac187	TCGA-JW-A5VK-01A-11D-A28A-01	TCGA-JW-A5VK-01	TCGA-JW-A5VK-01A-11D-A28A-01
TCGA-JW-A5VL-01	TCGA-JW-A5VL-01	TCGA-JW-A5VL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		37		4	N/A	TCGA-JW-A5VL-F58247	TCGA-JW-A5VL	TCGA-JW-A5VL-01A			4620		LDR							Cisplatin	Stage IB2	40 mg/m2	-13604					114		14			0	474			474				Pelvic Nodes Present		Once weekly	0	0		540				2014-4-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO			2		false			No	MX	NX	T1b2	TCGA-JW-A5VL.7C385D8F-CFDF-48DC-B421-4B2483CE9B25.pdf				A5VL	0	0	Post-Adjuvant Therapy	TUMOR FREE	NO	0		Complete Remission/Response	NO					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	JW	1	2		Cervical	A	LIVING	71	2012	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	TCGA-JW-A5VL-01	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	TCGA-JW-A5VL-01	TCGA-JW-A5VL-01	9180D48E-36DA-421A-933F-FD75E6515174	TCGA-JW-A5VL-01A-11D-A28C-05	TCGA-JW-A5VL-01A-11D-A28B-09	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9			TCGA-JW-A5VL-01A-11D-A28B-09	TCGA-JW-A5VL-01A-11D-A28B-09	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	TCGA-JW-A5VL-01A-11D-A28A-01	TCGA-JW-A5VL-01	TCGA-JW-A5VL-01A-11D-A28A-01
TCGA-JW-A69B-01	TCGA-JW-A69B-01	TCGA-JW-A69B	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		44		5	Follow up Visit	TCGA-JW-A69B-F69345	TCGA-JW-A69B	TCGA-JW-A69B-01A	Never Used		4631		LDR						Scheduling problems	Cisplatin	Stage IB2	40 mg/m2	-16080					231		34			0	863			863				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0	0		0				2015-1-20	FEMALE	155	Endocervical Type of Adenocarcinoma	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			3		true			No	MX	NX	T1b2	TCGA-JW-A69B.5C2BA942-7F36-496E-AB8F-0EF8A5DE9669.pdf				A69B	1	0	Other	TUMOR FREE	YES	0	NO	Complete Remission/Response	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	JW	1	4		Cervical	A	LIVING	69	2012	0697ab9a-88cc-4428-b02a-7666f0a772fa	TCGA-JW-A69B-01	0697ab9a-88cc-4428-b02a-7666f0a772fa	TCGA-JW-A69B-01	TCGA-JW-A69B-01		TCGA-JW-A69B-01A-11D-A32T-05	TCGA-JW-A69B-01A-11D-A32I-09	0697ab9a-88cc-4428-b02a-7666f0a772fa			TCGA-JW-A69B-01A-11D-A32I-09	TCGA-JW-A69B-01A-11D-A32I-09	0697ab9a-88cc-4428-b02a-7666f0a772fa	TCGA-JW-A69B-01A-11D-A32H-01	TCGA-JW-A69B-01	TCGA-JW-A69B-01A-11D-A32H-01
TCGA-JW-A852-01	TCGA-JW-A852-01	TCGA-JW-A852	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		42		4		TCGA-JW-A852-F69374	TCGA-JW-A852	TCGA-JW-A852-01A			4105		LDR						Scheduling problems	Cisplatin	Stage IIB	40 mg/m2	-15682					57	252	-1		6	0	156		187	13				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	1	0		0	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			2015-1-20	FEMALE	160	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Distant Metastasis	Breast		YES			3		true			No	MX	N1	T2b	TCGA-JW-A852.7333C03D-0CDA-4BDE-A213-6FD7D3ACB382.pdf	Cervical Cancer			A852	0	0	Pre-Adjuvant Therapy	WITH TUMOR	YES	0	NO	Complete Remission/Response	YES					External beam radiation	5382	Primary Tumor	01	11.1		2009	YES	YES	NO	JW	1	3		Cervical	A	DECEASED	100	2013	9795c475-908b-40e2-93d3-f07e5b94b91f	TCGA-JW-A852-01	9795c475-908b-40e2-93d3-f07e5b94b91f	TCGA-JW-A852-01	TCGA-JW-A852-01		TCGA-JW-A852-01A-11D-A357-05	TCGA-JW-A852-01A-11D-A351-09	9795c475-908b-40e2-93d3-f07e5b94b91f			TCGA-JW-A852-01A-11D-A351-09	TCGA-JW-A852-01A-11D-A351-09	9795c475-908b-40e2-93d3-f07e5b94b91f	TCGA-JW-A852-01A-11D-A350-01	TCGA-JW-A852-01	TCGA-JW-A852-01A-11D-A350-01
TCGA-JW-AAVH-01	TCGA-JW-AAVH-01	TCGA-JW-AAVH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		46	16		Postoperative follow up	TCGA-JW-AAVH-F70299	TCGA-JW-AAVH														Stage IB1		-16894							21			0	552			552				Bladder Present|Extra-Pelvic Metastatic Disease Absent|Pelvic Nodes Present			0							2015-2-3	FEMALE	155	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO	15			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	4	20				No	M0	N0	T1b1					AAVH	6		Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO	Adverse event/complications						Primary Tumor	01			2009	NO	YES	NO	JW	2	10		Cervical		LIVING	165	2013	ab32f0f9-4327-4189-9dd7-6951531c6e16	TCGA-JW-AAVH-01	ab32f0f9-4327-4189-9dd7-6951531c6e16	TCGA-JW-AAVH-01	TCGA-JW-AAVH-01		TCGA-JW-AAVH-01A-11D-A388-05		ab32f0f9-4327-4189-9dd7-6951531c6e16					ab32f0f9-4327-4189-9dd7-6951531c6e16	TCGA-JW-AAVH-01A-11D-A386-01	TCGA-JW-AAVH-01	TCGA-JW-AAVH-01A-11D-A386-01
TCGA-JX-A3PZ-01	TCGA-JX-A3PZ-01	TCGA-JX-A3PZ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					25					TCGA-JX-A3PZ	TCGA-JX-A3PZ-01A	Never Used					ABSENT					Not done per treating physicians discretion		Stage IB		-9303					5922	642	-1			0				538				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|			0	0						2014-4-17	FEMALE	175	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	210	NO	Keratinizing squamous cell carcinoma		22			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES	0	0	0		true			No	M0	N0	T1b	TCGA-JX-A3PZ.BE580A02-1AD8-4526-A0FF-042D4AAB6E15.pdf	Cervical Cancer			A3PZ	0	0	Pre-Adjuvant Therapy	WITH TUMOR	NO	0	YES	Complete Remission/Response	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	JX	1	0		Cervical	A	DECEASED	58	1995	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	TCGA-JX-A3PZ-01	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	TCGA-JX-A3PZ-01	TCGA-JX-A3PZ-01	E8E61B42-4CF6-470E-8067-18CC5A90FDF4	TCGA-JX-A3PZ-01A-11D-A21R-05	TCGA-JX-A3PZ-01A-11D-A21Q-09	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc			TCGA-JX-A3PZ-01A-11D-A21Q-09	TCGA-JX-A3PZ-01A-11D-A21Q-09	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	TCGA-JX-A3PZ-01A-11D-A21P-01	TCGA-JX-A3PZ-01	TCGA-JX-A3PZ-01A-11D-A21P-01
TCGA-JX-A3Q0-01	TCGA-JX-A3Q0-01	TCGA-JX-A3Q0	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		63	24		Follow-up	TCGA-JX-A3Q0-F71655	TCGA-JX-A3Q0	TCGA-JX-A3Q0-01A	Never Used		3300	Implants-tandem and ovoids	Other						Not done per treating physicians discretion		Stage III		-23313					5251		-1			0	6375			6369				Extra-Pelvic Metastatic Disease Present			0	0						2015-3-27	FEMALE	166	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			2	20	true			No	M0	N0	T3	TCGA-JX-A3Q0.3CE379FF-5E2B-4DE5-BBD8-51D70E6EFF73.pdf				A3Q0	0	0	Other	TUMOR FREE	NO	0	NO	Complete Remission/Response	[Discrepancy]			Whole pelvis split field		Other	3060	Primary Tumor	01		1997	1995	NO	NO	YES	JX	4	2		Cervical	A	LIVING	57	1997	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	TCGA-JX-A3Q0-01	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	TCGA-JX-A3Q0-01	TCGA-JX-A3Q0-01	1DDEE185-E1DE-44AE-AD36-FFCC69B5EE84	TCGA-JX-A3Q0-01A-11D-A21R-05	TCGA-JX-A3Q0-01A-11D-A21Q-09	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd			TCGA-JX-A3Q0-01A-11D-A21Q-09	TCGA-JX-A3Q0-01A-11D-A21Q-09	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	TCGA-JX-A3Q0-01A-11D-A21P-01	TCGA-JX-A3Q0-01	TCGA-JX-A3Q0-01A-11D-A21P-01
TCGA-JX-A3Q8-01	TCGA-JX-A3Q8-01	TCGA-JX-A3Q8	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		40			Follow-up visit	TCGA-JX-A3Q8-F71653	TCGA-JX-A3Q8	TCGA-JX-A3Q8-01A	Former User					ABSENT							Stage IB1		-14839					252				32	0	1357			1357							0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2015-3-27	FEMALE	158	Endocervical Type of Adenocarcinoma	No	PCR		31.33, 35.39, 45.51, 52.56.58.59.68	HPV 16|HPV 18|Other HPV type(s)		Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO	14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	1		true			No	MX	N0	T1b1	TCGA-JX-A3Q8.0BC4C48F-7EE3-40A4-85AB-44B85DE4EC65.pdf				A3Q8	1	1	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO							Primary Tumor	01	7.1		2009		NO	YES	JX	1	3		Cervical	A	LIVING	68	2011	21e92dd7-adee-4826-9470-fb7501ad280d	TCGA-JX-A3Q8-01	21e92dd7-adee-4826-9470-fb7501ad280d	TCGA-JX-A3Q8-01	TCGA-JX-A3Q8-01		TCGA-JX-A3Q8-01A-11D-A21R-05	TCGA-JX-A3Q8-01A-11D-A21Q-09	21e92dd7-adee-4826-9470-fb7501ad280d			TCGA-JX-A3Q8-01A-11D-A21Q-09	TCGA-JX-A3Q8-01A-11D-A21Q-09	21e92dd7-adee-4826-9470-fb7501ad280d	TCGA-JX-A3Q8-01A-11D-A21P-01	TCGA-JX-A3Q8-01	TCGA-JX-A3Q8-01A-11D-A21P-01
TCGA-JX-A5QV-01	TCGA-JX-A5QV-01	TCGA-JX-A5QV	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		37			Follow-up	TCGA-JX-A5QV-F71657	TCGA-JX-A5QV	TCGA-JX-A5QV-01A	Never Used		2400		LDR	ABSENT							Stage IB1		-13667					147				8	0	636			636							0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2015-3-27	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Keratinizing squamous cell carcinoma	NO	13			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	4		true			No	M0	N0	T1b1	TCGA-JX-A5QV.6C4DBD4D-8F4E-4680-AE60-1AFE2BF72732.pdf				A5QV	1	0	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	[Discrepancy]					IMRT	5120	Primary Tumor	01			2009	NO	NO	YES	JX	1	5		Cervical	A	LIVING	61	2012	5005b96a-a215-43a0-8b55-f212891bca11	TCGA-JX-A5QV-01	5005b96a-a215-43a0-8b55-f212891bca11	TCGA-JX-A5QV-01	TCGA-JX-A5QV-01	F32F346E-9E0B-4EDA-AB4D-09FCC54BED28	TCGA-JX-A5QV-01A-22D-A28C-05	TCGA-JX-A5QV-01A-22D-A28B-09	5005b96a-a215-43a0-8b55-f212891bca11			TCGA-JX-A5QV-01A-22D-A28B-09	TCGA-JX-A5QV-01A-22D-A28B-09	5005b96a-a215-43a0-8b55-f212891bca11	TCGA-JX-A5QV-01A-22D-A28A-01	TCGA-JX-A5QV-01	TCGA-JX-A5QV-01A-22D-A28A-01
TCGA-LP-A4AU-01	TCGA-LP-A4AU-01	TCGA-LP-A4AU	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		35			Date of Contact	TCGA-LP-A4AU-F58081	TCGA-LP-A4AU	TCGA-LP-A4AU-01A												Cisplatin|Other	Stage IIIB	75 mg/m2|750 MG/M2	-13074					272					0	343			343							3							2014-3-31	FEMALE	153	Cervical Squamous Cell Carcinoma	No						Simple Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	500	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			1		true		|5FU	No	M0	N1	T2	TCGA-LP-A4AU.A929AD30-1751-4BEB-BB5C-B5D191565385.pdf				A4AU			Other	TUMOR FREE	YES		YES		YES					External beam radiation	6500	Primary Tumor	01			2009	YES	YES	NO	LP	1	1		Cervical	A	LIVING	49	2011	9f1118f7-2469-4161-9930-58af9b633b66	TCGA-LP-A4AU-01	9f1118f7-2469-4161-9930-58af9b633b66	TCGA-LP-A4AU-01	TCGA-LP-A4AU-01		TCGA-LP-A4AU-01A-32D-A244-05	TCGA-LP-A4AU-01A-32D-A243-09	9f1118f7-2469-4161-9930-58af9b633b66			TCGA-LP-A4AU-01A-32D-A243-09	TCGA-LP-A4AU-01A-32D-A243-09	9f1118f7-2469-4161-9930-58af9b633b66	TCGA-LP-A4AU-01A-32D-A242-01	TCGA-LP-A4AU-01	TCGA-LP-A4AU-01A-32D-A242-01
TCGA-LP-A4AV-01	TCGA-LP-A4AV-01	TCGA-LP-A4AV	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					63					TCGA-LP-A4AV	TCGA-LP-A4AV-01A													Stage IB							413					0	0																	2013-3-12	FEMALE	153	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO			3					G2							NO			4		true			No	M0	N0	T1b	TCGA-LP-A4AV.7880E0A0-01B8-4A31-967D-8833B20752BB.pdf				A4AV				TUMOR FREE	NO		YES		NO							Primary Tumor	01			2009		YES	NO	LP	1	4		Cervical	A	LIVING	42	2011	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	TCGA-LP-A4AV-01	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	TCGA-LP-A4AV-01	TCGA-LP-A4AV-01	41413CCA-EDCB-4BA1-945E-81C34DBFF006	TCGA-LP-A4AV-01A-11D-A244-05	TCGA-LP-A4AV-01A-11D-A243-09	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d			TCGA-LP-A4AV-01A-11D-A243-09	TCGA-LP-A4AV-01A-11D-A243-09	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	TCGA-LP-A4AV-01A-11D-A242-01	TCGA-LP-A4AV-01	TCGA-LP-A4AV-01A-11D-A242-01
TCGA-LP-A4AW-01	TCGA-LP-A4AW-01	TCGA-LP-A4AW	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					52					TCGA-LP-A4AW	TCGA-LP-A4AW-01A													Stage IA		-19079					259					0	27																	2013-3-12	FEMALE	158	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	420	NO	Keratinizing squamous cell carcinoma		3				Peri (6-12 months since last menstrual period)	G1							NO			2		true			No	M0	N0	T1b	TCGA-LP-A4AW.6FE2BF04-559B-4650-921B-C1674E76EEEB.pdf				A4AW				TUMOR FREE	NO		YES		NO							Primary Tumor	01			2009		YES	NO	LP	1	2		Cervical	A	LIVING	52	2011	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	TCGA-LP-A4AW-01	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	TCGA-LP-A4AW-01	TCGA-LP-A4AW-01	85E20D48-3D30-4459-BFB5-95F947CED890	TCGA-LP-A4AW-01A-11D-A244-05	TCGA-LP-A4AW-01A-11D-A243-09	985c5f28-72d3-49f6-bc9b-31e565b2ba7c			TCGA-LP-A4AW-01A-11D-A243-09	TCGA-LP-A4AW-01A-11D-A243-09	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	TCGA-LP-A4AW-01A-11D-A242-01	TCGA-LP-A4AW-01	TCGA-LP-A4AW-01A-11D-A242-01
TCGA-LP-A4AX-01	TCGA-LP-A4AX-01	TCGA-LP-A4AX	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		45				TCGA-LP-A4AX-F69765	TCGA-LP-A4AX	TCGA-LP-A4AX-01A													Stage IB1		-16544					263					0	380			380							1							2015-1-19	FEMALE		Cervical Squamous Cell Carcinoma	No						Simple Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	240	NO		NO	2				Peri (6-12 months since last menstrual period)	G3							NO	0		2		true			No	M0	N0	T1b1	TCGA-LP-A4AX.06D6C5C2-EE8F-40DF-9F99-05E9DA394840.pdf				A4AX			Post-Adjuvant Therapy	TUMOR FREE	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	LP	1	2		Cervical	A	LIVING		2011	f7e2e36f-3018-4570-9ed2-f256048a9427	TCGA-LP-A4AX-01	f7e2e36f-3018-4570-9ed2-f256048a9427	TCGA-LP-A4AX-01	TCGA-LP-A4AX-01	D61E568A-FB64-4C66-A46D-B835AB2B7F46	TCGA-LP-A4AX-01A-12D-A244-05	TCGA-LP-A4AX-01A-12D-A243-09	f7e2e36f-3018-4570-9ed2-f256048a9427			TCGA-LP-A4AX-01A-12D-A243-09	TCGA-LP-A4AX-01A-12D-A243-09	f7e2e36f-3018-4570-9ed2-f256048a9427	TCGA-LP-A4AX-01A-12D-A242-01	TCGA-LP-A4AX-01	TCGA-LP-A4AX-01A-12D-A242-01
TCGA-LP-A5U2-01	TCGA-LP-A5U2-01	TCGA-LP-A5U2	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					30					TCGA-LP-A5U2	TCGA-LP-A5U2-01A	Never Used					ABSENT							Stage IIIB		-11049					226					0	9			6							1							2014-7-3	FEMALE	160	Endocervical Adenocarcinoma of the Usual Type	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	550	NO			7	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	2				true			No	MX	N1	T2a	TCGA-LP-A5U2.21CF3259-2E5C-48A6-B6BC-094001C4DB87.pdf				A5U2		1	Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	LP	1	1		Cervical	A	LIVING	51	2012	2953ceed-8418-4c63-b260-307aea1d9e63	TCGA-LP-A5U2-01	2953ceed-8418-4c63-b260-307aea1d9e63	TCGA-LP-A5U2-01	TCGA-LP-A5U2-01	094DF0CC-0C59-4855-B581-56FB17D71468	TCGA-LP-A5U2-01A-11D-A28C-05	TCGA-LP-A5U2-01A-11D-A28B-09	2953ceed-8418-4c63-b260-307aea1d9e63			TCGA-LP-A5U2-01A-11D-A28B-09	TCGA-LP-A5U2-01A-11D-A28B-09	2953ceed-8418-4c63-b260-307aea1d9e63	TCGA-LP-A5U2-01A-11D-A28A-01	TCGA-LP-A5U2-01	TCGA-LP-A5U2-01A-11D-A28A-01
TCGA-LP-A5U3-01	TCGA-LP-A5U3-01	TCGA-LP-A5U3	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					40					TCGA-LP-A5U3	TCGA-LP-A5U3-01A	Never Used					ABSENT							Stage IB1		-14698					168					0	25										1							2014-1-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	520	NO	Non-keratinizing squamous cell carcinoma					ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			3		true			No	M0	N0	T1b1	TCGA-LP-A5U3.153C30F0-1533-4056-9E90-F1568B8130D9.pdf				A5U3			Preoperative	TUMOR FREE			NO	Complete Remission/Response								Primary Tumor	01			2009		YES	NO	LP	1	3		Cervical	A	LIVING	50	2012	7db85d66-16a3-4062-b98f-1ebe628d2b13	TCGA-LP-A5U3-01	7db85d66-16a3-4062-b98f-1ebe628d2b13	TCGA-LP-A5U3-01	TCGA-LP-A5U3-01	D4F30F80-47CD-44E7-A1C9-419484388AF4	TCGA-LP-A5U3-01A-11D-A28C-05	TCGA-LP-A5U3-01A-11D-A28B-09	7db85d66-16a3-4062-b98f-1ebe628d2b13			TCGA-LP-A5U3-01A-11D-A28B-09	TCGA-LP-A5U3-01A-11D-A28B-09	7db85d66-16a3-4062-b98f-1ebe628d2b13	TCGA-LP-A5U3-01A-11D-A28A-01	TCGA-LP-A5U3-01	TCGA-LP-A5U3-01A-11D-A28A-01
TCGA-LP-A7HU-01	TCGA-LP-A7HU-01	TCGA-LP-A7HU	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		53				TCGA-LP-A7HU-F69614	TCGA-LP-A7HU	TCGA-LP-A7HU-01A	Never Used					ABSENT							Stage II		-19595					141					0	406			406							1							2015-1-15	FEMALE	155	Endocervical Type of Adenocarcinoma	No						Simple Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	250	NO		NO	2	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		2		true			No	M0	N0	T2	TCGA-LP-A7HU.73BE0D97-1598-42A4-905B-3E652FF7D295.pdf				A7HU			Post-Adjuvant Therapy	TUMOR FREE	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	YES	NO	LP	1	3		Cervical	A	LIVING	58	2013	33849579-965e-47e7-8fbe-016db46b3d77	TCGA-LP-A7HU-01	33849579-965e-47e7-8fbe-016db46b3d77	TCGA-LP-A7HU-01	TCGA-LP-A7HU-01	BCB3CB2B-4807-4B75-BEBA-8B33C4F18C18	TCGA-LP-A7HU-01A-11D-A340-05	TCGA-LP-A7HU-01A-11D-A33O-09	33849579-965e-47e7-8fbe-016db46b3d77			TCGA-LP-A7HU-01A-11D-A33O-09	TCGA-LP-A7HU-01A-11D-A33O-09	33849579-965e-47e7-8fbe-016db46b3d77	TCGA-LP-A7HU-01A-11D-A33N-01	TCGA-LP-A7HU-01	TCGA-LP-A7HU-01A-11D-A33N-01
TCGA-MA-AA3W-01	TCGA-MA-AA3W-01	TCGA-MA-AA3W	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		54	18	5		TCGA-MA-AA3W-F65477	TCGA-MA-AA3W	TCGA-MA-AA3W-01A						PRESENT	negative					Cisplatin	Stage IB1	70	-20066					512		5		65	0	685			685				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0	1			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-9-23	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Non-keratinizing squamous cell carcinoma	NO	40	Other Location, specify	left parametrium		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1	0	4	5.7	false			No	M0	N1	T1b1	TCGA-MA-AA3W.1C91223A-5529-46CD-AA9C-40A974F1843E.pdf				AA3W	1		Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	YES					IMRT	4500	Primary Tumor	01	0		2009	YES	YES	NO	MA	2	6		Cervical	A	LIVING	84	2012	52041760-a4d7-43e0-b2be-6b7055fe49ed	TCGA-MA-AA3W-01	52041760-a4d7-43e0-b2be-6b7055fe49ed	TCGA-MA-AA3W-01	TCGA-MA-AA3W-01	E9FE952A-0600-4871-B650-997628E6A1C0	TCGA-MA-AA3W-01A-11D-A388-05		52041760-a4d7-43e0-b2be-6b7055fe49ed					52041760-a4d7-43e0-b2be-6b7055fe49ed	TCGA-MA-AA3W-01A-11D-A386-01	TCGA-MA-AA3W-01	TCGA-MA-AA3W-01A-11D-A386-01
TCGA-MA-AA3X-01	TCGA-MA-AA3X-01	TCGA-MA-AA3X	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		50	12	5		TCGA-MA-AA3X-F65478	TCGA-MA-AA3X	TCGA-MA-AA3X-01A			2900		HDR							Cisplatin	Stage IIIB	70	-18412					471		83	1	77	0	595			595				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	0				Bladder AbsentParametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|			2014-9-23	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			2	9.5	false			No	MX	NX	T3b	TCGA-MA-AA3X.FE614842-9700-472D-B1D8-F2DFF940D489.pdf				AA3X	1		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					3D conformal	5040	Primary Tumor	01			2009	YES	YES	NO	MA	2	3		Cervical	A	LIVING	73	2012	476a57b4-654c-48b3-929b-37996cd93f45	TCGA-MA-AA3X-01	476a57b4-654c-48b3-929b-37996cd93f45	TCGA-MA-AA3X-01	TCGA-MA-AA3X-01		TCGA-MA-AA3X-01A-22D-A42P-05		476a57b4-654c-48b3-929b-37996cd93f45					476a57b4-654c-48b3-929b-37996cd93f45	TCGA-MA-AA3X-01A-22D-A42N-01	TCGA-MA-AA3X-01	TCGA-MA-AA3X-01A-22D-A42N-01
TCGA-MA-AA3Y-01	TCGA-MA-AA3Y-01	TCGA-MA-AA3Y	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		48			Post operative	TCGA-MA-AA3Y-F65479	TCGA-MA-AA3Y	TCGA-MA-AA3Y-01A	Never Used					ABSENT	negative						Stage IB1		-17795					478		20			0	542			542				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0							2014-9-23	FEMALE	156	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	250	NO	Keratinizing squamous cell carcinoma	NO	29			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0			false			No	M0	N0	T1b1	TCGA-MA-AA3Y.AA310801-F827-47D4-9A53-9C63D65F12C8.pdf				AA3Y	1		Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	YES	NO	MA	1	1		Cervical	A	LIVING	65	2012	32de6610-4b6b-443f-bd20-f67d97558cbd	TCGA-MA-AA3Y-01	32de6610-4b6b-443f-bd20-f67d97558cbd	TCGA-MA-AA3Y-01	TCGA-MA-AA3Y-01	D9039497-FD01-4832-966C-FCE8F17A7971	TCGA-MA-AA3Y-01A-11D-A388-05		32de6610-4b6b-443f-bd20-f67d97558cbd					32de6610-4b6b-443f-bd20-f67d97558cbd	TCGA-MA-AA3Y-01A-11D-A386-01	TCGA-MA-AA3Y-01	TCGA-MA-AA3Y-01A-11D-A386-01
TCGA-MA-AA3Z-01	TCGA-MA-AA3Z-01	TCGA-MA-AA3Z	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		43		6		TCGA-MA-AA3Z-F65480	TCGA-MA-AA3Z	TCGA-MA-AA3Z-01A	Former User		2800		HDR							Cisplatin	Stage IB2	70	-15762					352		41		52	0	595			595				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-9-23	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Other, specify	HPV Hybrid Capture II	There are several types of HPV the patient could be positive for.	Other HPV type(s)			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	230	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			5		false			No	M0	N0	T1b2	TCGA-MA-AA3Z.9CE46816-BE2F-46EA-880C-709BE2D40A1A.pdf				AA3Z			Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					3D conformal	5040	Primary Tumor	01	28.8		2009	YES	YES	NO	MA	1	5		Cervical	A	LIVING	84	2013	cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	TCGA-MA-AA3Z-01	cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	TCGA-MA-AA3Z-01	TCGA-MA-AA3Z-01	58DA0BF4-6F81-404C-B348-29BDA4104BAE	TCGA-MA-AA3Z-01A-11D-A388-05		cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8					cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	TCGA-MA-AA3Z-01A-11D-A386-01	TCGA-MA-AA3Z-01	TCGA-MA-AA3Z-01A-11D-A386-01
TCGA-MA-AA41-01	TCGA-MA-AA41-01	TCGA-MA-AA41	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		33	14	2|6|6|5		TCGA-MA-AA41-F65481	TCGA-MA-AA41	TCGA-MA-AA41-01A	Former User		6817	pulse dose rate	Other							Cisplatin|Carboplatin|Other|Other	Stage IIB	57|AUC/5|175mg/m2; 135mg/m2|15mg/kg	-12398					197				15	0	254			254						Once weekly|Once weekly|Once weekly|	4				Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			2014-9-23	FEMALE	159	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	340	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			3	5	false		Paclitaxel|Bevacizumab	No	M1	N1	T2	TCGA-MA-AA41.3E26B1B5-771B-4F99-BB78-C83C9F6557D2.pdf				AA41			Post-Adjuvant Therapy	WITH TUMOR	YES		NO	Progressive Disease	YES					3D conformal	3420	Primary Tumor	01			2009	YES	YES	NO	MA	2	3		Cervical	A	LIVING	47	2013	b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	TCGA-MA-AA41-01	b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	TCGA-MA-AA41-01	TCGA-MA-AA41-01	EAD0873A-0639-48FC-B340-C009F8FC6984	TCGA-MA-AA41-01A-11D-A388-05		b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e					b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	TCGA-MA-AA41-01A-11D-A386-01	TCGA-MA-AA41-01	TCGA-MA-AA41-01A-11D-A386-01
TCGA-MA-AA42-01	TCGA-MA-AA42-01	TCGA-MA-AA42	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		75		5		TCGA-MA-AA42-F65482	TCGA-MA-AA42	TCGA-MA-AA42-01A			3100		HDR							Cisplatin	Stage IIB	62	-27460					57			14	19	0	259			259					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-9-23	FEMALE	140	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			6		false			No	M0	N0	T2b	TCGA-MA-AA42.62F4EBB5-6F2F-4D4C-817E-88EEF577BF1C.pdf				AA42	2		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					3D conformal	5040	Primary Tumor	01	18.5		2009	YES	YES	NO	MA	1	8		Cervical	A	LIVING	63	2013	4523956c-5427-45e0-a640-cc5ce875b022	TCGA-MA-AA42-01	4523956c-5427-45e0-a640-cc5ce875b022	TCGA-MA-AA42-01	TCGA-MA-AA42-01	8C54A0B1-1E91-40CE-8BC8-2CC140B4310C	TCGA-MA-AA42-01A-12D-A388-05		4523956c-5427-45e0-a640-cc5ce875b022					4523956c-5427-45e0-a640-cc5ce875b022	TCGA-MA-AA42-01A-12D-A386-01	TCGA-MA-AA42-01	TCGA-MA-AA42-01A-12D-A386-01
TCGA-MA-AA43-01	TCGA-MA-AA43-01	TCGA-MA-AA43	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		48	16	2		TCGA-MA-AA43-F65483	TCGA-MA-AA43	TCGA-MA-AA43-01A	Never Used		8239	pulse dose rate	Other							Cisplatin	Stage IIIB	68	-17658					180			70	66	0	346			346					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent	Once weekly	0			4500	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			2014-9-23	FEMALE	152	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma	NO					Peri (6-12 months since last menstrual period)	G3							NO			6	11.6	false			No	MX	NX	T3b	TCGA-MA-AA43.662EBBFF-1A0B-4217-8E3D-C453AAA4BDAD.pdf				AA43			Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					3D conformal	11400	Primary Tumor	01		2013	2009	YES	YES	NO	MA	4	6		Cervical	A	LIVING	72	2013	eb0b4f03-9121-4c2a-bc13-4d9109d6b894	TCGA-MA-AA43-01	eb0b4f03-9121-4c2a-bc13-4d9109d6b894	TCGA-MA-AA43-01	TCGA-MA-AA43-01	030704AA-5162-44EE-B68B-7D35FB6DD2A0	TCGA-MA-AA43-01A-11D-A42P-05		eb0b4f03-9121-4c2a-bc13-4d9109d6b894					eb0b4f03-9121-4c2a-bc13-4d9109d6b894	TCGA-MA-AA43-01A-11D-A42N-01	TCGA-MA-AA43-01	TCGA-MA-AA43-01A-11D-A42N-01
TCGA-MU-A51Y-01	TCGA-MU-A51Y-01	TCGA-MU-A51Y	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		27				TCGA-MU-A51Y-F69301	TCGA-MU-A51Y	TCGA-MU-A51Y-01A								uninvolved margins	Other Location, specify				Stage IIA1		-10199					127				52	0	854			854							1							2014-12-31	FEMALE		Cervical Squamous Cell Carcinoma	No	Other, specify	Hybrid Capture 2	High risk	Other HPV type(s)		Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	90	NO	Non-keratinizing squamous cell carcinoma	NO	17				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	1		true			No	MX	N0	T2a1	TCGA-MU-A51Y.6E5C4ACB-C01C-4AE3-B060-E354CFEF08A0.pdf				A51Y		3	Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	YES	Not done per treating physician discretion						Primary Tumor	01	6.47		2009	YES	YES	NO	MU	1			Cervical	A	LIVING	31	2012	e2f4f6ea-e643-421e-96ec-3618bb46b91d	TCGA-MU-A51Y-01	e2f4f6ea-e643-421e-96ec-3618bb46b91d	TCGA-MU-A51Y-01	TCGA-MU-A51Y-01	9D208C1A-C282-49B9-8271-BDDD8D5792A6	TCGA-MU-A51Y-01A-11D-A26S-05	TCGA-MU-A51Y-01A-11D-A26G-09	e2f4f6ea-e643-421e-96ec-3618bb46b91d			TCGA-MU-A51Y-01A-11D-A26G-09	TCGA-MU-A51Y-01A-11D-A26G-09	e2f4f6ea-e643-421e-96ec-3618bb46b91d	TCGA-MU-A51Y-01A-11D-A26F-01	TCGA-MU-A51Y-01	TCGA-MU-A51Y-01A-11D-A26F-01
TCGA-MU-A5YI-01	TCGA-MU-A5YI-01	TCGA-MU-A5YI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	YES	Progressive Disease		60	37			TCGA-MU-A5YI-F60258	TCGA-MU-A5YI	TCGA-MU-A5YI-01A													Stage IA1		-21927					593					0	1053	662	630	1053							2							2014-6-4	FEMALE	175	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Hysterectomy	Other method, specify:	150	NO	Non-keratinizing squamous cell carcinoma	NO	18			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	CT Guided biopsy		Distant Metastasis	Thoracic Spine	YES	YES	0			10	true			No	MX	NX	T1a1	TCGA-MU-A5YI.A762F957-1504-4FD5-9862-D7C8DD94A693.pdf				A5YI			Post-Adjuvant Therapy	WITH TUMOR	YES		YES		YES							Primary Tumor	01		1991	2009	YES	YES	NO	MU	3			Cervical	A	LIVING	101	2011	736a30f9-fb53-422d-b66e-1af964011d15	TCGA-MU-A5YI-01	736a30f9-fb53-422d-b66e-1af964011d15	TCGA-MU-A5YI-01	TCGA-MU-A5YI-01	2A20CB75-42F9-4895-B3DC-9A6FBC9A1E59	TCGA-MU-A5YI-01A-11D-A32T-05	TCGA-MU-A5YI-01A-11D-A32I-09	736a30f9-fb53-422d-b66e-1af964011d15			TCGA-MU-A5YI-01A-11D-A32I-09	TCGA-MU-A5YI-01A-11D-A32I-09	736a30f9-fb53-422d-b66e-1af964011d15	TCGA-MU-A5YI-01A-11D-A32H-01	TCGA-MU-A5YI-01	TCGA-MU-A5YI-01A-11D-A32H-01
TCGA-MU-A8JM-01	TCGA-MU-A8JM-01	TCGA-MU-A8JM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		46	16		postoperative	TCGA-MU-A8JM-F69302	TCGA-MU-A8JM	TCGA-MU-A8JM-01A									Microscopic parametrial involvement				Stage IB1		-17156					278				28	0	607			607							1							2014-12-31	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	210	NO	Non-keratinizing squamous cell carcinoma	NO	29	Pelvic (external iliac, internal iliac, obturator)|Common iliac				G2							NO	0		1	30	true			No	MX	N0	T1b	TCGA-MU-A8JM.A70CA320-58BF-4165-BD92-D791A4385247.pdf				A8JM	1		Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01	6.0	2012	2009	NO	YES	NO	MU	4	2		Cervical	A	LIVING	86	2013	78fd9869-2ed5-40a6-a846-07d5089dd810	TCGA-MU-A8JM-01	78fd9869-2ed5-40a6-a846-07d5089dd810	TCGA-MU-A8JM-01	TCGA-MU-A8JM-01	6DEA112A-68FE-4D44-A1D3-94F52FA9D333	TCGA-MU-A8JM-01A-11D-A36K-05		78fd9869-2ed5-40a6-a846-07d5089dd810					78fd9869-2ed5-40a6-a846-07d5089dd810	TCGA-MU-A8JM-01A-11D-A36I-01	TCGA-MU-A8JM-01	TCGA-MU-A8JM-01A-11D-A36I-01
TCGA-MY-A5BD-01	TCGA-MY-A5BD-01	TCGA-MY-A5BD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		62				TCGA-MY-A5BD-F67085	TCGA-MY-A5BD	TCGA-MY-A5BD-01A						PRESENT							Stage IIB		-22901					983					0	1667										0							2014-10-30	FEMALE	157	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	10	NO		NO	26			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	0			true			No	M0	N0	T2b	TCGA-MY-A5BD.4BCA8C55-997E-4700-A12C-B520575C3608.pdf				A5BD			Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Stable Disease	YES							Primary Tumor	01			2009	YES	NO	YES	MY	1			Cervical	A	LIVING	91	2010	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	TCGA-MY-A5BD-01	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	TCGA-MY-A5BD-01	TCGA-MY-A5BD-01		TCGA-MY-A5BD-01A-11D-A26S-05	TCGA-MY-A5BD-01A-11D-A26G-09	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1			TCGA-MY-A5BD-01A-11D-A26G-09	TCGA-MY-A5BD-01A-11D-A26G-09	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	TCGA-MY-A5BD-01A-11D-A26F-01	TCGA-MY-A5BD-01	TCGA-MY-A5BD-01A-11D-A26F-01
TCGA-MY-A5BE-01	TCGA-MY-A5BE-01	TCGA-MY-A5BE	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		42				TCGA-MY-A5BE-F67177	TCGA-MY-A5BE	TCGA-MY-A5BE-01A													Stage IB1		-15466					386					0	1066																	2014-10-31	FEMALE	157	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO		Pelvic (external iliac, internal iliac, obturator)|Common iliac		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO					true			No	MX	N0	T1b1	TCGA-MY-A5BE.8D0A3856-45BE-458D-996A-49B5C255296C.pdf				A5BE				TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	NO	YES	MY	1			Cervical	A	LIVING	84	2011	8e7c9d3f-137c-4f4d-829d-76f11c133267	TCGA-MY-A5BE-01	8e7c9d3f-137c-4f4d-829d-76f11c133267	TCGA-MY-A5BE-01	TCGA-MY-A5BE-01		TCGA-MY-A5BE-01A-21D-A26S-05	TCGA-MY-A5BE-01A-21D-A26G-09	8e7c9d3f-137c-4f4d-829d-76f11c133267			TCGA-MY-A5BE-01A-21D-A26G-09	TCGA-MY-A5BE-01A-21D-A26G-09	8e7c9d3f-137c-4f4d-829d-76f11c133267	TCGA-MY-A5BE-01A-21D-A26F-01	TCGA-MY-A5BE-01	TCGA-MY-A5BE-01A-21D-A26F-01
TCGA-MY-A5BF-01	TCGA-MY-A5BF-01	TCGA-MY-A5BF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		68				TCGA-MY-A5BF-F67160	TCGA-MY-A5BF	TCGA-MY-A5BF-01A													Stage IIA2		-25082					97					0	634																	2014-10-31	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable	robotic	Other	C53.9	8071/3	C53.9	YES		Lymph node sampling or dissection	190	NO		NO	6	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	6			true			No	MX	N0	T2a2	TCGA-MY-A5BF.1BFC6DC1-D8FF-4C55-8925-BA52DEB3ECD3.pdf				A5BF				TUMOR FREE	YES		YES	Stable Disease	YES							Primary Tumor	01			2009	YES	YES	NO	MY	1			Cervical	A	LIVING	74	2012	77019674-09ef-416d-a02a-8135b048af91	TCGA-MY-A5BF-01	77019674-09ef-416d-a02a-8135b048af91	TCGA-MY-A5BF-01	TCGA-MY-A5BF-01	C4584FD2-F3A6-4475-96F1-7897310781FA	TCGA-MY-A5BF-01A-11D-A26S-05	TCGA-MY-A5BF-01A-11D-A26G-09	77019674-09ef-416d-a02a-8135b048af91			TCGA-MY-A5BF-01A-11D-A26G-09	TCGA-MY-A5BF-01A-11D-A26G-09	77019674-09ef-416d-a02a-8135b048af91	TCGA-MY-A5BF-01A-11D-A26F-01	TCGA-MY-A5BF-01	TCGA-MY-A5BF-01A-11D-A26F-01
TCGA-MY-A5BF-11	TCGA-MY-A5BF-11	TCGA-MY-A5BF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		68				TCGA-MY-A5BF-F67160	TCGA-MY-A5BF														Stage IIA2		-25082										0	634																	2014-10-31	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable	robotic	Other	C53.9	8071/3	C53.9	YES		Lymph node sampling or dissection				NO	6	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	6						No	MX	N0	T2a2					A5BF				TUMOR FREE	YES		YES	Stable Disease	YES							Solid Tissue Normal	11			2009	YES	YES	NO	MY	1			Cervical		LIVING	74	2012	ea52408f-b5e1-4a15-80bc-945cc74135e4	TCGA-MY-A5BF-11	ea52408f-b5e1-4a15-80bc-945cc74135e4	TCGA-MY-A5BF-11			TCGA-MY-A5BF-11A-11D-A26S-05		ea52408f-b5e1-4a15-80bc-945cc74135e4					ea52408f-b5e1-4a15-80bc-945cc74135e4			
TCGA-MY-A913-01	TCGA-MY-A913-01	TCGA-MY-A913	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		28		5		TCGA-MY-A913-F71177	TCGA-MY-A913	TCGA-MY-A913-01A			50		HDR							Cisplatin	Stage IIA	40mg	-10379					107		166	21	-7	0	524			524				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	1				Bladder AbsentPelvic Nodes Present|			2015-3-20	FEMALE	163	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	210	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			5		true			No	M1	N0	Tis	TCGA-MY-A913.E17EECA7-26DE-4456-94B2-6B5A9F4931AD.pdf				A913	1	1	Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					External beam radiation	50	Primary Tumor	01	26.1		2009	YES	YES	NO	MY	5	7		Cervical	A	LIVING	76	2013	4b1da384-ab8a-4c6f-a76a-54ddc5314594	TCGA-MY-A913-01	4b1da384-ab8a-4c6f-a76a-54ddc5314594	TCGA-MY-A913-01	TCGA-MY-A913-01	263D2292-E1D0-4937-90C2-C733495AFF02	TCGA-MY-A913-01A-11D-A37Q-05		4b1da384-ab8a-4c6f-a76a-54ddc5314594					4b1da384-ab8a-4c6f-a76a-54ddc5314594	TCGA-MY-A913-01A-11D-A37M-01	TCGA-MY-A913-01	TCGA-MY-A913-01A-11D-A37M-01
TCGA-PN-A8M9-01	TCGA-PN-A8M9-01	TCGA-PN-A8M9	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix											TCGA-PN-A8M9-01A																				232																																								430	NO																				false							TCGA-PN-A8M9.FA47BD02-CC7A-430C-9811-9A8C911E2EF2.pdf																				Primary Tumor	01												A				c9ccb91c-8643-4642-8fa7-e49a945dd938		c9ccb91c-8643-4642-8fa7-e49a945dd938						c9ccb91c-8643-4642-8fa7-e49a945dd938					c9ccb91c-8643-4642-8fa7-e49a945dd938			
TCGA-PN-A8MA-01	TCGA-PN-A8MA-01	TCGA-PN-A8MA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Stable Disease		43		3	during adjuvant therapy	TCGA-PN-A8MA-F64853	TCGA-PN-A8MA		Former User											Cisplatin	Stage IIB	50mg	-15918										0	90			90						Once weekly	1							2014-10-17	FEMALE	167	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3										8					No	M0	N0	T2b					A8MA	1		Other	WITH TUMOR	YES		NO	Stable Disease	YES	Adverse event/complications				External beam radiation		Primary Tumor	01			2009	YES	YES	NO	PN		9		Cervical		LIVING	71	2013	fa2cdebd-8b7c-452a-8191-994ceeb1e763	TCGA-PN-A8MA-01	fa2cdebd-8b7c-452a-8191-994ceeb1e763	TCGA-PN-A8MA-01	TCGA-PN-A8MA-01		TCGA-PN-A8MA-01A-11D-A36K-05		fa2cdebd-8b7c-452a-8191-994ceeb1e763					fa2cdebd-8b7c-452a-8191-994ceeb1e763	TCGA-PN-A8MA-01A-11D-A36I-01	TCGA-PN-A8MA-01	TCGA-PN-A8MA-01A-11D-A36I-01
TCGA-Q1-A5R1-01	TCGA-Q1-A5R1-01	TCGA-Q1-A5R1	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		32			Post-operative	TCGA-Q1-A5R1-F56897	TCGA-Q1-A5R1		Current User					ABSENT							Stage IB1		-11705										0	474			474							0							2014-2-25	FEMALE	183	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.9	8482/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)			Non-keratinizing squamous cell carcinoma	NO	4			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	1					No	MX	N0	T1b1					A5R1			Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	YES	NO	Q1	1	2		Cervical		LIVING	92	2012	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	TCGA-Q1-A5R1-01	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	TCGA-Q1-A5R1-01	TCGA-Q1-A5R1-01		TCGA-Q1-A5R1-01A-11D-A28C-05	TCGA-Q1-A5R1-01A-11D-A28B-09	ca1c37f0-52c9-4702-87ea-1a81a09c12e8			TCGA-Q1-A5R1-01A-11D-A28B-09	TCGA-Q1-A5R1-01A-11D-A28B-09	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	TCGA-Q1-A5R1-01A-11D-A28A-01	TCGA-Q1-A5R1-01	TCGA-Q1-A5R1-01A-11D-A28A-01
TCGA-Q1-A5R2-01	TCGA-Q1-A5R2-01	TCGA-Q1-A5R2	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		64		6	Post-operative	TCGA-Q1-A5R2-F56898	TCGA-Q1-A5R2		Former User		300		HDR							Cisplatin			-23523										0	499			406						Once weekly	0							2014-2-25	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2					No	MX	NX	TX					A5R2			Other	TUMOR FREE	YES		NO		YES							Primary Tumor	01			7th	YES	YES	NO	Q1	1	2		Cervical		LIVING	76	2012	e0dc1957-256a-4ffe-9521-66dd3970639c	TCGA-Q1-A5R2-01	e0dc1957-256a-4ffe-9521-66dd3970639c	TCGA-Q1-A5R2-01	TCGA-Q1-A5R2-01		TCGA-Q1-A5R2-01A-11D-A28C-05	TCGA-Q1-A5R2-01A-11D-A28B-09	e0dc1957-256a-4ffe-9521-66dd3970639c			TCGA-Q1-A5R2-01A-11D-A28B-09	TCGA-Q1-A5R2-01A-11D-A28B-09	e0dc1957-256a-4ffe-9521-66dd3970639c	TCGA-Q1-A5R2-01A-11D-A28A-01	TCGA-Q1-A5R2-01	TCGA-Q1-A5R2-01A-11D-A28A-01
TCGA-Q1-A5R3-01	TCGA-Q1-A5R3-01	TCGA-Q1-A5R3	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		56				TCGA-Q1-A5R3-F56894	TCGA-Q1-A5R3	TCGA-Q1-A5R3-01A	Former User		3000		HDR							Cisplatin			-20574					115					0	485			485							0							2014-2-25	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	420	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			3		true			No	MX	NX	TX	TCGA-Q1-A5R3.1E8B41FC-2317-4EEA-BDD8-40BC40D36BA6.pdf				A5R3			Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES							Primary Tumor	01			7th	YES	YES	NO	Q1	1	5		Cervical	A	LIVING	50	2012	2807ba60-128f-49fc-9e15-bb3678c12f56	TCGA-Q1-A5R3-01	2807ba60-128f-49fc-9e15-bb3678c12f56	TCGA-Q1-A5R3-01	TCGA-Q1-A5R3-01	677D93FA-9BC4-4BDC-A8E7-EC89133566BD	TCGA-Q1-A5R3-01A-11D-A28C-05	TCGA-Q1-A5R3-01A-11D-A28B-09	2807ba60-128f-49fc-9e15-bb3678c12f56			TCGA-Q1-A5R3-01A-11D-A28B-09	TCGA-Q1-A5R3-01A-11D-A28B-09	2807ba60-128f-49fc-9e15-bb3678c12f56	TCGA-Q1-A5R3-01A-11D-A28A-01	TCGA-Q1-A5R3-01	TCGA-Q1-A5R3-01A-11D-A28A-01
TCGA-Q1-A6DT-01	TCGA-Q1-A6DT-01	TCGA-Q1-A6DT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Progressive Disease		55				TCGA-Q1-A6DT-F62826	TCGA-Q1-A6DT														Stage I		-20286						275				0	103																	2014-7-25	FEMALE		Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO								No	MX	NX	TX		Cervical Cancer			A6DT				WITH TUMOR	NO		NO		NO							Primary Tumor	01			2009		YES	NO	Q1	1			Cervical		DECEASED		2013	a11fe2cb-92b2-463c-873c-b179e1d352cd	TCGA-Q1-A6DT-01	a11fe2cb-92b2-463c-873c-b179e1d352cd	TCGA-Q1-A6DT-01	TCGA-Q1-A6DT-01		TCGA-Q1-A6DT-01A-11D-A32T-05	TCGA-Q1-A6DT-01A-11D-A32I-09	a11fe2cb-92b2-463c-873c-b179e1d352cd			TCGA-Q1-A6DT-01A-11D-A32I-09	TCGA-Q1-A6DT-01A-11D-A32I-09	a11fe2cb-92b2-463c-873c-b179e1d352cd	TCGA-Q1-A6DT-01A-11D-A32H-01	TCGA-Q1-A6DT-01	TCGA-Q1-A6DT-01A-11D-A32H-01
TCGA-Q1-A6DV-01	TCGA-Q1-A6DV-01	TCGA-Q1-A6DV	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		36				TCGA-Q1-A6DV-F62827	TCGA-Q1-A6DV	TCGA-Q1-A6DV-01A	Current User					ABSENT							Stage IB1		-13166					79					0	491			-12							0							2014-7-25	FEMALE	152	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.0	8482/3	C53.0	YES	Hysterectomy	Other method, specify:	80	NO	Non-keratinizing squamous cell carcinoma	NO	2			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0			true			No	M0	N0	T1b1	TCGA-Q1-A6DV.B42DEC07-001A-4766-BFD6-DE67D04ABA65.pdf				A6DV			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009	NO	YES	NO	Q1	1	0		Cervical	A	LIVING	60	2013	432d3081-de85-448f-8499-2446b25af20c	TCGA-Q1-A6DV-01	432d3081-de85-448f-8499-2446b25af20c	TCGA-Q1-A6DV-01	TCGA-Q1-A6DV-01		TCGA-Q1-A6DV-01A-11D-A32T-05	TCGA-Q1-A6DV-01A-11D-A32I-09	432d3081-de85-448f-8499-2446b25af20c			TCGA-Q1-A6DV-01A-11D-A32I-09	TCGA-Q1-A6DV-01A-11D-A32I-09	432d3081-de85-448f-8499-2446b25af20c	TCGA-Q1-A6DV-01A-11D-A32H-01	TCGA-Q1-A6DV-01	TCGA-Q1-A6DV-01A-11D-A32H-01
TCGA-Q1-A6DW-01	TCGA-Q1-A6DW-01	TCGA-Q1-A6DW	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					44	35	5		TCGA-Q1-A6DW-F62829	TCGA-Q1-A6DW	TCGA-Q1-A6DW-01A			2900		HDR	ABSENT						Cisplatin	Stage I	40mg	-16200					100					0	534			114						Once weekly	0							2014-7-25	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			1	2.5	true			No	MX	NX	TX	TCGA-Q1-A6DW.5C7158E0-E120-4D7C-A68D-FA3853507A83.pdf				A6DW			Post-Adjuvant Therapy		YES		NO		YES							Primary Tumor	01		2009	2009	YES	YES	NO	Q1	4	1		Cervical	A	LIVING	62	2013	c564836c-e7fd-48cc-8896-7d18028039f7	TCGA-Q1-A6DW-01	c564836c-e7fd-48cc-8896-7d18028039f7	TCGA-Q1-A6DW-01	TCGA-Q1-A6DW-01	D724F57C-3058-4E1F-9B5F-F899F7388CF2	TCGA-Q1-A6DW-01A-11D-A32T-05	TCGA-Q1-A6DW-01A-11D-A32I-09	c564836c-e7fd-48cc-8896-7d18028039f7			TCGA-Q1-A6DW-01A-11D-A32I-09	TCGA-Q1-A6DW-01A-11D-A32I-09	c564836c-e7fd-48cc-8896-7d18028039f7	TCGA-Q1-A6DW-01A-11D-A32H-01	TCGA-Q1-A6DW-01	TCGA-Q1-A6DW-01A-11D-A32H-01
TCGA-Q1-A73O-01	TCGA-Q1-A73O-01	TCGA-Q1-A73O	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		37		6	Post-surgery	TCGA-Q1-A73O-F62831	TCGA-Q1-A73O	TCGA-Q1-A73O-01A						ABSENT						Cisplatin	Stage IB2	40mg/m2	-13601					77					0	428			425						Once weekly	0							2014-7-25	FEMALE	152	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO					true			No	MX	NX	TX	TCGA-Q1-A73O.2D4BBE0A-11E4-46C1-8416-FA0E724B53FC.pdf				A73O			Other	TUMOR FREE	YES		NO	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	Q1	1			Cervical	A	LIVING	76	2013	48ad4bbc-d720-43da-98a8-e002c69ff5aa	TCGA-Q1-A73O-01	48ad4bbc-d720-43da-98a8-e002c69ff5aa	TCGA-Q1-A73O-01	TCGA-Q1-A73O-01	FA37518B-8DC1-4510-8DF4-6E7021ECC8B5	TCGA-Q1-A73O-01A-11D-A32T-05	TCGA-Q1-A73O-01A-11D-A32I-09	48ad4bbc-d720-43da-98a8-e002c69ff5aa			TCGA-Q1-A73O-01A-11D-A32I-09	TCGA-Q1-A73O-01A-11D-A32I-09	48ad4bbc-d720-43da-98a8-e002c69ff5aa	TCGA-Q1-A73O-01A-11D-A32H-01	TCGA-Q1-A73O-01	TCGA-Q1-A73O-01A-11D-A32H-01
TCGA-Q1-A73P-01	TCGA-Q1-A73P-01	TCGA-Q1-A73P	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		45			Post-surgery	TCGA-Q1-A73P-F62731	TCGA-Q1-A73P	TCGA-Q1-A73P-01A	Former User					ABSENT							Stage IB1		-16450					92					0	483			295							0							2014-7-23	FEMALE	173	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO		NO	17			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0	0	5		true			No	MX	N0	T1b	TCGA-Q1-A73P.5269DE35-6DEC-417C-B618-6F7717FFA55A.pdf				A73P			Other	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	Q1	1	6		Cervical	A	LIVING	82	2013	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	TCGA-Q1-A73P-01	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	TCGA-Q1-A73P-01	TCGA-Q1-A73P-01	0095AB4C-70E1-460B-AFEB-74AAB65D1E95	TCGA-Q1-A73P-01A-11D-A32T-05	TCGA-Q1-A73P-01A-11D-A32I-09	265dd9bb-8b5e-4cad-a43e-f21ae0953f22			TCGA-Q1-A73P-01A-11D-A32I-09	TCGA-Q1-A73P-01A-11D-A32I-09	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	TCGA-Q1-A73P-01A-11D-A32H-01	TCGA-Q1-A73P-01	TCGA-Q1-A73P-01A-11D-A32H-01
TCGA-Q1-A73Q-01	TCGA-Q1-A73Q-01	TCGA-Q1-A73Q	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Partial Response		46	13	5		TCGA-Q1-A73Q-F62730	TCGA-Q1-A73Q	TCGA-Q1-A73Q-01A			2900		HDR							Cisplatin	Stage I	40mg/m2	-16851					96					0	284			179						Once weekly	0	1						2014-7-23	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1260	NO	Keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			1	3.3	true			No	MX	NX	TX	TCGA-Q1-A73Q.C29EC084-5A50-4007-B281-391965A67F43.pdf				A73Q			Post-Adjuvant Therapy	WITH TUMOR	YES		NO		YES							Primary Tumor	01			2009	YES	YES	NO	Q1	2	2		Cervical	A	LIVING	87	2013	c7f8cb76-3d15-41f0-8217-908db558eedc	TCGA-Q1-A73Q-01	c7f8cb76-3d15-41f0-8217-908db558eedc	TCGA-Q1-A73Q-01	TCGA-Q1-A73Q-01	E7F7A921-F39C-4DB0-AC65-0A6AE9578FC6	TCGA-Q1-A73Q-01A-21D-A32T-05	TCGA-Q1-A73Q-01A-21D-A32I-09	c7f8cb76-3d15-41f0-8217-908db558eedc			TCGA-Q1-A73Q-01A-21D-A32I-09	TCGA-Q1-A73Q-01A-21D-A32I-09	c7f8cb76-3d15-41f0-8217-908db558eedc	TCGA-Q1-A73Q-01A-21D-A32H-01	TCGA-Q1-A73Q-01	TCGA-Q1-A73Q-01A-21D-A32H-01
TCGA-Q1-A73R-01	TCGA-Q1-A73R-01	TCGA-Q1-A73R	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		45			Post-surgery	TCGA-Q1-A73R-F62729	TCGA-Q1-A73R	TCGA-Q1-A73R-01A													Stage I		-16701					118					0	567			335							0							2014-7-23	FEMALE	155	Endocervical Type of Adenocarcinoma	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	580	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO					true			No	MX	NX	TX	TCGA-Q1-A73R.2294E1F2-FA18-4E80-A7C8-F7089B24298A.pdf				A73R			Other	TUMOR FREE	NO		NO	Complete Remission/Response	NO							Primary Tumor	01			2009		YES	NO	Q1	1			Cervical	A	LIVING	95	2013	a661f07b-e207-4221-b9f2-a5704be3650b	TCGA-Q1-A73R-01	a661f07b-e207-4221-b9f2-a5704be3650b	TCGA-Q1-A73R-01	TCGA-Q1-A73R-01	6922055B-2C39-4A60-80D9-ADF3269CD2DB	TCGA-Q1-A73R-01A-11D-A340-05	TCGA-Q1-A73R-01A-11D-A33O-09	a661f07b-e207-4221-b9f2-a5704be3650b			TCGA-Q1-A73R-01A-11D-A33O-09	TCGA-Q1-A73R-01A-11D-A33O-09	a661f07b-e207-4221-b9f2-a5704be3650b	TCGA-Q1-A73R-01A-11D-A33N-01	TCGA-Q1-A73R-01	TCGA-Q1-A73R-01A-11D-A33N-01
TCGA-Q1-A73S-01	TCGA-Q1-A73S-01	TCGA-Q1-A73S	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		33	19	6		TCGA-Q1-A73S-F62725	TCGA-Q1-A73S	TCGA-Q1-A73S-01A	Former User					PRESENT						Cisplatin	Stage IB1	40mg/m2	-12229					232					0	688			589						Once weekly	0							2014-7-23	FEMALE	160	Adenosquamous	No						Radical Hysterectomy	C53.9	8560/3	C53.9	YES	Hysterectomy	Other method, specify:	490	NO	Non-keratinizing squamous cell carcinoma	NO	18	Other Location, specify	Obturator	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	2	0	2	7.5	true			No	MX	N1	T1b1	TCGA-Q1-A73S.264F3D75-C462-4904-8AFB-2D18B0A59CB7.pdf				A73S			Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01		2012	2009	YES	YES	NO	Q1	4	4		Cervical	A	LIVING	68	2012	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	TCGA-Q1-A73S-01	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	TCGA-Q1-A73S-01	TCGA-Q1-A73S-01	8338B88E-C70C-435A-B4A1-F7D869485F60	TCGA-Q1-A73S-01A-11D-A340-05	TCGA-Q1-A73S-01A-11D-A33O-09	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20			TCGA-Q1-A73S-01A-11D-A33O-09	TCGA-Q1-A73S-01A-11D-A33O-09	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	TCGA-Q1-A73S-01A-11D-A33N-01	TCGA-Q1-A73S-01	TCGA-Q1-A73S-01A-11D-A33N-01
TCGA-R2-A69V-01	TCGA-R2-A69V-01	TCGA-R2-A69V	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					42					TCGA-R2-A69V	TCGA-R2-A69V-01A			4500		HDR	ABSENT						Cisplatin	Stage IB		-15479					548				15	0	596														Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2013-7-15	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	780	NO	Non-keratinizing squamous cell carcinoma		18			PRESENT	Peri (6-12 months since last menstrual period)	G3							NO	0	0	1		false			No	M0	N0	T1b	TCGA-R2-A69V.13EE4EE8-9C51-4EBC-9562-7233A148810B.pdf				A69V				TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	YES	YES	NO	R2	1			Cervical	A	LIVING	116	2011	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	TCGA-R2-A69V-01	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	TCGA-R2-A69V-01	TCGA-R2-A69V-01	C070ECB0-DB6E-46BD-8B6F-80795F0B65E2	TCGA-R2-A69V-01A-11D-A32T-05	TCGA-R2-A69V-01A-11D-A32I-09	74b2fff7-243f-4eb5-9c67-2ab77b3ca059			TCGA-R2-A69V-01A-11D-A32I-09	TCGA-R2-A69V-01A-11D-A32I-09	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	TCGA-R2-A69V-01A-11D-A32H-01	TCGA-R2-A69V-01	TCGA-R2-A69V-01A-11D-A32H-01
TCGA-RA-A741-01	TCGA-RA-A741-01	TCGA-RA-A741	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		34	21	6		TCGA-RA-A741-F66178	TCGA-RA-A741	TCGA-RA-A741-01A			5500		HDR							Cisplatin	Stage IIB	40 MG/M2	-12607					22		-15	14		0	444			444				Pelvic Nodes Absent|	Bladder AbsentParametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|	Once weekly	0	0						2014-10-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Non-keratinizing squamous cell carcinoma	NO	4	Pelvic (external iliac, internal iliac, obturator)			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO	0	0	0	10	false			No				TCGA-RA-A741.4CC49B26-FA09-4B3C-BB2F-236914852C7A.pdf				A741	0	0	Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	YES					IMRT	4500	Primary Tumor	01		2013	2009	YES	YES	NO	RA	4	0		Cervical	A	LIVING	86	2013	58e01e27-fe36-4ee7-9560-f668bf6dcb48	TCGA-RA-A741-01	58e01e27-fe36-4ee7-9560-f668bf6dcb48	TCGA-RA-A741-01	TCGA-RA-A741-01	B1B3C261-B418-4B28-AAEA-749C4370A347	TCGA-RA-A741-01A-11D-A340-05	TCGA-RA-A741-01A-11D-A33O-09	58e01e27-fe36-4ee7-9560-f668bf6dcb48			TCGA-RA-A741-01A-11D-A33O-09	TCGA-RA-A741-01A-11D-A33O-09	58e01e27-fe36-4ee7-9560-f668bf6dcb48	TCGA-RA-A741-01A-11D-A33N-01	TCGA-RA-A741-01	TCGA-RA-A741-01A-11D-A33N-01
TCGA-UC-A7PD-01	TCGA-UC-A7PD-01	TCGA-UC-A7PD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					21	13				TCGA-UC-A7PD		Former User			vaginal implant	Other			perineural space invasion	Other Location, specify				Stage IB		-7855						355				0				-1							1	0						2014-2-4	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	tumor resection	Other method, specify:			Keratinizing squamous cell carcinoma		11			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES	0	0	4	1.75				No	M0	N0	T1b		Cervical Cancer			A7PD	0	1	Preoperative	WITH TUMOR	NO	0	YES	Complete Remission/Response	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	UC	2	5		Cervical		DECEASED		1997	be979660-2d11-4707-9c74-b1222c7cb56e	TCGA-UC-A7PD-01	be979660-2d11-4707-9c74-b1222c7cb56e	TCGA-UC-A7PD-01	TCGA-UC-A7PD-01		TCGA-UC-A7PD-01A-11D-A357-05	TCGA-UC-A7PD-01A-11D-A351-09	be979660-2d11-4707-9c74-b1222c7cb56e			TCGA-UC-A7PD-01A-11D-A351-09	TCGA-UC-A7PD-01A-11D-A351-09	be979660-2d11-4707-9c74-b1222c7cb56e	TCGA-UC-A7PD-01A-11D-A350-01	TCGA-UC-A7PD-01	TCGA-UC-A7PD-01A-11D-A350-01
TCGA-UC-A7PF-01	TCGA-UC-A7PF-01	TCGA-UC-A7PF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					44					TCGA-UC-A7PF	TCGA-UC-A7PF-01A						PRESENT							Stage IB1		-16412					5050	2859				0												2						2014-2-4	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	210	NO			30	Pelvic (external iliac, internal iliac, obturator)|Other Location, specify	anterior parametrium	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								5		2		true			No	M0	N1	T1b1	TCGA-UC-A7PF.EF390F2F-A13F-4661-86C6-2679E4FAEE72.pdf				A7PF	0	0				0	YES									Primary Tumor	01			2009		NO	YES	UC	2	4		Cervical	A	DECEASED	210	1999	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	TCGA-UC-A7PF-01	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	TCGA-UC-A7PF-01	TCGA-UC-A7PF-01	1F3D85EE-2B7F-4EDF-B976-4471D4AE5C08	TCGA-UC-A7PF-01A-11D-A357-05	TCGA-UC-A7PF-01A-11D-A351-09	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8			TCGA-UC-A7PF-01A-11D-A351-09	TCGA-UC-A7PF-01A-11D-A351-09	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	TCGA-UC-A7PF-01A-11D-A350-01	TCGA-UC-A7PF-01	TCGA-UC-A7PF-01A-11D-A350-01
TCGA-UC-A7PG-01	TCGA-UC-A7PG-01	TCGA-UC-A7PG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					44	18	6			TCGA-UC-A7PG	TCGA-UC-A7PG-01A			4400		HDR							Cisplatin	Stage IIIB		-16231					3610	370	-54			0				-10				|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0						2014-7-17	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma		9	Pelvic (external iliac, internal iliac, obturator)|Common iliac		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	8	0	3	52	true			No	MX	N1	T3b	TCGA-UC-A7PG.AB821E7F-7CED-4191-A82D-B411A7C1AA45.pdf	Cervical Cancer			A7PG	0	2	Preoperative	WITH TUMOR	YES	0	YES	Progressive Disease	YES			external beam and bilateral parametrial boost		Other	5400	Primary Tumor	01			1995	YES	NO	YES	UC	2	5		Cervical	A	DECEASED	82	2003	13b94e1c-6bd0-420f-bf57-c14c91e8f28e	TCGA-UC-A7PG-01	13b94e1c-6bd0-420f-bf57-c14c91e8f28e	TCGA-UC-A7PG-01	TCGA-UC-A7PG-01		TCGA-UC-A7PG-01A-11D-A42P-05		13b94e1c-6bd0-420f-bf57-c14c91e8f28e					13b94e1c-6bd0-420f-bf57-c14c91e8f28e	TCGA-UC-A7PG-01A-11D-A42N-01	TCGA-UC-A7PG-01	TCGA-UC-A7PG-01A-11D-A42N-01
TCGA-UC-A7PG-06	TCGA-UC-A7PG-06	TCGA-UC-A7PG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					44	18	6			TCGA-UC-A7PG	TCGA-UC-A7PG-06A			4400		HDR							Cisplatin	Stage IIIB		-16231					3610	370	-54			0				-10				|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0						2014-7-17	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma		9	Pelvic (external iliac, internal iliac, obturator)|Common iliac		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	8	0	3	52	true			No	MX	N1	T3b	TCGA-UC-A7PG.3B9B2CF0-2BFB-45D2-BAB8-7DC83277ACCE.pdf	Cervical Cancer			A7PG	0	2	Preoperative	WITH TUMOR	YES	0	YES	Progressive Disease	YES			external beam and bilateral parametrial boost		Other	5400	Metastatic	06			1995	YES	NO	YES	UC	2	5		Cervical	A	DECEASED	82	2003	22727b4c-d2ab-4ebf-a681-d2dd20eb4f43	TCGA-UC-A7PG-06	22727b4c-d2ab-4ebf-a681-d2dd20eb4f43	TCGA-UC-A7PG-06			TCGA-UC-A7PG-06A-11D-A42P-05		22727b4c-d2ab-4ebf-a681-d2dd20eb4f43					22727b4c-d2ab-4ebf-a681-d2dd20eb4f43			
TCGA-UC-A7PI-01	TCGA-UC-A7PI-01	TCGA-UC-A7PI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	YES	Complete Response		44				TCGA-UC-A7PI-F72053	TCGA-UC-A7PI	TCGA-UC-A7PI-01A	Former User					ABSENT							Stage IB1		-16427					1647		25			0	2114	799	778	2114				|Extra-Pelvic Metastatic Disease AbsentParaaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0						2015-4-6	FEMALE		Endometrioid Adenocarcinoma of Endocervix	No						Radical Hysterectomy	C53.0	8380/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	30	NO		NO	47			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1	Other, specify			Locoregional Recurrence		YES	YES	0		0		true			No	MX	N0	T1b1	TCGA-UC-A7PI.9FA775F9-4A52-498E-93B3-BAEE344324CC.pdf				A7PI	0	1	Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	NO				R0			Primary Tumor	01			2009		NO	YES	UC	1	1		Cervical	A	LIVING	64	2009	110bcd0d-95b5-4387-bfa3-837fbde32085	TCGA-UC-A7PI-01	110bcd0d-95b5-4387-bfa3-837fbde32085	TCGA-UC-A7PI-01	TCGA-UC-A7PI-01		TCGA-UC-A7PI-01A-11D-A42P-05		110bcd0d-95b5-4387-bfa3-837fbde32085					110bcd0d-95b5-4387-bfa3-837fbde32085	TCGA-UC-A7PI-01A-11D-A42N-01	TCGA-UC-A7PI-01	TCGA-UC-A7PI-01A-11D-A42N-01
TCGA-VS-A8EB-01	TCGA-VS-A8EB-01	TCGA-VS-A8EB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					41		4			TCGA-VS-A8EB	TCGA-VS-A8EB-01A	Never Used											Cisplatin	Stage IIIB		-15215					1189	305				0				28						Once weekly	1							2014-4-22	FEMALE	153	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			3		false			No	M1	NX	T3b	TCGA-VS-A8EB.ED146C1D-315F-4628-A529-62D235938DFF.pdf	Cervical Cancer			A8EB	1		Pre-Adjuvant Therapy	WITH TUMOR	NO			Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	2	4		Cervical	A	DECEASED	64	2010	69e3b16b-5515-416b-808a-0321a107e5c0	TCGA-VS-A8EB-01	69e3b16b-5515-416b-808a-0321a107e5c0	TCGA-VS-A8EB-01	TCGA-VS-A8EB-01		TCGA-VS-A8EB-01A-11D-A36K-05		69e3b16b-5515-416b-808a-0321a107e5c0					69e3b16b-5515-416b-808a-0321a107e5c0	TCGA-VS-A8EB-01A-11D-A36I-01	TCGA-VS-A8EB-01	TCGA-VS-A8EB-01A-11D-A36I-01
TCGA-VS-A8EC-01	TCGA-VS-A8EC-01	TCGA-VS-A8EC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		55				TCGA-VS-A8EC-F70920	TCGA-VS-A8EC		Former User												Stage IIIB		-20286										0	1415			46							1							2015-3-10	FEMALE	154	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Peri (6-12 months since last menstrual period)	G2							NO			3					No	M0	NX	T3b					A8EC	1			TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS		4		Cervical		LIVING	46	2011	f00b3401-8432-4748-8d19-267e945cd3c0	TCGA-VS-A8EC-01	f00b3401-8432-4748-8d19-267e945cd3c0	TCGA-VS-A8EC-01	TCGA-VS-A8EC-01		TCGA-VS-A8EC-01A-11D-A36K-05		f00b3401-8432-4748-8d19-267e945cd3c0					f00b3401-8432-4748-8d19-267e945cd3c0	TCGA-VS-A8EC-01A-11D-A36I-01	TCGA-VS-A8EC-01	TCGA-VS-A8EC-01A-11D-A36I-01
TCGA-VS-A8EG-01	TCGA-VS-A8EG-01	TCGA-VS-A8EG	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		36				TCGA-VS-A8EG-F72387	TCGA-VS-A8EG		Current User		2800		HDR								Stage IB1		-13166										0	1386			76							0							2015-7-23	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Peri (6-12 months since last menstrual period)	GX							NO			4					No	M0	NX	T1b1					A8EG	1		Pre-Adjuvant Therapy	TUMOR FREE	NO			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	1	5		Cervical		LIVING	66	2011	aa91c19b-008d-497a-8121-a06cf9dc7b29	TCGA-VS-A8EG-01	aa91c19b-008d-497a-8121-a06cf9dc7b29	TCGA-VS-A8EG-01	TCGA-VS-A8EG-01		TCGA-VS-A8EG-01A-11D-A36K-05		aa91c19b-008d-497a-8121-a06cf9dc7b29					aa91c19b-008d-497a-8121-a06cf9dc7b29	TCGA-VS-A8EG-01A-11D-A36I-01	TCGA-VS-A8EG-01	TCGA-VS-A8EG-01A-11D-A36I-01
TCGA-VS-A8EH-01	TCGA-VS-A8EH-01	TCGA-VS-A8EH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		56	39	4		TCGA-VS-A8EH-F70875	TCGA-VS-A8EH	TCGA-VS-A8EH-01A	Never Used		2400		HDR						Adverse event/ complications	Cisplatin	Stage IIIB		-20728					507					0	986			41						Once weekly	2							2015-3-10	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Peri (6-12 months since last menstrual period)	G2							NO			4	3	false			No	M0	NX	T3b	TCGA-VS-A8EH.0CC29204-715D-465B-8F93-7DE27B85FD5F.pdf				A8EH			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	2	4		Cervical	A	LIVING	44	2012	9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	TCGA-VS-A8EH-01	9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	TCGA-VS-A8EH-01	TCGA-VS-A8EH-01		TCGA-VS-A8EH-01A-11D-A36K-05		9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a					9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	TCGA-VS-A8EH-01A-11D-A36I-01	TCGA-VS-A8EH-01	TCGA-VS-A8EH-01A-11D-A36I-01
TCGA-VS-A8EI-01	TCGA-VS-A8EI-01	TCGA-VS-A8EI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		38		6		TCGA-VS-A8EI-F70922	TCGA-VS-A8EI		Never Used		2800		HDR							Cisplatin	Stage IIB		-14129										0	729			-1						Once weekly	1							2015-3-10	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			4					No	M0	NX	T3b					A8EI			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	4		Cervical		LIVING	58	2012	a32d716b-4fc9-4451-9106-b4c7cda9bfc1	TCGA-VS-A8EI-01	a32d716b-4fc9-4451-9106-b4c7cda9bfc1	TCGA-VS-A8EI-01	TCGA-VS-A8EI-01		TCGA-VS-A8EI-01A-11D-A37Q-05		a32d716b-4fc9-4451-9106-b4c7cda9bfc1					a32d716b-4fc9-4451-9106-b4c7cda9bfc1	TCGA-VS-A8EI-01A-11D-A37M-01	TCGA-VS-A8EI-01	TCGA-VS-A8EI-01A-11D-A37M-01
TCGA-VS-A8EJ-01	TCGA-VS-A8EJ-01	TCGA-VS-A8EJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					60		4			TCGA-VS-A8EJ				2700		HDR							Cisplatin	Stage IIB		-22000						607				0				0						Once weekly	0							2014-4-22	FEMALE	167	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			3					No	M1	NX	T2b		Cervical Cancer			A8EJ			Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	3		Cervical		DECEASED	113	2008	fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	TCGA-VS-A8EJ-01	fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	TCGA-VS-A8EJ-01	TCGA-VS-A8EJ-01		TCGA-VS-A8EJ-01A-11D-A37Q-05		fc6c05b9-e904-4c4e-b26a-65b4ac455cf1					fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	TCGA-VS-A8EJ-01A-11D-A37M-01	TCGA-VS-A8EJ-01	TCGA-VS-A8EJ-01A-11D-A37M-01
TCGA-VS-A8EK-01	TCGA-VS-A8EK-01	TCGA-VS-A8EK	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					65		7			TCGA-VS-A8EK	TCGA-VS-A8EK-01A												Cisplatin	Stage IVA		-23817					1784	829				0				58						Once weekly	0							2014-4-22	FEMALE	153	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO								G2							NO			5		false			No	M0	NX	T4	TCGA-VS-A8EK.C5B99AC6-E318-4608-8E70-96176F97EF90.pdf	Cervical Cancer			A8EK	1		Pre-Adjuvant Therapy	WITH TUMOR	YES			Partial Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS		6		Cervical	A	DECEASED	50	2008	8d5e2fac-878b-440c-a19b-09c972b840ac	TCGA-VS-A8EK-01	8d5e2fac-878b-440c-a19b-09c972b840ac	TCGA-VS-A8EK-01	TCGA-VS-A8EK-01	18D2E64E-B473-4594-BECE-25C028266FA4	TCGA-VS-A8EK-01A-12D-A37Q-05		8d5e2fac-878b-440c-a19b-09c972b840ac					8d5e2fac-878b-440c-a19b-09c972b840ac			
TCGA-VS-A8EL-01	TCGA-VS-A8EL-01	TCGA-VS-A8EL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		38		5		TCGA-VS-A8EL-F71214	TCGA-VS-A8EL	TCGA-VS-A8EL-01A	Former User		2800		HDR							Cisplatin	Stage IIB		-14162					1589					0	1992			-9						Once weekly	1							2015-3-23	FEMALE	166	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			3		false			No	M0	NX	T2b	TCGA-VS-A8EL.14765542-0003-41A9-8863-BDC90E87594D.pdf				A8EL			Preoperative	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	3		Cervical	A	LIVING	78	2009	79a31785-793f-4878-8c09-64c8fb0c53e3	TCGA-VS-A8EL-01	79a31785-793f-4878-8c09-64c8fb0c53e3	TCGA-VS-A8EL-01	TCGA-VS-A8EL-01		TCGA-VS-A8EL-01A-11D-A37Q-05		79a31785-793f-4878-8c09-64c8fb0c53e3					79a31785-793f-4878-8c09-64c8fb0c53e3	TCGA-VS-A8EL-01A-11D-A37M-01	TCGA-VS-A8EL-01	TCGA-VS-A8EL-01A-11D-A37M-01
TCGA-VS-A8Q8-01	TCGA-VS-A8Q8-01	TCGA-VS-A8Q8	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					26					TCGA-VS-A8Q8	TCGA-VS-A8Q8-01A	Former User												Stage IB		-9571					1348	978				0				-84							0							2014-3-31	FEMALE	166	Cervical Squamous Cell Carcinoma	No					Radical trachelectomy and pelvic lymphadenectomy	Other	C53.9	8070/3	C53.9	YES	Surgery	Other method, specify:	60	NO			11			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES	0				false			No	MX	N0	T1b	TCGA-VS-A8Q8.DF0B7CA7-20B3-45CE-A25D-D4F622AF9C9B.pdf	Cervical Cancer			A8Q8			Preoperative	WITH TUMOR	NO		YES	Progressive Disease	YES					3D conformal		Primary Tumor	01			2009	NO	NO	YES	VS	1	0		Cervical	A	DECEASED	92	2010	4601c9ab-da58-46f4-a875-5ef03727b756	TCGA-VS-A8Q8-01	4601c9ab-da58-46f4-a875-5ef03727b756	TCGA-VS-A8Q8-01	TCGA-VS-A8Q8-01		TCGA-VS-A8Q8-01A-11D-A37Q-05		4601c9ab-da58-46f4-a875-5ef03727b756					4601c9ab-da58-46f4-a875-5ef03727b756	TCGA-VS-A8Q8-01A-11D-A37M-01	TCGA-VS-A8Q8-01	TCGA-VS-A8Q8-01A-11D-A37M-01
TCGA-VS-A8Q9-01	TCGA-VS-A8Q9-01	TCGA-VS-A8Q9	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		79				TCGA-VS-A8Q9-F68140	TCGA-VS-A8Q9				2700		HDR								Stage IB1		-28881										0	1630			90							1							2014-11-13	FEMALE	150	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			8					No	MX	NX	TX					A8Q9	4		Pre-Adjuvant Therapy	TUMOR FREE	NO			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	1	12		Cervical		LIVING	49	2010	c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	TCGA-VS-A8Q9-01	c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	TCGA-VS-A8Q9-01	TCGA-VS-A8Q9-01		TCGA-VS-A8Q9-01A-12D-A37Q-05		c43ed784-3bfe-4485-8dd9-cee08f8c0fa8					c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	TCGA-VS-A8Q9-01A-12D-A37M-01	TCGA-VS-A8Q9-01	TCGA-VS-A8Q9-01A-12D-A37M-01
TCGA-VS-A8QA-01	TCGA-VS-A8QA-01	TCGA-VS-A8QA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		44				TCGA-VS-A8QA-F67672	TCGA-VS-A8QA										Positive vaginal margin				Stage IB1		-16072										0	1099			0							0							2014-11-9	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	26				Peri (6-12 months since last menstrual period)	GX							NO	0	0	2					No	MX	N0	T1b1					A8QA			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	1	2		Cervical		LIVING	67	2011	ca559bd7-454b-463c-9751-1f772f738599	TCGA-VS-A8QA-01	ca559bd7-454b-463c-9751-1f772f738599	TCGA-VS-A8QA-01	TCGA-VS-A8QA-01		TCGA-VS-A8QA-01A-11D-A37Q-05		ca559bd7-454b-463c-9751-1f772f738599					ca559bd7-454b-463c-9751-1f772f738599	TCGA-VS-A8QA-01A-11D-A37M-01	TCGA-VS-A8QA-01	TCGA-VS-A8QA-01A-11D-A37M-01
TCGA-VS-A8QC-01	TCGA-VS-A8QC-01	TCGA-VS-A8QC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					51		5			TCGA-VS-A8QC													Cisplatin	Stage IVA		-18743						350				0				-1						Once weekly	2							2014-3-30	FEMALE	152	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Peri (6-12 months since last menstrual period)	G2							YES			7					No	MX	NX	TX		Cervical Cancer			A8QC			Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	2	7		Cervical		DECEASED	90	2009	cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	TCGA-VS-A8QC-01	cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	TCGA-VS-A8QC-01	TCGA-VS-A8QC-01		TCGA-VS-A8QC-01A-11D-A37Q-05		cad09fcd-1d43-4fb4-8d65-6f52c9a17d86					cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	TCGA-VS-A8QC-01A-11D-A37M-01	TCGA-VS-A8QC-01	TCGA-VS-A8QC-01A-11D-A37M-01
TCGA-VS-A8QF-01	TCGA-VS-A8QF-01	TCGA-VS-A8QF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		42	12	4		TCGA-VS-A8QF-F70917	TCGA-VS-A8QF	TCGA-VS-A8QF-01A			2800		HDR						Adverse event/ complications	Cisplatin	Stage IIB		-15374					1399					0	1800			92						Once weekly	0							2015-3-10	FEMALE	159	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			5		false			No	MX	NX	TX	TCGA-VS-A8QF.9E014162-B8BD-4DDD-9E8C-A1D18A6A8A7A.pdf				A8QF			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01		2010	2009	YES	NO	YES	VS	4	5		Cervical	A	LIVING	68	2010	151ea5c1-80f3-473f-af58-f43df84879f2	TCGA-VS-A8QF-01	151ea5c1-80f3-473f-af58-f43df84879f2	TCGA-VS-A8QF-01	TCGA-VS-A8QF-01	AFE9BCB4-EE5E-426D-87FF-0F823DDF7351	TCGA-VS-A8QF-01A-21D-A37Q-05		151ea5c1-80f3-473f-af58-f43df84879f2					151ea5c1-80f3-473f-af58-f43df84879f2	TCGA-VS-A8QF-01A-21D-A37M-01	TCGA-VS-A8QF-01	TCGA-VS-A8QF-01A-21D-A37M-01
TCGA-VS-A8QH-01	TCGA-VS-A8QH-01	TCGA-VS-A8QH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					76		3|3			TCGA-VS-A8QH						HDR						Adverse event/ complications	Other|Other	Stage IB1		-27909						1210				0				-1						Once weekly|Once weekly	0							2014-3-30	FEMALE	159	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			3				Cisplatin|Gemcitabine	No	MX	NX	TX		Cervical Cancer			A8QH	1		Pre-Adjuvant Therapy	WITH TUMOR	YES			Partial Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	4		Cervical		DECEASED	73	2010	b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	TCGA-VS-A8QH-01	b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	TCGA-VS-A8QH-01	TCGA-VS-A8QH-01		TCGA-VS-A8QH-01A-11D-A37Q-05		b21b7604-5292-4f80-b0d9-8a99b9c0c1a6					b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	TCGA-VS-A8QH-01A-11D-A37M-01	TCGA-VS-A8QH-01	TCGA-VS-A8QH-01A-11D-A37M-01
TCGA-VS-A8QM-01	TCGA-VS-A8QM-01	TCGA-VS-A8QM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					47	15	3|3			TCGA-VS-A8QM												Adverse event/ complications	Cisplatin|Other	Stage IVB		-17168						951				0				-334						Once weekly|Once weekly	0							2014-4-1	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)										GX							NO			3	16			|Fluorouracil	No	M1	NX	TX		Cervical Cancer			A8QM	1		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	2	4		Cervical		DECEASED	53	2009	babc730d-6170-4503-8502-d794575fe993	TCGA-VS-A8QM-01	babc730d-6170-4503-8502-d794575fe993	TCGA-VS-A8QM-01	TCGA-VS-A8QM-01		TCGA-VS-A8QM-01A-11D-A37Q-05		babc730d-6170-4503-8502-d794575fe993					babc730d-6170-4503-8502-d794575fe993	TCGA-VS-A8QM-01A-11D-A37M-01	TCGA-VS-A8QM-01	TCGA-VS-A8QM-01A-11D-A37M-01
TCGA-VS-A94W-01	TCGA-VS-A94W-01	TCGA-VS-A94W	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		39		5		TCGA-VS-A94W-F70923	TCGA-VS-A94W		Never Used		2800		HDR						Adverse event/ complications	Cisplatin	Stage IIB		-14399										0	1243			0						Once weekly	0							2015-3-10	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	47	Pelvic (external iliac, internal iliac, obturator)			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1		2					No	MX	N1	T2b					A94W			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	2		Cervical		LIVING	79	2011	f99240d0-32ea-438a-b350-862202b18a30	TCGA-VS-A94W-01	f99240d0-32ea-438a-b350-862202b18a30	TCGA-VS-A94W-01	TCGA-VS-A94W-01		TCGA-VS-A94W-01A-12D-A37Q-05		f99240d0-32ea-438a-b350-862202b18a30					f99240d0-32ea-438a-b350-862202b18a30	TCGA-VS-A94W-01A-12D-A37M-01	TCGA-VS-A94W-01	TCGA-VS-A94W-01A-12D-A37M-01
TCGA-VS-A94X-01	TCGA-VS-A94X-01	TCGA-VS-A94X	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					40		5			TCGA-VS-A94X	TCGA-VS-A94X-01A			2800		HDR							Cisplatin	Stage IIB		-14955					1281	506				0				0						Once weekly	0							2014-5-21	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO								G2							NO			3		false			No	MX	NX	T2b	TCGA-VS-A94X.434AA106-443D-4A8E-93AD-14DFFD8A2B76.pdf	Cervical Cancer			A94X			Pre-Adjuvant Therapy	WITH TUMOR	YES		NO	Partial Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	3		Cervical	A	DECEASED	42	2010	7626194c-9fc3-4b7f-a759-2834583f3890	TCGA-VS-A94X-01	7626194c-9fc3-4b7f-a759-2834583f3890	TCGA-VS-A94X-01	TCGA-VS-A94X-01	94F1E446-754F-4DBB-A416-2551278C763F	TCGA-VS-A94X-01A-11D-A388-05		7626194c-9fc3-4b7f-a759-2834583f3890					7626194c-9fc3-4b7f-a759-2834583f3890	TCGA-VS-A94X-01A-11D-A386-01	TCGA-VS-A94X-01	TCGA-VS-A94X-01A-11D-A386-01
TCGA-VS-A94Y-01	TCGA-VS-A94Y-01	TCGA-VS-A94Y	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					47	44				TCGA-VS-A94Y		Current User										Adverse event/ complications		Stage IIB		-17465						144				0				1							1							2014-5-27	FEMALE	154	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			1	1				No	MX	NX	T2b		Cervical Cancer			A94Y			Pre-Adjuvant Therapy	WITH TUMOR	YES		NO	Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	2	1		Cervical		DECEASED	44	2010	b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	TCGA-VS-A94Y-01	b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	TCGA-VS-A94Y-01	TCGA-VS-A94Y-01		TCGA-VS-A94Y-01A-11D-A388-05		b52d5d7a-3104-4d2a-a36b-aa9ac75e341d					b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	TCGA-VS-A94Y-01A-11D-A386-01	TCGA-VS-A94Y-01	TCGA-VS-A94Y-01A-11D-A386-01
TCGA-VS-A94Z-01	TCGA-VS-A94Z-01	TCGA-VS-A94Z	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		38	27	5		TCGA-VS-A94Z-F71215	TCGA-VS-A94Z		Never Used		2800		HDR							Cisplatin	Stage IIB		-14046										0	1015			39						Once weekly	1							2015-3-23	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			3	2				No	MX	NX	T2b					A94Z	1		Pre-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01		2010	2009	YES	NO	YES	VS	4	4		Cervical		LIVING	96	2012	c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	TCGA-VS-A94Z-01	c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	TCGA-VS-A94Z-01	TCGA-VS-A94Z-01		TCGA-VS-A94Z-01A-11D-A388-05		c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4					c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	TCGA-VS-A94Z-01A-11D-A386-01	TCGA-VS-A94Z-01	TCGA-VS-A94Z-01A-11D-A386-01
TCGA-VS-A950-01	TCGA-VS-A950-01	TCGA-VS-A950	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Partial Response		42				TCGA-VS-A950-F72073	TCGA-VS-A950	TCGA-VS-A950-01A	Never Used		2600		HDR								Stage IIIA		-15365					874					0	1221			0							0							2015-4-9	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			3		false			No	MX	NX	T3a	TCGA-VS-A950.F095B0C9-4855-495D-89C9-B303D7756BFB.pdf				A950			Pre-Adjuvant Therapy	WITH TUMOR	NO			Partial Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	NO	NO	YES	VS	1	3		Cervical	A	LIVING	57	2011	1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	TCGA-VS-A950-01	1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	TCGA-VS-A950-01	TCGA-VS-A950-01		TCGA-VS-A950-01A-11D-A42P-05		1560b26a-bc8d-4bdd-b317-f04b66c2ce5b					1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	TCGA-VS-A950-01A-11D-A42N-01	TCGA-VS-A950-01	TCGA-VS-A950-01A-11D-A42N-01
TCGA-VS-A952-01	TCGA-VS-A952-01	TCGA-VS-A952	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		66				TCGA-VS-A952-F72388	TCGA-VS-A952	TCGA-VS-A952-01A	Never Used												Stage IB1		-24345					1288					0	1778			0							0							2015-6-11	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO	15			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	3		false			No	MX	N0	T1b	TCGA-VS-A952.B7893751-3A8F-4FD8-996F-D8C93C108336.pdf				A952			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	NO							Primary Tumor	01			2009		NO	YES	VS	1	3		Cervical	A	LIVING	65	2010	01a6c838-ea9c-488c-8dcb-8bac73253a33	TCGA-VS-A952-01	01a6c838-ea9c-488c-8dcb-8bac73253a33	TCGA-VS-A952-01	TCGA-VS-A952-01		TCGA-VS-A952-01A-11D-A388-05		01a6c838-ea9c-488c-8dcb-8bac73253a33					01a6c838-ea9c-488c-8dcb-8bac73253a33	TCGA-VS-A952-01A-11D-A386-01	TCGA-VS-A952-01	TCGA-VS-A952-01A-11D-A386-01
TCGA-VS-A953-01	TCGA-VS-A953-01	TCGA-VS-A953	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					63					TCGA-VS-A953	TCGA-VS-A953-01A	Never Used										Adverse event/ complications		Stage IVA		-23277					1274	477				0				0							0							2014-10-17	FEMALE	155	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO			11		false			No	MX	NX	T4	TCGA-VS-A953.C5CCCB76-671A-4498-BA9F-A5D5AF6DD215.pdf	Cervical Cancer			A953			Pre-Adjuvant Therapy	WITH TUMOR	YES			Partial Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	NO	NO	YES	VS	1	11		Cervical	A	DECEASED	47	2010	1893be96-6727-4bfa-aa28-2a2df326c464	TCGA-VS-A953-01	1893be96-6727-4bfa-aa28-2a2df326c464	TCGA-VS-A953-01	TCGA-VS-A953-01		TCGA-VS-A953-01A-11D-A388-05		1893be96-6727-4bfa-aa28-2a2df326c464					1893be96-6727-4bfa-aa28-2a2df326c464	TCGA-VS-A953-01A-11D-A386-01	TCGA-VS-A953-01	TCGA-VS-A953-01A-11D-A386-01
TCGA-VS-A954-01	TCGA-VS-A954-01	TCGA-VS-A954	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		67		5		TCGA-VS-A954-F71212	TCGA-VS-A954	TCGA-VS-A954-01A	Never Used		2700		HDR							Cisplatin	Stage IIIB		-24498					1259					0	1714			92						Once weekly	1							2015-3-23	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			10		false			No	MX	NX	T3b	TCGA-VS-A954.5A62ACAB-9170-49CB-AA5A-82E90CA3A200.pdf				A954			Pre-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	10		Cervical	A	LIVING	58	2010	01ab5f23-487f-4a57-97b3-6a110a789124	TCGA-VS-A954-01	01ab5f23-487f-4a57-97b3-6a110a789124	TCGA-VS-A954-01	TCGA-VS-A954-01		TCGA-VS-A954-01A-11D-A388-05		01ab5f23-487f-4a57-97b3-6a110a789124					01ab5f23-487f-4a57-97b3-6a110a789124	TCGA-VS-A954-01A-11D-A386-01	TCGA-VS-A954-01	TCGA-VS-A954-01A-11D-A386-01
TCGA-VS-A957-01	TCGA-VS-A957-01	TCGA-VS-A957	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		64		4		TCGA-VS-A957-F72066	TCGA-VS-A957	TCGA-VS-A957-01A	Never Used										Adverse event/ complications	Cisplatin	Stage IB1		-23585					1210					0	1688			118						Once weekly	0							2015-4-9	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			4		false			No	MX	NX	T1b1	TCGA-VS-A957.A1599777-E100-4429-8872-764AE82C9258.pdf				A957			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	4		Cervical	A	LIVING	91	2010	78879d70-1eb8-4677-869c-a4c51e537062	TCGA-VS-A957-01	78879d70-1eb8-4677-869c-a4c51e537062	TCGA-VS-A957-01	TCGA-VS-A957-01		TCGA-VS-A957-01A-11D-A42P-05		78879d70-1eb8-4677-869c-a4c51e537062					78879d70-1eb8-4677-869c-a4c51e537062	TCGA-VS-A957-01A-11D-A42N-01	TCGA-VS-A957-01	TCGA-VS-A957-01A-11D-A42N-01
TCGA-VS-A958-01	TCGA-VS-A958-01	TCGA-VS-A958	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		46		4		TCGA-VS-A958-F68144	TCGA-VS-A958	TCGA-VS-A958-01A	Never Used		2800		HDR						Adverse event/ complications	Cisplatin	Stage IIB		-16905					1189					0	1525			0						Once weekly	1							2014-11-13	FEMALE	151	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			4		false			No	MX	NX	T2b	TCGA-VS-A958.643CD93E-47D0-4D40-96C8-DDF836EEF501.pdf				A958			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	4		Cervical	A	LIVING	61	2010	5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	TCGA-VS-A958-01	5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	TCGA-VS-A958-01	TCGA-VS-A958-01		TCGA-VS-A958-01A-11D-A42P-05		5fd1a695-76a4-4ccb-8623-6b1e65e7de3a					5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	TCGA-VS-A958-01A-11D-A42N-01	TCGA-VS-A958-01	TCGA-VS-A958-01A-11D-A42N-01
TCGA-VS-A959-01	TCGA-VS-A959-01	TCGA-VS-A959	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		76				TCGA-VS-A959-F70914	TCGA-VS-A959	TCGA-VS-A959-01A	Never Used		2700		HDR								Stage IIB		-27897					1181					0	1561																	2015-3-10	FEMALE	145	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			11		false			No	MX	NX	T2b	TCGA-VS-A959.10A6CADD-C99B-4A34-9D5D-02AD37C1AB80.pdf				A959				TUMOR FREE	NO			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009		NO	YES	VS	1	11		Cervical	A	LIVING	47	2010	33be2852-1252-432d-9f4e-2d0749f2563a	TCGA-VS-A959-01	33be2852-1252-432d-9f4e-2d0749f2563a	TCGA-VS-A959-01	TCGA-VS-A959-01		TCGA-VS-A959-01A-11D-A42P-05		33be2852-1252-432d-9f4e-2d0749f2563a					33be2852-1252-432d-9f4e-2d0749f2563a	TCGA-VS-A959-01A-11D-A42N-01	TCGA-VS-A959-01	TCGA-VS-A959-01A-11D-A42N-01
TCGA-VS-A9U5-01	TCGA-VS-A9U5-01	TCGA-VS-A9U5	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		57		5		TCGA-VS-A9U5-F70880	TCGA-VS-A9U5	TCGA-VS-A9U5-01A	Never Used		2800		HDR							Cisplatin	Stage IIB		-21149					1114					0	1535			-3						Once weekly	0							2015-3-10	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	300	NO		NO					Peri (6-12 months since last menstrual period)	G3							NO			3		false			No	MX	NX	T2b	TCGA-VS-A9U5.4DCCBB92-3E31-4B62-8F8E-00264488ADD0.pdf				A9U5			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	3		Cervical	A	LIVING	74	2010	e5241411-aec5-4822-8522-8e74c51a0d79	TCGA-VS-A9U5-01	e5241411-aec5-4822-8522-8e74c51a0d79	TCGA-VS-A9U5-01	TCGA-VS-A9U5-01	FF774297-756E-40BC-910D-6702417510C2	TCGA-VS-A9U5-01A-11D-A42P-05		e5241411-aec5-4822-8522-8e74c51a0d79					e5241411-aec5-4822-8522-8e74c51a0d79	TCGA-VS-A9U5-01A-11D-A42N-01	TCGA-VS-A9U5-01	TCGA-VS-A9U5-01A-11D-A42N-01
TCGA-VS-A9U6-01	TCGA-VS-A9U6-01	TCGA-VS-A9U6	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease		52		4		TCGA-VS-A9U6-F68123	TCGA-VS-A9U6		Never Used		2600		HDR							Cisplatin	Stage IVB		-19109										0	1320		1311	0						Once weekly	1							2014-11-13	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX	Other, specify			Distant Metastasis	Ovary	NO	YES			1					No	M1	NX	T4					A9U6	1		Preoperative	WITH TUMOR	YES			Stable Disease	YES					3D conformal	5400	Primary Tumor	01			2009		NO	YES	VS	1	2		Cervical		LIVING	66	2011		TCGA-VS-A9U6-01		TCGA-VS-A9U6-01	TCGA-VS-A9U6-01		TCGA-VS-A9U6-01A-11D-A42P-05								TCGA-VS-A9U6-01A-11D-A42N-01	TCGA-VS-A9U6-01	TCGA-VS-A9U6-01A-11D-A42N-01
TCGA-VS-A9U7-01	TCGA-VS-A9U7-01	TCGA-VS-A9U7	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		30		5		TCGA-VS-A9U7-F70919	TCGA-VS-A9U7	TCGA-VS-A9U7-01A	Current User		2800		HDR							Cisplatin	Stage IB1		-11210					1029					0	1472			0						Once weekly	0							2015-3-10	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO	18	Pelvic (external iliac, internal iliac, obturator)			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	3	0	1		false			No	M0	N1	T1b	TCGA-VS-A9U7.3FB4D6F8-6625-49A7-AA2C-533FB9EC9310.pdf				A9U7	2		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	3		Cervical	A	LIVING	82	2011	78f72cda-30eb-41f6-8713-795ced251abb	TCGA-VS-A9U7-01	78f72cda-30eb-41f6-8713-795ced251abb	TCGA-VS-A9U7-01	TCGA-VS-A9U7-01		TCGA-VS-A9U7-01A-11D-A42P-05		78f72cda-30eb-41f6-8713-795ced251abb					78f72cda-30eb-41f6-8713-795ced251abb	TCGA-VS-A9U7-01A-11D-A42N-01	TCGA-VS-A9U7-01	TCGA-VS-A9U7-01A-11D-A42N-01
TCGA-VS-A9UA-01	TCGA-VS-A9UA-01	TCGA-VS-A9UA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		60		4		TCGA-VS-A9UA-F70278	TCGA-VS-A9UA		Never Used		2400		HDR							Cisplatin	Stage IIIA		-22221										0	867			0						Once weekly	2							2015-2-3	FEMALE	134	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2					No	MX	NX	T3					A9UA			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	2		Cervical		LIVING	88	2012		TCGA-VS-A9UA-01		TCGA-VS-A9UA-01			TCGA-VS-A9UA-01A-11D-A42P-05								TCGA-VS-A9UA-01A-11D-A42N-01		TCGA-VS-A9UA-01A-11D-A42N-01
TCGA-VS-A9UB-01	TCGA-VS-A9UB-01	TCGA-VS-A9UB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		54		6		TCGA-VS-A9UB-F72389	TCGA-VS-A9UB	TCGA-VS-A9UB-01A	Never Used		2800		HDR							Cisplatin	Stage IIB		-19737					435					0	911			0						Once weekly	1							2015-6-11	FEMALE	166	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO	51				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		11		false			No	MX	N0	T2b	TCGA-VS-A9UB.73D61A64-9435-4E72-898C-3A4E7C109CF3.pdf				A9UB			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	11		Cervical	A	LIVING	79	2012	389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	TCGA-VS-A9UB-01	389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	TCGA-VS-A9UB-01	TCGA-VS-A9UB-01	F54758E3-15BA-49F2-8F6A-B68B540D499C	TCGA-VS-A9UB-01A-22D-A42P-05		389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a					389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	TCGA-VS-A9UB-01A-22D-A42N-01	TCGA-VS-A9UB-01	TCGA-VS-A9UB-01A-22D-A42N-01
TCGA-VS-A9UC-01	TCGA-VS-A9UC-01	TCGA-VS-A9UC	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					32		5		TCGA-VS-A9UC-F72065	TCGA-VS-A9UC		Never Used											Cisplatin	Stage IIB		-11790										0	825			-2						Once weekly	1							2015-4-9	FEMALE	153	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Peri (6-12 months since last menstrual period)	G2							NO			4					No	MX	NX	T2b					A9UC			Pre-Adjuvant Therapy	WITH TUMOR	YES			Stable Disease	YES					3D conformal	3240	Primary Tumor	01			2009	YES	NO	YES	VS	1	4		Cervical		LIVING	76	2012	c9b500aa-3196-4dc2-8580-8696b6c52c4d	TCGA-VS-A9UC-01	c9b500aa-3196-4dc2-8580-8696b6c52c4d	TCGA-VS-A9UC-01	TCGA-VS-A9UC-01		TCGA-VS-A9UC-01A-11D-A42P-05		c9b500aa-3196-4dc2-8580-8696b6c52c4d					c9b500aa-3196-4dc2-8580-8696b6c52c4d	TCGA-VS-A9UC-01A-11D-A42N-01	TCGA-VS-A9UC-01	TCGA-VS-A9UC-01A-11D-A42N-01
TCGA-VS-A9UD-01	TCGA-VS-A9UD-01	TCGA-VS-A9UD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					73		6		TCGA-VS-A9UD-F70279	TCGA-VS-A9UD	TCGA-VS-A9UD-01A	Never Used		2400		HDR							Cisplatin	Stage IIIA		-26815					327					0	739			-1						Once weekly	0							2015-2-3	FEMALE	161	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			9		false			No	MX	NX	T3a	TCGA-VS-A9UD.D0920498-DCB8-454A-A294-204A280D4129.pdf				A9UD	5		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	14		Cervical	A	LIVING	64	2013	c518438f-04e1-4330-b440-4046002d10b8	TCGA-VS-A9UD-01	c518438f-04e1-4330-b440-4046002d10b8	TCGA-VS-A9UD-01	TCGA-VS-A9UD-01	BF375F3D-D2CF-49AB-BD47-43A4062F0781	TCGA-VS-A9UD-01A-11D-A42P-05		c518438f-04e1-4330-b440-4046002d10b8					c518438f-04e1-4330-b440-4046002d10b8	TCGA-VS-A9UD-01A-11D-A42N-01	TCGA-VS-A9UD-01	TCGA-VS-A9UD-01A-11D-A42N-01
TCGA-VS-A9UH-01	TCGA-VS-A9UH-01	TCGA-VS-A9UH	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		53		5	Follow up	TCGA-VS-A9UH-F68149	TCGA-VS-A9UH	TCGA-VS-A9UH-01A	Never Used											Cisplatin	Stage IVA		-19454					1098					0	1427			1216						Once weekly	1							2014-11-13	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO						GX							NO			3		false			No	MX	NX	T4	TCGA-VS-A9UH.0A4B7512-EA49-4210-B588-939F58D602FE.pdf				A9UH			Other	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	3		Cervical	A	LIVING		2010	2410b783-e6c3-4c07-b944-8818d0b0cacb	TCGA-VS-A9UH-01	2410b783-e6c3-4c07-b944-8818d0b0cacb	TCGA-VS-A9UH-01	TCGA-VS-A9UH-01		TCGA-VS-A9UH-01A-11D-A42P-05		2410b783-e6c3-4c07-b944-8818d0b0cacb					2410b783-e6c3-4c07-b944-8818d0b0cacb	TCGA-VS-A9UH-01A-11D-A42N-01	TCGA-VS-A9UH-01	TCGA-VS-A9UH-01A-11D-A42N-01
TCGA-VS-A9UI-01	TCGA-VS-A9UI-01	TCGA-VS-A9UI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		76				TCGA-VS-A9UI-F71210	TCGA-VS-A9UI	TCGA-VS-A9UI-01A	Never Used		2800		HDR								Stage IIB		-27838					1050	1372				0	953			62			Cardiopulmonary arrest				1							2015-3-23	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO			5		false			No	MX	NX	T2b	TCGA-VS-A9UI.0907F0B0-7E43-40EB-881F-2ED5E39DB600.pdf	Other, specify			A9UI			Pre-Adjuvant Therapy	TUMOR FREE	NO			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	NO	NO	YES	VS	1	5		Cervical	A	DECEASED	70	2011	66a29b88-60e4-4fae-90b3-5c32560dd3ba	TCGA-VS-A9UI-01	66a29b88-60e4-4fae-90b3-5c32560dd3ba	TCGA-VS-A9UI-01	TCGA-VS-A9UI-01		TCGA-VS-A9UI-01A-11D-A42P-05		66a29b88-60e4-4fae-90b3-5c32560dd3ba					66a29b88-60e4-4fae-90b3-5c32560dd3ba	TCGA-VS-A9UI-01A-11D-A42N-01	TCGA-VS-A9UI-01	TCGA-VS-A9UI-01A-11D-A42N-01
TCGA-VS-A9UJ-01	TCGA-VS-A9UJ-01	TCGA-VS-A9UJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					55			No treatment performed		TCGA-VS-A9UJ	TCGA-VS-A9UJ-01A	Current User												Stage IIB		-20264					538	52				0				0							1							2014-9-9	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO					false			No	MX	NX	T2b	TCGA-VS-A9UJ.41D3937F-69E0-4C7F-B38D-A5067B2C3C0B.pdf	Cervical Cancer			A9UJ			Other	WITH TUMOR	NO				NO							Primary Tumor	01			2009		NO	YES	VS	1	0		Cervical	A	DECEASED		2012	9817f939-fcd5-4130-986b-95228c78e17d	TCGA-VS-A9UJ-01	9817f939-fcd5-4130-986b-95228c78e17d	TCGA-VS-A9UJ-01	TCGA-VS-A9UJ-01		TCGA-VS-A9UJ-01A-11D-A42P-05		9817f939-fcd5-4130-986b-95228c78e17d					9817f939-fcd5-4130-986b-95228c78e17d	TCGA-VS-A9UJ-01A-11D-A42N-01	TCGA-VS-A9UJ-01	TCGA-VS-A9UJ-01A-11D-A42N-01
TCGA-VS-A9UL-01	TCGA-VS-A9UL-01	TCGA-VS-A9UL	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					79					TCGA-VS-A9UL	TCGA-VS-A9UL-01A	Never Used		2800		HDR								Stage IIIB		-29033					1126	442				0				-1							1							2014-9-5	FEMALE	149	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							YES			5		false			No	MX	NX	T3b	TCGA-VS-A9UL.79869158-C990-45B6-B77B-A6CEC4886E5C.pdf	Cervical Cancer			A9UL			Pre-Adjuvant Therapy	WITH TUMOR	NO			Progressive Disease	YES					3D conformal	5400	Primary Tumor	01			2009		NO	YES	VS	1	5		Cervical	A	DECEASED	56	2010	4749bc16-8e1b-4e8e-b975-f07fd2ae885e	TCGA-VS-A9UL-01	4749bc16-8e1b-4e8e-b975-f07fd2ae885e	TCGA-VS-A9UL-01	TCGA-VS-A9UL-01		TCGA-VS-A9UL-01A-11D-A42P-05		4749bc16-8e1b-4e8e-b975-f07fd2ae885e					4749bc16-8e1b-4e8e-b975-f07fd2ae885e	TCGA-VS-A9UL-01A-11D-A42N-01	TCGA-VS-A9UL-01	TCGA-VS-A9UL-01A-11D-A42N-01
TCGA-VS-A9UM-01	TCGA-VS-A9UM-01	TCGA-VS-A9UM	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					39					TCGA-VS-A9UM		Never Used		2000		HDR							Cisplatin	Stage IVB		-14255						829				0				0						Once weekly	0							2014-9-9	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Peri (6-12 months since last menstrual period)	G2							NO			5					No	MX	NX	T3b					A9UM			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	5		Cervical		DECEASED	75	2011	d8259ddb-5f41-43ea-889c-1e7dba9d32bc	TCGA-VS-A9UM-01	d8259ddb-5f41-43ea-889c-1e7dba9d32bc	TCGA-VS-A9UM-01	TCGA-VS-A9UM-01		TCGA-VS-A9UM-01A-11D-A42P-05		d8259ddb-5f41-43ea-889c-1e7dba9d32bc					d8259ddb-5f41-43ea-889c-1e7dba9d32bc	TCGA-VS-A9UM-01A-11D-A42N-01	TCGA-VS-A9UM-01	TCGA-VS-A9UM-01A-11D-A42N-01
TCGA-VS-A9UO-01	TCGA-VS-A9UO-01	TCGA-VS-A9UO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		43		3		TCGA-VS-A9UO-F70918	TCGA-VS-A9UO		Never Used		2800		HDR							Cisplatin	Stage IIB		-15813										0	1456			0						Once weekly	1							2015-3-10	FEMALE	159	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	45				Peri (6-12 months since last menstrual period)	G2							NO	0		1					No	MX	N0	T2b					A9UO			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	1		Cervical		LIVING	40	2011	b4df19ac-b93c-4de6-b0f6-823bca30b1d7	TCGA-VS-A9UO-01	b4df19ac-b93c-4de6-b0f6-823bca30b1d7	TCGA-VS-A9UO-01	TCGA-VS-A9UO-01		TCGA-VS-A9UO-01A-11D-A42P-05		b4df19ac-b93c-4de6-b0f6-823bca30b1d7					b4df19ac-b93c-4de6-b0f6-823bca30b1d7	TCGA-VS-A9UO-01A-11D-A42N-01	TCGA-VS-A9UO-01	TCGA-VS-A9UO-01A-11D-A42N-01
TCGA-VS-A9UP-01	TCGA-VS-A9UP-01	TCGA-VS-A9UP	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Partial Response		43	34	6		TCGA-VS-A9UP-F72390	TCGA-VS-A9UP		Never Used		2800		HDR							Cisplatin	Stage IIA		-15849										0	1444		1360	54						Once weekly	1							2015-6-11	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Peri (6-12 months since last menstrual period)	G3	Other, specify			Distant Metastasis	Brain	YES	YES			4	1				No	MX	NX	T2a					A9UP			Pre-Adjuvant Therapy	WITH TUMOR	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	2	4		Cervical		LIVING	68	2011	b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	TCGA-VS-A9UP-01	b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	TCGA-VS-A9UP-01	TCGA-VS-A9UP-01		TCGA-VS-A9UP-01A-11D-A42P-05		b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd					b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	TCGA-VS-A9UP-01A-11D-A42N-01	TCGA-VS-A9UP-01	TCGA-VS-A9UP-01A-11D-A42N-01
TCGA-VS-A9UQ-01	TCGA-VS-A9UQ-01	TCGA-VS-A9UQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Complete Response		32				TCGA-VS-A9UQ-F68152	TCGA-VS-A9UQ	TCGA-VS-A9UQ-01A	Current User		2000		HDR								Stage IB		-11853					771					0	1263		988															2015-6-11	FEMALE	160	Mucinous Adenocarcinoma of Endocervical Type	No					Wertheim Meiggs	Other	C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO		NO	22				Peri (6-12 months since last menstrual period)	G2	Other, specify			Distant Metastasis	Paraortic lymph node	NO	NO	0				false			No	MX	N0	T1b	TCGA-VS-A9UQ.AF3A1FB4-1FC6-4CB7-93EF-0E3E2FEE3E8B.pdf				A9UQ	4			TUMOR FREE	NO		YES	Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	1	4		Cervical	A	LIVING	72	2011	57955c20-b0c4-4d4c-aea6-cee9179a4118	TCGA-VS-A9UQ-01	57955c20-b0c4-4d4c-aea6-cee9179a4118	TCGA-VS-A9UQ-01	TCGA-VS-A9UQ-01	D909165F-5AF8-4C45-8925-C8BA473B43F4	TCGA-VS-A9UQ-01A-21D-A42P-05		57955c20-b0c4-4d4c-aea6-cee9179a4118					57955c20-b0c4-4d4c-aea6-cee9179a4118	TCGA-VS-A9UQ-01A-21D-A42N-01	TCGA-VS-A9UQ-01	TCGA-VS-A9UQ-01A-21D-A42N-01
TCGA-VS-A9UR-01	TCGA-VS-A9UR-01	TCGA-VS-A9UR	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	YES	NO	Progressive Disease		53		6		TCGA-VS-A9UR-F72067	TCGA-VS-A9UR		Never Used		2800		HDR							Cisplatin	Stage IIA		-19688										0	793		675	0						Once weekly	1							2015-4-9	FEMALE	161	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO						GX	Other, specify			Distant Metastasis	Retroperitoneal	NO	YES			5					No	MX	NX	T2a					A9UR			Pre-Adjuvant Therapy	WITH TUMOR	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	5		Cervical		LIVING	64	2013	c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	TCGA-VS-A9UR-01	c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	TCGA-VS-A9UR-01	TCGA-VS-A9UR-01		TCGA-VS-A9UR-01A-11D-A42P-05		c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a					c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	TCGA-VS-A9UR-01A-11D-A42N-01	TCGA-VS-A9UR-01	TCGA-VS-A9UR-01A-11D-A42N-01
TCGA-VS-A9UT-01	TCGA-VS-A9UT-01	TCGA-VS-A9UT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		72				TCGA-VS-A9UT-F68155	TCGA-VS-A9UT	TCGA-VS-A9UT-01A	Never Used							Uninvolved margins	Other Location, specify				Stage IB		-26603					210					0	482			-1							1							2014-11-13	FEMALE	144	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO	14	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1		3		false			No	MX	N1	T1b1	TCGA-VS-A9UT.2CBE50B6-D35F-495B-AF90-7536DBA459D0.pdf				A9UT			Pre-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	YES							Primary Tumor	01			2009		NO	YES	VS	1	3		Cervical	A	LIVING	42	2013	541b5a26-2819-4cab-bbc7-e88df4999681	TCGA-VS-A9UT-01	541b5a26-2819-4cab-bbc7-e88df4999681	TCGA-VS-A9UT-01	TCGA-VS-A9UT-01		TCGA-VS-A9UT-01A-11D-A42P-05		541b5a26-2819-4cab-bbc7-e88df4999681					541b5a26-2819-4cab-bbc7-e88df4999681	TCGA-VS-A9UT-01A-11D-A42N-01	TCGA-VS-A9UT-01	TCGA-VS-A9UT-01A-11D-A42N-01
TCGA-VS-A9UU-01	TCGA-VS-A9UU-01	TCGA-VS-A9UU	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		42	23	3		TCGA-VS-A9UU-F67691	TCGA-VS-A9UU		Current User		2800		HDR							Cisplatin	Stage IIB		-15534										0	442			26						Once weekly	0							2014-11-9	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO			7	2				No	MX	NX	T2b			HIV		A9UU			Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	2	7		Cervical		LIVING	67	2013	ab8b70eb-04a6-4c52-8301-fa904fa5870a	TCGA-VS-A9UU-01	ab8b70eb-04a6-4c52-8301-fa904fa5870a	TCGA-VS-A9UU-01	TCGA-VS-A9UU-01		TCGA-VS-A9UU-01A-11D-A42P-05		ab8b70eb-04a6-4c52-8301-fa904fa5870a					ab8b70eb-04a6-4c52-8301-fa904fa5870a	TCGA-VS-A9UU-01A-11D-A42N-01	TCGA-VS-A9UU-01	TCGA-VS-A9UU-01A-11D-A42N-01
TCGA-VS-A9UV-01	TCGA-VS-A9UV-01	TCGA-VS-A9UV	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					74			The patient did not perform treatment		TCGA-VS-A9UV	TCGA-VS-A9UV-01A	Never Used												Stage IVA		-27348					125	104				0				-2							1							2014-8-11	FEMALE	152	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO			5		false			No	MX	NX	T4	TCGA-VS-A9UV.EAF200A1-9A0C-4A51-A241-14173B4F323E.pdf	Cervical Cancer			A9UV			Other	WITH TUMOR	NO				NO							Primary Tumor	01			2009		NO	YES	VS	1	5		Cervical	A	DECEASED	31	2013	2f48ea8f-6e03-4f00-acc5-e9bc491ad673	TCGA-VS-A9UV-01	2f48ea8f-6e03-4f00-acc5-e9bc491ad673	TCGA-VS-A9UV-01	TCGA-VS-A9UV-01		TCGA-VS-A9UV-01A-11D-A42P-05		2f48ea8f-6e03-4f00-acc5-e9bc491ad673					2f48ea8f-6e03-4f00-acc5-e9bc491ad673	TCGA-VS-A9UV-01A-11D-A42N-01	TCGA-VS-A9UV-01	TCGA-VS-A9UV-01A-11D-A42N-01
TCGA-VS-A9UY-01	TCGA-VS-A9UY-01	TCGA-VS-A9UY	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					29		5			TCGA-VS-A9UY				2800		HDR							Cisplatin	Stage IVB		-10707						555				0				0						Once weekly	2							2014-9-5	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma							G2							YES								No	MX	NX	T1b2		Cervical Cancer			A9UY			Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1			Cervical		DECEASED	46	2012	df428368-b3b0-4e70-b930-2e143645a779	TCGA-VS-A9UY-01	df428368-b3b0-4e70-b930-2e143645a779	TCGA-VS-A9UY-01	TCGA-VS-A9UY-01		TCGA-VS-A9UY-01A-11D-A42P-05		df428368-b3b0-4e70-b930-2e143645a779					df428368-b3b0-4e70-b930-2e143645a779	TCGA-VS-A9UY-01A-11D-A42N-01	TCGA-VS-A9UY-01	TCGA-VS-A9UY-01A-11D-A42N-01
TCGA-VS-A9UZ-01	TCGA-VS-A9UZ-01	TCGA-VS-A9UZ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		61				TCGA-VS-A9UZ-F68142	TCGA-VS-A9UZ	TCGA-VS-A9UZ-01A	Never Used		3600		HDR								Stage IB1		-22344					1723					0	2044																	2014-11-13	FEMALE	149	Mucinous Adenocarcinoma of Endocervical Type	No					Wertheim Meiggs	Other	C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO	26				Peri (6-12 months since last menstrual period)	G2							NO	0		4		false			No	MX	N0	T1b	TCGA-VS-A9UZ.F340AC28-F1AC-4AC3-9C7D-CAC4F3EE04E5.pdf				A9UZ				TUMOR FREE	NO		YES	Complete Remission/Response	YES							Primary Tumor	01			2009	NO	NO	YES	VS	1	4		Cervical	A	LIVING	54	2009	56ec376d-abc2-4bcd-87d2-cf10141ab979	TCGA-VS-A9UZ-01	56ec376d-abc2-4bcd-87d2-cf10141ab979	TCGA-VS-A9UZ-01	TCGA-VS-A9UZ-01		TCGA-VS-A9UZ-01A-11D-A42P-05		56ec376d-abc2-4bcd-87d2-cf10141ab979					56ec376d-abc2-4bcd-87d2-cf10141ab979	TCGA-VS-A9UZ-01A-11D-A42N-01	TCGA-VS-A9UZ-01	TCGA-VS-A9UZ-01A-11D-A42N-01
TCGA-VS-A9V0-01	TCGA-VS-A9V0-01	TCGA-VS-A9V0	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		58	27	4	Follow up	TCGA-VS-A9V0-F67690	TCGA-VS-A9V0	TCGA-VS-A9V0-01A	Never Used		2800		HDR							Cisplatin	Stage IB		-21215					264					0	573			551						Once weekly	1							2014-11-9	FEMALE	158	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			7	4.5	false			No	MX	NX	T1b	TCGA-VS-A9V0.98E32BD3-DB7B-4E70-B254-19A5CC29B4D3.pdf				A9V0			Other	WITH TUMOR	YES			Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01		2012	2009	YES	NO	YES	VS	4	7		Cervical	A	LIVING	76	2013	b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	TCGA-VS-A9V0-01	b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	TCGA-VS-A9V0-01	TCGA-VS-A9V0-01	46F8B610-944B-4BA8-A595-83B0EB4C4614	TCGA-VS-A9V0-01A-11D-A42P-05		b6c90737-2ec8-46e6-801a-7e64ba2b5b0b					b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	TCGA-VS-A9V0-01A-11D-A42N-01	TCGA-VS-A9V0-01	TCGA-VS-A9V0-01A-11D-A42N-01
TCGA-VS-A9V1-01	TCGA-VS-A9V1-01	TCGA-VS-A9V1	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					46	24	5			TCGA-VS-A9V1	TCGA-VS-A9V1-01A	Never Used											Cisplatin	Stage IVB		-17001					217	157				0										Once weekly								2014-9-5	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES			3	2.4	false			No	MX	NX	T3b	TCGA-VS-A9V1.BC3B49BB-004C-4079-B1A2-97B74891BFD6.pdf	Cervical Cancer			A9V1	1			WITH TUMOR	YES			Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	2	4		Cervical	A	DECEASED	45	2013	7d481f46-fd01-47ce-b321-39240129af48	TCGA-VS-A9V1-01	7d481f46-fd01-47ce-b321-39240129af48	TCGA-VS-A9V1-01	TCGA-VS-A9V1-01		TCGA-VS-A9V1-01A-11D-A42P-05		7d481f46-fd01-47ce-b321-39240129af48					7d481f46-fd01-47ce-b321-39240129af48	TCGA-VS-A9V1-01A-11D-A42N-01	TCGA-VS-A9V1-01	TCGA-VS-A9V1-01A-11D-A42N-01
TCGA-VS-A9V2-01	TCGA-VS-A9V2-01	TCGA-VS-A9V2	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		29				TCGA-VS-A9V2-F70886	TCGA-VS-A9V2	TCGA-VS-A9V2-01A	Never Used												Stage IB1		-10637					119					0	555			-1							1							2015-3-10	FEMALE	156	Cervical Squamous Cell Carcinoma	No					Wertheim Meiggs	Other	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO		NO	26				Peri (6-12 months since last menstrual period)	G2							NO	0	0	2		false			No	MX	N0	T1b	TCGA-VS-A9V2.0D5FE178-46D8-41A5-BA54-E9746F3D2B4C.pdf				A9V2			Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	1	2		Cervical	A	LIVING	49	2013	8cdfa086-9681-4b94-98c7-855d713cd877	TCGA-VS-A9V2-01	8cdfa086-9681-4b94-98c7-855d713cd877	TCGA-VS-A9V2-01	TCGA-VS-A9V2-01		TCGA-VS-A9V2-01A-11D-A42P-05		8cdfa086-9681-4b94-98c7-855d713cd877					8cdfa086-9681-4b94-98c7-855d713cd877	TCGA-VS-A9V2-01A-11D-A42N-01	TCGA-VS-A9V2-01	TCGA-VS-A9V2-01A-11D-A42N-01
TCGA-VS-A9V3-01	TCGA-VS-A9V3-01	TCGA-VS-A9V3	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix	NO	NO	Stable Disease		62		6		TCGA-VS-A9V3-F70883	TCGA-VS-A9V3	TCGA-VS-A9V3-01A	Former User		2600		HDR							Cisplatin	Stage IVB		-22990					125					0	540		601	-2						Once weekly	1							2015-3-10	FEMALE	164	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO						G3	Other, specify			Distant Metastasis	Supraclavicular lymph nodes	NO	YES					false			No	MX	NX	T4	TCGA-VS-A9V3.DCCE7881-D3D1-4DCF-875F-94E83F51D5E2.pdf				A9V3			Pre-Adjuvant Therapy	WITH TUMOR	YES			Complete Remission/Response	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	0		Cervical	A	LIVING	60	2013	11c5127d-0115-4149-8304-1556e175d0ba	TCGA-VS-A9V3-01	11c5127d-0115-4149-8304-1556e175d0ba	TCGA-VS-A9V3-01	TCGA-VS-A9V3-01		TCGA-VS-A9V3-01A-11D-A42P-05		11c5127d-0115-4149-8304-1556e175d0ba					11c5127d-0115-4149-8304-1556e175d0ba	TCGA-VS-A9V3-01A-11D-A42N-01	TCGA-VS-A9V3-01	TCGA-VS-A9V3-01A-11D-A42N-01
TCGA-VS-A9V4-01	TCGA-VS-A9V4-01	TCGA-VS-A9V4	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					63	15	4			TCGA-VS-A9V4													Cisplatin	Stage IVA		-23334						132				0				-1						Once weekly	2							2014-10-1	FEMALE	161	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							YES			3	30				Yes	MX	NX	T4		Cervical Cancer			A9V4			Pre-Adjuvant Therapy	WITH TUMOR	YES				YES					3D conformal	4500	Primary Tumor	01		2013	2009	YES	NO	YES	VS	4	3		Cervical		DECEASED	52	2013	a4e4724d-bd99-4c46-9130-e34a89c3ef7b	TCGA-VS-A9V4-01	a4e4724d-bd99-4c46-9130-e34a89c3ef7b	TCGA-VS-A9V4-01	TCGA-VS-A9V4-01		TCGA-VS-A9V4-01A-12D-A42P-05		a4e4724d-bd99-4c46-9130-e34a89c3ef7b					a4e4724d-bd99-4c46-9130-e34a89c3ef7b	TCGA-VS-A9V4-01A-12D-A42N-01	TCGA-VS-A9V4-01	TCGA-VS-A9V4-01A-12D-A42N-01
TCGA-VS-A9V5-01	TCGA-VS-A9V5-01	TCGA-VS-A9V5	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					50		6			TCGA-VS-A9V5	TCGA-VS-A9V5-01A	Never Used											Carboplatin	Stage IIB		-18577					1019	494				0				0						Once weekly	1							2014-10-1	FEMALE	157	Mucinous Adenocarcinoma of Endocervical Type	No							C53.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			1		false			No	MX	NX	T2b	TCGA-VS-A9V5.3EF810E0-17D2-4D40-9D81-29D896915C92.pdf				A9V5			Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	1	1		Cervical	A	DECEASED	98	2011	288f90b8-5be8-4077-b578-62b80b14f0c0	TCGA-VS-A9V5-01	288f90b8-5be8-4077-b578-62b80b14f0c0	TCGA-VS-A9V5-01	TCGA-VS-A9V5-01		TCGA-VS-A9V5-01A-11D-A42P-05		288f90b8-5be8-4077-b578-62b80b14f0c0					288f90b8-5be8-4077-b578-62b80b14f0c0	TCGA-VS-A9V5-01A-11D-A42N-01	TCGA-VS-A9V5-01	TCGA-VS-A9V5-01A-11D-A42N-01
TCGA-VS-AA62-01	TCGA-VS-AA62-01	TCGA-VS-AA62	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					51		5			TCGA-VS-AA62		Current User		2800		HDR							Cisplatin	Stage IIB		-18792						469				0				-1						Once weekly	0							2014-11-13	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Peri (6-12 months since last menstrual period)	G2							NO			4					No	MX	NX	T2b		Cervical Cancer			AA62			Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	1	4		Cervical		DECEASED	67	2009	be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	TCGA-VS-AA62-01	be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	TCGA-VS-AA62-01	TCGA-VS-AA62-01		TCGA-VS-AA62-01A-11D-A42P-05		be0d33e0-2aa6-48bb-b8e3-69259e28f8e3					be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	TCGA-VS-AA62-01A-11D-A42N-01	TCGA-VS-AA62-01	TCGA-VS-AA62-01A-11D-A42N-01
TCGA-WL-A834-01	TCGA-WL-A834-01	TCGA-WL-A834	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix			Complete Response		57	43			TCGA-WL-A834-F66179	TCGA-WL-A834	TCGA-WL-A834-01A	Former User								Microscopic parametrial involvement											414		0	0		0	791			791				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		1							2014-10-3	FEMALE	162	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma	NO	28	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	4		2	6.5	false			No		N1	T1b1	TCGA-WL-A834.BADCCC27-5838-469E-97AC-FADBE3757376.pdf				A834			Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Partial Remission/Response	YES							Primary Tumor	01		2012		YES	NO	YES	WL	4	3		Cervical	A	LIVING	79	2012	0d138b3f-4212-47cf-a65e-fc1cbf618e99	TCGA-WL-A834-01	0d138b3f-4212-47cf-a65e-fc1cbf618e99	TCGA-WL-A834-01	TCGA-WL-A834-01	D8E06BD2-30E2-48A5-B1CD-4F056E6CB193	TCGA-WL-A834-01A-11D-A357-05	TCGA-WL-A834-01A-11D-A351-09	0d138b3f-4212-47cf-a65e-fc1cbf618e99			TCGA-WL-A834-01A-11D-A351-09	TCGA-WL-A834-01A-11D-A351-09	0d138b3f-4212-47cf-a65e-fc1cbf618e99	TCGA-WL-A834-01A-11D-A350-01	TCGA-WL-A834-01	TCGA-WL-A834-01A-11D-A350-01
TCGA-XS-A8TJ-01	TCGA-XS-A8TJ-01	TCGA-XS-A8TJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					41		1			TCGA-XS-A8TJ	TCGA-XS-A8TJ-01A	Former User					ABSENT		FREE MARGINS	Other Location, specify		Participant refusal	Cisplatin	Stage IB1		-15298					642					0	890			0						Once weekly	0	1						2014-7-28	FEMALE	146	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma		20	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	5	0	1		true			No	M0	N1	T1b1	TCGA-XS-A8TJ.C8BBFFAA-4A45-44D3-921B-6F2BD8DB5B19.pdf				A8TJ			Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	YES	Participant refusal						Primary Tumor	01			2009	YES	YES	NO	XS	5	2		Cervical	A	LIVING	51	2012	7f3a2afd-ef8e-4035-8fec-8dab2b53672c	TCGA-XS-A8TJ-01	7f3a2afd-ef8e-4035-8fec-8dab2b53672c	TCGA-XS-A8TJ-01	TCGA-XS-A8TJ-01		TCGA-XS-A8TJ-01A-11D-A36K-05		7f3a2afd-ef8e-4035-8fec-8dab2b53672c					7f3a2afd-ef8e-4035-8fec-8dab2b53672c	TCGA-XS-A8TJ-01A-11D-A36I-01	TCGA-XS-A8TJ-01	TCGA-XS-A8TJ-01A-11D-A36I-01
TCGA-ZJ-A8QO-01	TCGA-ZJ-A8QO-01	TCGA-ZJ-A8QO	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					73					TCGA-ZJ-A8QO	TCGA-ZJ-A8QO-01A															-26723					2261					0	0																	2014-12-19	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO	Non-keratinizing squamous cell carcinoma																			true			No				TCGA-ZJ-A8QO.F1113E49-016E-4D32-86C3-2620C9839F2E.pdf				A8QO																Primary Tumor	01					NO	YES	ZJ				Cervical	A	LIVING		2007	acb24854-1e1a-4de8-a52f-f0c742cb82a1	TCGA-ZJ-A8QO-01	acb24854-1e1a-4de8-a52f-f0c742cb82a1	TCGA-ZJ-A8QO-01	TCGA-ZJ-A8QO-01	D29EE792-E846-4EF2-A5EB-EB3C44AACD84	TCGA-ZJ-A8QO-01A-11D-A37Q-05		acb24854-1e1a-4de8-a52f-f0c742cb82a1					acb24854-1e1a-4de8-a52f-f0c742cb82a1	TCGA-ZJ-A8QO-01A-11D-A37M-01	TCGA-ZJ-A8QO-01	TCGA-ZJ-A8QO-01A-11D-A37M-01
TCGA-ZJ-A8QQ-01	TCGA-ZJ-A8QQ-01	TCGA-ZJ-A8QQ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					24	11	6			TCGA-ZJ-A8QQ		Never Used		3000		HDR							Cisplatin	Stage IIB	40mg/m2	-8918										0	2056			845						Once weekly	0							2014-2-25	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO				20				No	M0	N0	T1b2					A8QQ			Preoperative	TUMOR FREE	YES		NO	Complete Remission/Response	YES							Primary Tumor	01			1995	YES	NO	YES	ZJ	2	0		Cervical		LIVING	71	2007	aefd1510-484d-43c7-ab67-931b1e7406fa	TCGA-ZJ-A8QQ-01	aefd1510-484d-43c7-ab67-931b1e7406fa	TCGA-ZJ-A8QQ-01	TCGA-ZJ-A8QQ-01		TCGA-ZJ-A8QQ-01A-11D-A37Q-05		aefd1510-484d-43c7-ab67-931b1e7406fa					aefd1510-484d-43c7-ab67-931b1e7406fa	TCGA-ZJ-A8QQ-01A-11D-A37M-01	TCGA-ZJ-A8QQ-01	TCGA-ZJ-A8QQ-01A-11D-A37M-01
TCGA-ZJ-A8QR-01	TCGA-ZJ-A8QR-01	TCGA-ZJ-A8QR	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					38	36				TCGA-ZJ-A8QR	TCGA-ZJ-A8QR-01A													Stage I		-14225					2173	582				0				-2							0							2014-2-25	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	840	NO	Keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO				0.4	true			No	MX	NX	TX	TCGA-ZJ-A8QR.0C8716BD-1A48-4392-9F40-6A5C04FA8004.pdf				A8QR			Preoperative				NO									Primary Tumor	01		2009	2009		NO	YES	ZJ	2			Cervical	A	DECEASED	58	2007	5ad0c6f5-9be9-46f2-a705-fb9c616464ae	TCGA-ZJ-A8QR-01	5ad0c6f5-9be9-46f2-a705-fb9c616464ae	TCGA-ZJ-A8QR-01	TCGA-ZJ-A8QR-01	8C2F3F49-6B5E-481A-8DAB-346D97893907	TCGA-ZJ-A8QR-01A-11D-A37Q-05		5ad0c6f5-9be9-46f2-a705-fb9c616464ae					5ad0c6f5-9be9-46f2-a705-fb9c616464ae	TCGA-ZJ-A8QR-01A-11D-A37M-01	TCGA-ZJ-A8QR-01	TCGA-ZJ-A8QR-01A-11D-A37M-01
TCGA-ZJ-AAX4-01	TCGA-ZJ-AAX4-01	TCGA-ZJ-AAX4	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					85	23				TCGA-ZJ-AAX4		Never Used								Positive vaginal margin				Stage II		-31258										0	21																	2014-12-19	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma		26			PRESENT		G3								0	0	3	.57				Yes	M0	N0	T2					AAX4							YES									Primary Tumor	01		1949	2009		NO	YES	ZJ	4	3		Cervical		LIVING	77	2008	cc3f9a0e-0984-42dc-82bd-965f0c2b6109	TCGA-ZJ-AAX4-01	cc3f9a0e-0984-42dc-82bd-965f0c2b6109	TCGA-ZJ-AAX4-01	TCGA-ZJ-AAX4-01		TCGA-ZJ-AAX4-01A-11D-A42P-05		cc3f9a0e-0984-42dc-82bd-965f0c2b6109					cc3f9a0e-0984-42dc-82bd-965f0c2b6109	TCGA-ZJ-AAX4-01A-11D-A42N-01	TCGA-ZJ-AAX4-01	TCGA-ZJ-AAX4-01A-11D-A42N-01
TCGA-ZJ-AAX8-01	TCGA-ZJ-AAX8-01	TCGA-ZJ-AAX8	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					58					TCGA-ZJ-AAX8	TCGA-ZJ-AAX8-01A													Stage IIIB		-21481					1789					0	0																	2014-12-19	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Non-keratinizing squamous cell carcinoma							G2												true			No	M0	N1	T3b	TCGA-ZJ-AAX8.8CCFD872-3834-4769-A6C6-809E77108BE5.pdf				AAX8							YES									Primary Tumor	01			2009		NO	YES	ZJ				Cervical	A	LIVING		2009	1f431436-f6bd-4f64-81ad-820e11385e94	TCGA-ZJ-AAX8-01	1f431436-f6bd-4f64-81ad-820e11385e94	TCGA-ZJ-AAX8-01	TCGA-ZJ-AAX8-01	41ECD370-91AA-4D24-BF11-EE3BD9A84619	TCGA-ZJ-AAX8-01A-11D-A42P-05		1f431436-f6bd-4f64-81ad-820e11385e94					1f431436-f6bd-4f64-81ad-820e11385e94	TCGA-ZJ-AAX8-01A-11D-A42N-01	TCGA-ZJ-AAX8-01	TCGA-ZJ-AAX8-01A-11D-A42N-01
TCGA-ZJ-AAXA-01	TCGA-ZJ-AAXA-01	TCGA-ZJ-AAXA	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					64	18				TCGA-ZJ-AAXA	TCGA-ZJ-AAXA-01A													Stage IB1		-23603					1479					0	43																	2014-12-30	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	140	NO	Non-keratinizing squamous cell carcinoma							G2										4	26	true			No	MX	N0	T1b	TCGA-ZJ-AAXA.01EB0759-6676-494E-9044-263629A7BD93.pdf				AAXA																Primary Tumor	01		1989	2009		NO	YES	ZJ	3	4		Cervical	A	LIVING	78	2009	38d23f3a-0380-4759-930f-bdcb89a4eafe	TCGA-ZJ-AAXA-01	38d23f3a-0380-4759-930f-bdcb89a4eafe	TCGA-ZJ-AAXA-01	TCGA-ZJ-AAXA-01	6EE028AB-9CE6-46AD-8B4E-488E38706EDF	TCGA-ZJ-AAXA-01A-11D-A42P-05		38d23f3a-0380-4759-930f-bdcb89a4eafe					38d23f3a-0380-4759-930f-bdcb89a4eafe	TCGA-ZJ-AAXA-01A-11D-A42N-01	TCGA-ZJ-AAXA-01	TCGA-ZJ-AAXA-01A-11D-A42N-01
TCGA-ZJ-AAXB-01	TCGA-ZJ-AAXB-01	TCGA-ZJ-AAXB	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					42					TCGA-ZJ-AAXB	TCGA-ZJ-AAXB-01A													Stage IB2		-15492					1591					0	0																	2014-12-31	FEMALE	163	Endocervical Adenocarcinoma of the Usual Type	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO								G3										3		true			No	M0	N0	T1b2	TCGA-ZJ-AAXB.AB550C0A-6FE6-4D92-A5E3-A7141A32CC26.pdf				AAXB																Primary Tumor	01			2009		NO	YES	ZJ	1	3		Cervical	A	LIVING	97	2009	aa304440-f222-41d7-8ced-7387a8ac4ea3	TCGA-ZJ-AAXB-01	aa304440-f222-41d7-8ced-7387a8ac4ea3	TCGA-ZJ-AAXB-01	TCGA-ZJ-AAXB-01	BE8443E8-A912-4790-A922-DE3D5D97B398	TCGA-ZJ-AAXB-01A-11D-A42P-05		aa304440-f222-41d7-8ced-7387a8ac4ea3					aa304440-f222-41d7-8ced-7387a8ac4ea3	TCGA-ZJ-AAXB-01A-11D-A42N-01	TCGA-ZJ-AAXB-01	TCGA-ZJ-AAXB-01A-11D-A42N-01
TCGA-ZJ-AAXD-01	TCGA-ZJ-AAXD-01	TCGA-ZJ-AAXD	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					35					TCGA-ZJ-AAXD	TCGA-ZJ-AAXD-01A													Stage IIIB		-12968					1164					0	0																	2014-12-30	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma							G2												true			No	M0	N0	T3b	TCGA-ZJ-AAXD.AAEBC293-E409-4B14-9310-6820BA844EE6.pdf				AAXD																Primary Tumor	01			2009		NO	YES	ZJ				Cervical	A	LIVING		2010	fc9e612c-8909-47de-b6f0-8691d5bc67c5	TCGA-ZJ-AAXD-01	fc9e612c-8909-47de-b6f0-8691d5bc67c5	TCGA-ZJ-AAXD-01	TCGA-ZJ-AAXD-01	D459FFAC-DA2A-48F3-AE6F-FB3205338C3E	TCGA-ZJ-AAXD-01A-21D-A42P-05		fc9e612c-8909-47de-b6f0-8691d5bc67c5					fc9e612c-8909-47de-b6f0-8691d5bc67c5	TCGA-ZJ-AAXD-01A-21D-A42N-01	TCGA-ZJ-AAXD-01	TCGA-ZJ-AAXD-01A-21D-A42N-01
TCGA-ZJ-AAXF-01	TCGA-ZJ-AAXF-01	TCGA-ZJ-AAXF	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					62					TCGA-ZJ-AAXF	TCGA-ZJ-AAXF-01A													Stage IIB		-22709					1264					0	0																	2015-1-28	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	270	NO	Keratinizing squamous cell carcinoma							G3												true			No	M0	N0	T2b	TCGA-ZJ-AAXF.DB279590-B849-44D4-B781-BA72CE72C427.pdf				AAXF																Primary Tumor	01			2009		NO	YES	ZJ				Cervical	A	LIVING		2010	48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	TCGA-ZJ-AAXF-01	48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	TCGA-ZJ-AAXF-01	TCGA-ZJ-AAXF-01	AFA27E8B-A438-4D1A-9344-6E760E7A890F	TCGA-ZJ-AAXF-01A-31D-A42P-05		48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834					48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	TCGA-ZJ-AAXF-01A-31D-A42N-01	TCGA-ZJ-AAXF-01	TCGA-ZJ-AAXF-01A-31D-A42N-01
TCGA-ZJ-AAXI-01	TCGA-ZJ-AAXI-01	TCGA-ZJ-AAXI	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					67					TCGA-ZJ-AAXI														Stage IIB		-24497										0	0																	2014-12-31	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma							G2															No	M0	NX	T2b					AAXI																Primary Tumor	01			2009		NO	YES	ZJ				Cervical		LIVING		2010		TCGA-ZJ-AAXI-01		TCGA-ZJ-AAXI-01	TCGA-ZJ-AAXI-01		TCGA-ZJ-AAXI-01A-11D-A42P-05								TCGA-ZJ-AAXI-01A-11D-A42N-01	TCGA-ZJ-AAXI-01	TCGA-ZJ-AAXI-01A-11D-A42N-01
TCGA-ZJ-AAXJ-01	TCGA-ZJ-AAXJ-01	TCGA-ZJ-AAXJ	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					43					TCGA-ZJ-AAXJ														Stage IIB		-16007										0	0																	2014-12-31	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Keratinizing squamous cell carcinoma																						No	MX	N0	T2b					AAXJ																Primary Tumor	01			2009		NO	YES	ZJ				Cervical		LIVING		2010	ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	TCGA-ZJ-AAXJ-01	ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	TCGA-ZJ-AAXJ-01	TCGA-ZJ-AAXJ-01		TCGA-ZJ-AAXJ-01A-11D-A42P-05		ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4					ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	TCGA-ZJ-AAXJ-01A-11D-A42N-01	TCGA-ZJ-AAXJ-01	TCGA-ZJ-AAXJ-01A-11D-A42N-01
TCGA-ZJ-AAXN-01	TCGA-ZJ-AAXN-01	TCGA-ZJ-AAXN	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					34	21				TCGA-ZJ-AAXN	TCGA-ZJ-AAXN-01A													Stage IB2		-12701					1190					0	0																	2014-12-31	FEMALE	173	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	250	NO	Non-keratinizing squamous cell carcinoma																	1	2.1	true			No	M0	N1	T1b2	TCGA-ZJ-AAXN.33662E91-6459-47D9-858A-243D8E54EB63.pdf				AAXN																Primary Tumor	01			2009		NO	YES	ZJ	2	1		Cervical	A	LIVING	59	2010	878b8551-fb42-48bc-9403-178c568372cd	TCGA-ZJ-AAXN-01	878b8551-fb42-48bc-9403-178c568372cd	TCGA-ZJ-AAXN-01	TCGA-ZJ-AAXN-01	41D2098E-6DAA-424E-9FFB-24A6C1D89A13	TCGA-ZJ-AAXN-01A-11D-A42P-05		878b8551-fb42-48bc-9403-178c568372cd					878b8551-fb42-48bc-9403-178c568372cd	TCGA-ZJ-AAXN-01A-11D-A42N-01	TCGA-ZJ-AAXN-01	TCGA-ZJ-AAXN-01A-11D-A42N-01
TCGA-ZJ-AAXT-01	TCGA-ZJ-AAXT-01	TCGA-ZJ-AAXT	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					54	20				TCGA-ZJ-AAXT	TCGA-ZJ-AAXT-01A													Stage IIIB		-19847					1571					0	0																	2014-12-31	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma							G2										3	0.2	true			No	M0	N1	T3b	TCGA-ZJ-AAXT.963154F2-CBB5-4556-B94D-3E2977CBB3D7.pdf				AAXT																Primary Tumor	01		1982	2009		NO	YES	ZJ	4	3		Cervical	A	LIVING	76	2009	2e6fd34c-eccc-42a2-a806-bf69f55c0b27	TCGA-ZJ-AAXT-01	2e6fd34c-eccc-42a2-a806-bf69f55c0b27	TCGA-ZJ-AAXT-01	TCGA-ZJ-AAXT-01		TCGA-ZJ-AAXT-01A-11D-A42P-05		2e6fd34c-eccc-42a2-a806-bf69f55c0b27					2e6fd34c-eccc-42a2-a806-bf69f55c0b27	TCGA-ZJ-AAXT-01A-11D-A42N-01	TCGA-ZJ-AAXT-01	TCGA-ZJ-AAXT-01A-11D-A42N-01
TCGA-ZJ-AAXU-01	TCGA-ZJ-AAXU-01	TCGA-ZJ-AAXU	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					51	15				TCGA-ZJ-AAXU	TCGA-ZJ-AAXU-01A													Stage IIB		-18773					1437					0	5																	2014-12-19	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma							G2											52.86	true			No	M0	N0	T2b	TCGA-ZJ-AAXU.6A8C28EF-7774-492D-99D0-C197662699AE.pdf				AAXU																Primary Tumor	01			2009		NO	YES	ZJ	2	0		Cervical	A	LIVING	70	2010	39dc6ace-24eb-499b-ad94-64cf08849087	TCGA-ZJ-AAXU-01	39dc6ace-24eb-499b-ad94-64cf08849087	TCGA-ZJ-AAXU-01	TCGA-ZJ-AAXU-01		TCGA-ZJ-AAXU-01A-11D-A42P-05		39dc6ace-24eb-499b-ad94-64cf08849087					39dc6ace-24eb-499b-ad94-64cf08849087	TCGA-ZJ-AAXU-01A-11D-A42N-01	TCGA-ZJ-AAXU-01	TCGA-ZJ-AAXU-01A-11D-A42N-01
TCGA-ZJ-AB0H-01	TCGA-ZJ-AB0H-01	TCGA-ZJ-AB0H	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					48					TCGA-ZJ-AB0H														Stage IIIB		-17869										0	0																	2014-12-19	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma																						No	M0	N1	T3b					AB0H							YES									Primary Tumor	01			2009		NO	YES	ZJ				Cervical		LIVING		2006	ad34a739-074f-4463-b053-d1368c4d34db	TCGA-ZJ-AB0H-01	ad34a739-074f-4463-b053-d1368c4d34db	TCGA-ZJ-AB0H-01	TCGA-ZJ-AB0H-01		TCGA-ZJ-AB0H-01A-11D-A42P-05		ad34a739-074f-4463-b053-d1368c4d34db					ad34a739-074f-4463-b053-d1368c4d34db	TCGA-ZJ-AB0H-01A-11D-A42N-01	TCGA-ZJ-AB0H-01	TCGA-ZJ-AB0H-01A-11D-A42N-01
TCGA-ZJ-AB0I-01	TCGA-ZJ-AB0I-01	TCGA-ZJ-AB0I	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					25	13				TCGA-ZJ-AB0I	TCGA-ZJ-AB0I-01A	Never Used												Stage IIB		-9486					2643					0	0																	2014-12-19	FEMALE	173	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO	Keratinizing squamous cell carcinoma																	4	13	true			No	MX	N1	T2b	TCGA-ZJ-AB0I.77538CA6-8ACB-4224-BF03-DC7A4BABCEF7.pdf				AB0I							YES									Primary Tumor	01		2006	1995		NO	YES	ZJ	4	4		Cervical	A	LIVING	78	2006	f77f995c-4e18-4803-a703-8f3aee49837b	TCGA-ZJ-AB0I-01	f77f995c-4e18-4803-a703-8f3aee49837b	TCGA-ZJ-AB0I-01	TCGA-ZJ-AB0I-01	C9EB2866-AF28-4560-95FB-CF546AEDDD83	TCGA-ZJ-AB0I-01A-11D-A42P-05		f77f995c-4e18-4803-a703-8f3aee49837b					f77f995c-4e18-4803-a703-8f3aee49837b	TCGA-ZJ-AB0I-01A-11D-A42N-01	TCGA-ZJ-AB0I-01	TCGA-ZJ-AB0I-01A-11D-A42N-01
TCGA-ZX-AA5X-01	TCGA-ZX-AA5X-01	TCGA-ZX-AA5X	TCGA Cervical Cancer (CESC)	cervical & endocervical cancer	Cervix					64				TCGA-ZX-AA5X-F69357	TCGA-ZX-AA5X	TCGA-ZX-AA5X-01A							Bilateral pelvic wall involvement on imaging				Participant refusal		Stage IIIB		-23440					46		-2		52	0	119			7				Bladder Present|			1	0			|Extra-Pelvic Metastatic Disease AbsentParaaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2015-1-7	FEMALE	157	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Non-keratinizing squamous cell carcinoma	YES				ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										2		true			No	MX	NX	TX	TCGA-ZX-AA5X.AFCAEB29-0F3E-48E6-8F0D-92860BCF0640.pdf		Other, specify	Positive for Hepatitis A	AA5X	0	0	Pre-Adjuvant Therapy	WITH TUMOR		0	NO			Participant refusal						Primary Tumor	01	15.8		2009	NO	YES	NO	ZX	1	2		Cervical	A	LIVING	56	2013	212eae3c-4ad5-48e0-90af-b6fe1dfc5554	TCGA-ZX-AA5X-01	212eae3c-4ad5-48e0-90af-b6fe1dfc5554	TCGA-ZX-AA5X-01	TCGA-ZX-AA5X-01		TCGA-ZX-AA5X-01A-11D-A42P-05		212eae3c-4ad5-48e0-90af-b6fe1dfc5554					212eae3c-4ad5-48e0-90af-b6fe1dfc5554	TCGA-ZX-AA5X-01A-11D-A42N-01	TCGA-ZX-AA5X-01	TCGA-ZX-AA5X-01A-11D-A42N-01